BDSPPatientID,annot,y_pred,NoteContent
119906019,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Surrogate Decision ***** Name: ***** *****            Care Plan *****: ***** *****       Code Status at *****: Full Code (Presumed)       Discharge address same as *****: No                   Hospitalization Summary     Admission Diagnosis     Hydrocephalus [*****.9]               Principal Problem:    Hydrocephalus  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** Placement Shunt Ventricular Peritoneal *****, ***** *****              ***** this Admission     Procedure/Test Authorizing Provider    IR IVC ***** Placement ***** ***** *****, MD        Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    Patient should hold ASA 1 week, and follow up with Vascular medicine to restart Coumadin. No need to restart the Plavix.     Patient will follow up with vascular medicine in 4-6 weeks for anticoagulation management.     Patient should be seen within 1-2 weeks for suture removal with Dr. *****.           Pending Results     Procedure Component Value Ref Range Date/Time    Culture with Gram stain, CSF [*****] Collected:  *****/*****/***** 1712    Lab Status:  Preliminary result Specimen:  Cerebrospinal Fluid from ***** ***** *****:  *****/*****/***** 0752     Specimen Source/ Description CSF CSF     SPECIAL REQUESTS None     GRAM STAIN Rare *****     GRAM STAIN NO EPITHELIAL CELLS     GRAM STAIN NO ORGANISMS SEEN    
 CULTURE / TEST NO GROWTH 4 DAYS     REPORT STATUS PENDING           Hospital Course   ***** PREVIOUSLY on ASA/Plavix for PVD (Left ***** open bypass 2010 in ***** - by pt report), and coumadin for DVT of the left leg (2 years ago) found to have INR 4.2 with ***** taken for emergent OR for R SDH evac on the day of direct transfer *****/*****/*****. Postop he was taken back the same day emergently for evacuation of R IPH for a venous infarct. His hospital course was complicated seizures for which he was put on keppra 750BID. ASA/Plavix was held for 1 month postop.     Now he returns for Right sided Headaches persisting since surgery, *****, imaging . Head CT shows resolving postop changes and stable subdural collections without acute hemorrhage. However, it also shows enlarged ventricles compared to his postop CTA on *****/*****/***** (which, of note showed IVH) that could potentially represent developing communicating hydrocephalus. Patient was admitted under the care of Dr. ***** for a VPS placement on *****/*****/*****.      Patient was admitted to the Neurosurgical Service on *****/*****/*****  for a ***** shunt placement with Dr. *****.  Patient was taken to the operating room on the day of admission and underwent an uncomplicated procedure. Please see Dr. *****'s separately dictated operative note for details. Post-operatively patient was extubated and transferred to the Neurosurgical ICU for close monitoring. He remained hemodynamically stable, neurologically at baseline, and with his pain well-controlled throughout his hospital stay. On POD#1 he was transferred to the floor in stable condition and was deemed ready for discharge on Post Op Day #3 to Rehab.    NEURO: Patient remained neurologically at baseline throughout his hospital stay. A+O x 3, EOMI, PERRL, FS, TM, sensation grossly intact, LLE *****/*****, ***** 4+/5, which is stable from preop, no drift. Post op imaging showed no complications over surgical regions.  He will continue 
home dose of Keppra 1,500 BID, and Vimpat ***** *****.     CV: Hemodynamically stable at all times.    RESP: Patient became hypoxic on POD#2, and had new O2 requirement, He was sent for lower extremity ultrasound and CT PE which was positive for L proximal peroneal DVT and PE.      GU: Voiding on his own after foley removed with no signs of retention or UTI.    GI: Tolerating a regular diet with no nausea or vomiting.    HEME: SQH and SCDs for DVT prophylaxis. He Received IVC filter on *****/*****/***** for DVT/PE found postop. Should hold ASA 1 week, and follow up with Vascular medicine to restart Coumadin. No need to restart the Plavix.     ID: ***** at all times. Perioperative ABX. Incision remained clean, dry, and intact with no evidence of erythema, warmth, or hematoma.    *****: Ambulating on his own and feels ready to go home with no services needed. At the time of discharge his pain remained well controlled on oral medications. Patient will follow up with Dr. ***** in 1-2 weeks.           Medications   Allergies: Review of patient's allergies indicates no known allergies.    Prior to Admission Medications   Prescriptions   FLUoxetine (PROZAC) 20 MG capsule   Sig: Take 1 capsule (20 mg total) by mouth daily.   MENTHOL (***** COLD THERAPY *****)   Sig: by Topical (*****) route 3 (three) times a day as needed. Apply moderate amount to neck and lumbar spine for ***** pain   QUEtiapine (SEROQUEL) 25 MG tablet   Sig: Take 25 mg by mouth nightly. 12.***** *****   aluminum-magnesium hydroxide-simethicone (MAALOX) *****-*****-***** mg/5 mL Susp   Sig: Take 30 mL by mouth every 4 (four) hours as needed.   bisacodyl (DULCOLAX) 10 mg suppository   Sig: Place 10 mg rectally daily as needed.   docusate sodium (COLACE) 100 MG capsule   Sig: Take 100 mg by mouth 2 (two) times a day as needed for constipation.   lacosamide (VIMPAT) 100 mg Tab   Sig: Take 1 tablet (100 mg total) by mouth 2 (two) times a day.   levETIRAcetam (KEPPRA) 750 MG 
tablet   Sig: Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   magnesium hydroxide (MOM) 400 mg/5 mL Susp   Sig: Take 30 mL by mouth nightly as needed.   oxyCODONE 5 MG immediate release tablet   Sig: Take 1 tablet (5 mg total) by mouth every 6 (six) hours as needed for moderate pain. Partial fill ok at patient request.   senna (SENOKOT) 8.6 mg tablet   Sig: Take 2 tablets by mouth nightly as needed for constipation.   traZODone (DESYREL) 50 MG tablet   Sig: Take 50 mg by mouth nightly as needed.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          oxyCODONE 5 MG immediate release tablet         START taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 4 (four) hours as needed for mild pain or fever.   Last time this was given:  *****/*****/***** 10:59 AM       heparin 5,000 unit/mL injection    Inject 1 mL (5,000 Units total) under the skin every 8 (eight) hours.   Last time this was given:  *****/*****/*****  5:07 AM       traMADol 50 mg tablet   Also known as:  ULTRAM    Take 1 tablet (50 mg total) by mouth every 6 (six) hours as needed.   Last time this was given:  *****/*****/***** 10:59 AM         CONTINUE taking these medications       Dose, Frequency, and Details    aluminum-magnesium hydroxide-simethicone *****-*****-***** mg/5 mL Susp   Also known as:  MAALOX    Take 30 mL by mouth every 4 (four) hours as needed.       ***** COLD THERAPY *****    by Topical (*****) route 3 (three) times a day as needed. Apply moderate amount to neck and lumbar spine for ***** pain       bisacodyl 10 mg suppository   Also known as:  DULCOLAX    Place 10 mg rectally daily as needed.       docusate sodium 100 MG capsule   Also known as:  COLACE    Take 100 mg by mouth 2 (two) times a day as needed for constipation.   Last time this was given:  *****/*****/*****  8:24 
AM       FLUoxetine 20 MG capsule   Also known as:  PROzac    Take 1 capsule (20 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:24 AM       lacosamide 100 mg Tab   Also known as:  VIMPAT    Take 1 tablet (100 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:24 AM       levETIRAcetam 750 MG tablet   Also known as:  KEPPRA    Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:24 AM       magnesium hydroxide 400 mg/5 mL Susp   Also known as:  MOM    Take 30 mL by mouth nightly as needed.       QUEtiapine 25 MG tablet   Also known as:  SEROquel    Take 25 mg by mouth nightly. 12.***** *****   Last time this was given:  *****/*****/***** 11:13 PM       senna 8.6 mg tablet   Also known as:  SENOKOT    Take 2 tablets by mouth nightly as needed for constipation.       traZODone 50 MG tablet   Also known as:  DESYREL    Take 50 mg by mouth nightly as needed.                        Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** *****. *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  8:30 AM *****   NEW PATIENT with ***** ***** *****, MD   ***** Vascular Medicine (--)    ***** ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            ACADEMY ***** ***** ANDOVER   Specialty:  Skilled Nursing Facility    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1248  Activity as tolerated         *****/*****/***** 1248  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1248  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the 
hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1248  Reason for not ordering smoking cessation medication(s)     Question:  Reason for not ordering medication(s):  Answer:  No tobacco cessation medication(s): medically contraindicated  Comment:  Allow for healing of surgical site           Additional Patient Instructions     Please resume all your home medications except blood thinners (no aspirin, motrin, ibuprofen) unless otherwise instructed by your surgeon.  Please take pain medications only as needed for pain. Tylenol in addition to prescribed narcotics may help for severe pain. Please do not drive, operate machinery, or drink alcohol while taking narcotic pain medications.     Please do not lift heavy weights (>20 lbs) for one month. No exercise or strenuous activity until after your follow-up appointment.    Please call Dr. *****'s office to schedule your follow up appointment.  You should be seen within 1-2 weeks for suture removal.      If you need to reach Dr. *****'s office during normal business hours, M-F 8am-5pm, please call the phone numbers listed in this order:  1. *****-*****-***** (Administrative assistant ***** *****)  2. *****-*****-***** (***** *****, *****-C)    If you are unable to reach someone at the above numbers or it is not during business hours please call:  *****-*****-*****, ***** ***** ***** paged, the Neurosurgery resident on call.  If you do not receive a call back from the Neurosurgery resident on call, ***** ***** ***** paged.    Please do not get your incision wet until after sutures are removed at follow-up. It is OK to shower but keep incision dry.  Incision must be covered when showering, and the dressing or shower cap may be removed after showering.    Please call your MD immediately or 
go to the Emergency Department if the following symptoms occur: headaches, neck pain, fever, chills, nausea, vomiting, diarrhea, worsening weakness, numbness, visual changes, chest pain, shortness of breath, or any other symptoms of your concern.    Return to the Emergency Department or see your own doctor right away if any problems develop, including the following:  --Fever >101 F or shaking chills.  --Purulent discharge (pus) from wound, or any increased drainage.  --Increased redness or swelling around the wound.  --Worsening Headache or Neck Stiffness.  --Seizures or any loss of consciousness, dizziness, or fainting.  --Blurry vision, double vision, or eye irritation.  --Nausea or vomiting.  --Chest or back pain, or shortness of breath.    PLEASE REMEMBER: It is OK to shower but do NOT get incision wet.  Incision must be covered when showering and dressing may be removed after showering.  No driving while taking pain medication.  Avoid strenuous activity until follow-up appointment, at least.  Call office or come to ER if: fever>101, increasing pain/headache, increasing nausea/vomiting, signs of wound infection (increasing pain, redness, warmth, swelling, or discharge), new or worsening neurologic deficit, or anything else that is ***** to you. Sutures will be removed in clinic.                           Exam   Temperature: 36.7 C (98 F) (*****/*****/***** 0747) | Heart Rate: 87 (*****/*****/***** 0900) | BP: 98/56 (*****/*****/***** 0747) | Respiratory Rate: 20 (*****/*****/***** 0747)  | SpO2: 90 % (*****/*****/***** 0900)  O2 Device: None (Room air) (off O2) (*****/*****/***** 0900)  O2 Flow Rate (L/min): 3  O2 Flow Rate (mL/min): 6 |        Weight: 65.8 kg (145 lb) (*****/*****/***** 1137)  Height: 167.6 cm (5' 6"") (*****/*****/***** 1137)         BMI (Calculated): 23.4 (*****/*****/***** 1137)    Discharge Exam    Significant Discharge Exam Findings:  Alert, Awake, Oriented to Name, Year, and *****  ***** movements are intact, tongue midline, left nasolabial fold 
flattening  No pronator drift  Right side: full strength  Left side: *****/*****  Incision clean, dry, and intact              Orientation Level: Oriented X7   Cognition: Follows commands         Speech: Clear     Vision: Functional  Hearing: Functional   Assistive Devices: None         Data/Results    Results are shown for the following tests if performed (CBC, Na, K, BUN, Cr).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 11.13 (H) *****/*****/***** *****    HCT 35.2 (L) *****/*****/***** *****    ***** 12.0 (L) *****/*****/***** *****    HGB 11.3 (L) *****/*****/***** *****    PLT 313 *****/*****/***** *****      Lab Results   Component Value Date/Time    BUN 9 *****/*****/***** *****    CRE 0.62 *****/*****/***** *****    ***** 4.5 *****/*****/***** *****    ***** ***** *****/*****/***** *****                            "
120714530,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. female (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): None   Does patient have a Health Care Proxy form completed?: Patient declines      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Full Code     Discharge Order              Discharge Patient        Discharge Disposition: Home or Self Care    Signed by: ***** *****, MD                   Patient/Family/Caregiver discharge preference/goals : Home                            Historical information     Reason for Admission: Falls, syncope  Principal Problem:    Syncope  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    Please refer to boxed items as listed in Hospital Course.       Pending Results     None             Hospital Course   ***** with PSP, ***** on lithium, discoid lupus, migraine, and prior SDH, presenting with a multiple falls c/b head strike, soft tissue contusion of left thigh with hematoma, and ?loss of pulse s/p chest compressions in the ED, admitted for syncope workup.     DISCHARGE SUMMARY    ============================  Hospital Course by Problem:  ============================  # Loss of consciousness  # Recurrent falls  # Progressive supranuclear palsy  History of ***** prior falls c/b SDH x2 most recently in *****/*****. Now presented to ***** ***** on *****/***** after tripping and falling with a *****. Did not lose consciousness or have preceding symptoms. While in ED she developed 
sudden onset nausea and a feeling of warmth and then lost consciousness. Providers could not find a pulse so she received 2 minutes of CPR, although she was not hooked up to any monitors. Subsequently woke up. EKG showed NSR and labs unrevealing (electrolytes and glucose wnl, trop 7>9, tox screen negative) other than elevated prolactin of 204. CTH showed left periorbital soft tissue contusion but no acute intracranial findings. CT C-spine showed no fractures or dislocations. CT CAP notable only for 9.9cm L thigh hematoma. Neurology was consulted. Initial ***** likely mechanical related to PSP and parkinsonism. Syncopal event likely due to vasovagal or orthostatic hypotension from *****. She was evaluated by PT, and orthostatic VS negative for orthostasis. Routine EEG was obtained and was negative for epileptiform activity or seizures. She continued on her home lamotrigine and level was 13 (within range).  [] FOLLOW-UP with neurology, consider MRI brain with contrast    # Incidental pulmonary nodules  [] For a low-risk patient, no routine follow-up is required per ***** criteria. For a high-risk patient, CT in 12 months should be considered.    ============================  Admission History & Physical:  ============================  ***** ***** is a ***** y.o. female with a past medical history of PSP, mild parkinsonism, ***** on lithium, discoid lupus, migraine, and prior subdural hematoma who presents with a ***** concerning for seizure.      On day of presentation, patient came in for outpatient appointment and fell with head strike. She described feeling dizzy upon exiting the ***** when she arrived, and falling in that setting. No palpitations, diaphoresis. She had a brief loss of consciousness for a few seconds. She was transferred to the ED, where she went to fast track, and underwent a CT head/abd/pel scan w/o intracranial bleed or fractures. She was found to have a hematoma of the left thigh.  While in ***** 
*****, she had an episode of nausea, diaphoresis and came down, did not have any urinary incontinence, however she was reported to have lost pulses. CPR was started (15 compressions), transferred to acute, ***** in the 130s, in sinus rhythm, a little confused briefly and did not remember the event. Because of concern for seizure, neurology was consulted and they recommended EEG, however did not have high suspicion for seizure. Deferred MRI.         ED Course:   Initial Vitals: 35.6 째C (96.1 째F) | HR 74 | BP 133/61 | RR 18  | SpO2 97 % on room air. | Weight 66.7 kg (147 lb)     Labs  WBC 12.71, neutrophilic predominance  Hgb 12.8  Cr. 0.77  Prolactin 204  UA negative  Urine tox screen: negative     Imaging  CT head/A/P/spine: No acute infarct, intracranial mass, or hemorrhage. Left periorbital soft tissue contusion. No displaced fracture of the pelvis or left hip. No cervical fractures or dislocation of cervical spine. Soft tissue contusion of the left thigh with an associated subcutaneous hematoma measuring up to 9.9 cm. No focal consolidations to suggest pneumonia     On arrival to the floor, the patient is mentating well, feels overall well. Endorsed the above study. Denied any *****. Endorsed having pain at left thigh at the site of the hematoma. She reports she has had history of falls like these in the past.    ============================  Key Imaging Studies:  ============================    EEG/LTM    Result Date: *****/*****/*****  EEG REPORT Time course of findings is described in the detail.  Epochs are reported from most recent to most remote, top to bottom. *****------------------------------------------------------***** HISTORY/REASON FOR MONITORING:  ***** y.o. female with a history of PSP, *****, discoid lupus, migraine, and prior subdural hematoma who presents with a ***** concerning for seizure. *****------------------------------------------------------***** DETAIL *****------------------------------------------------------***** EPOCH: 
*****/*****/***** ***** to *****/*****/***** ***** MEDICATIONS: Lamotrigine BACKGROUND: The background was continuous with 15-40uV mixed frequency activity and had a good organization with an anterior-posterior gradient and a reactive posterior dominant rhythm of 8-9Hz. There was an occasional subtle loss of faster frequencies with admixed delta activity over the left frontotemporal/anterior temporal region, most notably at F7. Drowsiness was characterized by decreased myogenic artifact, blinking cessation, and increased slowing. Stage II sleep was characterized by K complexes and sleep spindles. SPORADIC DISCHARGES:  None.  PERIODIC OR RHYTHMIC PATTERNS: None. SEIZURES: None. EVENTS: None reported. ARTIFACTS: T4 disconnected. EPOCH     Abnormal EEG due to: 1) Occasional left frontotemporal slowing. No epileptiform discharges or seizures were seen. *****------------------------------------------------------***** EKG: No significant dysrhythmia at ***** of 60-80BPM. *****------------------------------------------------------***** Fellow: ***** ***** *****, MD, ***** *****------------------------------------------------------***** EPOCH: *****/*****/***** 3:11 PM to *****/*****/***** ***** MEDICATIONS: Lamotrigine, Levetiracetam BACKGROUND: The background was continuous with 15-40uV mixed frequency activity and had a good organization with an anterior-posterior gradient and a reactive posterior dominant rhythm of 8-9Hz. There was an occasional subtle loss of faster frequencies with admixed delta activity over the left frontotemporal/anterior temporal region, most notably at F7. Drowsiness was characterized by decreased myogenic artifact, blinking cessation, and increased slowing. Stage II sleep was characterized by K complexes and sleep spindles. SPORADIC DISCHARGES:  None. PERIODIC OR RHYTHMIC PATTERNS: None. SEIZURES: None. EVENTS: None reported. ARTIFACTS: T4 disconnected by 1950. EPOCH IMPRESSION: Abnormal EEG due to: 1) Occasional left frontotemporal slowing. No 
epileptiform discharges or seizures were seen. *****------------------------------------------------------***** EKG: No significant dysrhythmia at ***** of 60-80BPM. *****------------------------------------------------------***** Fellow: ***** ***** *****, MD, MS I ( ) have personally reviewed this EEG recording and edited this report. *****------------------------------------------------------***** METHODOLOGY: Continuous EEG/CCTV, standard *****-***** electrode placement with standard referential & bipolar montages and other montages as needed for manual EEG review; compressed spectral array analysis; & continuous computerized spike and seizure detection. ***** were able to flag the occurrence of subjective or objective behavioral abnormalities. EKG samples were reviewed during each epoch. *****------------------------------------------------------***** ***** ***** ***** USED ABBREVIATIONS & DESCRIPTIVE TERMS: Available through the following link: *****://*****.*****.*****/*****/*****/*****-*****-*****-*****.*****     ***** Chest Portable    Result Date: *****/*****/*****  ***** CHEST PORTABLE  COMPARISON: *****/*****/*****  FINDINGS:  Devices/Tubes/Lines: None.  Lungs: The lungs remain clear  Pleura: Normal. No pleural effusion or pneumothorax.  Heart/Mediastinum: Normal heart and mediastinum.  Bones/Soft Tissues: Normal. No significant skeletal abnormality.      Clear lungs, no evidence pneumothorax.               Medications   Allergies: Benzoin, Codeine, and Penicillins    Prior to Admission Medications   Prescriptions   OLANZapine (ZYPREXA) 7.5 MG tablet   Sig: Take 7.5 mg by mouth nightly at bedtime. And 2.5 prn   botulinum toxin type A (BOTOX) 200 unit SolR   Sig: Dose: 200 UNITS; Form:  Take  1 *****; Route: IM; Frequency: *****; Directions: Not available; Details: Duration: 90 day(s); Dispense: 1 Bottle(s); Date: *****/*****/*****   Note (*****/*****/*****): Needs MD Verification. ***** Med Transfer Process.    cholecalciferol (VITAMIN D3) 400 unit tablet   Sig: Take 800 
Units by mouth daily.   Patient not taking: Reported on *****/*****/*****   cyanocobalamin, vitamin B-12, 1000 MCG tablet   Sig: Take 1 tablet (1,000 mcg total) by mouth daily.   desvenlafaxine succinate (PRISTIQ) 25 mg 24 hr tablet   lamoTRIgine (LAMICTAL) 100 MG tablet   Sig: Take 250 mg by mouth 2 (two) times a day.   levothyroxine (SYNTHROID, LEVOTHROID) 125 MCG tablet   Sig: Take 100 mcg by mouth daily. Taking 100mcg daily and 125mcg on Saturdays   lithium carbonate 150 mg capsule   Sig: Take 900 mg by mouth every evening.   pancrelipase, lipase-protease-amylase, (*****) 12,000-38,000 -60,000 unit ***** capsule   Sig: Take by mouth.   pantoprazole (PROTONIX) 40 MG tablet   Sig: Take 40 mg by mouth 2 (two) times a day.   rizatriptan (*****-MLT) 10 MG disintegrating tablet   Sig: rizatriptan 10 mg disintegrating tablet      Facility-Administered Medications: None        Medication List      TAKE these medications        Instructions    botulinum toxin type A 200 unit Solr  Commonly known as: BOTOX   Dose: 200 UNITS; Form:  Take  1 *****; Route: IM; Frequency: *****; Directions: Not available; Details: Duration: 90 day(s); Dispense: 1 Bottle(s); Date: *****/*****/*****      cyanocobalamin (vitamin B-12) 1000 MCG tablet  Last time this was given: ***** *****, *****  8:17 AM   Take 1 tablet (1,000 mcg total) by mouth daily.      desvenlafaxine succinate 25 mg 24 hr tablet  Commonly known as: PRISTIQ       lamoTRIgine 100 MG IMMEDIATE release tablet  Commonly known as: LaMICtal  Last time this was given: ***** *****, *****  8:17 AM   Take 250 mg by mouth 2 (two) times a day.      levothyroxine 125 MCG tablet  Commonly known as: SYNTHROID, LEVOTHROID  Last time this was given: ***** *****, *****  5:34 AM   Take 100 mcg by mouth daily. Taking 100mcg daily and 125mcg on Saturdays      lithium carbonate 150 mg capsule  Last time this was given: Ask your nurse or doctor   Take 900 mg by mouth every evening.      OLANZapine 7.5 MG 
tablet  Commonly known as: ZyPREXA  Last time this was given: ***** *****, *****  9:13 PM   Take 7.5 mg by mouth nightly at bedtime. And 2.5 prn      pancrelipase (lipase-protease-amylase) 12,000-38,000 -60,000 unit ***** capsule  Commonly known as: *****  ***** time this was given: ***** *****, *****  8:17 AM   Take by mouth.      pantoprazole 40 MG tablet  Commonly known as: PROTONIX   Take 40 mg by mouth 2 (two) times a day.      rizatriptan 10 MG disintegrating tablet  Commonly known as: *****-MLT   rizatriptan 10 mg disintegrating tablet        ASK your doctor about these medications        Instructions    cholecalciferol 400 unit tablet  Commonly known as: VITAMIN D3   Take 800 Units by mouth daily.                       Hospital Care Team   Service: Medicine  Inpatient Attending: ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, *****  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 9:30 AM ***** ***** *****, ***** ***** Outpt Occupational Therapy *****-*****-***** ***** Main FOLLOW *****    *****/*****/***** 1:30 PM ***** ***** *****, MD ***** Neuro Oph Main Campus *****-*****-***** ***** Main ESTABLISHED          Signed Discharge Orders (From admission, onward)     Ordered        *****/*****/***** 1037  Activity as tolerated            *****/*****/***** 1037  Discharge diet        Comments: Diet Regular       *****/*****/***** 1037  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD at (*****)*****-*****.        Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1037  For immediate questions regarding your 
hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, DO at *****-*****-*****.        Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, DO at *****-*****-*****.                       Discharge instructions and important events and results       Dear ***** *****    It was a privilege providing care for you at *****. You were hospitalized for falls and loss of consciousness. Your EEG was negative for seizures and your heart rhythm was normal. This was most likely related to changes in blood pressure. If you feel lightheaded or dizzy, make sure you drink adequate fluids, and take extra time when you are changing positions.    We changed some of your medications during this hospitalization. Please see the attached Patient ***** ***** ***** for these changes. If you have any questions regarding these changes or any difficulty filling your prescriptions, please call your primary care doctor or the number below.     If your symptoms worsen or if you develop new symptoms including fevers, shaking chills, night sweats, weight loss, dizziness, chest pain, shortness of breath, new or worsening sputum production, palpitations,  nausea, vomiting, or any other new/concerning symptom, please seek medical attention with either your PCP or in an emergency department.     If you have any questions about this hospitalization, please call the attending doctor.    ***** regards,  Your Medicine Team               Exam   Temperature: 36.5 째C (97.7 째F) (*****/*****/***** 0803) | Heart Rate: 72 (*****/*****/***** 0803) | BP: 115/57 (*****/*****/***** 0803) | Respiratory Rate: 18 (*****/*****/***** 0803)  | SpO2: 99 % (*****/*****/***** 0803)  O2 Device: None (Room air) (*****/*****/***** 0803)    |        Weight: 73 kg (160 lb 15 oz) (*****/*****/***** 0838)  Height: 157.5 cm (5' 2"") (*****/*****/***** 2210)         BMI (Calculated): 
26.88 (*****/*****/***** 2210)    Discharge Exam    Significant Discharge Exam Findings: GEN: NAD.  HEENT: MMM, EEG leads on  CV: RRR without m/r/g, JVP flat, no carotid bruits. Tender to palpation around sternum  ABD: +BS, non-tender, non-distended. No HSM.   EXTR: No edema, clubbing, cyanosis. 2+ pulses b/l. No CVA or spinal tenderness.  NEURO: alert and *****, sensation intact throughout. Gait not assessed  SKIN: No rashes or concerning lesions.             Orientation Level: Oriented X3   Cognition: Follows commands, Age appropriate         Speech: Appropriate for age, Clear     Disability Identity and Disability Accommodations Comments    Disability Identity   Deaf/***** of Hearing    Disability Accommodations Comments   Hearing Impairment                  Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 6.34 *****/*****/***** *****    RBC 3.42 (L) *****/*****/***** *****    HGB 10.2 (L) *****/*****/***** *****    HCT 32.0 (L) *****/*****/***** *****    MCH 29.8 *****/*****/***** *****    MCV 93.6 *****/*****/***** *****    PLT 217 *****/*****/***** *****    RDW 13.4 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 142 *****/*****/***** *****    ***** 4.0 *****/*****/***** *****    ***** 108 *****/*****/***** *****    CO2 27 *****/*****/***** *****    BUN 9 *****/*****/***** *****    CRE 0.74 *****/*****/***** *****    ***** 9.3 *****/*****/***** *****    GLU 101 *****/*****/***** *****    GLUPOC 90 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.3 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 12.6 *****/*****/***** *****    ***** 1.0 *****/*****/***** *****                        "
120448878,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient/family will provide an existing copy      Health Care Agents     Status Name ***** ***** ***** ***** Home Work Mobile    Not Active *****,***** ***** .Primary Health Care ***** (Proxy form on file) *****-*****-***** (Home) *****-*****-***** - *****-*****-*****          Code Status at *****: DNR/DNI (No CPR/No Intubation)       Discharge address same as *****: No  Discharge Address: ***** ***** *****., *****, *****                Hospitalization Summary     Admission Diagnosis     Bacteremia, gastroparesis              Principal Problem (Resolved):    AKI (acute kidney injury)  Active Problems:    ***** No active hospital problems. *****  Resolved Problems:    Aspiration into airway          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** Esophagogastroduodenoscopy With Gastrostomy Jejunostomy Tube Placement *****, ***** *****                ***** (OR) Procedures:   *****/***** 1012 Note By: ***** *****, MD  *****/***** 1850 ENDOSCOPY PROCEDURE  *****/***** 1445 ENDOSCOPY PROCEDURE  *****/***** 1607 URINARY CATHETER INSERTION      Pending Results     Procedure Component Value Ref Range Date/Time    HSV culture [*****] Collected:  *****/*****/***** 1152    Lab Status:  Preliminary result Specimen:  Vesicle Updated:  *****/*****/***** 1116     Specimen Source/ Description VESICLE CHEST WALL VESICLE VESICLE     SPECIAL REQUESTS Test Added 
by MD/Care Unit on:     CULTURE / TEST NO VIRUS ISOLATED AFTER 5 DAYS     REPORT STATUS PENDING    Anatomic Pathology [*****] Collected:  *****/*****/***** 0000    Lab Status:  In process Updated:  *****/*****/***** 1002           Hospital Course   DNR/DNI: ***** h/o HTN, complete heart block s/p PPM,  ***** SVT (on Digoxin), recent MVA resulting in *****/SDH and non-displaced R medial orbital wall fracture recent admit for non-operative management and discharged to rehab p/w transient SIRS response likely *****/***** aspiration due to large gastric air bubble and gastroparesis s/p G-J-tube placement (*****/*****); course c/b VRE bacteremia and bullous rash on chests and UE.      Mr. ***** was admitted to the hospital with a transient SIRS-like presentation, though to be due to aspiration in the setting of recurrent gastroparesis. Workup here was notable for an E. Faecium bacteremia treated with daptomycin with quick culture clearance and no vegetations on TTE. Gastroparesis was refractory to medical management and so a GJ tube was placed for venting and feeding. He was started on tube feeds. He was discharged to rehab.     ---------------------------  HOSPITAL COURSE BY PROBLEM:  ---------------------------  #Gastroparesis: The patient presented with worsening gastroparesis on erythromycin therapy. Though the pt was asymptomatic, his belly was quite tympanitic and distended and he had a markedly enlarged gastric bubble on KUB. In the ED, he had an aspiration event (see ""recurrent aspiration""), so an NGT was placed and he was started on metoclopramide (erythromycin was discontinued). Repeat KUB several hours later (while the NGT was on intermittent suction) did not demonstrate adequate compression, and soon ***** the pt became agitated/altered and pulled out his NGT. NGT was replaced and set to continuous wall suction; repeat KUB did show adequate decompression this time. On *****/*****, the pt once again pulled out his NGT, so a trial of medical 
therapy (metoclopramide) alone was undertaken, which did not result in adequate decompression. As such, the decision was made to proceed with placement of a feeding J-tube/venting G-tube, which was successfully placed on *****/*****. Metoclopramide was discontinued at this time. Following placement he was started on tube feeds nocturnally through the J-port. He tolerated these relatively well, initially having some diarrhea and also some refeeding syndrome with low potassium, phosphate and calcium which required repletion. At time of discharge he required minimal supplemental K-phos.  - continue to follow electrolytes daily until stabilized, attempt to pull off K-phos when available   - replete lytes prn     #Aspiration: In the emergency room, the pt became acutely hypotensive to SBP 80s with WBC 17 and new infiltrates on CXR, thought to be consistent with aspiration pneumonitis. The pt's WBC count rapidly improved to 11.77 within 10 hours, and he did not experience any additional hypotensive events. Overall, it was thought that his aspiration was secondary to his gastroparesis, which was managed as above. SLP was consulted and the patient was made NPO. After G tube placement, tube feeds were re-started without episodes of continued aspiration.    #Enterococcal Bacteremia: The pt's blood cultures were positive for VRE (E. Faecium). Though he was started on vancomycin/ceftriaxone for GPC coverage, this was switched to daptomycin/ampicillin upon speciation. Importantly, the pt was able to clear his own cultures prior to starting appropriate antibiotic therapy. Several theories were postulated as to the source of his bacteremia:  A) This represented transient bacteremia in the setting of GI aspiration-->pneumonitis-->bacteremia (supporting evidence: same E. Faecium pathogen growing from sputum)  B) This represented indolent bacteremia from gut translocation in the setting of his recurrent gastroparesis (which may or may not 
have been present prior to his hospitalization)  C) This represented urinary colonization (rare enterococcus, <*****/mL, seen on urine culture)    Given that the pt has a pacemaker implanted, a TTE was obtained, which showed no vegetations. In consultation with ID, the pt was treated with a 4-week course of daptomycin/ampicillin (2 weeks) followed by linezolid (2 weeks) for presumed urosepsis with possible prostatitis (i.e., option C from above). Ampicillin was discontinued when he developed a rash (see below) on the rare chance this was related.   -Continue linezolid (end date: *****/*****)    # Rash: Mr. ***** developed a rash during his hospitalization with multiple erythematous pustules (not ever vesicular) on arms and upper chest. It did not respond to topical steroidals and dermatology was consulted. They biopsied the rash which was pending at time of discharge.  - Follow-up biopsy    # Urinary retention: he was noted to have intermittent urinary retention and was started on flomax in addition to finasteride. He was treated with intermittent straight cath.  - continue straight cath, bladder scan, cath if PVR > 300cc, daily voiding trials    # Diarrhea: With initiation of tube feeds he was noted to have some diarrhea. Since he has denuded sacral skin once he was ruled out for C. Diff we started low-dose loperamide. Could also consider banana ***** or psyllium prn, but likely to resolve as he is further out from initiating tube feeds. If he has a sudden output change he is on antibiotics and would consider ***** *****. Diff and stopped anti-*****.   - continue low-dose loperamide for 3d-1w, reassess following              Medications   Allergies: Vancomycin    Prior to Admission Medications   Prescriptions   acetaminophen (TYLENOL) 650 mg/20.3 mL Soln   Sig: Take 20.3 mL (650 mg total) by mouth every 4 (four) hours as needed.   bisacodyl (DULCOLAX) 5 mg EC tablet   Sig: Take 1 tablet (5 mg total) by mouth daily 
as needed.   captopril (CAPOTEN) 12.5 MG tablet   Sig: Take 1 tablet (12.5 mg total) by mouth every 8 (eight) hours.   digoxin (LANOXIN) 125 mcg tablet   Sig: Take 125 mcg by mouth daily.   docusate sodium (COLACE) 100 MG capsule   Sig: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.   enoxaparin (LOVENOX) 40 mg/0.4 mL ***** subcutaneous syringe   Sig: Inject 0.4 mL (40 mg total) under the skin daily.   erythromycin ethylsuccinate (*****) 200 mg/5 mL suspension   Sig: Take 1.3 mL (50 mg total) by mouth 3 (three) times a day before meals.   finasteride (PROSCAR) 5 mg tablet   Sig: Take 1 tablet (5 mg total) by mouth daily.   guaiFENesin 200 mg tablet   Sig: Take 600 mg by mouth every 8 (eight) hours as needed for congestion (cough). Indications: Cough   levoFLOXacin (LEVAQUIN) 500 MG tablet   Sig: Take 1 tablet (500 mg total) by mouth every morning for 2 doses.   omeprazole (PRILOSEC) 20 MG capsule   Sig: Take 1 capsule (20 mg total) by mouth daily before breakfast.   polyethylene glycol (GLYCOLAX) 17 gram packet   Sig: Take 17 g by mouth daily.   potassium, sodium phosphates (PHOS-*****) *****-*****-***** mg *****   Sig: Take 1 packet by mouth 3 (three) times a day before meals for 2 days.   senna (SENOKOT) 8.6 mg tablet   Sig: Take 2 tablets by mouth nightly.   simvastatin (ZOCOR) 40 MG tablet   Sig: Take 10 mg by mouth nightly.    verapamil (*****) 120 MG 24 hr capsule   Sig: Take 120 mg by mouth nightly.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          bisacodyl 5 mg EC tablet   Also known as:  DULCOLAX       captopril 12.5 MG tablet   Also known as:  CAPOTEN       digoxin 125 mcg tablet   Also known as:  LANOXIN       docusate sodium 100 MG capsule   Also known as:  COLACE       erythromycin ethylsuccinate 200 mg/5 mL suspension   Also known as:  *****       levoFLOXacin 500 MG tablet   Also known as:  LEVAQUIN       polyethylene glycol 17 gram 
packet   Also known as:  GLYCOLAX       potassium, sodium phosphates *****-*****-***** mg *****   Also known as:  PHOS-*****       senna 8.6 mg tablet   Also known as:  SENOKOT       verapamil 120 MG 24 hr capsule   Also known as:  *****         START taking these medications       Dose, Frequency, and Details    amino acids-protein hydrolysate 15-60 gram-kcal/30 mL *****   Also known as:  ***** ***** CARB    Take 30 mL by mouth daily.   Last time this was given:  *****/*****/*****  8:16 AM       calcium acetate-aluminum sulfate 952-1,347 mg *****   Also known as:  DOMEBORO    Apply 1 application (1 each total) topically 3 (three) times a day for 3 days.   Last time this was given:  *****/*****/***** 12:26 PM       fexofenadine 180 MG tablet   Also known as:  *****    Take 1 tablet (180 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:17 AM       linezolid 600 mg tablet   Also known as:  ZYVOX   Start taking on:  *****/*****/*****    Take 1 tablet (600 mg total) by mouth every 12 (twelve) hours.       loperamide 1 mg/5 mL solution   Also known as:  IMODIUM    Take 10 mL (2 mg total) by mouth 2 (two) times a day as needed for diarrhea.       melatonin 5 mg Tab    Take 1 tablet (5 mg total) by mouth nightly.   Last time this was given:  *****/*****/*****  8:23 PM       nystatin ointment    Apply topically 3 (three) times a day.   Last time this was given:  *****/*****/*****  8:18 AM       sodium *****-monophosphate-K phosphate 250 mg elemental phosphorus Tab   Also known as:  K-PHOS NEUTRAL    1 tablet (250 mg of phosphate total) by Jejunostomy Tube route 3 (three) times a day for 5 doses.   Last time this was given:  *****/*****/*****  8:18 AM       tamsulosin 0.4 mg *****   Also known as:  FLOMAX    Take 1 capsule (0.4 mg total) by mouth nightly.   Last time this was given:  *****/*****/*****  8:09 PM       thiamine 100 MG tablet   Also known as:  Vitamin B-1    Take 1 tablet (100 mg total) by mouth daily for 5 days.   Last time this was given:  *****/*****/*****  8:19 AM    
     CONTINUE taking these medications       Dose, Frequency, and Details    acetaminophen 650 mg/20.3 mL Soln   Also known as:  TYLENOL    Take 20.3 mL (650 mg total) by mouth every 4 (four) hours as needed.       enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe   Also known as:  LOVENOX    Inject 0.4 mL (40 mg total) under the skin daily.   Last time this was given:  *****/*****/*****  8:17 AM       finasteride 5 mg tablet   Also known as:  PROSCAR    Take 1 tablet (5 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:17 AM       guaiFENesin 200 mg tablet    Take 600 mg by mouth every 8 (eight) hours as needed for congestion (cough). Indications: Cough   For:  Cough       omeprazole 20 MG capsule   Also known as:  PriLOSEC    Take 1 capsule (20 mg total) by mouth daily before breakfast.   Last time this was given:  *****/*****/*****  8:18 AM       simvastatin 40 MG tablet   Also known as:  ZOCOR    Take 10 mg by mouth nightly.   Last time this was given:  *****/*****/*****  8:09 PM                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate *****  Deferred ()             Hospital Care Team   Service: Medicine  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: ***** *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  3:***** ***** *****   ***** ***** ***** ***** *****   ***** ***** Center for Outpatient Care - CT (***** ***** - Main Campus)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****           *****If you are having a CT Abdomen/Pelvis in addition to this CT exam please arrive 1 hour before your scheduled time to drink oral contrast. Some exams may require additional oral contrast at the time of the exam.*****  Please refer to the CT Abdomen/Pelvis instruction sheet for additional information.  Please check in ***** ***** 20 
minutes prior to your scheduled exam time. You should not eat solid foods for two hours prior to your test. Please drink plenty of fluids such as water, clear soups, juice, or black ***** coffee or tea.  Medications: If you need to take your medication in the morning prior to the scan, take it with water. If you take any oral diabetic medications you may not be able to take these medications for 48 hours after receiving intravenous contrast, (x-ray dye) from your CT scan examination. Please consult your prescribing physician to answer any questions about substitute medications that may be necessary. You will receive specific instructions at the time of the exam.  What to wear: Wear loose-fitting, comfortable clothes with no metal (zippers, under wire *****, etc) for the test. Leave your watch, jewelry, and other valuables at home.  Other Information: If ***** ever had an allergic reaction to contrast tell your doctor and the technologist. The doctor may prescribe special medicine for you to take before the exam and also while you are here for the exam. You should bring the last dose of medicine with you prior to the scan.  Children who are not patients are not allowed to enter the scan room. Please make alternative arrangements for them or have another adult accompany you to watch your child in the ***** ***** ***** you are having your scan.            ***** *****, ***** 10:15 AM EDT   (Arrive by 10:00 AM)   Follow Up with ***** ***** *****, MD   Acute Care Neurosurgery on WAC 8 (--)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            ***** *****   Specialty:  Rehabilitation    ***** ***** *****.  ***** ***** *****-*****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1349  Activity as tolerated         *****/*****/***** 1349  Discharge diet     Question:  Diet Type  Answer:  Regular       
*****/*****/***** 1349  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact ***** 9 at *****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact ***** 9 at *****-*****-*****.                     Exam   Temperature: 37.1 C (98.7 F) (*****/*****/***** 1200) | Heart Rate: (!) 103 (*****/*****/***** 1200) | BP: 118/59 (*****/*****/***** 1200) | Respiratory Rate: 18 (*****/*****/***** 1200)  | SpO2: 96 % (*****/*****/***** 1200)  O2 Device: None (Room air) (*****/*****/***** 1200)  O2 Flow Rate (L/min): 6 |        Weight: 47.9 kg (105 lb 9.6 oz) (*****/*****/***** 0900)  Height: 162.6 cm (5' 4"") (*****/*****/***** 2304)         BMI (Calculated): 21.9 (*****/*****/***** 2304)    Discharge Exam    Significant Discharge Exam Findings:  Physical Exam: (include baseline and relevant changes to status)   General: The patient is lying in bed in no apparent distress.  HEENT: Normocephalic/Atraumatic, Sclera is anicteric   Lung Exam: Crackles at bases   Cardiac Exam: Tachycardic  Abdominal Exam: Mildly distended with gas, nontender, bowel sounds hypoactive   Extremity: No edema is noted in the lower extremities  Skin: no lesions or wounds are noted    NEUROLOGIC EXAM:  Cognitive: Very hard of hearing which limits exam. A+Ox3, speech appears to be fluent, naming/calculation/higher order orientation with deficits.   Cranial Nerves: Intact and symmetrical  Motor: The patient's strength exam appears to be *****/***** in the upper extremities bilaterally. *****/***** in the hip flexors bilaterally, *****/***** with knee flexion bilaterally and *****/***** dorsiflexion and *****/***** plantar flexion bilaterally.   Sensation: The patient's sensation to light touch appears to be intact              Orientation Level: Oriented to person, ***** to place (name of this place), Oriented to month   Cognition: Follows commands         Speech: Clear     Vision: Functional with Correction  Hearing: Impaired       
    Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 7.97 *****/*****/***** *****    RBC 2.91 (L) *****/*****/***** *****    HGB 8.5 (L) *****/*****/***** *****    HCT 27.1 (L) *****/*****/***** *****    MCH 29.2 *****/*****/***** *****    MCV 93.1 *****/*****/***** *****    PLT 287 *****/*****/***** *****    RDW 15.1 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 132 (L) *****/*****/***** *****    ***** 4.2 *****/*****/***** *****    ***** 99 *****/*****/***** *****    CO2 23 *****/*****/***** *****    BUN 19 *****/*****/***** *****    CRE 0.79 *****/*****/***** *****    ***** 8.2 (L) *****/*****/***** *****    GLU 140 (H) *****/*****/***** *****    GLUPOC 149 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 1.9 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 15.2 (H) *****/*****/***** *****    PTT 33.5 *****/*****/***** *****    INR 1.2 (H) *****/*****/***** *****                        "
150024732,0,1,"

Note Date: *****/*****/*****  Time: 1130

Note Type: Initial note

Note Title: Orthopaedic Surgery Consult Note

Signed by ***** *****, MD on *****/*****/***** at 1:21 pm  Affiliation: *****

***** by ***** ***** *****, MD on *****/*****/***** at 6:07 pm

 

ORTHOPAEDIC SURGERY CONSULT NOTE



NAME: *****,*****   

*****: *****   

DATE: *****/*****/*****

RESIDENT: ***** *****

ATTENDING: ***** *****

CONSULTING SERVICE:  *****



CC: ***** down stairs



HPI: 

Mr. ***** is a ***** yo male with PMHx ***** (10-15%), recent MV

repair, severe dilated cardiomyopathy, s/p ICD/pacer, hx CVA on

warfarin, VT, HTN, CKD, transferred for traumatic ICH and

admitted to ***** for further evaluation. Patient fell down 12

stairs and is unsure of how or why. Reports had been walking with

his walker. He reports he has had some pain in the left shoulder

since the *****. Denies any chest pain, SOB, cough. After the

*****, he went to ***** was found to have ICH, INR of 2.1, treated

with Vitamin K and

anti-epileptic (per wife, not clearly documented) and

referred here. On evaluation here, he denies LOC, headache,

vision changes, confusion, speech difficulties, nausea, vomiting.

He was evaluated by neurosurgery here who did not believe there

was SAH and more likely artifact. Patient remained neurologically

intact here and *****.



ROS: Negative except as detailed above.



PMHx: cardiomyopathy (EF 10-15% *****/*****) s/p ICD/PPM, MVI s/p

MVR, HTN, HL, ventricular tachycardia, cervical sinal stenosis,

adjustment disorder w/ anxiety, achalasia, hypothyroidism *****/*****

amiodarone, CKD stage III, OSA, basal cell carcinoma, traumatic

SDH



PSHx: median sternotomy w/ MVR, ICD/PPM placement



*****:  coumadin 0.5', align 4'', amiodarone 200', bumex 3', MVI,

ferrous sulfate 325', gabapentin 200''', levothyroxine 100',

metolazone 2.5', PEG 17 prn, simvastatin 20'



ALL: spironolactone(itchy)

                

FH: HTN, hyperparathyroidism.



PHYSICAL EXAMINATION:

Vitals: T 96.7 HR 77 BP 90/65 RR 18 Sat 99% on 2L  

General: NAD, AAOx3, speech fluent, GCS 15



Left upper extremity:

- 4 cm abrasion over anterolateral left shoulder, ecchymoses over

medial superior shoulder and trapezius

- No gross deformity, erythema, edema

- Mild TTP over distal clavicle

- Soft, non-tender arm and forearm

- Full, painless AROM/PROM of elbow, wrist, and digits

- Full PROM of shoulder with minimal discomfort

- EPL/FPL/***** (index) fire

- SILT axillary/radial/median/ulnar nerve distributions

- 2+ radial pulse



LABS: 

 

135  87   72	

--------------<100

2.5  32	  2.1	



8.0>10.*****/*****.1<107



INR: 1.4 (from 2.1)



UA: negative         



IMAGING: 

Xray Right Shoulder *****/*****/*****

IMPRESSION:  There is an acute mildly displaced comminuted

fracture of the left distal clavicle. However, the AC joint and

glenohumeral joint appear intact 



*****/*****/***** CT Head *****: Decreased conspicuity of a small

subarachnoid hemorrhage along the right sylvian fissure as

compared to the outside reference head CT. No new intracranial

hemorrhage is identified.



ASSESSMENT/RECOMMENDATIONS: 

***** w/ multiple medical comorbidities now seen in consultation

after sustaining a mechanical ***** down 12 stairs for left distal

comminuted clavicle fracture. Patient with minimal tenderness on

examination and neurologically intact. 



- Non-operative management

- Sling to *****

- Activity: NWB ***** at this time

- Follow-up in clinic with Dr. ***** in 2 weeks



Please see attending ***** ***** final recommendations.



***** *****, MD PGY-2

***** ***** Orthopaedic Residency Program 

*****



This is only an initial consult. For questions regarding daily

care, please page resident rounding daily or *****





Addendum by ***** ***** *****, MD on *****/*****/***** at 6:07 pm:

Patient was seen and treated for his left distal clavicle

fracture.



Sling and non-weight bearing for now. Disposition pending PT

evaluation.

"
121233135,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****., ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient/family will provide an existing copy      Health Care Agents          There are no health care agents on file.          Code Status at *****: DNR/DNI/*****/***** *****                           Hospitalization Summary       Principal Problem:    Altered mental status  Active Problems:    Probable sepsis    Encounter for palliative care  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     None          Non (OR) Procedures:          Pending Results     Procedure Component Value Ref Range Date/Time    Arterial blood gas [*****] Collected:  *****/*****/***** 0256    Lab Status:  Preliminary result Updated:  *****/*****/***** 0307     Base Excess, unspecified PENDING 0.0 - 3.0 mmol/L      HEMATOCRIT PENDING 41.0 - 53.0 %      HGB PENDING g/dL      PCO2 PENDING mm[Hg]      PH PENDING 7.32 - 7.45      PO2 PENDING mm[Hg]      SO2, unspecified PENDING 94.0 - 99.9 %      ***** PENDING mmol/L      BASE DEFICIT PENDING mmol/L     Arterial blood gas [*****] Collected:  *****/*****/***** 0840    Lab Status:  Preliminary result Specimen:  Blood Updated:  *****/*****/***** 0846     Base Excess, unspecified PENDING 0.0 - 3.0 mmol/L      HEMATOCRIT PENDING 41.0 - 53.0 %      HGB PENDING g/dL      PCO2 PENDING mm[Hg]      PH PENDING 7.32 - 7.45      PO2 PENDING mm[Hg]      SO2, unspecified PENDING 94.0 - 99.9 %      ***** PENDING mmol/L      BASE DEFICIT PENDING 
mmol/L            Hospital Course   ***** s/p evacuation of recurrent b/l SDH c/b seizures, admitted from nursing facility on *****/***** for worsening MS, found to have urosepsis. Course c/b aspiration PNA and worsening AMS, now CMO  PMH: CAD s/p *****, ***** (***** 35%), s/p TAVR     ***** y/o M s/p evacuation of recurrent b/l SDH c/b seizures, h/o CAD s/p CABG, ***** (***** 35%), TAVR, admitted from nursing facility on *****/***** for worsening *****. ***** evidence of recurrent SDH, found to have urosepsis.    # AMS. Sent in from his nursing facility on *****/***** due to worsening mental status, raising a concern for acute on chronic subdural hematomas.Ruled out recurrent SDH with CT head and decline in ***** at nursing facility felt to be toxic metabolic encephalopathy in the setting of infection. Patient started on vancomycin, ***** and narrowed to ceftriaxone after urine culture grew ceftriaxone sensitive Proteus. Mental status improved to A&***** on *****/***** but worsened to A&***** on *****/*****. Differential included reaccumulation of SDH (unlikely given patient continues to be responsive with no focal neurological findings) versus baseline fluctuating MS s/p 3rd craniotomy 2 weeks ago for 3rd SDH. Called SNF (***** *****) and caretaker there confirmed that patient was A&***** at best and had fluctuating course. Repeat CT Head (patient minimally responsive to sternal rub) on *****/***** demonstrated no significant change from prior. CT Chest showed right greater than left consolidation consistent with aspiration pneumonia. Patient's acute decompensation felt to be secondary to toxic metabolic encephalopathy from aspiration pneumonia but also ***** by his recent resolving SDH. His mental status remained minimally interactive, occasionally somnolent despite sternal rub and occasional single word responses.     # Hypoxemia/Aspiration Pneumonia. Initially thought to be PE vs aspiration PNA - WBC 14.56 -> 16.37, procal 0.09 -> 0.13 -> 0.20. CT Chest on *****/***** 
demonstrated aspiration pneumonia and patient's ceftriaxone broadened to Vanc/Ceftaz/Flagyl on *****/***** and he completed a course. He recurrently desatted throughout admission, followed by resolution with deep suctioning. Then on *****/***** he desatted again to 70% with BPs 70. He was placed on high flow nasal canula, suctioned with improved respiratory status and ABGs were notable for ***** of 70-90s. His CXR was notable for a recurrent aspiration vs volume overload and at the request of the HCP< he was started on vanc/ceftaz on *****/*****. Cultures were drawn and notable for Staph *****. Patient was continued on antibiotics until patient was moved to *****.    # Atrial fibrillation with RVR. Patient had atrial fibrillation with RVR during admission in the setting of persistent aspiration, increased O2 requirement, and worsening mental status. Patient was treated with metoprolol (PO and IV) and diltiazem.    #Sacral ulcers. Patient's decline in mental status accompanied by worsening sacral ulcers - patient previously has had stage II sacral ulcers unstageable (black necrotic) on *****/*****. Wound nurse consulted, specialty bed ordered for patient, and wound care recommendations were followed throughout admission.    #Nutrition. Given recurrent aspirations, attempts were made to consolidate his tube feeds to daytime feeds only. This was complicated by hyperglycemia and he was switched to continuous tube feeding followed by an aspiration event. His tube feeds were ultimately stopped in the setting of persistent aspiration and oxygen desaturation, as tube feed was identified during suctioning of oral secretions.     # UTI.Found to have urosepsis on admission on *****/*****,started on Vanc/Ceftaz and urine culture on *****/***** grew Proteus. Sensitivities on *****/***** returned and Proteus sensitive to ceftriaxone. Vanc/Ceftaz narrowed to CTX on *****/*****. Antibiotics broadened to vanc/ceftaz/flagyl on *****/***** after CT Chest demonstrated aspiration pneumonia iso 
patient being unresponsive and he completed a course of antibiotics for UTI.     # *****. (resolved) Likely secondary to recurrent CNS insults, as well as insensible losses iso infection. Patient fluctuating between *****-***** on *****/***** but appropriately corrected to Na 139 ***** *****/***** after increasing FWB from 200cc q4h to 250 q4h. D/ced FWB on *****/***** iso patient's aspiration.     #GOC Mr. ***** ***** is the HCP. He was continuously involved in all treatment decisions for his father. He requested that the patient by full code initially but then on *****/*****/***** decided on DNR/DNI status after an ***** hypoxemic respiratory event and hypotension to the 70s, which resolved with IV fluids and briefly required pressors. Subsequently, the HCP also agreed to no ICU transfer, no pressors and no central line placement. Mr. ***** ***** was treated with aggressive medical care in all other respects inclusive of antibiotics, frequent suctioning and serial BP checks with continued IVF to maintain goal BPs and MAPS. Social work followed closely throughout admission. After palliative care consult, patient was moved to *****; glycopyrrolate was used to decrease oral secretions and morphine was administered to diminish sensation of air *****.         Medications   Allergies: Review of patient's allergies indicates no known allergies.    Prior to Admission Medications   Prescriptions   acetaminophen (TYLENOL) 500 MG tablet   Sig: 500 mg by Gastrostomy Tube route every 4 (four) hours as needed for pain (specific location in comments).   carboxymethylcellulose (REFRESH TEARS) 0.5 % *****   Sig: Place 1 drop into each eye nightly.   colestipol (COLESTID) 5 gram packet   Sig: Take 5 g by mouth 2 (two) times a day.   cyanocobalamin (VIT B-12) 1000 MCG tablet   Sig: Take 1 tablet (1,000 mcg total) by mouth daily.   guaiFENesin 400 mg Tab   Sig: 400 mg by Gastrostomy Tube route 2 (two) times a day. For 7 days   insulin glargine (LANTUS) 100 unit/mL 
injection vial   Sig: Inject 8 Units under the skin nightly.   insulin lispro (HUMALOG) 100 unit/mL injection vial   Sig: Inject per sliding scale TID before meals  *****-*****= *****  *****-*****= 4 units  *****-*****= 6 units  *****-*****= 8 units  *****-*****= 10 units  >400 = call provider   lacosamide (VIMPAT) 150 mg Tab   Sig: Take 1 tablet (150 mg total) by mouth 2 (two) times a day.   lansoprazole (PREVACID) 15 MG capsule   Sig: Take 15 mg by mouth daily.   levETIRAcetam (KEPPRA) 750 MG tablet   Sig: Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   lisinopril (PRINIVIL,ZESTRIL) 2.5 MG tablet   Sig: 2.5 mg by Gastrostomy Tube route daily.   metFORMIN (GLUCOPHAGE) 500 MG tablet   Sig: Take 500 mg by mouth daily.    metoprolol tartrate (LOPRESSOR) 25 MG tablet   Sig: 1 tablet (25 mg total) by Gastrostomy Tube route 2 (two) times a day.   nystatin (MYCOSTATIN) 100,000 unit/mL suspension   Sig: Take 500,000 Units by mouth 3 (three) times a day.   pyridoxine, vitamin B6, (B-6) 50 MG tablet   Sig: Take 1 tablet (50 mg total) by mouth daily.   sertraline (ZOLOFT) 100 MG tablet   Sig: Take 1 tablet (100 mg total) by mouth daily.   tamsulosin (FLOMAX) 0.4 mg *****   Sig: Take 0.4 mg by mouth daily.   thiamine (VITAMIN B-1) 100 MG tablet   Sig: Take 1 tablet (100 mg total) by mouth daily.      Facility-Administered Medications: None        Discharge Medications      ASK your doctor about these medications       Dose, Frequency, and Details    acetaminophen 500 MG tablet   Also known as:  TYLENOL    500 mg by Gastrostomy Tube route every 4 (four) hours as needed for pain (specific location in comments).   Last time this was given:  *****/*****/*****  8:37 AM       carboxymethylcellulose 0.5 % *****   Also known as:  REFRESH TEARS    Place 1 drop into each eye nightly.       colestipol 5 gram packet   Also known as:  COLESTID    Take 5 g by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  9:00 AM       cyanocobalamin 
1000 MCG tablet   Also known as:  VIT B-12    Take 1 tablet (1,000 mcg total) by mouth daily.   Last time this was given:  *****/*****/*****  9:01 AM       guaiFENesin 400 mg Tab    400 mg by Gastrostomy Tube route 2 (two) times a day. For 7 days       insulin glargine 100 unit/mL injection vial   Also known as:  LANTUS    Inject 8 Units under the skin nightly.       insulin lispro 100 unit/mL injection vial   Also known as:  HumaLOG    Inject per sliding scale TID before meals *****-*****= ***** *****-*****= 4 units *****-*****= 6 units *****-*****= 8 units *****-*****= 10 units >400 = call provider       lacosamide 150 mg Tab   Also known as:  VIMPAT    Take 1 tablet (150 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:37 AM       lansoprazole 15 MG capsule   Also known as:  PREVACID    Take 15 mg by mouth daily.       levETIRAcetam 750 MG tablet   Also known as:  KEPPRA    Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:37 PM       lisinopril 2.5 MG tablet   Also known as:  PRINIVIL,ZESTRIL    2.5 mg by Gastrostomy Tube route daily.       metFORMIN 500 MG tablet   Also known as:  GLUCOPHAGE    Take 500 mg by mouth daily.       metoprolol tartrate 25 MG tablet   Also known as:  LOPRESSOR    1 tablet (25 mg total) by Gastrostomy Tube route 2 (two) times a day.   Last time this was given:  *****/*****/***** 12:17 AM       nystatin 100,000 unit/mL suspension   Also known as:  MYCOSTATIN    Take 500,000 Units by mouth 3 (three) times a day.       pyridoxine (vitamin B6) 50 MG tablet   Also known as:  B-6    Take 1 tablet (50 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  9:02 AM       sertraline 100 MG tablet   Also known as:  ZOLOFT    Take 1 tablet (100 mg total) by mouth daily.   Last time this was given:  *****/*****/***** 10:40 AM       tamsulosin 0.4 mg *****   Also known as:  FLOMAX    Take 0.4 mg by mouth daily.   Last time this was given:  
*****/*****/*****  9:02 AM       thiamine 100 MG tablet   Also known as:  Vitamin B-1    Take 1 tablet (100 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  9:00 AM                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate ***** *****/*****/*****             Hospital Care Team   Service: Medicine  Inpatient Attending: ***** ***** *****, MD,*****     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 9:30 AM ***** ***** *****, MD, PhD *****, Department of Neurology *****-*****-*****     *****/*****/***** 1:00 ***** *****-***** *****, MD ***** and Women's Department of Neurology *****-*****-*****          Follow-Up Services            ***** *****   Specialty:  Skilled Nursing Facility    ***** ***** *****, *****  ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     None                  Exam   Temperature: 36.8 째C (98.3 째F) (*****/*****/***** 1911) | Heart Rate: (!) 117 (*****/*****/***** 1818) | BP: (!) 140/94 (*****/*****/***** 1818) | Respiratory Rate: 30 (*****/*****/***** 1547)  | SpO2: 92 % (*****/*****/***** 1547)  O2 Device: Nasal cannula (*****/*****/***** 1547)  O2 Flow Rate (L/min): 2 | FiO2 (%): 35 % (*****/*****/***** 1300)      Weight: 75.3 kg (166 lb) (*****/*****/***** 1600)  Height: 183 cm (6' 0.05"") (*****/*****/***** 1100)         BMI (Calculated): 21.1 (*****/*****/***** 0026)            Orientation Level: Other (Comment) (*****)   Cognition: Unable to follow commands         Speech: No Speech     Vision: Impaired  Hearing: Impaired   Assistive Devices: Chair lift       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 10.70 (H) 
*****/*****/***** *****    RBC 3.55 (L) *****/*****/***** *****    HGB 9.8 (L) *****/*****/***** *****    ***** 11.6 (L) *****/*****/***** *****    HCT 31.3 (L) *****/*****/***** *****    MCH 27.6 *****/*****/***** *****    MCV 88.2 *****/*****/***** *****    PLT 289 *****/*****/***** *****    RDW 15.7 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 139 *****/*****/***** *****    ***** 3.9 *****/*****/***** *****    ***** 103 *****/*****/***** *****    CO2 27 *****/*****/***** *****    BUN 20 *****/*****/***** *****    CRE 0.40 (L) *****/*****/***** *****    ***** 8.0 (L) *****/*****/***** *****    GLU 149 (H) *****/*****/***** *****    GLUPOC 167 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.1 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 16.5 (H) *****/*****/***** *****    INR 1.4 (H) *****/*****/***** *****                        "
150005076,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: Neurosurgery Consult Note

Electronically signed by ***** ***** *****, NP on *****/*****/***** at 8:22 am  Affiliation: *****

NEEDS COSIGN

 

CC: left hand/arm numbness x2; new onset numbness localized to

left toes



HPI: ***** s/p right craniotomy for evacuation of SDH on *****/***** and

s/p right craniotomy for re-evacuation of SDH on *****/***** now

presents with episode of left hand numbness x2 with new onset

numbness of the toes. She states that around 7PM this evening,

she experienced an episode of numbness localized to the left hand

which lasted for approximately 15 minutes prior to

self-resolving. She was eating dinner at the time this episode

occurred. She denies any weakness of the hand and was able to

move her fingers in a coordinated manner.



Ms. ***** experienced a second episode of left hand numbness

around 9:30PM. She states that the numbness was also present in

her left arm. She denies any weakness of the left hand at this

time and was still able to move her fingers in a coordinated

manner. She also noted numbness localized to her toes at this

time and states that she had never experienced these symptoms

prior. This episode lasted 45 minutes prior to self-resolving.



Tonight, she denies nausea, vomiting, fever, chills, headache,

diplopia, blurred vision or visual changes. She denies any aura

precipitating this episode. 



PMHx:

Thyroid cyst; aortic aneurysm; ADHD



All: NKDA



Medications prior to admission:

Acetaminophen 650mg Q4H prn pain

Docusate Sodium 100mg PO BID

Heparin 5000 units SC TID

Hydralazine 10-20mg IV Q6H prn SBP >160

Lidocaine Viscous 2% 15mL PO TID prn lip pain

Ondansetron 4mg IV Q8H prn nausea

Oxycodone 5-10mg PO Q6H prn pain

PHenytoin Sodium Extended release tabs 100mg PO Q8H

Polyethylene Glycol 17g PO BID prn constipation

***** Lotion 1 App TP QID prn pruritis

***** 17.2mg PO BID prn constipation

Trazodone 25mg PO QHS prn insomnia



Social Hx: Denies the use of tobacco. Consumes 2 glasses of wine

nightly. Currently at ***** *****.



Family Hx: NC.

ROS: Per HPI.



PHYSICAL EXAM:

T: 98  BP: 116/64  HR: 80  RR: 16  ***** 96% RA

Gen: WD/WN, comfortable, NAD.

HEENT: Pupils: 3-2mm bilaterally. EOMs intact. 

Extrem: Warm and well-perfused.

Neuro:

Mental status: Awake and alert, cooperative with exam, normal

affect.

Orientation: Oriented to person, place, and date.

Language: Speech fluent with good comprehension and repetition.

Naming intact. No dysarthria or paraphasic errors.



Cranial Nerves:

I: Not tested.

II: Pupils equally round and reactive to light, 3mm to

2mm bilaterally. 

III, IV, VI: Extraocular movements intact bilaterally without

nystagmus.

V, VII: Facial strength and sensation intact and symmetric.

VIII: Hearing intact to voice.

IX, X: Palatal elevation symmetrical.

*****: Sternocleidomastoid and trapezius normal bilaterally.

XII: Tongue midline without fasciculations.



Motor: Normal bulk and tone bilaterally. No abnormal movements,

tremors. Strength full power 5/5 throughout. No pronator drift.



Sensation: Intact to light touch bilaterally.



Coordination: normal on finger-nose-finger.



Handedness: Right.



CT Head: *****/*****/*****

Preliminary Report:

No significant interval change with persistent right frontal

extra-axial hypodense collection measuring approximately 1.3 cm

from the inner table causing mass effect on the subjacent sulci.

No acute hemorrhage or large vascular territorial infarction. 



Labs: *****/*****/*****

WBC  RBC   Hgb   Hct   MCV MCH  MCHC  RDW  Plt Ct 

5.2  3.71  11.4  32.4  87  30.8 35.3  13.0 307 

PT 11.2   PTT 36.7 INR 1.0 

Glucose ***** Creat Na   K   Cl  HCO3  ***** 

106     13    0.5   136  4.1 98  27    15 



Assessment/Plan:

***** s/p right craniotomy for evacuation of SDH on *****/***** and s/p

right craniotomy for re-evacuation of SDH on *****/***** now presents

with episode of left hand numbness x2 with new onset numbness of

the toes. Neurology recommends follow-up as an outpatient. They

will contact the Neurology Urgent Care Office to arrange a

follow-up appointment for the end of this week or beginning of

next week. At this time, we will start Keppra 500mg PO BID and

she will return to ***** *****. 



I have reviewed this case with Dr. ***** who formulated

the above plan.



Thank you for this consult,

***** *****, NP

*****



Attending Physician:

***** *****, MD

























"
112065953,0,1,"    Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Full Code (Confirmed)       Patient/Family/Caregiver discharge preference/goals : Home with services                          Hospitalization Summary     Reason for Admission: NPH  Principal Problem:    NPH (normal pressure hydrocephalus)  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:   *****/***** 0000 Note By:     Items for Post-Hospitalization Follow-Up:    [ ] follow up headache control on current regimen. On discharge using prn fioricet q6hrs        Pending Results     Procedure Component Value Ref Range Date/Time    Comprehensive metabolic panel [*****] Collected:  *****/*****/***** 0602    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 0759             Hospital Course   ***** ***** is a ***** y.o. with PMH significant for HTN, HIV on ART, HIV encephalopathy, and ocular syphilis who presented with symptoms and imaging concerning for NPH.  He is now s/p right parietal VPS placement with Dr. ***** on *****/*****/*****.     Patient was admitted to the Neurosurgical Service on *****/*****/***** for a right parietal VP shunt placement with Dr. *****. Patient was taken to the operating room on the day of admission and underwent an uncomplicated procedure. 
Please see Dr. *****'s separately dictated operative note for details. Post-operatively patient was extubated and after a brief uneventful stay in *****, patient was transferred to the Neurosurgical floor for close monitoring. He remained hemodynamically stable, neurologically at baseline, and with his pain well-controlled throughout his hospital stay. He was deemed ready for discharge on POD#2 to ***** where he made functional gains. Patient followed up with Dr. ***** while at rehab stay on *****/***** where his sutures were removed and follow up CT was reviewed. Dr. ***** reviewed the CT imaging which revealed small right sided subdural hematoma with stable ventricle size. Patient's programmable shunt valve was increased from 150mm to 180mm of H20. Patient continued to progress while here and headaches stabilized on the regimen below.       NPH:  Sp R parietal VPS *****/*****/*****  - precautions: no lifting>5-10lbs x2 weeks (end *****/*****)   - headache: gabapentin *****-*****-*****, tylenol 650mg q6h PRN, fioricet q6h PRN  - sleep: melatonin 5mg PRN, seroquel 200mg qhs  - bladder: ***** 1g BID, oxybutynin 5mg TID *****/*****   - bowel: senna prn     Hx HIV encephalopathy  - ***** 1 tablet qd  - ***** 50mg qd     Hx ocular syphilis  - prednisolone eye drops  - latanoprost eye drops      Hypertension: stable on home meds  - propranolol 10mg TID      GERD  - cont famotidine       Hx agitation: currently stable   - seroquel *****/*****/200mg  - depakote 750mg BID        Medications   Allergies: Bee venom protein (honey bee); ***** oil-beeswax (bulk); Cashew nut; Cefaclor; Cephalosporins; Penicillins; ***** nuts; and Sulfa (sulfonamide antibiotics)    Prior to Admission Medications   Prescriptions   EPIPEN 2-***** 0.3 mg/0.3 mL auto-injector   Sig: Inject 0.3 mL (0.3 mg total) into the muscle as needed for anaphylaxis.   Note (*****/*****/*****): Only with bee stings   QUEtiapine (SEROQUEL) 200 MG tablet   Sig: Take 1 
tablet (200 mg total) by mouth nightly at bedtime.   QUEtiapine (SEROQUEL) 25 MG tablet   Sig: Take 3 tablets (75 mg total) by mouth 2 (two) times a day. Take 75 mg twice a day. Indications: 8am and 2 pm   acetaminophen (TYLENOL) 500 MG tablet   Sig: Take 500 mg by mouth every 6 (six) hours as needed for pain (specific location in comments).   amoxicillin-clavulanate (AUGMENTIN) 875-125 mg per tablet   Sig: Take 1 tablet (875 mg of amoxicillin total) by mouth 2 (two) times a day.   Patient not taking: Reported on *****/*****/*****   bacillus coagulans-inulin 1 billion-250 cell-mg Cap   Sig: Take 250 mg by mouth daily.   butalbital-acetaminophen-caffeine (FIORICET, *****) 50-325-40 mg per tablet   Sig: Take 1 tablet by mouth every 4 (four) hours as needed for headache.   calcium carbonate 1,000 mg (400 mg elemental) *****   Sig: Take 1 tablet (1,000 mg total) by mouth 2 (two) times a day with meals.   catheter (CURITY ***** CATHETER *****) *****   Sig: Use 1 insertion kit twice per month to relieve urinary retention   catheter 18 Fr Misc   Sig: Use 1 catheter twice per month to relieve urinary retention   divalproex (DEPAKOTE) 250 MG DR *****   Sig: Take 3 tablets (750 mg total) by mouth every 12 (twelve) hours.   dolutegravir (*****) 50 mg Tab   Sig: Take 1 tablet (50 mg total) by mouth daily.   emtricitabine-tenofovir alafenamide (*****) 200-25 mg tablet   Sig: Take 1 tablet by mouth daily.   famotidine (PEPCID) 20 MG tablet   Sig: Take 1 tablet (20 mg total) by mouth 2 (two) times a day.   gabapentin (NEURONTIN) 300 MG capsule   Sig: Take 3 capsules (900 mg total) by mouth every evening.   Patient taking differently: Take 900 mg by mouth every evening. 1200/1200/900   gabapentin (NEURONTIN) 400 MG capsule   Sig: Take 3 capsules (1,200 mg total) by mouth 2 (two) times a day.   ibuprofen (ADVIL,MOTRIN) 600 MG tablet   Sig: Take 1 tablet (600 mg total) by mouth every 6 (six) hours as needed.   latanoprost (XALATAN) 0.005 % 
ophthalmic solution   Sig: Place 1 drop into each eye nightly at bedtime.   levoFLOXacin (LEVAQUIN) 500 MG tablet   Sig: Take 1 tablet (500 mg total) by mouth daily.   lidocaine (*****) 2 % ***** jelly   Sig: Apply 10 mL topically every 28 days.   melatonin 3 mg Tab   Sig: Take 2 tablets (6 mg total) by mouth nightly.   Patient taking differently: Take 5 mg by mouth nightly at bedtime.    Note (*****/*****/*****): Taking 3mg nightly   methenamine (HIPREX) 1 gram tablet   Sig: Take 1 tablet (1 g total) by mouth 2 (two) times a day with meals.   miscellaneous medical supply Misc   Sig: Use 1 catheter secure when changing catheter twice per month to relieve urinary retention   oxybutynin (DITROPAN) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth 3 (three) times a day.   prednisoLONE acetate (PRED *****) 1 % ophthalmic suspension   Sig: Place 1 drop into each eye daily.   propranoloL (INDERAL) 10 MG immediate release tablet   Sig: Take 1 tablet (10 mg total) by mouth 3 (three) times a day.   senna (SENOKOT) 8.6 mg tablet   Sig: Take 1 tablet by mouth daily.       Facility-Administered Medications: None        Medication List      STOP taking these medications     amoxicillin-clavulanate *****-***** mg per tablet  Commonly known as:  Augmentin      ibuprofen 600 MG tablet  Commonly known as:  ADVIL,MOTRIN      levoFLOXacin 500 MG tablet  Commonly known as:  LEVAQUIN        TAKE these medications        Instructions    acetaminophen 500 MG tablet  Commonly known as:  TYLENOL   Take 500 mg by mouth every 6 (six) hours as needed for pain (specific location in comments).      bacillus coagulans-inulin 1 billion-250 cell-mg Cap   Take 250 mg by mouth daily.      butalbital-acetaminophen-caffeine 50-325-40 mg per tablet  Commonly known as:  FIORICET, *****  Last time this was given:  ***** *****, *****  8:42 PM   Take 1 tablet by mouth every 6 (six) hours as needed for headache.  What changed:  when to take this      calcium carbonate 
1,000 mg (400 mg elemental) *****  Last time this was given:  ***** *****, *****  8:37 AM   Take 1 tablet (1,000 mg total) by mouth 2 (two) times a day with meals.      ***** Curity ***** ***** ***** *****  Generic drug:  catheter   Use 1 insertion kit twice per month to relieve urinary retention      ***** catheter 18 Fr Misc   Use 1 catheter twice per month to relieve urinary retention      divalproex 250 MG DR *****  Commonly known as:  DEPAKOTE  Last time this was given:  ***** *****, *****  8:35 AM   Take 3 tablets (750 mg total) by mouth every 12 (twelve) hours.      emtricitabine-tenofovir alafenamide 200-25 mg tablet  Commonly known as:  *****  Last time this was given:  ***** *****, *****  8:36 AM   Take 1 tablet by mouth daily.      EpiPen 2-***** 0.3 mg/0.3 mL auto-injector  Generic drug:  EPINEPHrine   Inject 0.3 mL (0.3 mg total) into the muscle as needed for anaphylaxis.      famotidine 20 MG tablet  Commonly known as:  PEPCID   Take 1 tablet (20 mg total) by mouth 2 (two) times a day.      ***** gabapentin 400 MG capsule  Commonly known as:  NEURONTIN  Last time this was given:  Ask your nurse or doctor   Take 3 capsules (1,200 mg total) by mouth 2 (two) times a day.  What changed:  Another medication with the same name ***** *****. Make sure you understand how and when to take each.      ***** gabapentin 300 MG capsule  Commonly known as:  NEURONTIN  Last time this was given:  Ask your nurse or doctor   Take 3 capsules (900 mg total) by mouth every evening.  What changed:  additional instructions      latanoprost 0.005 % ophthalmic solution  Commonly known as:  XALATAN  Last time this was given:  ***** *****, *****  8:***** *****   ***** 1 drop into each eye nightly at bedtime.      lidocaine 2 % ***** jelly  Commonly known as:  *****   Apply 10 mL topically every 28 days.      melatonin 3 mg Tab   Take 2 tablets (6 mg total) by mouth nightly.  What changed:  how much to take      methenamine 1 gram tablet  Commonly known as:  HIPREX  Last 
time this was given:  ***** *****, *****  8:36 AM   Take 1 tablet (1 g total) by mouth 2 (two) times a day with meals.      miscellaneous medical supply Misc   Use 1 catheter secure when changing catheter twice per month to relieve urinary retention      oxybutynin 5 MG tablet  Commonly known as:  DITROPAN  Last time this was given:  ***** *****, *****  8:35 AM   Take 1 tablet (5 mg total) by mouth 3 (three) times a day.      prednisoLONE acetate 1 % ophthalmic suspension  Commonly known as:  PRED *****  Last time this was given:  ***** *****, *****  8:34 AM   Place 1 drop into each eye daily.      propranoloL 10 MG immediate release tablet  Commonly known as:  INDERAL  Last time this was given:  ***** *****, *****  8:37 AM   Take 1 tablet (10 mg total) by mouth 3 (three) times a day.      ***** QUEtiapine 200 MG tablet  Commonly known as:  SEROquel  Last time this was given:  Ask your nurse or doctor   Take 1 tablet (200 mg total) by mouth nightly at bedtime.      ***** QUEtiapine 25 MG tablet  Commonly known as:  SEROquel  For:  8am and 2 pm  Last time this was given:  Ask your nurse or doctor   Take 3 tablets (75 mg total) by mouth 2 (two) times a day. Take 75 mg twice a day. Indications: 8am and 2 pm      senna 8.6 mg tablet  Commonly known as:  SENOKOT  Last time this was given:  ***** *****, *****  8:32 PM   Take 1 tablet by mouth daily.      ***** 50 mg Tab  Generic drug:  dolutegravir  Last time this was given:  ***** *****, *****  8:36 AM   Take 1 tablet (50 mg total) by mouth daily.         ***** This list has 6 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.               Where to Get Your Medications      Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 butalbital-acetaminophen-caffeine 50-325-40 mg per tablet                    Hospital Care Team 
  Service: Brain Injury  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 9:00 AM ***** ***** *****, MD ***** Infectious Disease Medicine *****-*****-*****     *****/*****/***** 3:15 PM (Arrive by 3:00 PM) ***** BTM CT1 ***** CT *****, ***** *****-*****-***** ***** Rad Main    *****/*****/***** 3:30 PM ***** ***** *****, MD ***** Department of Neurosurgery *****-*****-*****     *****/*****/***** 3:00 PM ***** ***** *****-*****, ***** ***** Rehab Services at ***** ***** *****-*****-***** ***** 850 *****    *****/*****/***** 1:00 PM ***** ***** *****'*****, MD Ophthalmic Consultants of ***** in ***** *****-*****-***** ***** *****    *****/*****/***** 9:30 AM ***** ***** *****, MD ***** ***** Center for Primary Care *****-*****-*****         Your Follow-Up Appointments            ***** ***** *****, MD   Specialty:  Neurosurgery    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Follow up on *****/*****/*****    Instructions:  at 3:30pm        Signed Discharge Orders (From admission, onward)     Ordered        *****/*****/***** 0930  Activity as tolerated         *****/*****/***** 0930  Discharge diet     Question:  Diet type  Answer:  Regular       *****/*****/***** 0930  No dressing needed         *****/*****/***** 0930  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.       *****/*****/***** 1257  Ambulatory referral to External Speech Language     Question Answer Comment   Reason for Referral Cognitive Impairment    Reason for Referral Executive Function  
  Patient level of mobility supervision    Please select all situations that apply Recent stroke/trauma           *****/*****/***** 1258  Ambulatory referral to External Physical Therapy     Question Answer Comment   Location: PT External    Reason for Referral: Weakness    Reason for Referral: Loss of Motion    Reason for Referral: Difficulty with ADL's    Reason for Referral: Conditioning    Reason for Referral: Gait    Reason for Referral: Balance           *****/*****/***** 1258  Ambulatory referral to External Occupational Therapy     Question Answer Comment   Location: Patient *****    Reason for Referral: Decreased Functional Mobility    Reason for Referral: Decreased Safety at *****    Reason for Referral: Impaired Balance                     Discharge instructions and important events and results    *****  ***** ***** *****  *****, *****, *****      Dear ***** *****,    You were admitted to ***** to provide rehabilitation services after your shunt was placed for NPH. You were evaluated by the physical therapists, occupational therapists, and speech/language pathologists who played a significant role in your rehabilitation.    You were evaluated regularly by the physiatrists, rehabilitation doctors, who helped guide your medical and rehabilitation course while you were in the hospital.    Please follow-up with your Primary Care Physician regarding this admission. Please also follow up with your neurosurgeon.    Please call ***** with any questions regarding this rehabilitation stay. The main hospital phone number is *****-*****-*****. For emergencies, please call 911 or proceed to the nearest emergency department.    Please continue to take all of your medications as prescribed, and please attend all of your follow-up appointments as scheduled.    We wish you the best of health,    ***** *****, MD   On behalf of your entire 
rehabilitation team at *****         Community Services     ***** Physiatry  ***** ***** *****  ***** *****  *****, ***** *****  Tel: (*****) *****-*****  Brain Injury Association of Massachusetts - Main Office  ***** ***** *****, ***** *****  *****, ***** *****  Telephone: (*****) *****-***** or (*****) *****-*****  Email: *****@*****.*****   Website: *****://*****.*****    ***** (***** Acquired Brain Injury) Support Group  *****: This group is for brain injury survivors, family and friends. It is a large support group, averaging 60 or more people each month.  There is no registration or fee to attend. We also have a facilitated family/caregiver (brain injury-related) support group which meets at the same time.     Where: ***** ***** ***** and B   When: Usually meets on the first Saturday of the month, from 10 am to Noon. If a first Saturday falls on a holiday weekend, the ***** Support Group will meet on the second Saturday. There is no meeting in *****.  Outings: We have two outings a year (***** and *****), which take the place of that month's meetings.   Contact: ***** *****, ***** ***** *****-*****-***** or *****@*****.*****  Visit our website for more information    Website Resources:  *****.*****.*****  *****.*****.*****  *****.*****.*****- this website has a free electronic version of ***** *****  written by TBI survivors.  Contact Information  It has been a pleasure working with you and your family during your stay here at *****.  If you have any questions/concerns regarding your discharge plan or post hospital arrangements, please do not hesitate to contact me:    ***** *****, *****/L, CCM  Tel: (*****) *****-*****    Email: *****@*****.*****                     Exam   Temperature: 36.5 째C (97.7 째F) (*****/*****/***** 0720) | Heart Rate: (!) 59 (*****/*****/***** 0720) | BP: 129/75 (*****/*****/***** 0834) | Respiratory Rate: 20 (*****/*****/***** 0720)  | 
SpO2: 97 % (*****/*****/***** 0720)  O2 Device: None (Room air) (*****/*****/***** 0752)    |        Weight: 98 kg (216 lb) (*****/*****/***** 1447)  Height: 188 cm (6' 2.02"") (*****/*****/***** 1545)         BMI (Calculated): 28.11 (*****/*****/***** 1545)    Discharge Exam    Significant Discharge Exam Findings:  Gen:WDWN age appropriate adult M, NAD   HEENT:normocephalic, *****  *****: regular rate and rhythm, pulses in tact and symmetric, no edema  Pulm: clear bilaterally, comfortable on room air  Abd: soft, nontender, nondistended  Extremities: symmetric, normal bulk, no atrophy  Skin: no lesions or wounds  Neuro:Awake, alert, appropriate to simple conversation  Executive function: accurate *****, cube drawing limited (incomplete, unsteady lines)  Moves all 4 extremities purposefully, spontaneously and to command. *****/***** B/l upper and lower extremity strength except ***** *****/***** b/l   Psych: consistent mood and affect; pleasant, cooperative             Orientation Level: Oriented X3   Cognition: Follows commands         Speech: Clear     Special Needs    Special Needs:  Physical Mobility Impairment  Comments:  walker/wheelchair              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 6.10 *****/*****/***** *****    RBC 4.26 (L) *****/*****/***** *****    HGB 13.6 (L) *****/*****/***** *****    HCT 40.4 (L) *****/*****/***** *****    MCH 31.9 (H) *****/*****/***** *****    MCV 94.8 *****/*****/***** *****    PLT 176 *****/*****/***** *****    RDW 13.3 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 141 *****/*****/***** *****    ***** 4.6 *****/*****/***** *****    ***** 104 *****/*****/***** *****    CO2 28 *****/*****/***** *****    BUN 7 (L) *****/*****/***** *****    CRE 0.73 *****/*****/***** *****    ***** 9.2 *****/*****/***** *****    GLU 100 *****/*****/***** *****                                "
151027748,0,1,"

Note Date: *****/*****/*****  Time: 1042

Note Type: Initial note

Note Title: Vascular Surgery Consult Note

Signed by ***** *****, MD on *****/*****/***** at 4:58 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 6:37 am

 

Consulting Service: medicine 

Reason for Consult: bilateral DVT and contraindication to

anticoagulation



HPI: ***** history of metastatic prostate cancer (last chemotherapy

*****/*****), thrombocytopenia,recent admission for chronic subdural

hematoma with midline shift s/p evacuation (*****/*****) who is now

readmitted as a transfer from *****-***** for bilateral posterior

tibial vein thrombosis. He presented initially one week ago with

complaint of lower abdominal pain and was treated with oral

antibiotics for what was thought to be diverticulitis. His

abdominal symptoms are now resolved. However, three days ago, he

developed acute onset of bilateral lower extremity edema that has

persisted. Denies pain, weakness or parasthesias in the legs. No

chest pain or SOB. Of note, he has also developed hematuria

during his OSH stay thought to be secondary to radiation cystitis

that has since resolved. 

Repeat ***** ***** ***** was performed on *****/***** showing

increase in size of his residual SDH from 1.2cm to 2.4cm though

there is no midline shift. Neurosurgery has recommended that no

anticoagulation be started given his recent SDH and chronic

thrombocytopenia. Vascular surgery is now being consulted to

comment on need for possible IVC filter placement given the

contraindication to anticoagulation. 



PMH: 

metastatic prostate cancer (to bone, liver, lung, jaw)- last

chemotherapy *****/***** 

radiation cystitis c/b hematuria 

bladder tumor (with plan for TURP) 

HTN 

polymyalgia rheumatica (on prednisone) 

thrombocytopenia 



PSH: 

Prostatectomy 

R burr ***** for evacuation of SDH (*****/*****) 



*****: Prednisone 20mg QD, Triamterene/HCTZ 75mg/50mg QD,

Lisinopril 10mg QD, Amlodipine 5mg QD, Omeprazole 20mg daily,

APAP prn, KCl 40mEq BID, Mag Oxide 400mg QD, Oxycontin 15mg BID,

Oxy IR 5mg prn 



Allergies: doxycycline / Penicillins 



Social History: 

Past history ETOH, ***** many years. Denies tobacco or illicit 

drug use. 



Family History:  Denies family history of clotting disorder.  



ROS: Otherwise negative except as noted in *****. 



Physical exam: 

Vitals- 98.3 *****/***** 77 18 95 RA

General- well-appearing, NAD 

HEENT- PERRL, EOMI, sclera anicteric, moist mucus membranes 

Cardiac- RRR 

Chest- no increased work of breathing on room air 

Abdomen- soft, nontender, nondistended. No rebound or guarding. 

Ext- WWP, 1+ edema of feet and calves. Palpable

femoral/popliteal/DP/PT pulses bilaterally. No overlying skin

changes. Motor and sensation to light tough intact bilaterally.  



Labs: 

*****/*****/*****/*****   

3.*****/*****/0.8  

 

4.8>8.*****/*****.8<71 

  

PT: 12.2  PTT: 23.2  INR: 1.1 



Imaging: 



*****/***** bilateral lower extremity duplex 

FINDINGS: There is normal *****, flow, and augmentation

of the bilateral common femoral, femoral, and popliteal veins.

One of the paired posterior tibial veins demonstrate lack of

***** and lack of flow on color and spectral Doppler

imaging bilaterally, compatible with thrombosis. The peroneal

veins are suboptimally visualized bilaterally. There is normal

respiratory variation in the common femoral veins bilaterally. 

No evidence of medial popliteal fossa (*****) cyst. 

IMPRESSION: Thrombosis of posterior tibial veins bilaterally. 



*****/***** CT head non-contrast: 

FINDINGS: Predominantly hypodense mixed density right

subdural/epidural fluid collection measures 2.4 cm in thickness, 

increased from ***** ***** (previously 1.2 cm). Amount of

hyperdense component in the fluid collection is similar or less

compared to before. There is increased effacement of right

frontal sulci. Leftward midline shift by 4 mm is stable. The

ventricles stable in size and configuration. Right frontal burr

hole is noted. Mild mucosal thickening is noted in the right

sphenoid sinus. The visualized portion of the orbits are

unremarkable. 

IMPRESSION: 

1. Predominantly hypodense mixed density right subdural/epidural 

fluid collection is increased in thickness compared to *****

*****. There is increased right frontal sulcal effacement but

leftward midline shift is unchanged. 



Assessment/plan: ***** history of metastatic prostate cancer (on

chemotherapy), thrombocytopenia, with recent admission for

chronic subdural hematoma with midline shift s/p evacuation

(*****/*****) who is now readmitted as a transfer from *****-***** with

bilateral posterior tibial vein thrombosis. On exam, he has lower

extremity edema to the knee but no skin or neurological changes

with palpable pulses. There is no evidence of threat to limb.

Vascular surgery consulted given neurosurgery concerns that the

patient should not be anticoagulated. Agree with IVC filter

placement with IR service today given they are available. Please

contact us if they are not and we can add on as able.  Keep both

legs ace wrap compressed and elevated. Otherwise vascular surgery

to sign off if not needed for IVC filter placement. 



Plan formulated with Dr. ***** *****, vascular surgery chief

resident.



***** ***** 

General Surgery ***** 

"
111626896,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. female (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Patient is unable to respond      Health Care Agents          There are no health care agents on file.          Code Status at *****: Full Code (Presumed)       Discharge address same as *****: No                   Hospitalization Summary     Admission Diagnosis     Subdural hematoma [*****.00]               Principal Problem:    Subdural hematoma  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** Left ***** ***** Vs. Mini Craniotomy For Subdural Hematoma *****, *****                ***** (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    Patient cleared for discharge to rehab    Patient to follow up with Dr. ***** in 2 weeks.         Pending Results     None           Hospital Course   ***** year old female with a hx of HTN, Hyperlipidemia, CAD on 81 mg ASA for cardioprotection,presents as a transfer from ***** with intermittent word finding difficulty and headache, head CT with 2cm chronic subdural hematoma.       Hospital Course: Patient was admitted to the Neurosurgical Service on *****/*****/***** for a Left ***** for subdural hematoma evacuation with Dr. *****.  Patient was taken to the operating room on HD#2 (*****/*****) and underwent an uncomplicated procedure. Please see Dr. *****'s separately dictated operative note for details. Post-operatively patient was 
extubated and after a brief uneventful stay in *****, patient was transferred to the Neurosurgical ICU for close monitoring. She remained hemodynamically stable, neurologically at baseline, and with her pain well-controlled throughout her hospital stay. On POD#1 she was transferred to the floor in stable condition and was deemed ready for discharge on POD#3.    NEURO: Patient remained neurologically at baseline throughout her hospital stay. A+O x 3, EOMI, FS, TM, sensation grossly intact, ***** *****/***** RUE/RLE, *****/LLE *****/***** x4, no drift. Post op Head CT showed changes of left parietal mini crani with post surgical pneumocephalus. Decreased hypoattenuating left subdural collection with remaining hyperdense component. Decreased effacement of left lateral ventricle and left to right midline shift. Prior to subdural drain pull - CT obtained and showed decreasing pneumocephalus and similar hemorrhage appearance (stable). Subdural drain was pulled on POD#2 without complication and closed with a figure of 8 Monocryl suture. Keppra x7 days.     Post operatively the patient was with word finding difficulties -- LTM started. LTM with left >right ***** slowing consistent with cerebral dysfunction and mild encephalopathy. No epileptiform activity. LTM discontinued on *****/*****.    CV: Hemodynamically stable at all times. Hold home ASA x1 month.    GU: Voiding on her own after foley removed without signs of retention or UTI.    GI: Tolerating a regular diet with no nausea or vomiting.    HEME: SQH and SCDs for DVT prophylaxis.    ID: ***** at all times. Perioperative ABX. Incision remained clean, dry, and intact with no evidence of erythema, warmth, or hematoma.    *****: Ambulating on her own and feels ready to go home with no services needed. At the time of discharge her pain remained well controlled on oral medications. Patient will follow up with Dr. ***** in 2 weeks.         Medications   Allergies: Ace inhibitors; Amlodipine; 
Codeine; Macrolide antibiotics; Penicillins; Phs other free text-see phs viewer; Statins-hmg-coa reductase inhibitors; and Vancomycin    None        Discharge Medications      START taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.       carvedilol 3.125 MG tablet   Also known as:  COREG    Take 1 tablet (3.125 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:30 AM       hydroCHLOROthiazide 25 MG tablet   Also known as:  HYDRODIURIL    Take 1 tablet (25 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:28 AM       levETIRAcetam 500 MG tablet   Also known as:  KEPPRA    Take 1 tablet (500 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:28 AM                 Immunizations Administered for This Admission     Name *****    Pneumococcal polysaccharide PPSV23  Deferred (Patient Refused)             Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** *****. ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:     Follow-Up Services            ***** ***** REHABILITATION HOSPITAL   Specialty:  Rehabilitation    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1430  Activity as tolerated         *****/*****/***** 1430  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1430  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD, PhD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your 
medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD, PhD at (*****)*****-*****.                     Exam   Temperature: 37.1 째C (98.8 째F) (*****/*****/***** 1126) | Heart Rate: 61 (*****/*****/***** 1126) | BP: 154/68 (*****/*****/***** 1126) | Respiratory Rate: 20 (*****/*****/***** 1126)  | SpO2: 96 % (*****/*****/***** 1126)  O2 Device: None (Room air) (*****/*****/***** 1126)  O2 Flow Rate (L/min): 2  O2 Flow Rate (mL/min): 2 | FiO2 (%): 40 % (*****/*****/***** 1400)      Weight: 51.4 kg (113 lb 6.4 oz) (*****/*****/***** 0024)  Height: 152.4 cm (5') (*****/*****/***** 1449)         BMI (Calculated): 21.5 (*****/*****/***** 1449)    Discharge Exam    Significant Discharge Exam Findings:  A+O x 3,  EOMI, PERRL,  FS, TM,   Sensation grossly intact,  ***** RUE/RLE *****/*****, *****/LLE *****/***** x4, no drift.  Incision CDI              Orientation Level: Oriented X7   Cognition: Follows commands         Speech: Clear     Vision: Functional  Hearing: Functional   Assistive Devices: None       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 9.95 *****/*****/***** *****    RBC 3.89 (L) *****/*****/***** *****    HGB 11.9 *****/*****/***** *****    HCT 37.0 *****/*****/***** *****    MCH 30.6 *****/*****/***** *****    MCV 95.1 (H) *****/*****/***** *****    PLT 221 *****/*****/***** *****    RDW 14.4 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 144 *****/*****/***** *****    ***** 3.7 *****/*****/***** *****    ***** 108 (H) *****/*****/***** *****    CO2 24 *****/*****/***** *****    BUN 11 *****/*****/***** *****    CRE 0.44 (L) *****/*****/***** *****    ***** 8.5 (L) *****/*****/***** *****    GLU 124 (H) *****/*****/***** *****    GLUPOC 110 *****/*****/***** *****    GLUPOC 110 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.1 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.9 *****/*****/***** *****    PTT 26.8 *****/*****/***** *****    INR 1.1 *****/*****/***** *****                        "
150649394,0,1,"

Note Date: *****/*****/*****  Time: 1942

Note Type: Initial note

Note Title: Neurology Consult Note

Signed by ***** *****, MD on *****/*****/***** at 11:42 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 3:18 pm

 



Neurology Resident ***** *****



Reason for Consultation: ?*****



HPI: The patient is a ***** with history of Afib and unprovoked DVT

now off Coumadin due to suspected R traumatic frontal SDH

diagnosed ***** *****, recent hip fracture s/p ORIF *****/*****, CLL

(untreated, followed here) here with two episodes of ***** numbness

and one accompanying ""robotic speech"" and eye closure now

resolved. 

 

In ***** *****, patient had a mechanical fall from tripping on a

slipper without head strike and without loss of consciousness. 

Noncontrast head CT at that time showed what was thought to be

6mm right subdural hematoma with slight midline shift and

effacement of the lateral ventricle and significant sulcal

effacement.  She was also found to have right superior pubic

ramus and ischial fracture as well as rectus sheath hematoma with

active extravasation in the setting of INR of 4.1.  She was

reversed with ***** ***** and vitamin K and her hip fracture was

managed conservatively.  She was then discharged ***** rehab.

She re-presented with a mechanical fall on ***** ***** with posterior

head strike and severe left hip pain.  This is managed with left

hip ORIF on ***** *****.  On this presentation noncontrast head CT

showed unchanged extra-axial hyperdensity in the right subdural

space.  It was noted that this was unusual for subdural hematoma

not evolving over time with differential including slow

hemorrhage vs diffuse dural thickening. MRI was recommended per

radiology.  She was discharged on 500 mg Keppra twice daily. She

re-presented on ***** ***** with worsening pain and inability to

weight-bear on her left leg. ***** films and CT pelvis were

reassuring and she was again discharged with no acute surgical

intervention. NCHCT again repeated with the same unchanged

***** and interpretation.



Today, she presents for 2 episodes of left hand numbness and one

episode accompanied by alteration in speech.  While some

documentation reports left facial droop, it is confirmed with

family that there was no droop or slurred speech on today's

episode. 



The first episode occurred on Saturday when the patient was

sitting at the dinner table.  Patient reports that she

experienced gradual onset numbness in all 5 fingers as well as

possible weakness in the hand.  She would try to pick something

up but was ""unable to"" but she is unsure if this was due to

weakness or the numbness.  Denies any pain.  This episode was

witnessed by 1 of her daughters who felt that when she spoke, one

side of her mouth was not moving but no dysarthria.  The family

also reports that when the episode happened, her left arm was

""hanging"" but patient reports that she was definitely able to

move it.  The symptoms lasted just several minutes per the

daughter.  The patient reports that it lasted around half an

hour.  No adventitious movements were noted by patient or family.

She was not confused afterwards   And was otherwise at her

baseline for the rest of the day in the next day.



Today, at around 5:30 PM, when sitting at the dinner table she

again experienced the same gradual onset left hand numbness

involving all 5 fingers.  In addition, her son reported she was

talking ""strangely"" with a ""robotic like quality"".  For example,

she said the phrase ""I will be okay"" with prolonged spaces in

between the words.  She also started to close her eyes and seemed

to be in a ""***** state"".  Family denies any facial droop or

talking out of one side of her mouth.  No adventitious movements.

Patient reports that she thinks the episode lasted around 30

minutes.





In addition, the patient's daughter reports that she has had

intermittent, very short duration, every other day tingling in

her left hand.  They have also noticed that her left foot has

been swollen for several days.  Of note, she has had increasing

fatigue, increasing pain in her left hip, inability to walk as

well with her walker, and continued night sweats.



On neurologic review of systems, the patient denies headache,

lightheadedness, or confusion. Denies difficulty with producing

or comprehending speech. Denies loss of vision, blurred vision,

diplopia, vertigo, tinnitus, hearing difficulty, dysarthria, or

dysphagia.  Denies any current muscle weakness, numbness,

paresthesia.  Denies loss of sensation. Denies bowel or bladder

incontinence or retention. + Difficulty with gait and using

walker since her left hip fracture and surgery.



On general review of systems, the pt denies recent fever or

chills.  No night sweats or recent weight loss or gain. Denies

cough, shortness of breath.  Denies chest pain or tightness,

palpitations.  Denies nausea, vomiting, diarrhea, constipation or

abdominal pain.  No recent change in bowel or bladder habits.  No

dysuria. ++ Left hip pain.



PMH/PSH:

CLL (dx in 2014, did not complete first cycle of chemo due

to side effects and has thus far declined other treatments,

followed by heme/onc here)

Depression

Fibromyalgia

Paroxysmal Afib

HTN

DVT (spontaneous in right leg within last 5 years, prompting

anticoagulation with Coumadin that was held due to recurrent

falls and subdural hematoma)

Osteoarthritis





MEDICATIONS:

In addition to the following, she is taking: 



Keppra 500mg BID

Tramadol 25mg BID vs Oxycodone 5mg Q6H PRN pain. 

Calcium carbonate 500mg TID PRN reflux

Timolol 0.5% drops - 1 drop OU BID



 --------------- --------------- --------------- ---------------

Active Medication list as of *****/*****/*****:

 

Medications - Prescription

ACYCLOVIR - acyclovir 5 % topical ointment. Apply small amount

Three times/day as needed for Cold sores around mouth

ALBUTEROL SULFATE [VENTOLIN HFA] - Ventolin HFA 90 mcg/actuation

aerosol inhaler. INHALE 1-2 PUFFS PO EVERY 4 TO 6 HOURS AS NEEDED

FOR COUGHING OR WHEEZE

FLUTICASONE - fluticasone 50 mcg/actuation nasal

spray,suspension. SPRAY 2 PUFFS INTO EACH NOSTRIL TWICE DAILY

X3*****, ***** ONCE A DAY

METOPROLOL SUCCINATE - metoprolol succinate ER 50 mg

tablet,extended release 24 hr. 1 tablet(s) by mouth Once/Day

OMEPRAZOLE - omeprazole 40 mg capsule,delayed release. 1

capsule(s) by mouth Once/day as needed for heartburn/reflux - 

(Dose adjustment - no new Rx)

PAROXETINE HCL - paroxetine 20 mg tablet. TAKE 1 TABLET BY MOUTH

DAILY

 

Medications - OTC

ACETAMINOPHEN [TYLENOL EXTRA STRENGTH] - Tylenol Extra Strength

500 mg tablet. up to 3 tablet(s) by mouth daily as needed for

pain -  (Prescribed by Other Provider: med rec)

--------------- --------------- --------------- ---------------





ALLERGIES:

 ----------------------------------------------------------------

Allergies  (Last Verified *****/*****/***** by *****,***** M..):

----------------------------------------------------------------

Lipitor                                                          

Pravachol                                                        

Sulfa (Sulfonamide Antibiotics)                                  

Xarelto                                                          



SOCIAL HISTORY:

 Lives at home alone - smokes 1 cigarette/5 days. No ETOH. NO

illicits. Lives at home alone. Walking with walker since the hip

fracture. Family very involved and spends time with her. One son,

two daughters local. 





FAMILY HISTORY:

n/a                       



PHYSICAL EXAMINATION

98.*****, HR 73, *****/*****, RR 14, 97% on RA Glu 102



General: Awake, cooperative, NAD.

HEENT: NC/AT, no scleral icterus noted, Dry mucous membranes.

Neck: Supple

Pulmonary: Lungs CTA anteriorly

Cardiac: RRR, nl. S1S2, no M/R/G noted

Abdomen: soft, NT/ND

Extremities: +b/l ankle edema left more than right. 

Skin: no rashes or lesions noted.



Neurologic:



-Mental Status: Alert, oriented x 3. Able to relate history

without difficulty. Attentive, able to name ***** ***** *****

*****. Language is fluent with intact repetition and

comprehension. Normal prosody. There were no paraphasic errors.

Speech was not dysarthric. Able to follow both midline and

appendicular commands. Possible mild visual neglect of left

hemifield with DSS. There was no evidence of apraxia.



-Cranial Nerves:

II, III, IV, VI:  PERRL 2 to 1.5mm and brisk. EOMI without

nystagmus or diplopia. Mild b/l ptosis vs dermatochalasia. VFF to

confrontation with DSS to visual stim on the left as above.

V: Facial sensation intact to light touch.

VII: No facial droop, facial musculature symmetric.

VIII: Hearing intact to finger-rub bilaterally.

IX, X: Palate elevates symmetrically.

*****: 5/5 strength in trapezii and SCM bilaterally.

XII: Tongue protrudes in midline.



-Motor: Decreased bulk globally - pt cachectic. Mild pronation of

the left hand. 

+head, jaw, vocal tremor. 



  Delt Bic Tri ***** FFl ***** ***** Quad ***** ***** ***** EHL 

L 4+    5   *****-  *****   5  4+ 5   4*****   4***** 4+*****   5     5-  

R  5    5   5   5   5  5  5   5    5  5     5     4+   

*****Very pain limited. 



-Sensory: No deficits to light touch, pinprick, vibratory sense

(10-12 seconds at great toes). No extinction to DSS on repeated

testing.



-DTRs:

  *****  ***** ***** *****

*****  2   2    0   0

R  2   2    0   0

Plantar response was extensor bilaterally. 



-Coordination: +postural tremor bilaterally on

finger/nose/finger. HKS not tested due to left hip pain. 



-Gait: Deferred because of significant left hip pain. 



Laboratory Data:



 *****/*****/*****: WBC: 79.1***** (A.***** 1900 *****/*****/*****)

 *****/*****/*****: HGB: 7.8*****

 *****/*****/*****: HCT: 25.4*****

 *****/*****/*****: Plt Count: 75*****

 *****/*****/*****: MCV: 104*****

 *****/*****/*****: RDW: 15.9*****



*****/*****/*****: Neuts%: 8***** (200 CELL DIFFERENTIAL)

 

 *****/*****/*****: Lymphs: 84*****

 *****/*****/*****: *****: 2*****

 *****/*****/*****: Eos: 1

 *****/*****/*****: BASOS: 0

 *****/*****/*****: Atyps: 0

 *****/*****/*****: Metas: 1*****

 *****/*****/*****: *****: 2*****



*****/*****/*****: PTT: 23.8*****

 *****/*****/*****: PT: 10.8

 *****/*****/*****: INR: 1.0

 *****/*****/*****: Target INR: 2.0-3.0



*****/*****/*****: Na: 138

 *****/*****/*****: K: 4.4

 *****/*****/*****: Cl: 100

 *****/*****/*****: CO2: 26

 *****/*****/*****: BUN: 22*****

 *****/*****/*****: Creat: 1.0

 *****/*****/*****: Glucose: 99 (If fasting, 70-100 normal, >125

provisional diabetes)



 

*****/*****/*****: BUN: 22*****

 *****/*****/*****: Creat: 1.0

 *****/*****/*****: Urine Blood (*****): *****

 *****/*****/*****: Urine Nitrite (*****): NEG

 *****/*****/*****: Urine Protein (*****): 30*****

 *****/*****/*****: Urine Glucose (*****): NEG

 *****/*****/*****: Urine Ketone (*****): NEG

 

 *****/*****/*****: Urine ***** (*****): *****

 *****/*****/*****: Sp Grav: 1.015

 

 *****/*****/*****: WBC: 130*****

 *****/*****/*****: Bacteria: MOD*****



 



IMAGING:

Non-Contrast CT of Head: Persistent R subdural hyperintensity

with associated R hemispheric sulcal effacement and R lateral

ventricle effacement and MLS around 5-6mm on my measurement not

significantly changed since *****/***** or *****/*****. 



ASSESSMENT:

***** with history of Afib now off Coumadin due to suspected R

traumatic frontal SDH diagnosed ***** *****, recent hip fracture

s/p ORIF *****/*****, CLL (untreated, followed here) here with two

episodes of ***** numbness and one accompanying ""robotic speech""

and possible altered consciousness, now resolved. 

General exam significant for left more than right ankle edema,

cachexia, pallor, fatigue, severe left leg hip pain with passive

and active ROM. Neurologic exam with normal MS, possible left

visual hemifield neglect with double simultaneous stim, mild L

facial asymmetry with good activation, mild left pronation and

mild UMN pattern weakness in left arm, pain limited testing of

left leg, b/l upgoing toes with decreased reflexes in legs. 



From her description and from the known findings on her NCHCT,

her episodes sound most consistent with seizure vs symptomatic R

subdural/dural process. There is a significant amount of swelling

on her NCHCT in *****, ***** and again today. It is interesting

that the appearance of the subdural collection has not changed

since *****/*****. On her last presentation, an MRI Brain was suggested

and I agree because the lack of change may indicate that the

hyperdense substance is not blood. ***** metastases is a

possibility but is atypical of CLL. If the subdural process is

not blood, then she needs a malignancy workup - ?malignant

conversion of CLL, development of lymphoma?



Given the gradual nature of her symptoms during each episode, the

relatively stereotyped nature of each episode, and the fact that

she has a known/active subdural process causing a significant

amount of sulcal effacement/edema in the right hemisphere, I do

not think that it is likely that these episodes are reflective of

***** (a new process).  I do acknowledge that she is off

anticoagulation and is at risk for ischemic stroke.  However, she

would not be a candidate for any anticoagulation or antiplatelet

until the workup of this subdural process is resolved.



 - MRI Brain w and w/o contrast to evaluate for dural metastases.

Would request that this be done in the ED as it drastically

changes dispo/management. (If the MRI confirms that subdural

process is blood - management per neurosurgery. 

 If the MRI raises the possibility of malignancy - defer workup

and management to oncology in discussion with patient. Workup may

require LP and meningeal biopsy.)

 - Consult neurosurgery given the possibility of a slow subdural

bleed per radiology

 - ***** to neurosurg regarding the need for intervention given

8mm MLS and symptomatic - UMN weakness in the left arm and

episodes of numbness. 

 - Increase Keppra to 1000mg BID

 - If Brain MRI unable to be obtained in the ED, pending

neurosurgery recs, pt could be admitted to oncology since she is

followed here with neurology/***** following. She additionally

is having generalized fatigue, worsening pain from left hip, and

night sweats - may need discussion regarding treatment of CLL. 

 - If oncology feels this is inappropriate, please page us.

 







***** *****, MD

Neurology Resident, PGY-4

*****





Addendum by ***** *****, MD on *****/*****/***** at 3:18 pm:

The history and examination were reviewed with the neurology

resident. I have interviewed and examined the patient. The

history of present illness, past medical history, family and

social history are described in detail in the neurology resident

notes. The pertinent systems are reviewed.  All other systems are

negative. I agree with the history, examination, assessment and

plan as delineated in the resident note. I would add the

following. 



Ms. ***** states that she is feeling restless today. She recalls

taking medications this morning and wonders if this is related.

She denies any new neurologic symptoms. She recalls that over the

last few months, she has had a few episodes of L hand numbness

and a sensation that her arm is ""ice cold"" lasting for 20-30

minutes. She pointes to the forearm in the T1 distribution and

note that this happens sometimes when she is leaning on her arm.

When it happens her fingers are stiff and difficult to control. 



ROS: She states that she has lost about 10 pounds unintentionally

this year. 



On exam she has diffuse sarcopenia superimposed on focal atrophy

of the *****'s bilaterally, R>L. There is 4+ weakness throughout her

reflexes are 1's throughout except the ankles where they are

absent. Her cortical sensory testing is normal. 



MRI 

IMPRESSION:  

  

1.  Thickening of the extra-axial space with homogeneous

enhancement overlying  the right cerebral hemisphere most likely

reflects lymphoma given the clinical history of CLL, and also

chloroma is a consideration.  There is also abnormal signal

intensity and enhancement within the right masticator space,

likely also lymphoma.  These findings not clearly changed from

the most recent CT head, however are worse from a ***** ***** ***** CT

head and sinus exam.  The extra-axial thickening result in 6 mm

right to left midline shift.  The basilar cisterns are patent. 

2.  Probable small subacute infarct within the left superior

frontal gyrus. 

3.  Diffusely abnormal signal intensity within the bone marrow. 

This may related to anemia, smoking, metabolic disease, and/or

diffuse marrow infiltration. 



Labs: 



79.1 \ 7.8 / 75 

       25.4 



Impression: Ms. ***** is an ***** yo woman with a PMH of CLL who

was admitted after an episode of ""robotic speech"" and L hand

numbness. Her son provided additional history at the bedside

consistent with what is described above. This is more suggestive

of a seizure than ***** although she remains at risk for a stroke.

I agree with the increased dose of Keppra to 1000 mg BID. If she

continues to have symptoms of feeling restless, this can be a

side effect of the keppra however and should be monitored. If she

tolerates it poorly or has recurrent episodes, another AED can be

considered. She does not require an EEG at this time as it would

not change management. 



Her MRI findings are highly concerning for CNS lymphoma. An LP

would be warranted for diagnosis if in line with her goals of

care. Her platelets must be monitored in anticipation of the

procedure as she is prone to thrombocytopenia.



Her MRI identified a probable subacute left superior frontal

gyrus infarct. If possible, she should be started on antiplatelet

therapy and a statin. Her last LDL was 113 *****/*****/*****. Her lipids

and A1c should be rechecked, an MRA of the head and neck should

be obtained and a TTE. She is at high risk for cerebral

infarction due to her history of malignancy.



Her intermittent L forearm numbness is more suggestive of

cervical radiculopathy and she would benefit from a soft collar.

She has a history of reported cervical stenosis.   



Recommendations discussed with the primary team. Please page with

questions. "
150003985,0,1,"

Note Date: *****/*****/*****  Time: 1656

Note Type: Initial note

Note Title: Cardiology Consultation Initial Note

Signed by ***** *****, MD on *****/*****/***** at 5:01 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 8:48 am

 

DIVISION OF CARDIOLOGY COMPREHENSIVE CONSULTATION NOTE



CHIEF COMPLAINT: Patient is seen in consultation today at the

request of ***** *****-*****, MD. We are asked to give

consultative advice regarding evaluation and management of aortic

stenosis.



Requesting Attending: *****-*****,*****

Outpatient Cardiologist: *****, ***** ***** MD



HISTORY OF PRESENT ILLNESS: Mr. ***** is an ***** y/o man with

history of CAD s/p PCI (***** to RCA and PTCA of the OM2 in 1994

and ***** to mid-RCA 2004), PVD s/p bilateral iliac artery

angioplasty, AAA s/p open repair, HTN, HLD, former smoker, and

history of chronic subdural hematomas who presented for this

admission with lethargy after an unwitnessed ***** and was found

to have unchanged SDH. Cardiology is consulted for evaluation and

management of newly discovered aortic stenosis.



The patient initially presented to ***** on *****/***** after being

found down by his wife in his bathroom. The patient reports that

he felt a pain in his leg and grabbed for the shower ***** but

fell and hit his head. He denies any antecedent chest pain,

palpitations, or shortness of breath. A NCHCT showed bilateral,

chronic SDH. During his hospitalization he was admitted to the

neurosurgical service for monitoring and was treated with keppra

for 7 days. He was discharged to rehab on *****/*****.  



On *****/*****, the patient was readmitted after family concern for

increased lethargy revealed increased size of his chronic SDH.

The patient went to the OR on *****/***** for relief of cerebral

compression, which was uncomplicated. Repeat NCHCT on *****/*****

demonstrated stability of the SDH and the patient was discharged

to rehab. During this hospitalization he was also noted to have

recurrent episodes of NSVT including one episode on reported VT

on *****/***** in the ?PACU with flat A-line, reportedly recovered

without intervention.  



While at rehab the patient was noted to be climbing out of his

bed and may have had an unwitnessed ***** after being found on the

floor of his room on his hands and knees. The patient does not

recall the circumstances of this *****. He had repeat head imaging

and was also seen by neurosurgery who stated that his SDH was

stable and that he required no neurosurgical intervention. He was

admitted to medicine for further evaluation of his *****.



On interview, the patient reports that he feels well. His head is

sore, and an old left shoulder injury is bothering him. But

otherwise he denies any chest pain, shortness of breath, or

palpitations. He tells me that he is able to climb a flight of

stairs with difficulty. He denies any other complaints.



A full 10 point review of systems was reviewed and is otherwise

negative in detail.



PAST MEDICAL/SURGICAL HISTORY:

CAD s/p RCA stenting and ***** PTCA *****/***** and s/p RCA stenting in

2004

PVD s/p PTA of bilateral iliac arteries

AAA s/p open repair (2004)

Hypertension

Hyperlipidemia

Microvascular ischemic 4th nerve palsy 

COPD  

*****'s diverticulum  

Gallstone pancreatitis, s/p lap chole 2005   

Nephrolithiasis  

BPH   

Osteoarthritis, s/p cortisone injections of the right hip

Spinal stenosis

Right total hip replacement 2010  

Right frozen shoulder  

Left flank neuroma  



HOME MEDICATIONS:

The Preadmission Medication list may be inaccurate and requires

***** investigation

1. Acetaminophen *****-***** mg PO Q8H:PRN Pain - Mild 

  Reason for PRN duplicate override: Alternating agents for

similar severity

2. Albuterol Inhaler 1 ***** ***** Q6H:PRN SOB 

3. Docusate Sodium 100 mg PO BID 

4. Gabapentin 300 mg PO DAILY 

5. Gabapentin 600 mg PO QHS 

6. Heparin 5000 UNIT SC BID 

7. Isosorbide Dinitrate 10 mg PO BID 

8. LevETIRAcetam 500 mg PO Q12H 

9. Lidocaine 5% Patch 1 PTCH TD QAM:PRN pain 

10. Losartan Potassium 50 mg PO DAILY 

11. Metoprolol Tartrate 25 mg PO BID 

12. ***** 17.2 mg PO HS 

13. Tamsulosin 0.4 mg PO QHS 

14. TraMADol 25 mg PO Q6H:PRN pain 

15. Lisinopril 5 mg PO DAILY 



CURRENT MEDICATIONS:

Albuterol Inhaler 1 ***** ***** Q6H:PRN SOB

CefTRIAXone 1 gm IV Q24H

Docusate Sodium 100 mg PO BID

Gabapentin 300 mg PO/NG DAILY

Gabapentin 300 mg PO/NG QHS

Heparin 5000 UNIT SC BID

Isosorbide Dinitrate 10 mg PO/NG BID

Lidocaine 5% Patch 1 PTCH TD QAM:PRN pain

Losartan Potassium 50 mg PO/NG DAILY

LevETIRAcetam 500 mg PO Q12H Duration: 4 Days

Metoprolol Tartrate 25 mg PO/NG BID

***** 17.2 mg PO/NG HS

Tamsulosin 0.4 mg PO QHS



ALLERGIES: NKDA



SOCIAL HISTORY: Former smoker (smoked ***** ***** ***** years, quit

2004), rare alcohol, ***** *****. Retired industrial machine knives

manufacturer (used to supply all the knives for *****-*****).

Lives at home with wife who is blind and hard of hearing.  



FAMILY HISTORY: Mother died from ""coronary thrombosis"" at age *****.

Father died from cerebral hemorrhage at age *****.



PHYSICAL EXAMINATION     

Vitals: T: 98.9 degrees Fahrenheit, BP: 147/73 mmHg supine, HR 75

bpm, ***** ***** *****, *****: 97% on RA.

Orthostatic vital signs: +by BP criteria

Lying: HR 62 BP 135/90

Sitting: HR 74 BP 132/74

Standing: HR 77 BP 105/70

Gen: Pleasant, calm. No acute distress.

HEENT: No conjunctival pallor. No icterus. MMM. OP clear. Right

cranial sutures.

NECK: Supple, No LAD. No JVD. ***** carotid upstrokes.

CV: PMI in 5th intercostal space, mid clavicular line. RRR.

normal S1,S2. Mid-late peaking crescendo-decrescendo III/VI

systolic murmur in ***** without radiation to carotids.

LUNGS: ***** expiratory wheeze.

ABD: NABS. Soft, NT, ND. 

EXT: WWP, NO CCE. Full distal pulses bilaterally.

SKIN: No rashes/lesions, ecchymoses.

NEURO: A&Ox3. CN 2-12 grossly intact. Preserved sensation

throughout and moves all four extremities. Gait assessment

deferred

PSYCH: Mood and affect normal.



TELEMETRY *****/*****/*****: NSR



#ECG *****/*****/***** (03;16): NSR at 67 bpm, left axis deviation, LBBB

(known), ST elevations and T wave inversions in V1-V3 (new

compared to ECG from *****/*****/*****)



#ECHO *****/*****/*****:

The estimated right atrial pressure is 0-5 mmHg. There is

moderate symmetric left ventricular hypertrophy. The left

ventricular cavity size is normal. There is mild regional left

ventricular systolic dysfunction with basal to mid inferior

hypokinesis. Diastolic function could not be assessed. The right

ventricular cavity is mildly dilated with normal free wall

contractility. The aortic valve leaflets are moderately

thickened. Significant aortic stenosis is present (not

quantified). Trace aortic regurgitation is seen. The mitral valve

leaflets are not well seen. There is moderate functional mitral

stenosis (mean gradient 6 mmHg at a heart rate of 102 bpm) due to

mitral annular calcification. Moderate (2+) mitral regurgitation

is seen. The pulmonary artery systolic pressure could not be

determined. There is a trivial/physiologic pericardial effusion. 



IMPRESSION: Suboptimal image quality. 

1) Moderate LVH with mild regional LV systolic dysfunction c/w

prior myocardial infarction in the RCA territory.

2) Significant aortic stenosis is present (visual assessment for

parasternal short axis) however was not further quantified using

traditional methods. However, judging from the LV to ***** pressure

difference, the aortic stenosis severity is likely severe.

3) Moderate mitral annular calcification with moderate mitral

regurgitation and moderate functional mitral stenosis.



Compared with the prior study (images reviewed) of *****/*****/*****,

there now is AS and ***** with functional *****. ***** has progressed.



#ECHO (*****/*****/*****):

The left atrium is normal in size. There is mild regional left

ventricular systolic dysfunction with hypokinesis of the basal

inferior wall. The aortic valve leaflets are mildly thickened. No

aortic regurgitation is seen. The mitral valve leaflets are

mildly thickened. Trivial mitral regurgitation is seen. The

estimated pulmonary artery systolic pressure is normal. There is

no pericardial effusion.  



#Cardiac catheterization (*****/*****/*****):



1.Selective coronary angiography of this right-dominant system 

demonstrated no significant flow-limiting lesions. The LMCA was 

angiographically normal. The LAD had mild luminal irregularities.

The LCX had a 30% proximal stenosis, and OM1 had a 40% stenosis. 

The RCA had a 30% proximal stenosis and a widely patent

previously-placed ***** stent. 

2. Limited resting hemodynamics demonstrated moderate systemic

arterial hypertension with an aortic pressure of *****/***** mmHg. 

  

FINAL DIAGNOSIS:     

1. No angiographically-apparent flow-limiting coronary artery

disease. 

2. Moderate systemic arterial hypertension. 



#Cardiac catheterization (*****/*****/*****):

1. Selective coronary angiography demonstrated a right dominant 

circulation. The LMCA was without angiographically-apparent 

flow-limiting disease. The LAD was free of angiographic apparent

lesions until mild disease of 50% was seen in the mid vessel near

the takeoff of a moderate-sized first diagonal. The remainder of

the LAD and its smaller diagonal and septal branches were without

angiographically apparent flow limiting disease. The LCX had a

50% stenosis at the takeoff of a moderate-sized OM1. The

remainder of the distal LCX was without angiographically-*****

flow limiting disease through its course in the AV groove. The

RCA was dominant vessel and had a 20% proximal stenosis and a 90%

stenosis near the takeoff of the first marginal. 

2. Left sided filling pressures were high normal. 

3. Left ventriculogram showed an LVEF of 55% with preserved LV

function. 

4. The right iliac artery was tortuous requiring a glidewire for

access. 

5. Successful stenting of the mid RCA with a 3.***** ***** *****

(See 

PTCA comments). 

  

FINAL DIAGNOSIS:     

1. Three vessel coronary artery disease. 

2. Normal ventricular function. 

3. Left ventricular end-diastolic pressure was high normal. 

4. Successful stenting of the mid RCA with a Drug Eluting Stent. 



#Cardiac catheterization (*****/*****/*****):



COMMENTS: 1) Angiography revealed a normal Left Main, minimal 

disease in the LAD, a 60-70% eccentric lesion in the LCX at the

level of the OM1 and a 30% lesion at the origin of the OM1, and a

90% lesion in the mid-portion of a large branching OM2.  The RCA

was occluded in its mid-portion with the distal vessel and its

branches filling by ***** and left to right collaterals. 

2) Resting hemodynamics were within normal limits. 

3) Successful stent placement in the RCA and PTCA of the OM2 (see

PTCA comments for details). 

  

FINAL DIAGNOSIS:     

1. Two vessel coronary artery disease. 

2. Successful stent placement in the RCA, and successful PTCA of

the OM2. 



#Cardiac catheterization (*****/*****/*****):

1. Coronary arteriography of this right dominant system revealed 

two-vessel coronary artery disease.  The LM was normal.  The LAD

had only mild luminal irregularities; D1 had a 20% stenosis. The

LCX had diffuse disease with a maximal stenosis of 30% at its

proximal portion; OM1 had a 30% stenosis; a large OM2 had a 95%

stenosis. The RCA was subtotally occluded proximally and filled

distally anterograde and via left-to-right collaterals. 

2. The resting hemodynamic parameters were remarkable for

elevated left-sided filling pressures (LVEDP 20 mmHg), with a

normal cardiac index. 

3. ***** left ventriculography revealed an ejection fraction of 59%

with mild inferoapical hypokinesis. 

4. Aortography revealed severe aortoiliac disease with subtotal 

occlusion of the right iliac artery (see Radiology report for

details). 

5. Acute urinary retention was treated successfully with a ***** 

catheter. 

  

FINAL DIAGNOSIS:     

1. Two vessel coronary artery disease. 

2. Mild systolic and moderate diastolic ventricular dysfunction. 

3. Aortoiliac disease (see Radiology report). 



LABORATORY DATA:

CKMB: 2->2->1

Troponin: 0.02->0.03->-0.02



CBC: 7.*****/*****.*****/*****.*****/*****



BMP:

140,104,19

------------

3.7,26,0.9



PT/PTT/INR: 12.*****/*****.*****/*****.1



Imaging:



CTA Chest (*****/*****/*****):

1. No evidence of pulmonary embolism. 

2. ***** in bud and nodular opacities in the left lower lobe may

be reflective of aspiration/ small airway disease. 



CT Head without contrast (*****/*****/*****):

Status post frontal parietal craniotomy with recent removal of

subdural drain. Persistent bilateral mixed density subdural

hematomas are unchanged in volume with stable mass effect. No new

hemorrhage. 

  

ASSESSMENT: Mr. ***** is an ***** y/o man with history of CAD s/p

PCI (***** to RCA and PTCA of the OM2 in 1994 and ***** to mid-RCA

2004), PVD s/p bilateral iliac artery angioplasty, AAA s/p open

repair, HTN, HLD, former smoker, and history of chronic subdural

hematomas who presented for this admission with lethargy after an

unwitnessed ***** and was found to have unchanged SDH. Cardiology

is consulted for evaluation and management of newly discovered

aortic stenosis.



It is unclear at this time whether the patient's ***** is related

to his newly-discovered aortic stenosis. The patient reports that

he has good exercise tolerance and is able to climb a flight of

stairs without chest discomfort or shortness of breath. He is not

able to identify any antecedent symptoms for his *****. His aortic

valve area and gradient cannot be quantified on his

echocardiogram due to suboptimal image quality. Therefore we

recommend a repeat focused echocardiogram with ***** probe to

examine the aortic valve and LVOT with and without valsalva.



The patient is also noted to be orthostatic by blood pressure

criteria, which may have contributed to his *****. We recommend

holding the patient's ISDN given his orthostasis.



Thus far, he has had no arrhythmias on telemetry that would

explain his *****. However, his ECG from *****/*****/***** does show new

ST-T wave changes compared with prior. The patient is

asymptomatic, although he has been taking ISDN. His troponins are

mildly elevated with flat MB. We do not think he is having ACS

and he does not require urgent cardiac catheterization at this

time. If repeat focused echocardiogram confirms severe AS, the

patient would likely require angiography as part of evaluation

for valve repair.



RECOMMENDATIONS:

- Repeat focused echocardiogram to evaluate aortic valve

- Hold isosorbide dinitrate

- Restart aspirin when able to do so safely from neurosurgical

perspective



These recommendations are preliminary until reviewed by an

attending ***** ***** below.



***** *****, MD

*****, Internal Medicine





Addendum by ***** *****, MD on *****/*****/***** at 8:48 am:

Seen and examined with Dr *****.  I agree with her note above. 

Cause of his recurrent syncopal episodes is unclear and he is

unable to give any ***** history.  ***** he does have a

prominent murmur, by echo he has no significant AS.  In view of

orthostatic findings on exam, syncope could be related to

postural hypotension and would avoid any meds likely to cause

this.  He will follow up with Dr *****."
150688553,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: Psychiatric Consultation Initial Note

Signed by ***** ***** *****, MD on *****/*****/***** at 6:54 am  Affiliation: *****

 

***** PSYCHIATRIC CONSULTATION



CHIEF COMPLAINT (with identification of patient, consultee, and

sources with contact info): Agitation with QTc 530



DURATION (TOTAL UNIT TIME AND FACE-TO-FACE TIME) and COMPONENTS

IF RELEVANT (E/M, C/C, Psychotherapy): 60 minutes



HISTORY OF PRESENT ILLNESS:

     Mr. ***** is a ***** year old man with a PMH of HTN, DM, CAD

s/p CABG, AF, MR s/p bioprosthetic MVR, high degree AV block s/p

dual chamber PPM, chronic subdural hematomas, and dementia, who

was noted to be more lethargic than usual at his SNF, who was

sent to the ***** ***** and found to be bradycardic, and was

transferred to ***** for further evaluation and planned generator

change tomorrow. The patient became agitated overnight, and

psychiatry was consulted for recommendations for managing

agitation.

     The patient had reportedly become more lethargic and

fatigued than usual while at his nursing home. He had abrasions

on his left leg, which were concerning for a possible *****. He

was sent to the ***** *****, where head imaging was reassuring. When

he was found to be bradycardic in the high 30s-40s, he was

transferred to *****. He was admitted with the plan for a

generator change tomorrow morning. The patient became acutely

agitated overnight, trying to choke staff and pulling out lines.

He was on telemetry, but he pulled the leads off. Given his

*****, his QTc was 530, and he received 0.5mg IM Ativan x1.

No antipsychotics were administered. When this writer arrived at

the patient's room, he was found lying in bed asleep in physical

restraints. When his name ***** *****, ***** ***** ***** few phrases

that could not be understood. He was unable to open his eyes

voluntarily. 



Collateral information from the patient's son, *****-*****-*****:

At his baseline, he has no patience for hospitals or doctors. He

will ***** out his tubes and walk on out. At the nursing home, he

is much better. He's not happy, but he has a higher degree of

understanding and acceptance. He recognizes his children, but he

may forget a grandchild. He might know who the president *****. He

doesn't usually know what day of the week it is. He usually knows

where he is. He'll be close to the correct year. At the SNF, he

does not get agitated to the point where he would swing out at

somebody. Currently, he is able to dress himself and clean

himself. He is able to feed himself. He's been in the Carriage

***** for 6-7 weeks. He lives in the memory loss unit, which is a

locked unit. Over the last few months, it appears that the

dementia has been getting worse. His dementia first started 2

years ago. Yesterday he was more lethargic than usual. Normally,

he has a good ***** of energy. He spends his day sitting in a

chair, reading a newspaper for 10 minutes, sleeping for 15

minutes, etc. He spends most days with off and on naps. He's

normally able to sleep at night. He was never suicidal. *****-*****

months ago, he had visual hallucinations, but not at baseline.



PAST PSYCHIATRIC HISTORY:

Hospitalizations: none

Current treaters and treatment: none

Medication and ECT trials:

Self-injury: son denies

***** to others: son denies

Access to weapons: son denies



PAST MEDICAL HISTORY, per Dr. *****'s note *****/*****/*****:

-Coronary Artery Disease s/p 2 vessel CABG (*****->LAD and

reversed SVG->PDA) in *****/*****

-Ascending Aortic Aneurysm s/p replacement with Dacron *****

graft in *****/*****

-Mitral Regurgitation s/p MVR with porcine valve in *****/*****

-Atrial fibrillation on Coumadin

-h/o ***** s/p ablation *****/***** 

-h/o high degree AV block (presented with syncope) s/p Medtronic

PPM *****/*****

-Diabetes Mellitus  

-Hypertension  

-Hyperlipidemia

-Anemia

-s/p GI bleed *****/***** thought to be due to gastritis

-Lymphangiectasia in the ileum and jejunum

-Diverticulosis 

-Benign Prostatic Hypertrophy  

-Obesity  

-Hiatal hernia  

-S/p excisional biopsy of mass on left knee *****/***** (cavernous

hemangioma)

-Splenic hypodensity  

-Anti-K ***** (***** ***** antigen neg blood) 

-Bilateral cataracts



MEDICATIONS, per *****:

Terazosin 5 mg PO QHS 

Pravastatin 40 mg PO QPM 

Glucose Gel 15 g PO PRN hypoglycemia protocol 

Glucagon 1 mg IM *****:PRN hypoglycemia   

Dextrose 50% 12.5 gm IV PRN hypoglycemia 

Insulin SC  (per Insulin Flowsheet)

Finasteride 5 mg PO DAILY 

Aspirin 81 mg PO/NG DAILY 

 

ALLERGIES: NKDA 



SUBSTANCE ABUSE HISTORY:

None known



FORENSIC HISTORY:

Arrests: son denies

Convictions and jail terms: son denies

Current status (pending charges, probation, parole): N/A



FAMILY PSYCHIATRIC HISTORY, per son: none





SOCIAL HISTORY, per son:

Born and raised in: *****

Family/Support: 5 children, 8 grandchildren, 12 great

grandchildren

Housing: lives in ***** ***** memory unit, the Carriage *****

*****-*****-*****.

Education: finished optometry degree

Employment/Income: social security, savings

Spiritual: Jewish

Trauma history: none, but saw combat in *****



ROS: could not assess



EXAM: 

*****VS:  98.0 41 *****/***** 17 94% RA



Neurological:  

*****station and gait: could not assess

*****tone and strength: could not assess strength, but tone appeared

increased in the lower extremities

cranial nerves: pupils pinpoint, could not assess other CN's 

abnormal movements: writhing/fidgeting in all four

extremities,tremor in right hand 

frontal release: could not assess



Cognition: 

Wakefulness/alertness: could mumble in response to name, could

not voluntarily open eyes

*****Attention (digit span, *****): could not assess

*****Orientation: could not assess

*****Memory: could not assess

***** of knowledge: could not assess 

Executive function (go-no go, *****, trails, FAS): could not

assess

Calculations: could not assess 

Abstraction: could not assess

Visuospatial: could not assess

*****Speech: low volume, incoherent, *****

*****Language: could not assess

 

Mental Status:

*****Appearance: an elderly man with grey hair, lying asleep in bed

with mild writhing and fidgeting, in 3-point restraints (left leg

not restrained), with abrasions on his left leg, appears stated

age, wearing hospital gown

Behavior: sleeping, *****, will not/cannot open eyes

*****Mood and Affect: could not assess

*****Thought process / *****associations: could not assess

*****Thought Content: could not assess

*****Judgment and Insight: could not assess



DATA:

Labs:

*****/*****/*****: Na: 136

*****/*****/*****: K: 4.2

*****/*****/*****: Cl: 100

*****/*****/*****: CO2: 27

*****/*****/*****: BUN: 22*****

*****/*****/*****: Creat: 1.0

*****/*****/*****: Glucose: 78

*****/*****/*****: Ca: 8.8

*****/*****/*****: Mg: 2.2

*****/*****/*****: PO4: 2.8



*****/*****/*****: WBC: 7.1

*****/*****/*****: HGB: 12.1*****

*****/*****/*****: HCT: 37.8*****

*****/*****/*****: Plt Count: 93*****



*****/*****/*****: Urine Glucose (*****): NEG

*****/*****/*****: Urine Protein (*****): 30

*****/*****/*****: Urine Bilirubin (*****): NEG

*****/*****/*****: Urobilinogen: 4*****

*****/*****/*****: Urine Ketone (*****): *****

*****/*****/*****: Urine Blood (*****): ***** 

*****/*****/*****: Urine Nitrite (*****): NEG

*****/*****/*****: Urine ***** (*****): NEG

*****/*****/*****: TSH: 1.9



ALT 16, AST 45, Alk Phos 135, TBili 1.3, Alb 3.1



Other results: none

Releases obtained/outside records reviewed: none



DSM 5 DIAGNOSIS:

delirium



ASSESSMENT:

     Mr. ***** is a ***** year old man with a PMH of HTN, DM, CAD

s/p CABG, AF, MR s/p bioprosthetic MVR, high degree AV block s/p

dual chamber PPM, chronic subdural hematomas, and dementia, who

was noted to be more lethargic than usual at his SNF, who was

sent to the ***** ***** and found to be bradycardic, and was

transferred to ***** for further evaluation and planned generator

change tomorrow. The patient became agitated overnight, and

psychiatry was consulted for recommendations for managing

agitation.

     Mr. ***** is likely delirious, as he has an altered mental

status with increased fatigue at his nursing home, and now acute

agitation overnight. This pattern of being more fatigued than

usual, and then agitated, is consistent with the waxing and

waning pattern of delirium, as opposed to a more consistent

pattern of dementia. Collateral information from the patient's

son indicates that at baseline the patient is relatively calm,

sitting in a chair and reading a newspaper, and that this level

of agitation is very unusual for him. 

     Possible etiologies for delirium in this patient include

toxic-metabolic, infectious, seizures (pt was previously on

keppra which was reportedly tapered off), CVA (multiple vascular

risk factors), hypoxic damage *****/***** hypoperfusion in the setting of

bradycardia, or a worsening of his chronic subdural hematoma,

though this is less likely given reassuring head imaging at the

OSH. 

     As the patient's QTc is currently 530, and he cannot be

monitored on telemetry as he has ripped off his leads, we would

recommend holding all antipsychotics and QTc ***** agents.

Please see below for recommendations.



RECOMMENDATIONS:

-patient is currently delirious with likely etiologies including:

toxic-metabolic, infectious, seizures, CVA, hypoxic damage *****/*****

hypoperfusion in the setting of bradycardia, or a worsening of

his chronic subdural hematoma, another neurological condition

-would advise judicious use of deliriogenic medications

(specifically *****, pain medications, and

anticholinergics)&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;&#8206

;

-patient should be monitored on constant observation 



-as QTc is 530, would recommend avoiding antipsychotics

-avoid QTc ***** agents if possible

-benzodiazepines are deliriogenic, however in this case

controlling the patient's agitation to allow him to have this

procedure may outweigh this risk

-in cases of extreme agitation where the benefits of chemical

restraints outweigh the risks, would recommend the

following:&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;

ativan 0.25mg IM x1, if no response after 30 minutes can repeat

once

-please obtain full neuro exam when possible and consider a full

neurological and medical work-up for causes of delirium

-pt was previously on keppra, which was recently stopped, could

the patient be having seizures? Could consider EEG.

-consider consulting neurology



-would advise that pain can be a major source of

delirium&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;

-would advise that patient should have a regulated sleep/wake

cycle&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;&#8206;

-would advise that patient should have mechanical restraints

(e.g. soft-restraints vs. ***** vest) as necessary if in agitated

delirium but these should be used only if necessary to prevent

harm to patient or others&#8206;

&#8206;-would advise orienting stimuli (e.g. reminding patient of

their current situation frequently) and involvement of family and

friends as appropriate to reassure and calm patient&#8206; (they

can bring in photographs if this is helpful for family) 



***** *****, MD

***** ***** Psychiatry, PGY-2

*****, please page ***** on nights and weekends



This case was discussed with Dr. *****, psychiatry PGY-*****

***** ***** *****. *****"
121117250,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: Mandarin  What language do you prefer for written communication?: Mandarin    Type of Advance Care Directive(s): None   Does patient have a Health Care Proxy form completed?: Patient is unable to respond      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Full Code (Confirmed)    To be discharged to: Discharged / Transferred to an Inpatient rehabilitation (IRF) including rehabilitation distinct part unit of a hospital  Patient/Family/Caregiver discharge preference/goals : Need to re-evaluate        Discharge address same as *****: No                   Hospitalization Summary     Reason for Admission: Altered mental status  Principal Problem:    Pneumonia  Active Problems:    Altered mental status    Closed fracture of nasal bones    CSF leak    Facial nerve palsy    Impaired mobility and ADLs    NSTEMI (non-ST elevated myocardial infarction)    Subarachnoid hemorrhage following injury, with loss of consciousness  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     Past Procedures (*****/*****/***** to Today)     Date Procedures Providers       *****/*****/***** Occlusion Balloon Test *****, ***** ***** ***** case    *****: *****, ***** *****, MD - *****, ***** *****, MD - *****, ***** *****, MD - Anesthesia *****, ***** *****, CRNA - *****, ***** *****, MD - Primary    *****/*****/***** Endoscopic Endonasal Repair Cerebrospinal Fluid ***** *****, ***** *****, ***** ***** ***** case    *****: *****, ***** *****, MD, PhD - *****, *****, MD - *****, ***** *****, 
CRNA - *****, ***** *****, MD - Anesthesia *****, ***** *****, MD, PhD - Anesthesia *****, ***** *****, MD - Anesthesia *****, ***** *****, MD - *****, ***** *****, MD - Assisting    *****/*****/***** Placement Gastrostomy Tube *****, ***** Open case    *****: *****, ***** *****, MD - *****, *****, MD - *****, ***** *****, MD, PhD - Anesthesia *****, ***** *****, CRNA - ***** ***** *****, *****, MD - Primary              Procedures this admission     Procedure/Test Authorizing Provider    FL Gastrostomy Catheter Primary Placement ***** ***** *****, CNP        Non (OR) Procedures:   *****/***** 1221 Lumbar Puncture  *****/***** 1223 Lumbar Puncture  *****/***** 2200 Note By: ***** ***** *****, MD  *****/***** 1115 Note By: ***** ***** *****, CNP  *****/***** 1649 Arterial Line  *****/***** 1645 Central Line  *****/***** 1316 EXTERNAL VENTRICULAR DRAIN    Items for Post-Hospitalization Follow-Up:    -Fluconazole PO 400 qd for total 4 week course (day 1 is *****/*****/***** to end *****/*****/*****)  - You have CSF culture data pending at *****, it will be followed and it returns positive you will be contacted.        Pending Results     Procedure Component Value Ref Range Date/Time    Cell count & differential, tube 4 [*****]  (Abnormal) Collected:  *****/*****/***** 1213    Lab Status:  Preliminary result Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1341     CSF COLOR COLORLESS COLORLESS      Tube #, CSF 4     CSF TURBIDITY Clear Clear      XANTHOCHROMIA None None      RBC, CSF 5 0 - 5 /uL      CSF ***** Not Done 0.0 %      Nucleated cells, CSF 20 0 - 5 /uL      CSF NEUTS PENDING 0 %      CSF BANDS PENDING 0 %      CSF LYMPHS PENDING 0 - 100 %      CSF REACTIVE LYMPHS PENDING 0 %      CSF ***** PENDING 0 - 100 %      CSF EOS PENDING 0 %      CSF BASO PENDING 0 %      CSF BLAST PENDING 0 %      CSF MACROPHAGE/LINING PENDING 0 %      CSF UNCLASSIFIED PENDING 0 %      NRBC PENDING 0 
/100 WBCs     Cell count/differential, CSF [*****]  (Abnormal) Collected:  *****/*****/***** 1213    Lab Status:  Preliminary result Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1340     CSF COLOR COLORLESS COLORLESS      Tube #, CSF 1     CSF TURBIDITY Clear Clear      XANTHOCHROMIA None None      RBC, CSF 265 0 - 5 /uL      CSF ***** Not Done 0.0 %      Nucleated cells, CSF 27 0 - 5 /uL      CSF NEUTS PENDING 0 %      CSF BANDS PENDING 0 %      CSF LYMPHS PENDING 0 - 100 %      CSF REACTIVE LYMPHS PENDING 0 %      CSF ***** PENDING 0 - 100 %      CSF EOS PENDING 0 %      CSF BASO PENDING 0 %      CSF BLAST PENDING 0 %      CSF MACROPHAGE/LINING PENDING 0 %      CSF UNCLASSIFIED PENDING 0 %      NRBC PENDING 0 /100 WBCs     Culture/smear, CSF [*****] Collected:  *****/*****/***** 1213    Lab Status:  In process Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1307    Total protein, CSF [*****] Collected:  *****/*****/***** 1213    Lab Status:  In process Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1253    Serology Saved Specimen [*****] Collected:  *****/*****/***** 1213    Lab Status:  Preliminary result Updated:  *****/*****/***** 1249     SEROLOGY ***** TEST PENDING    Urine culture [*****]  (Abnormal)  (Susceptibility) Collected:  *****/*****/***** 1146    Lab Status:  Preliminary result Specimen:  Urine Updated:  *****/*****/***** 0741     Special Requests No Special Requests     Urine Culture Abundant (>=100,000 CFU/ml) KLEBSIELLA (ENTEROBACTER) AEROGENES    Fungal culture [*****] Collected:  *****/*****/***** 2019    Lab Status:  Preliminary result Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1155     Special Requests --     FUNGAL, MYCOBACTERIUM, BACTERIAL CULTURES, ***** EXTRA  NO, CSF SHUNT OR OTHER FOREIGN MATERIAL IS NOT PRESENT, AND PATIENT IS NOT RECEIVING INTRATHECAL MEDICATION.       Fungal Culture Only NO FUNGUS OR ***** ISOLATED AFTER 19 DAYS    Mycobacterial culture/smear [*****] Collected:  *****/*****/***** 2019    Lab Status:  
Preliminary result Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1424     Special Requests --     FUNGAL, MYCOBACTERIUM, BACTERIAL CULTURES, ***** EXTRA  NO, CSF SHUNT OR OTHER FOREIGN MATERIAL IS NOT PRESENT, AND PATIENT IS NOT RECEIVING INTRATHECAL MEDICATION.       SMEAR NO ACID FAST BACILLI OBSERVED     Mycobacterial Culture NEGATIVE FOR MYCOBACTERIA AFTER 16 DAYS    Fungal culture w/ wet prep [*****]  (Abnormal)  (Susceptibility) Collected:  *****/*****/***** 0812    Lab Status:  Preliminary result Specimen:  Cerebrospinal Fluid Updated:  *****/*****/***** 1028     Special Requests YES, CSF SHUNT OR OTHER FOREIGN MATERIAL ***** *****, ***** PATIENT IS RECEIVING INTRATHECAL MEDICATION.     WET PREP ***** ***** WITH PSEUDOHYPHAE     Fungal Cult/Wet Prep ***** ***** (***** parapsilosis complex)    Miscellaneous lab test [*****] Collected:  *****/*****/***** 1123    Lab Status:  Preliminary result Specimen:  Blood Updated:  *****/*****/***** 1135     TESTS REQUESTED ***** 2 TRANSFERRIN CSF     SPECIMEN/TUBE TYPE PENDING     REQUEST RECEIVED Request received.  A separate order for the requested test will be generated by the laboratory.    Miscellaneous lab test [*****] Collected:  *****/*****/***** 1822    Lab Status:  Preliminary result Specimen:  Blood Updated:  *****/*****/***** 1835     TESTS REQUESTED ***** 2 TRANSFERRIN     SPECIMEN/TUBE TYPE PENDING     REQUEST RECEIVED Request received.  A separate order for the requested test will be generated by the laboratory.             Hospital Course   RED | ***** West | S/P Repair of Skull Base Defect *****/*****    ***** ***** (*****) is a ***** y.o. male on ASA 81 PMH gout sp fall on *****/***** w/complex facial fractures including R mastoid fx (opacified mastoid air cells), L anterior fossa fx (opacified L ethmoid sinus), L orbital fx, SAH/SDH reportedly sp EVD at ***** *****/*****-*****/*****, sp complex facial repair at ***** *****/*****, He reportedly went to rehab neuro intact on a prednisone taper per OSH ENT. There, he was 
reported to have ***** of clear fluid from his R nares while bearing down in bathroom. On the day before presentation, he started to develop lethargy, altered mental status, and fevers. He went to ***** where CTH was significant for pneumocephalus and facial fx, and CXR was significant for multifocal PNA. LP here shows concern for meningitis. EVD placed *****/*****. S/P *****, nasoseptal flap for repair of skull base defect *****/*****. Obvious defect encountered with + fluorescein in sphenoidal sinus.      Mr. ***** was admitted to the ***** on *****/*****/***** and was admitted to the Medical ICU. On presentation to the *****, the patient was febrile to *****.***** and tachypneic to 24 on room air, but other VSS and wnl. His exam was notable for PERRL, dysconjugate gaze, neck stiffness, bibasilar crackles, movement of all extremities spontaneously, and intermittent ability to follow commands.    With guidance by the ID team, he was broadened to vanc/meropenem given concern for nosocomial meningitis, and then linezolid/meropenem when he was found to be VRE colonized. He remained intermittently febrile, with Tmax 101.***** on *****/*****, and WBCs stable at ~19. His PO steroids from ***** were converted to IV solumedrol 48mg qday. The steroids were ultimately tapered per ENT recommendations. Neurology, ENT and OMFS were also consulted, who reviewed a repeat CT head/neck/sinuses and deemed that the facial fracture was stable, although a combo endo/open repair of the CSF leak is being considered by Neurosurg/ENT once the patient is medically stable. 20% R ear TM perforation noted by ENT. Per neuro recs, an MRI brain has been ordered. His mental status per family has reportedly improved from his ED presentation, as he will sometimes respond to his name. Intermittent EEG was placed and was negative for seizures.     On *****/*****/***** he was Transferred to the medicine floor. Neurology, ENT and OMFS were also consulted. They reviewed a repeat CT head/neck/sinuses and 
deemed that the facial fracture was stable, although a combo endo/open repair of the CSF leak is being considered by Neurosurg/ENT once the patient is medically stable. On *****/***** He unfortunately declined overnight with concerning MRI imaging findings. He was ***** to the ICU for management of his persistent somnolence.     ----------------- Transferred to Neurosurgery -------------------    On *****/***** he was transferred to the ***** 6 Neuro ICU service under the care of Neurosurgery. He was intubated and an EVD was placed. Please see separately dictated procedure note by Dr. ***** ***** for details of this procedure.     On *****/*****/***** he was prepped and taken to the OR for an endoscopic endonasal repair of a CSF leak as well as an occlusion balloon test.  Please see separately dictated operative note by Dr. ***** and Dr. ***** ***** for details of this procedure.  Postoperatively, the patient remained intubated and transferred to the Neurological Intensive Care Unit (Neuro ICU) for continuous neurological surveillance and blood pressure control. Post-operatively, his right radial area was flat without hematoma, right hand was warm and well perfused.    He underwent routine post-operative care including periop antibiotics which were continued per ID recommendations and post-operative imaging that was completed and reviewed. He was found to have pneumocephalus for which the EVD remained in place. He remained intubated and an NG tube was placed. His blood pressure was monitored closely. Spot EEG was placed for fluctuating mental status which showed epileptiform discharges but no seizures. He was started on a trial of Keppra x3 days. Serial head CT's were obtained which showed improvement in pneumocephalus.    On *****/*****/***** he was extubated and slowly weaned to room air. His foley catheter was discontinued, and he subsequently required intermittent straight catheterization. He was restarted on his home flomax, 
however, despite several voiding trials he ultimately needed the catheter replaced on *****/*****/*****. At rehab, he should have another voiding and if unsuccessful, he should follow up in the Urology clinic.     His course was complicated by multiple infections for which the Infectious Disease team followed closely throughout his hospitalization and provided recommendations surrounding antibiotics. These antibiotics  included Linezolid and Meropenem for bacterial meningitis until *****/*****/*****, which was 2 weeks from surgery on *****/***** and presumed source control.  IV ambisome and flucytosine was started for complex fungal meningitis, which was eventually narrowed to fluconazole for a total 4-week course.  and a 5-day course of Cefepime for a hospital acquired pneumonia. He had an LP on *****/*****/*****, which showed no growth, and he had a repeat LP on *****/*****/***** (with results pending at the time of discharge). His antibiotic/antifungal regimen at discharge was PO Fluconazole 40mg daily ending on *****/*****/*****; and he should continue on PO Bactrim for a total of 3 days, day 1 was *****/*****/***** for a new UTI.      Endocrine was consulted for a question of adrenal insufficiency as evidenced by hypotension. At their discretion, steroids were started and titrated and he will continue on a slow steroid wean and will followed by endocrine as an outpatient. Taper as below:  - Prednisolone 25 mg po daily x1 week  - Prednisolone 20 mg po daily x 1 week  - Prednisolone 15 mg daily x 2 week.   - He should then have a fu at ***** clinic: ***** ***** at 1:30pm. After that his prednisolone may be adjusted.   Please do not stop GC abruptly.     The Neurology service was consulted on 01/0/2020 for concern of seizures. His Keppra was increased to ***** BID pending an EEG, which was obtained on *****/*****/*****. The EEG showed no frank seizures, and combined with a low clinical suspicion the Keppra was decreased to 500mg BID. He continued to be stable with no 
clinical concern for seizures, so his Keppra was discontinued prior to discharge.     His Ng tube remained and he continued to be followed by SLP who recommended the placement of a Peg tube for adequate nutrition and safe medication administration. On *****/*****/***** he was prepped and taken to interventional radiology for the placement of a G tube. Please see separately dictated procedure note by Dr. ***** ***** for details of this procedure. His tube feeds were advanced per protocol and he tolerated without issue.    His nasal packing remained in place per ENT and was ultimately removed on *****/*****/*****. His EVD remained at zero and open and the output and ICP's were monitored closely. It was slowly titrated starting on *****/***** and on *****/*****/***** the EVD was removed. It was removed at the bedside without complication and the incision was closed with a single absorbable suture.      He was then determined to be medically stable to transfer from the Neuro ICU to the neurosurgery floor service on *****/*****/*****. He was seen and evaluated by physical therapy and occupational therapy in anticipation of discharge. They recommended discharge to inpatient rehab to optimize his recovery.    By the day of discharge on *****/*****/*****, he continued to progress well, voiding good amounts of urine, and tolerating a diet with no complaints of nausea or vomiting. His vital signs were within normal limits on room air. He elicited only minimal discomfort and expressed readiness for discharge to inpatient rehab.          Medications   Allergies: Patient has no known allergies.    Prior to Admission Medications   Prescriptions   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 650 mg by mouth every 6 (six) hours as needed for pain (specific location in comments).   aluminum-magnesium hydroxide-simethicone (MAALOX) *****-*****-***** mg/5 mL Susp   Sig: Take 30 mL by mouth daily as needed (indigestion).   ampicillin sodium/sulbactam Na (UNASYN IV)   Sig: Inject 3 g into 
the vein every 6 (six) hours.   aspirin 81 mg chewable tablet   Sig: Take 81 mg by mouth daily.   atorvastatin (LIPITOR) 80 MG tablet   Sig: Take 80 mg by mouth daily.   bisacodyl (DULCOLAX) 10 mg suppository   Sig: Place 10 mg rectally daily as needed (constipation).   docusate (COLACE) 50 mg/5 mL liquid   Sig: Take 100 mg by mouth every 12 (twelve) hours as needed.   erythromycin (*****) ophthalmic ointment   Sig: Apply 0.5 inches to eye every 8 (eight) hours.   gabapentin (NEURONTIN) 100 MG capsule   Sig: Take 200 mg by mouth every 8 (eight) hours.   heparin 5,000 unit/mL injection   Sig: Inject 5,000 Units under the skin every 8 (eight) hours.   indomethacin (INDOCIN) 50 MG capsule   Sig: Take 50 mg by mouth 2 (two) times a day.   ipratropium-albuterol (DUONEB) 0.5-2.5 mg/3 mL nebulizer solution   Sig: Take 3 mL by nebulization every 4 (four) hours as needed for wheezing or shortness of breath/dyspnea.   lidocaine (LIDODERM) 5 %   Sig: Apply 2 patches topically daily.   melatonin 3 mg Tab   Sig: Take 3 mg by mouth nightly at bedtime as needed (insomnia).   metoprolol tartrate (LOPRESSOR) 25 MG tablet   Sig: Take 12.5 mg by mouth every 12 (twelve) hours.   pantoprazole (PROTONIX) 40 MG tablet   Sig: Take 40 mg by mouth daily.   pediatric multivitamin (*****-VI-*****) chewable tablet   Sig: Take 1 tablet by mouth daily.   polyethylene glycol (MIRALAX) 17 gram packet   Sig: Take 17 g by mouth daily as needed (constipation).   predniSONE (DELTASONE) 10 MG tablet   Sig: Take 30 mg by mouth once.   predniSONE (DELTASONE) 10 MG tablet   Sig: Take 10 mg by mouth once.   predniSONE (DELTASONE) 20 MG tablet   Sig: Take 40 mg by mouth once.   predniSONE (DELTASONE) 20 MG tablet   Sig: Take 20 mg by mouth once.   predniSONE (DELTASONE) 20 MG tablet   Sig: Take 60 mg by mouth.   predniSONE (DELTASONE) 50 MG tablet   Sig: Take 50 mg by mouth once.   sennosides 176 mg/5 mL *****   Sig: 352 mg nightly at bedtime.   tamsulosin 
(FLOMAX) 0.4 mg Cap   Sig: Take 0.4 mg by mouth daily.      Facility-Administered Medications: None        Medication List      STOP taking these medications     erythromycin ophthalmic ointment  Commonly known as:  *****      gabapentin 100 MG capsule  Commonly known as:  NEURONTIN      heparin 5,000 unit/mL injection      pantoprazole 40 MG tablet  Commonly known as:  PROTONIX      pediatric multivitamin chewable tablet  Commonly known as:  *****-VI-*****      predniSONE 10 MG tablet  Commonly known as:  DELTASONE      predniSONE 20 MG tablet  Commonly known as:  DELTASONE      predniSONE 50 MG tablet  Commonly known as:  DELTASONE      UNASYN IV        TAKE these medications        Instructions    acetaminophen 325 mg tablet  Commonly known as:  TYLENOL  Last time this was given:  Ask your nurse or doctor   Take 650 mg by mouth every 6 (six) hours as needed for pain (specific location in comments).      aluminum-magnesium hydroxide-simethicone *****-*****-***** mg/5 mL Susp  Commonly known as:  MAALOX   Take 30 mL by mouth daily as needed (indigestion).      amantadine HCl 50 mg/5 mL solution  Commonly known as:  SYMMETREL  Last time this was given:  ***** *****, ***** 11:59 AM   15 mL (150 mg total) by Gastrostomy Tube route 2 (two) times a day.  Start taking on:  ***** *****, *****      amino acids-protein hydrolysate 15-60 gram-kcal/30 mL *****  Commonly known as:  ***** No Carb  Last time this was given:  ***** *****, *****  9:24 AM   30 mL by Gastrostomy Tube route every 12 (twelve) hours.      aspirin 81 mg chewable tablet   Take 81 mg by mouth daily.      atorvastatin 80 MG tablet  Commonly known as:  LIPITOR  Last time this was given:  ***** *****, *****  8:28 PM   Take 80 mg by mouth daily.      bisacodyl 10 mg suppository  Commonly known as:  DULCOLAX   Place 10 mg rectally daily as needed (constipation).      *****-menthol lotion  Commonly known as:  *****   Apply topically 2 (two) times a day as needed.      
cholecalciferol 2,000 unit tablet  Commonly known as:  VITAMIN D3  Last time this was given:  ***** *****, *****  9:24 AM   Take 1 tablet (2,000 Units total) by mouth daily.  Start taking on:  ***** *****, *****      docusate 50 mg/5 mL liquid  Commonly known as:  COLACE   10 mL (100 mg total) by Gastrostomy Tube route daily as needed.  What changed:    쨌 how to take this  쨌 when to take this      enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  Commonly known as:  LOVENOX  Last time this was given:  ***** *****, *****  8:28 PM   Inject 0.4 mL (40 mg total) under the skin daily.      ergocalciferol 50,000 unit capsule  Commonly known as:  *****  Last time this was given:  ***** *****, *****  9:25 AM   Take 1 capsule (50,000 Units total) by mouth once a week for 3 doses.  Start taking on:  ***** *****, *****      fluconazole 10 mg/mL suspension  Commonly known as:  DIFLUCAN  Last time this was given:  ***** *****, *****  9:25 AM   Take 40 mL (400 mg total) by mouth daily for 3 days.  Start taking on:  ***** *****, *****      indomethacin 50 MG capsule  Commonly known as:  INDOCIN   Take 50 mg by mouth 2 (two) times a day.      insulin lispro 100 unit/mL injection vial  Commonly known as:  *****, HumaLOG  Last time this was given:  ***** *****, ***** 12:16 PM   Inject 0-12 Units under the skin every 6 (six) hours.      ipratropium-albuterol 0.5-2.5 mg/3 mL nebulizer solution  Commonly known as:  DUONEB   Take 3 mL by nebulization every 4 (four) hours as needed for wheezing or shortness of breath/dyspnea.      lidocaine 5 %  Commonly known as:  LIDODERM  Last time this was given:  Ask your nurse or doctor   Apply 2 patches topically daily.      melatonin 3 mg Tab   Take 3 mg by mouth nightly at bedtime as needed (insomnia).      metoprolol tartrate 25 MG tablet  Commonly known as:  LOPRESSOR  Last time this was given:  ***** *****, ***** 10:16 AM   Take 12.5 mg by mouth every 12 (twelve) hours.      omeprazole 2 mg/mL oral 
suspension  Commonly known as:  PriLOSEC  Last time this was given:  ***** *****, *****  9:24 AM   10 mL (20 mg total) by Gastrostomy Tube route daily.  Start taking on:  ***** *****, *****      polyethylene glycol 17 gram packet  Commonly known as:  MIRALAX   Take 17 g by mouth daily as needed (constipation).      ***** prednisoLONE 15 mg/5 mL (3 mg/mL) solution  Commonly known as:  *****  Last time this was given:  Ask your nurse or doctor   8.3 mL (25 mg total) by Gastrostomy Tube route daily for 2 doses.  Start taking on:  ***** *****, *****      ***** prednisoLONE 15 mg/5 mL (3 mg/mL) solution  Commonly known as:  *****  Last time this was given:  Ask your nurse or doctor   6.7 mL (20 mg total) by Gastrostomy Tube route daily for 7 doses.  Start taking on:  ***** *****, *****      ***** prednisoLONE 15 mg/5 mL (3 mg/mL) solution  Commonly known as:  *****  Last time this was given:  Ask your nurse or doctor   5 mL (15 mg total) by Gastrostomy Tube route daily.  Start taking on:  ***** *****, *****      sennosides 176 mg/5 mL *****   352 mg nightly at bedtime.      sulfamethoxazole-trimethoprim *****-***** mg per tablet  Commonly known as:  BACTRIM DS  Last time this was given:  ***** *****, ***** 11:59 AM   Take 1 tablet (160 mg of trimethoprim total) by mouth 2 (two) times a day for 3 days.      tamsulosin 0.4 mg Cap  Commonly known as:  FLOMAX   Take 0.4 mg by mouth daily.      vancomycin 50 mg/mL Soln  Commonly known as:  VANCOCIN  Last time this was given:  ***** *****, ***** 12:00 PM   Take 2.5 mL (125 mg total) by mouth every 6 (six) hours for 35 doses.         ***** This list has 3 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.               Where to Get Your Medications      Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 amantadine 
HCl 50 mg/5 mL solution  쨌 amino acids-protein hydrolysate 15-60 gram-kcal/30 mL *****  쨌 *****-menthol lotion  쨌 cholecalciferol 2,000 unit tablet  쨌 docusate 50 mg/5 mL liquid  쨌 enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  쨌 ergocalciferol 50,000 unit capsule  쨌 fluconazole 10 mg/mL suspension  쨌 insulin lispro 100 unit/mL injection vial  쨌 omeprazole 2 mg/mL oral suspension  쨌 prednisoLONE 15 mg/5 mL (3 mg/mL) solution  쨌 prednisoLONE 15 mg/5 mL (3 mg/mL) solution  쨌 prednisoLONE 15 mg/5 mL (3 mg/mL) solution  쨌 sulfamethoxazole-trimethoprim *****-***** mg per tablet  쨌 vancomycin 50 mg/mL Soln                    Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 1:30 PM (Arrive by 1:20 PM) ***** *****, MD ***** Neuroendocrine Clinical Center *****-*****-*****     *****/*****/***** 2:45 PM ***** ***** *****, MD ***** Sinus Center Main Campus *****-*****-***** ***** Main        Follow-Up Services            Services            ENCOMPASS HEALTH REHAB HOSPITAL ***** *****    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Follow up              Signed Discharge Orders (From admission, onward)     Ordered        *****/*****/***** 1403  Activity as tolerated         *****/*****/***** 1403  Discharge Tube Feeding     Comments:  Tube Feeding Formula              Adult/Pediatric tube feeding, No tray Formula: *****/*****-Jevity 1.5;   Route(s): Gastrostomy; Regimen(s): Continuous; Continuous rate (mL/hr):   50; Daily volume goal (mL): 1,200  Diet effective now                 Tube Feeding Flush              Free water feeding tube bolus Q6H ***** amount: 200cc  Every 6 hours       *****/*****/***** 1403  For immediate questions regarding your 
hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1902  Ambulatory referral to ***** Neurology     Question Answer Comment   Subspecialty: Neurology    Reason for Referral: Consult and Manage    Location: Main Campus    Is the patient currently being seen by a Neurologist? No    What is the patient's chief complain? (ex. headache, weakness, etc) ***** w/ mechanical ***** c/b severe facial trauma, c/b ***** and persistent AMS    Is imaging available? Yes    Is this accident related? No    Has a definitive neurological diagnosis been made? Yes    Diagnosis: Meningitis                     Discharge instructions and important events and results      DIET  - Please continue your hospital diet.   - This will be re-evaluated by Speech Therapy.      MEDICATIONS:  -Take all of your medications as ordered.  You do not have to take pain medication unless it is needed.  It is important that you are able to cough, breathe deeply, and is comfortable enough to walk.     -Do not use alcohol while taking pain medication.   -Medications that may be prescribed include:                -Narcotic pain medication such as Dilaudid (hydromorphone) or Oxycodone.                 -An over the counter stool softener for constipation (Colace or Docusate). If you become constipated, try products such as Dulcolax, Milk of Magnesia, first, and then Magnesium Citrate or ***** enema if needed). Often times, pain medication and anesthesia can cause constipation.  -You have been prescribed an anti-seizure medication. Continue to take this until you are told to discontinue by your physician.   -Unless directed by your doctor, do not take any 
anti-inflammatory medicines such as Motrin, Aspirin, Advil, and Ibuprofen etc, as this can increase your chances of bleeding.   -You are being discharged on steroid medication taper, make sure you are taking a medication to protect your stomach (Prilosec, Protonix, or Pepcid), as these medications can cause stomach irritation. Taper below:  -- Prednisolone 25 mg po daily x1 week  -- Prednisolone 20 mg po daily x 1 week  -- Prednisolone 15 mg daily x 2 week.   -- He should then have a fu at ***** clinic: ***** ***** at 1:30pm. After that his prednisolone may be adjusted.   Please do not stop GC abruptly.     ACTIVITY:  The first few weeks after you are discharged you may feel tired or fatigued. This is normal. You should become a little stronger every day. Activity is the most important measure you can take to prevent complications and to begin to feel like yourself again. In general:  -Follow the activity instructions given to you by your doctor and therapist.  -Increase your activity slowly; do not do too much because you are feeling good.   -You may resume sexual activity as your tolerance allows.  -If you feel light headed or fatigued after increasing activity, rest, decrease the amount of activity that you do, and begin building your tolerance to activity more slowly.  -Do not lift objects over 10 pounds until approved by your physician.  -Avoid any activity that causes you to hold your breath and push, for example weight lifting, lifting or moving heavy objects, or straining at stool.  -Do your breathing exercises every two hours.    -Use your incentive spirometer 10 times every hour, that you are awake.      WHEN TO CALL YOUR SURGEON:  With any surgery there are risks of complications. Although your surgery is over, there is the possibility of some of these complications developing. These complications include: infection, blood clots, or neurological changes. Call your Physician Immediately if you 
Experience:  -Confusion, fainting, blacking out, extreme fatigue, memory loss, or difficulty speaking.  -*****, or blurred vision. Loss of vision, either partial or total.  -Hallucinations  -Numbness, tingling, or weakness in your extremities or face.  -***** neck, and/or a fever of 101.***** or more.  -Severe sensitivity to light. (Photophobia)  -Severe headache or change in headache.  -Seizure  -Problems controlling your bowels or bladder.  -Productive cough with yellow or green sputum.  -Swelling, redness, or tenderness in your calf or thigh.  Important Instructions Regarding Emergencies and After-Hour Calls If you have what you feel is a true emergency at any time, please present immediately to your local emergency room, where a doctor there will evaluate you and contact us if needed. Due to the complexity of neurosurgical procedures and treatment of neurosurgical problems, effective advice regarding emergency situations cannot be given over the telephone.                 Exam   Temperature: 37 째C (98.6 째F) (*****/*****/***** 1129) | Heart Rate: 71 (*****/*****/***** 1129) | BP: 101/62 (*****/*****/***** 1129) | Respiratory Rate: 18 (*****/*****/***** 1129)  | SpO2: 100 % (*****/*****/***** 1129)  O2 Device: None (Room air) (*****/*****/***** 1129)  O2 Flow Rate (L/min): 15 | FiO2 (%): 100 % (*****/*****/***** 0000)      Weight: 56.4 kg (124 lb 5.4 oz) (*****/*****/***** 1602)  Height: 170.2 cm (5' 7"") (*****/*****/***** 2000)              Discharge Exam    Significant Discharge Exam Findings:  Eyes open spont, says name, waves to examiner  Following commands intermittently in native language  Moving spontaneously in all 4 extremities, at minimum will localize BUE and withdraw BLE - following in all 4             Orientation Level: Oriented to person   Cognition: Follows commands, Impulsive         Speech: No Speech     Vision: Impaired  Hearing: Unable to assess           Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not 
have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 7.45 *****/*****/***** *****    RBC 3.13 (L) *****/*****/***** *****    ***** 265 (H) *****/*****/***** *****    ***** 5 *****/*****/***** *****    ***** ***** GROWTH 7 DAYS *****/*****/***** *****    HGB 8.4 (L) *****/*****/***** *****    HCT 28.0 (L) *****/*****/***** *****    MCH 26.8 *****/*****/***** *****    MCV 89.5 *****/*****/***** *****    PLT 210 *****/*****/***** *****    RDW 15.0 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 141 *****/*****/***** *****    ***** 3.7 *****/*****/***** *****    ***** 99 *****/*****/***** *****    CO2 30 *****/*****/***** *****    BUN 23 *****/*****/***** *****    CRE 0.82 *****/*****/***** *****    ***** 9.3 *****/*****/***** *****    GLU 135 (H) *****/*****/***** *****    GLUPOC 157 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.3 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 12.8 *****/*****/***** *****    PTT 30.0 *****/*****/***** *****    INR 1.0 *****/*****/***** *****                        "
111355735,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. female (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Full Code     Discharge Order              Discharge Patient        Discharge Disposition: Rehab Facility    Signed by: ***** ***** ***** *****, MD, PhD                   Patient/Family/Caregiver discharge preference/goals : Acute Inpt Rehab Facility                            Historical information     Reason for Admission: *****  Principal Problem:    Intraparenchymal hematoma of brain  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    ---------------------------------------------------------------------  ITEMS FOR FOLLOW UP  ---------------------------------------------------------------------    Rehab  [ ] changed lovenox -->SQH for renal function/weight  [ ] fu urine micro, started empiric NF for asymptomatic bacteriuria    Vascular Neurology  [ ] repeat HCT 2-4 weeks, ***** expanding SDH, ***** ?***** frontal convexity SAH  [ ] Traumatic BL SDH/R ***** IPH, consider ***** referral for MMA embolization if worsening SDH, family declined    ---------------------------------------------------------------------  MEDICATION CHANGES  ---------------------------------------------------------------------    -CHANGED lovenox 20 QD for DVT ppx -->SQH for 
renal function  -STARTED nitrofurantoin x 5 days for empiric UTI         Pending Results     Procedure Component Value Ref Range Date/Time    MRSA nasal screen [*****] Collected: *****/*****/***** 0219    Lab Status: Preliminary result Specimen: Other from ***** *****: *****/*****/***** 0853     Special Requests No Special Requests     MRSA Nasal Culture NEGATIVE FOR MRSA    Vancomycin resistant Enterococci (VRE) rectal screen [*****] Collected: *****/*****/***** 0219    Lab Status: Preliminary result Specimen: Other from ***** *****: *****/*****/***** 0808     Special Requests No Special Requests     VRE Rectal Culture NEGATIVE FOR VRE    Blood culture, routine [*****] Collected: *****/*****/***** 1322    Lab Status: Preliminary result Specimen: Blood Updated: *****/*****/***** 0714     Special Requests No Special Requests     BLOOD CULTURE NO GROWTH 2 DAYS    Blood culture, routine [*****] Collected: *****/*****/***** 1322    Lab Status: Preliminary result Specimen: Blood Updated: *****/*****/***** 0714     Special Requests No Special Requests     BLOOD CULTURE NO GROWTH 2 DAYS    Urine culture [*****]  (Abnormal) Collected: *****/*****/***** 1523    Lab Status: Preliminary result Specimen: Urine Updated: *****/*****/***** 1355     Special Requests No Special Requests     Urine Culture Few (1000 to <10,000 CFU/ml) MIXED BACTERIA WITH 1 POTENTIAL PATHOGEN ***** ***** *****             Hospital Course   ***** ***** ***** is a ***** y.o. female with PMH PD, HTN, HLD, T2DM, recurrent diverticular bleeds (s/p hemicolectomy) and recent traumatic R temporo-occipital IPH, BL SDH, traumatic R SAH (*****/*****/*****) readmitted from ***** after ***** with stable appearing bleeds managed with supportive care.   ---------------------------------------------------------------------  ITEMS FOR FOLLOW UP  ---------------------------------------------------------------------    Rehab  [ ] changed lovenox -->SQH for renal function/weight  [ ] fu urine micro, started empiric NF for asymptomatic 
bacteriuria    Vascular Neurology  [ ] repeat HCT 2-4 weeks, ***** expanding SDH, ***** ?***** frontal convexity SAH  [ ] Traumatic BL SDH/R ***** IPH, consider ***** referral for MMA embolization if worsening SDH, family declined    ---------------------------------------------------------------------  MEDICATION CHANGES  ---------------------------------------------------------------------    -CHANGED lovenox 20 QD for DVT ppx -->SQH for renal function  -STARTED nitrofurantoin x 5 days for empiric UTI    ---------------------------------------------------------------------  STROKE MANAGEMENT AND WORK-UP  ICU+***** Course (*****/*****/*****-*****/*****/*****):    # a subdural hematoma.  #Traumatic R Temporo-occipital IPH, Chronic  #Traumatic Bifrontal SDH, Chronic  #Traumatic SAH, Resolved  Pt admitted from ***** following unwitnessed ***** following recent discharge from ***** for traumatic R temporo-occipital IPH, b/l SDH (R 0.6cm and L 0.9cm), BL SDH on *****/*****/*****. On initial presentation, was admitted to neuro-ICU for BP management in the setting of what was thought to be acute bleed, although follow-up imaging suggested chronic bleeds without evidence of hematoma expansion. ***** demonstrated no epileptiform discharges; etiology of recurrent falls was attributed to PD postural instability. She was monitored without evidence of further bleeding. Neurosurgery was consulted with recommendation for possible MMA given recurrent falls.    The intracranial hemorrhage etiology based on the available evidence was determined to be trauma/TBI.    In terms of management for stroke prevention in the future:  A. Antithrombotics  (1) Anticoagulation: Not clinically indicated  (2) Antiplatelet therapy: Not clinically indicated  B. Antihypertensive therapy: Antihypertensive prescribed with initial target SBP <140.   C. Statin Therapy: Admission LDL: Please see data summary below for lipid panel. No intensive statin because no evidence of 
atherosclerosis.  D. Diabetes Management: Please see data summary below for a1c. Insulin, injectable or oral agents prescribed.  E. Smoking Cessation or nicotine replacement therapy for smokers: Smoking cessation counseling or ***** not indicated as patient is non-smoker.      The following additional diagnostic tests, if any, are planned after discharge: Repeat CT imaging in *****/*****-*****/*****    The patient's discharge modified ***** score was estimated at:   4= Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance    ---------------------------------------------------------------------  ADDITIONAL HOSPITAL NEUROLOGY COURSE BY PROBLEM  ---------------------------------------------------------------------    #HTN  She was briefly treated with nicardipine gtt with transition to oral agents. Resumed on home diltiazem.     #UTI  UA on admission notable for + LE and 1+ bacteriuria with rare flora; she was empirically with 5 day course of nitrofurantoin.     Other Chronic Inactive Problems:     #Parkinsons  Diagnosed 2019, started sinemet *****/***** with improvement in resting tremors. Continued QID carbidopa/levodopa.     #Diabetes  Continued ***** 25mg QD, metformin 500mg BID and insulin glargine 5 Units daily.     #Depression  Continued Effexor 37.5mg daily     #Unspecified severe protein-calorie-malnutrition (*****)  PO <50% and 13% weight loss x 3 months and 10% in < 1 month, likely iso recent hospitalizations.      ---------------------------------------------------------------------  STROKE LAB-WORK AND IMAGING  ---------------------------------------------------------------------  Relevant Stroke Lab-Work  Lab Results   Component Value Date    HDL 39 *****/*****/*****    LDL 30 (L) *****/*****/*****    CALCULATED LDL 46 (L) *****/*****/*****    TRIGLYCERIDES 196 (H) *****/*****/*****    HEMOGLOBIN A1C 8.0 (H) *****/*****/*****    SCREENING PANEL: TSH 1.99 *****/*****/*****    ***** 29.3 *****/*****/***** 
      Relevant Stroke Imaging       MRI Brain [*****] *****/*****/***** (Final)    Impression  Scattered mild T2 hyperintensity within the white matter is most likely chronic  small vessel disease.    Signed by: ***** *****-*****, MD on *****/*****/***** 10:16 AM           CT Head [*****] *****/*****/***** (Final)    Impression  1.  Interval evolution of bilateral cerebral convexity mixed density subdural collections, unchanged in size.  2.  Stable size and appearance of the right temporo-occipital hematoma.  3.  No hydrocephalus or new intracranial hemorrhage.    Signed by: ***** ***** ***** *****, MD on *****/*****/*****  4:03 AM      No echo results in the past year.    -----------------------------------------  History of presenting illness  -----------------------------------------    ***** ***** ***** is a ***** y.o. female with PMH of h/o *****'s, macular degeneration, HTN, HLD, T2DM, and recent R parieto-occipital IPH and traumatic R SAH (*****/*****/*****) who presents as ***** after *****.     She was treated at ***** for recent IPH and traumatic SAH s/p ***** (*****/*****/*****) . During ***** admission, CTA H/N showed no aneurysm or vascular malformation. MRI brain showed no evidence of CAA pathology. The IPH and SAH were attributed to trauma. The patient was discharged to ***** on *****/*****/*****.     Patient found on ground at ***** at approximately 8:30 AM from a presumed fall from standing from her wheelchair with head strike. On evaluation, patient with new L pronator drift and subsequently transported to *****.        Upon arrival to *****, NIH SS scored as 3 (1 for minor left facial paralysis, 1 for drift in left UE, 1 for neglect to tactile stimulation).       ED course significant for: continued HTN (SBP 150s-180s) despite Diltiazem PO and 30mg IV labetalol.  She also is continuing to complain of a headache over her right forehead. The patient was started on ***** drip for BP management.  Although patient had been recently on Lovenox it was not 
therapeutic dosing.     ---------------------------------------------------------------------  STROKE PRESENTATION  ---------------------------------------------------------------------  Pre-Morbid Function   Modified ***** Score  ***** Timeframe: Pre-stroke  ***** Collection Method: Chart Abstraction  ***** ***** *****: Moderate disability, requiring some help, but able to walk without assistance    Last Known Well  Last known well date: *****/*****/***** Last known well time: 0830    Symptom Discovery  Symptom discovery date: *****/*****/***** Symptom discovery time: 0830    Syndrome on Arrival: L facial droop, ***** *****, L tactile neglect  NIHSS on Arrival: 3  Notable Exam Findings: see above    Acute Treatments Offered  Did the patient receive IV tPA?: No, due to clinical criteria        TPA Not given due to ***** criteria: Bleeding risk too high (coagulopathy, recent surgery, stroke, TBI, etc)     Candidate for endovascular therapy?: No, due to clinical criteria     No, due to clinical criteria: Stroke too mild (NIHSS<6)              Medications   Allergies: Valsartan, Sulfa (sulfonamide antibiotics), Atorvastatin calcium, Erythromycin base, Sulfamethoxazole-trimethoprim, and Lisinopril    Prior to Admission Medications   Prescriptions   GLUCOSE BLOOD test strip   Sig: 1 each by Miscellaneous route as needed. One touch ultra blue test strips  Code: *****.29 Type 2 diabetes mellitus without long-term current use of insulin   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 650 mg by mouth.   blood sugar diagnostic (ONETOUCH ULTRA BLUE TEST STRIP) Strp strips   Sig: Inject 1 each under the skin every morning.   carbidopa-levodopa (SINEMET) 25-100 mg per tablet   Sig: Take 1 tablet by mouth 4 (four) times a day.   cyanocobalamin, vitamin B-12, 250 MCG tablet   Sig: Take 500 mcg by mouth once a week.    dilTIAZem (CARDIZEM CD) 240 MG 24 hr capsule   Sig: Take 1 capsule (240 mg total) by mouth daily.   empagliflozin (JARDIANCE) 25 
mg tablet   Sig: Take 1 tablet (25 mg total) by mouth daily. New dose stop 10 mg *****   insulin glargine (BASAGLAR KWIKPEN U-100 INSULIN) 100 unit/mL (3 mL) ***** injection pen   Sig: Inject 5 Units under the skin daily. *****.29   insulin pen needles, disposable, 32 gauge x *****/*****"" *****   Sig: 1 each by Miscellaneous route every evening.   lancets (LANCETS,THIN) Misc   Sig: 1 each by Miscellaneous route every morning. One touch ultra  ***** *****.9  Pt tests 1 x daily   loratadine (CLARITIN) 10 mg tablet   Sig: Take 1 tablet (10 mg total) by mouth daily.   Patient taking differently: Take 10 mg by mouth daily as needed.   metFORMIN (GLUCOPHAGE-XR) 500 MG 24 hr tablet   Sig: Take 2 tablets (1,000 mg total) by mouth 2 (two) times a day.   rosuvastatin (CRESTOR) 5 MG tablet   Sig: TAKE 1 TABLET BY MOUTH EVERY DAY   Patient taking differently: Take 5 mg by mouth every other day. TAKE 1 TABLET BY MOUTH EVERY DAY   venlafaxine (EFFEXOR-XR) 37.5 MG 24 hr capsule   Sig: Take 1 capsule (37.5 mg total) by mouth every morning.   venlafaxine (EFFEXOR-XR) 37.5 MG 24 hr capsule   Sig: Take 37.5 mg by mouth.   Patient not taking: Reported on *****/*****/*****      Facility-Administered Medications: None        Medication List      TAKE these medications        Instructions    acetaminophen 325 mg tablet  Commonly known as: TYLENOL  Last time this was given: ***** *****, *****  8:24 AM   Take 650 mg by mouth.      Basaglar KwikPen U-100 Insulin 100 unit/mL (3 mL) ***** injection pen  Generic drug: insulin glargine  Last time this was given: Ask your nurse or doctor   Inject 5 Units under the skin daily. *****.29  *****'s comments: DX Code Needed  .      ***** blood sugar diagnostic Strp strips  Commonly known as: OneTouch Ultra Blue Test Strip   Inject 1 each under the skin every morning.      ***** glucose blood Strp strips  Generic drug: blood sugar diagnostic   1 each by Miscellaneous route as needed. One touch ultra blue test strips  Code: *****.29 Type 
2 diabetes mellitus without long-term current use of insulin      carbidopa-levodopa 25-100 mg per tablet  Commonly known as: SINEMET  Last time this was given: ***** *****, *****  8:25 AM   Take 1 tablet by mouth 4 (four) times a day.      cyanocobalamin (vitamin B-12) 250 MCG tablet  Last time this was given: ***** *****, *****  9:07 AM   Take 500 mcg by mouth once a week.      dilTIAZem 240 MG 24 hr capsule  Commonly known as: CARDIZEM CD  Last time this was given: Ask your nurse or doctor   Take 1 capsule (240 mg total) by mouth daily.      empagliflozin 25 mg tablet  Commonly known as: JARDIANCE   Take 1 tablet (25 mg total) by mouth daily. New dose stop 10 mg *****      heparin 5,000 unit/mL injection   Inject 1 mL (5,000 Units total) under the skin every 12 (twelve) hours.      insulin pen needles (disposable) 32 gauge x *****/*****"" *****   1 each by Miscellaneous route every evening.  *****'s comments: ***** ***** Ultra Fine-Pt needs ***** *****; *****.29      lancets Misc  Commonly known as: Lancets,Thin   1 each by Miscellaneous route every morning. One touch ultra  ***** *****.9  Pt tests 1 x daily      loratadine 10 mg tablet  Commonly known as: CLARITIN   Take 1 tablet (10 mg total) by mouth daily.  What changed:   쨌 when to take this  쨌 reasons to take this      metFORMIN 500 MG 24 hr tablet  Commonly known as: GLUCOPHAGE-XR   Take 2 tablets (1,000 mg total) by mouth 2 (two) times a day.      nitrofurantoin 100 MG capsule  Commonly known as: MACROBID  Last time this was given: ***** *****, *****  8:24 AM   Take 1 capsule (100 mg total) by mouth 2 (two) times a day for 9 doses.      rosuvastatin 5 MG tablet  Commonly known as: CRESTOR  Last time this was given: ***** *****, *****  8:25 AM   TAKE 1 TABLET BY MOUTH EVERY DAY  What changed:   쨌 when to take this  쨌 additional instructions      venlafaxine 37.5 MG 24 hr capsule  Commonly known as: EFFEXOR-XR  Last time this was given: ***** *****, *****  8:25 AM   Take 1 capsule (37.5 mg 
total) by mouth every morning.  What changed: Another medication with the same name ***** *****. Continue taking this medication, and follow the directions you see here.         ***** This list has 2 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.               Where to Get Your Medications      These medications were sent to *****/***** #***** - *****, ***** - ***** ***** ***** *****  ***** ***** ***** *****, ***** ***** *****    Phone: *****-*****-*****   쨌 nitrofurantoin 100 MG capsule     Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 heparin 5,000 unit/mL injection                    Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 11:00 AM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at ***** *****-*****-*****  NEW PATIENT    *****/*****/***** 1:30 PM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at ***** *****-*****-*****  Revisit 30    *****/*****/***** 2:30 PM (Arrive by 2:10 PM) ***** ***** *****, MD ***** Primary Care ***** *****-*****-***** ***** ***** SUB S RETURN INTERNAL MEDICINE    *****/*****/***** 4:00 PM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at ***** *****-*****-*****  Revisit 30    *****/*****/***** 2:00 PM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at ***** *****-*****-*****  Revisit 30    *****/*****/***** 1:00 PM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at ***** *****-*****-*****  Revisit 30    *****/*****/***** 4:00 PM ***** ***** *****, CCC-SLP ***** Speech/***** Pathology at 
***** *****-*****-*****  Revisit 30    *****/*****/***** 2:00 ***** ***** *****, MD, PhD ***** Neuromuscular Service *****-*****-***** ***** Main Follow Up    *****/*****/***** 2:00 PM (Arrive by 1:30 PM) ***** ***** CT, Mass General Imaging - ***** *****-*****-***** ***** ***** IMG CT HEAD    *****/*****/***** 11:00 AM ***** ***** *****, *****-C ***** Multispecialty *****-*****-*****            Signed Discharge Orders (From admission, onward)            Orders from this encounter     Ordered        *****/*****/***** 1045  Activity as tolerated            *****/*****/***** 1045  Discharge diet        Comments: Diet Dysphagia; Soft and bite sized (***** 6); Mildly thick (***** 2)       *****/*****/***** 1045  If you experience a medical emergency after discharge: please call 911 immediately.  For routine clinical questions related to your recent hospitalization duringBUSINESS HOURS(Monday to Friday, 8:00 AM-5:00 pm), please callthe***** Neurology cl...        Comments: If you experience a medical emergency after discharge: please call 911 immediately.     For routine clinical questions related to your recent hospitalization duringBUSINESS HOURS(Monday to Friday, 8:00 AM-5:00 pm), please callthe***** Neurology clinic (*****-*****-*****) and ask for the senior neurology resident, Dr. ***** ***** to call you back. You may also consider calling your established outpatient Neurologist or Primary Care Physician for advice.    For urgent questions that arise during no non-business hours, please call the main hospital number***** *****-*****-***** and request that the operator page Dr. ***** ***** *****. If you do not receive a call back within 20 minutes, call the main hospital number and have***** ***** ***** *****, MD, PhD (or their covering MD) paged.       *****/*****/***** 1035  CT Head        References:    Enterprise Outpatient Imaging *****   Question Answer Comment   Please provide any additional clinical context for this exam (additional indications, different diagnoses, other relevant 
history): follow up bilateral SDH    Is a particular imaging focus suggested (radiology may call to confirm)? Per Radiologist discretion/standard based on indications    Does the patient have a known prior CT contrast reaction? No    Intravenous Contrast Request: Per Radiologist discretion/standard protocol based on indications    Does this exam need to be performed at your institution***** for the purpose of imaging care coordination? No    Release to patient Automated           *****/*****/***** 1036  Ambulatory referral to ***** Neurology        Question Answer Comment   Subspecialty: Neurology    Reason for Referral: Consult and Manage    Location: Main Campus    Is the patient currently being seen by a Neurologist? No    What is the patient's chief complain? (ex. headache, weakness, etc) traumatic ICH    Is imaging available? Yes    Is this accident related? No    Has a definitive neurological diagnosis been made? Yes    Diagnosis: traumatic ICH                 Orders from suspended admission (***** ***** - ***** ***** *****, MD)     None              Discharge instructions and important events and results    ====================================  ABOUT YOUR HOSPITALIZATION  ====================================    Dear ***** *****,    You were admitted to ***** following a *****. During your hospitalization, we found no change in your prior traumatic brain bleeds. You were briefly admitted to the ICU for close monitoring following your *****. We believe the cause of your ***** was from imbalance from your longstanding Parkinsons.    ====================================  TEST RESULTS  ====================================    1. You had CT imaging of the brain showing STABLE appearing old bleeds in the brain.    ====================================  FURTHER CARE  ====================================    1. Please continue physical therapy at ***** Rehab.  2. Please follow up in neurology clinic as scheduled to follow up on your 
symptoms after your recent trauma. Please obtain a repeat CT Head in 2-4 weeks prior to your appointment.  3. Please follow up with Dr. ***** in movement clinic as scheduled.    ====================================  NEW MEDICATIONS  ====================================    -please complete a short course of antibiotics for bacteria growing in your urine.    ===========================================  ***** ***** SEEK FURTHER MEDICAL ATTENTION  ===========================================    If you experience any of the following symptoms, please contact your doctor to discuss if you need an in person evaluation: sudden weakness on one side, inability to speak, slurred speech, severe headache, nausea, vomiting, or loss of consciousness.    If you experience a medical emergency after discharge: please call 911 immediately.     For routine clinical questions related to your recent hospitalization duringBUSINESS HOURS(Monday to Friday, 8:00 AM-5:00 pm), please callthe***** Neurology clinic (*****-*****-*****) and ask for the senior neurology resident, Dr. ***** ***** to call you back. You may also consider calling your established outpatient Neurologist or Primary Care Physician for advice.    For urgent questions that arise during non-business hours, please call the main hospital number***** *****-*****-***** and request that the operator page Dr. ***** ***** *****. If you do not receive a call back within 20 minutes, call the main hospital number and have***** ***** ***** *****, ***** (or their covering MD) paged.     It was a pleasure to participate in your care,    Your ***** Care Team                Exam   Temperature: 36.3 째C (97.3 째F) (*****/*****/***** 0738) | Heart Rate: 100 (*****/*****/***** 0834) | BP: 96/60 (*****/*****/***** 0834) | Respiratory Rate: 20 (*****/*****/***** 0738)  | SpO2: 100 % (*****/*****/***** 0834)  O2 Device: None (Room air) (*****/*****/***** 0738)    |        Weight: 37.1 kg (81 lb 14.4 oz) (*****/*****/***** 1600)  Height: 157.5 cm (5' 2"") (*****/*****/***** 1600)  
       BMI (Calculated): 14.98 (*****/*****/***** 1600)    Discharge Exam    Significant Discharge Exam Findings: Alert, oriented  *****, hypomimia/*****  Face symmetric  L pronation without drift  Full ***** in *****  Mild rigidity R>L, no resting tremor noted             Orientation Level: Oriented X3   Cognition: Follows commands         Speech: Clear, Delayed, Slurred     Special Needs    Special Needs: None              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 5.64 *****/*****/***** *****    RBC 4.29 *****/*****/***** *****    HGB 11.8 (L) *****/*****/***** *****    HCT 35.7 (L) *****/*****/***** *****    MCH 27.5 *****/*****/***** *****    MCV 83.2 *****/*****/***** *****    PLT 387 *****/*****/***** *****    RDW 12.8 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 140 *****/*****/***** *****    ***** 3.6 *****/*****/***** *****    ***** 101 *****/*****/***** *****    CO2 26 *****/*****/***** *****    BUN 18 *****/*****/***** *****    CRE 0.76 *****/*****/***** *****    ***** 9.6 *****/*****/***** *****    GLU 155 (H) *****/*****/***** *****    GLUPOC 157 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.0 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.0 *****/*****/***** *****    ***** 1.0 *****/*****/***** *****    PTT 29.3 *****/*****/***** *****                        "
115294076,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****-*****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient/family will provide an existing copy      Health Care Agents          There are no health care agents on file.          Code Status at *****: Full Code (Presumed)       Discharge address same as *****: Yes                   Hospitalization Summary     Admission Diagnosis     Subdural hematoma [*****.00]  Arteriosclerotic heart disease [*****.10]  SDH (subdural hematoma) [*****.00]               Principal Problem:    Subdural hematoma  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** Left Sided Mini Craniotomy For Evacuation Of Subdural Hematoma *****, ***** *****                ***** (OR) Procedures:          Pending Results     None           Hospital Course   ***** hx DM, HTN and CAD with no stents or bypasses (but is on ASA 81 at baseline) presents after walking into a beam (no LOC) 2 weeks ago with 2 weeks of progressive HAs and loss of balance with multiple falls. He also complains of intermittent episodes of being ""tongue-tied"". He presented to an OSH ED today for his ***** and a head CT was performed showing a chronic left SDH 2.6cm diameter with 7mm MLS. The patient denies any recent falls with *****. He is now s/p ***** ***** for SDH evacuation with Dr. ***** on *****/*****.    Patient was admitted to the Neurosurgical Service on *****/*****  
for a ***** ***** for SDH evacuation with Dr. ***** on *****/*****.  Patient was taken to the operating room on the day of admission and underwent an uncomplicated procedure. Please see Dr. *****'s separately dictated operative note for details. Post-operatively patient was extubated and transferred to the Neurosurgical ICU for close monitoring. He remained hemodynamically stable, neurologically at baseline, and with his pain well-controlled throughout his hospital stay. On POD#3 he was transferred to the floor in stable condition and was deemed ready for discharge on POD#5.    NEURO: Patient remained neurologically at baseline throughout his hospital stay.   AAO x 3  EOMI, PERRL, FS, TM  ***** with 5/5 strength except ***** *****-*****+/5  No drift     Post op imaging showed stable size of subdural hematoma status post subdural drainage.  SDD removed on *****/***** with no complications.  He will continue Keppra 1,500mg BID.   Patient was placed on LTM for 48 hours. It remained negative.     CV: Hemodynamically stable at all times. Patient will hold ASA (heart health) indefinitely.    GU: Voiding on his own after foley removed with no signs of retention or UTI.    GI: Tolerating a regular diet with no nausea or vomiting.    HEME: SQH and SCDs for DVT prophylaxis.    ID: ***** at all times. Perioperative ABX. Incision remained clean, dry, and intact with no evidence of erythema, warmth, or hematoma.    *****: Ambulating on his own and feels ready to go home with home PT/OT/SLP. At the time of discharge his pain remained well controlled on oral medications. Patient will follow up with Dr. ***** in 1-2 weeks.           Medications   Allergies: Duloxetine; Neurontin (gabapentin); Lisinopril; Metformin; Nortriptyline; Pioglitazone; Rosiglitazone maleate; Sulfa (sulfonamide antibiotics); and Tetracycline    Prior to Admission Medications   Prescriptions   LORazepam (ATIVAN) 0.5 MG tablet   Sig: Take 0.5 mg by mouth daily as needed for anxiety. 
  aspirin 81 MG EC tablet   Sig: Take 81 mg by mouth daily.   atenolol (TENORMIN) 25 MG tablet   Sig: Take 37.5 mg by mouth daily.   dextroamphetamine-amphetamine (ADDERALL XR) 15 MG 24 hr capsule   Sig: Take 15 mg by mouth every morning.   insulin aspart (NOVOLOG) 100 unit/mL ***** injection pen   Sig: Inject 12 Units under the skin 2 (two) times a day with meals.   insulin aspart protamine-insulin aspart (NOVOLOG MIX 70/30) 100 unit/mL (70-30) injection pen   Sig: Inject under the skin 2 (two) times a day with meals.   tadalafil (CIALIS, ADCIRCA) 20 MG tablet   Sig: Take 20 mg by mouth daily as needed for erectile dysfunction.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          aspirin 81 MG EC tablet         START taking these medications       Dose, Frequency, and Details    levETIRAcetam 750 MG tablet   Also known as:  KEPPRA    Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:25 AM       ramelteon 8 mg tablet   Also known as:  *****    Take 1 tablet (8 mg total) by mouth nightly for 14 days.         CONTINUE taking these medications       Dose, Frequency, and Details    ADDERALL XR 15 MG 24 hr capsule   Also known as:  dextroamphetamine-amphetamine    Take 15 mg by mouth every morning.       atenolol 25 MG tablet   Also known as:  TENORMIN    Take 37.5 mg by mouth daily.   Last time this was given:  *****/*****/*****  8:25 AM       insulin aspart 100 unit/mL ***** injection pen   Also known as:  NovoLOG    Inject 12 Units under the skin 2 (two) times a day with meals.   Last time this was given:  *****/*****/***** 12:40 PM       insulin aspart protamine-insulin aspart 100 unit/mL (70-30) injection pen   Also known as:  NovoLOG Mix 70/30    Inject under the skin 2 (two) times a day with meals.       LORazepam 0.5 MG tablet   Also known as:  ATIVAN    Take 0.5 mg by mouth daily as needed for anxiety.   Last 
time this was given:  *****/*****/***** 11:02 PM       tadalafil 20 MG tablet   Also known as:  CIALIS, ADCIRCA    Take 20 mg by mouth daily as needed for erectile dysfunction.                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate *****  Deferred (Contraindication)             Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  3:***** ***** *****   ***** ***** ***** ***** BTM CT1   ***** Imaging CT BTM (***** Radiology at ***** *****)    ***** ***** *****  ***** ***** *****   *****-*****-*****           ***** and thank you for choosing ***** Hospital for your radiology exam. Our physicians and technologists are dedicated to providing highly skilled and compassionate care for you and your family. We understand that you may be apprehensive about your procedure. We hope that you will find the following information helpful as you prepare for the exam.  What should I expect BEFORE my CT scan? ***** When to arrive: You need to arrive 30 minutes before your scheduled appointment. ***** Medications: It is important for you to keep your regular medication schedule. Please take all the medications that have been prescribed to you by your doctor and bring a list to your CT appointment. ***** Diabetic conditions: If you are an insulin-dependent diabetic, please continue to take your insulin as prescribed, but remember to drink extra fruit juices to make up for the fasting of solid foods for the 2 period that your stomach is empty. Patients who are taking diabetic medications should take the prescribed dose as normally done on that day. Patients should notify their Primary Care Physician (PCP) that they had contrast and were instructed to 
discontinue their medication for 48 hours. If you need a substitute medication, please consult your doctor. ***** Food and drink: You should not eat solid foods for two hours prior to your test. You may, however, drink plenty of fluids, such as water, broth, clear soups, juice, or black ***** coffee or tea. We encourage you to drink plenty of fluids before your arrival to our facility. ***** What to wear: You should dress in comfortable clothing. It might be necessary for you to change into a hospital gown if there is metal in your clothing, such as a ***** or *****, within the area of interest of your study. If you are wearing jewelry or anything else that might interfere with your scan, we will ask you to remove it. It is best that you leave your valuable items at home. ***** Intravenous preparation: Many patients receive a contrast agent intravenously (IV) during their CT test. If your doctor or the radiologist has determined that this procedure will enhance your CT scan results, the technologist will place an IV in your arm or hand prior to going into the exam.  During the Scan: You will meet the CT technologist when you are taken into the exam room. The technologist will explain everything that is happening. You will be helped onto the table, positioned correctly and may be secured by a strap which helps prevent you from moving. ***** slight movement blurs the x-rays.  The CT technologist controls the procedure in another room where they can still see and hear you. You will be moved slightly after each scan, although you may not notice the change. When the CT scan is complete, the technologist will make sure he or she has all the information the doctor will need. Your time in the CT scan room will vary between 10 and 20 minutes per test depending on the procedure.  After your Scan: Once the technologist has all the images the physician requires, they will assist you off of the table. You are discharged immediately 
and you may resume your normal diet. Make sure you drink plenty of fluids for several days unless otherwise contraindicated. If you become constipated make sure you speak to the physician that ordered the test.  Contrast reactions happen rarely after leaving the hospital. However if you develop a skin rash, difficulty breathing or severe nausea or vomiting please contact your physician. If your symptoms are severe, call 911 or go to the closest emergency room.  The technologist cannot discuss results with you. The CT scan will be reviewed by a Radiologist and the results will be sent to the doctor who ordered your exam.  Thank-you for allowing us to care for you during your CT Scan            ***** *****, *****  4:30 PM EDT   POST OP VISIT with ***** ***** *****, MD, PhD   ***** Department of Neurosurgery (--)    ***** ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  3:00 PM *****   FOLLOW UP with ***** *****, MD   ***** ***** ***** Associates (--)    ***** ***** *****.  ***** ***** *****   *****-*****-*****                 Follow-Up Services            ***** ***** ***** - HOME CARE   Specialty:  Home Health Services    ***** ***** *****, ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1447  Referral to Home Health HOMEBOUND     Question Answer Comment   Location of Home Care referral? ***** at *****    Referral Priority Admit within 24 hours    Physician to Follow Patient's Care in the Community Referring Provider    Disciplines Requested Nursing (to assess, treat and teach)    Disciplines Requested Physical Therapy (to assess and treat)    Disciplines Requested Speech Language Pathology (to assess and treat)    Disciplines Requested Occupational Therapy (to assess and treat)    Services to Provide - Nursing Neurological    Service to Provide - Physical Therapy Functional Mobility    Service to Provide - Physical Therapy 
Musculoskeletal ROM/Strength    Service to Provide - Physical Therapy Safety    Service to Provide - Occupational Therapy ADLs & IADLs    Service to Provide - Occupational Therapy Safety    Service to Provide - Occupational Therapy Mobility    Service to Provide - Occupational Therapy Upper extremity ROM/Strength    Services to Provide - Speech Language Therapy Speech    Date of Face to Face Encounter: *****/*****/*****    This encounter with this patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care: subdural hematoma    In addition to clinical findings elsewhere in the medical record documentation the patient is homebound due to: Assistance of another person    Patient needs assistance of another person due to: impaired balance    Patient needs assistance of another person due to: congitive impairment and poor safety awareness    Patient needs assistance of another person due to: weakness and poor endurance when ambulating/transferring           *****/*****/***** 1626  Activity as tolerated         *****/*****/***** 1626  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1626  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at (*****)*****-*****.       *****/*****/***** 1703  Neuropsychological Testing     Question Answer Comment   Reason for Testing: Cognitive Ability s/p subdural evacuation   Reason for Testing: Evaluate for Dementia               Additional Patient Instructions     Discharge Instructions for Dr. *****s Post-Operative Patients:      Activity:    Do not lift >10 lbs for one month after surgery. You may gradually then begin 
to lift more with pain being the limiting/guiding factor.    Gradually resume normal activity. For the first few days - rest and relax. Until further notice, avoid bending at the waist, quick movements of your head, stretching your neck/shoulders, pulling, pushing, reaching above your head, shoveling, and *****/house work.    Avoid high impact activities (running) and activities with bending/twisting for 2 months.    You may walk as much as you can safely tolerate. Please use assistive devices and/or have supervision if necessary. This will increase circulation and prevent blood clots.    DO NOT *****. Smoking can cause poor wound healing.  If you need medications to help you quit (i.e. Chantix, Wellbutrin), please follow-up with your PCP.    Do not return to ***** ***** cleared at your two week follow up appointment.      Wound Care:    Dressings should be removed on post op day #2. You may leave the wound open to air.    ***** dressing with staples into the scalp should be removed prior to your discharge.    Call your surgeon if there are any signs of infection such as redness, fever, or drainage.    Your incision is closed with staples/suture. They will be removed at your two week post-op appointment.       Bathing:    Do not get your incision wet until after the sutures/staples are removed at follow up.    It is OK to shower, but keep the incision dry. Do not wash your hair. The incision must be covered with a waterproof barrier when showering. The dressing or shower cap used for coverage may be removed after showering.   Do not soak the wound (including baths, pools, and hot tubs) for 6 weeks after surgery.      Medications:    You may use Tylenol (Acetaminophen) for your pain. Do not take more than 4000 mg of Tylenol per day.    You may use prescribed narcotics for severe pain. As your pain improves, wean this medication as tolerated.    Do not drive or drink alcohol while taking narcotic pain 
medications.    Constipation is a common problem when using narcotics after surgery - use Colace (stool softener), fiber laxatives and/or *****, Senokot, Milk of Magnesia to prevent and treat constipation. Stay well-hydrated.    Resume the rest of your medications at their usual doses unless otherwise indicated.    Do NOT take any blood thinning medications (Aspirin, Ibuprofen/other NSAIDS, Plavix, Coumadin) unless otherwise instructed or you are cleared by your neurosurgeon.    If you were discharged with Keppra (levetiracetam), this medication helps to prevent seizures. Please take as instructed.    If you have been discharged on Decadron (dexamethasone), this is to help with brain swelling. Please take as instructed.       After a craniotomy you may experience:   Headaches- They should respond to pain medications. If they are severe and do not respond to medication, please seek medical attention.   Expect soreness/***** and needles around your wound. You will have soreness of the muscles of the neck and skull. Chewing may cause fatigue. These symptoms will improve with time.    You may also experience some post-operative swelling around your face and eyes (often worse after laying flat). Sleep with head propped up on pillows for 2 weeks after surgery, or sleep in a reclining chair.   You may feel very tired after surgery.       Please seek immediate medical attention if you experience:     Temperature greater than 101.5 times one or Temperature greater than 100.5 times 24 hours    Calf pain    Shortness of breath    Chest pain    Severe pain, swelling, redness, bleeding, or drainage from the incision site    New weakness or changes in sensation in your arms or legs    Extreme nausea and/or vomiting   Inability to stay awake    Severe headaches not relieved by medication   Seizures   Any new problems with your vision    Slurred speech/facial drooping   Changes in sensation of your 
face   Worsening Headache or Neck Stiffness.      Follow Up:     We will see you in our clinic in 1-2 weeks for follow up.     You have a follow-up appointment with Dr. ***** on *****/*****/***** at 4:30pm.  You have a head CT prior to this appointment at 3:45pm.     ***** do not take your Aspirin until further discussed at your follow-up appointment.     If you need to reach Dr. *****s office during normal business hours (M-F 8am-5pm) please call *****-*****-*****. If it is not during business hours please call: *****-*****-*****, ***** ***** ***** paged. This is the Neurosurgery resident on call.     Please call 911 if you sense that there is a medical emergency.                Additional Clinician Instructions for When to Call     Please call with any questions or concerns you may have.    Call with any concerns or changes in your Neurological status:   Changes in walking, balance, talking, swallowing, any new weakness or numbness and tingling, any new headaches or headaches not relieved by prescribed pain medications.  If the patient seems ""too sleepy"".     Any new or worsening redness or swelling at your incision.  Any drainage from your incision.  Fever > 100.5.  Nausea/Vomiting    Call your Neurosurgeons office directly with questions.  If off hours, or weekends/holidays: Call the ***** Paging Service at *****-*****-***** and have the Neurosurgery Resident on call paged to your home number.      Call 911 for any Loss of Consciousness or seizure activity.               Additional Clinician Instructions for Diet     Include protein in your diet to aid in wound healing, and to give you energy to participate in therapy if it is necessary for you.    Good examples of protein are : lean meats, fish, beans, eggs, and nuts.    If your jaw or throat is sore from surgery eating soft cold foods may be easier.    Protein smoothies are a good option when you are not very hungry.  You can add fruits, protein powder or yogurt to any liquid you 
like, add ice and ***** in *****.           Additional Clinician Instructions for Activity     No strenuous activity until after your follow up:   no running, jogging, *****, or stationary bicycles.  Do not lift anything greater than 10lbs, which is roughly a gallon of milk.  No housework such as vacuuming, or laundry until after your follow up.    Walking is encouraged, to prevent blood clots from forming in your legs.  Take at least 5 short walks a day around your house; in the morning, after each meal and at bedtime.    Change your position frequently and do not cross your legs.   If driving for longer than one hour, take breaks to stretch your legs.    Take your time changing your positions, getting out of bed, up from chair, etc to avoid dizziness.    Keep your head above your shoulders when you have to pick up anything from floor; bend at your knees.  We suggest sitting to put on clothing, shoes etc to avoid dizziness.    REST when you are tired.  It is normal to be more tired for 4-6 weeks after brain surgery.    No driving until cleared by your Neurosurgeon.           Additional Clinician Instructions for Wound/Tube Care     Keep incision DRY until your follow up appointment with ***** *****.  You must wear a shower cap when showering.  Keep it protected from direct sunlight, with a clean, loose fitting cap or scarf, otherwise keep open to the air at all times.    If you have a *****, keep in place until follow up appointment.  It may loosen over time and this is expected.  If it does ***** off, simply replace, and call your Neurosurgeon and let him/her know.    Do not apply any creams or ***** to your incision.  Once your sutures are removed you may wash your hair as normal.    Monitor for signs of infection:  Any increase in redness or swelling?  Any drainage noted?  Increase in pain at incision?  Temperature greater than 100.5?  If you notice any of these issues, call your Neurosurgeons 
office.                   Exam   Temperature: 36.8 째C (98.3 째F) (*****/*****/***** 1617) | Heart Rate: 62 (*****/*****/***** 1617) | BP: 104/54 (*****/*****/***** 1617) | Respiratory Rate: 18 (*****/*****/***** 1617)  | SpO2: 97 % (*****/*****/***** 1617)  O2 Device: None (Room air) (*****/*****/***** 1617)  O2 Flow Rate (L/min): 1 |        Weight: 98.2 kg (216 lb 7.9 oz) (*****/*****/***** 0435)  Height: 175.3 cm (5' 9"") (*****/*****/***** 1910)              Discharge Exam    Significant Discharge Exam Findings:  AAO x 3  EOMI, PERRL, FS, TM  ***** with 5/5 strength except ***** *****-*****+/5  No drift               Orientation Level: Oriented X7   Cognition: Follows commands         Speech: Clear     Vision: Functional with Correction  Hearing: Functional   Assistive Devices: None       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 3.53 (L) *****/*****/***** *****    RBC 4.83 *****/*****/***** *****    HGB 13.3 (L) *****/*****/***** *****    ***** 14.9 *****/*****/***** *****    HCT 39.0 (L) *****/*****/***** *****    MCH 27.5 *****/*****/***** *****    MCV 80.7 *****/*****/***** *****    PLT 158 *****/*****/***** *****    RDW 13.2 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 138 *****/*****/***** *****    ***** 136 *****/*****/***** *****    ***** 4.0 *****/*****/***** *****    ***** 4.2 *****/*****/***** *****    ***** 100 *****/*****/***** *****    CO2 28 *****/*****/***** *****    BUN 14 *****/*****/***** *****    CRE 0.54 *****/*****/***** *****    ***** 8.5 (L) *****/*****/***** *****    GLU 193 (H) *****/*****/***** *****    GLUPOC 251 (H) *****/*****/***** *****          Lab Results   Component Value Date/Time    PT 14.5 *****/*****/***** *****    PTT 29.2 *****/*****/***** *****    INR 1.2 (H) *****/*****/***** *****                        "
118306612,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): None                Care Plan *****: wife       Code Status at *****: Full Code (Confirmed)       Discharge address same as *****: No  Discharge Address: Northeast Rehab at *****  ***** ***** ***** ***** ***** *****  Phone : *****-*****-*****             Hospitalization Summary     Admission Diagnosis    Subdural hematoma          Principal Problem:    Subdural hemorrhage  Active Problems:    Atrial fibrillation    Coronary artery disease    Hypertension    Pulmonary hypertension    Nonsustained ventricular tachycardia    Nonrheumatic aortic valve stenosis    Non-rheumatic mitral regurgitation  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** ***** ***** For Subdural Hematoma, Evacuation Of Hematoma *****, ***** *****     *****/*****/***** Percutaneous Endoscopic Gastroscopy *****, ***** *****                ***** (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    None.         Pending Results     None           Hospital Course   ***** ***** is an ***** year old man referred to *****. ***** for neurosurgical treatment of a subdural hematoma (SDH).     He was a past medical history that includes COPD, CAD on *****, HTN, Afib on Coumadin who presented to an OSH with subacute confusion, gait problems. Imaging found to have a chronic L SDH. At the request of his wife he was transferred to ***** for further work up and treatment.      
  Neurologic: ***** ***** ***** was admitted to the Neurosurgical service on *****/*****/***** after presenting with subacute confusion, gait instability. A CT of the head was performed, showing chronic left SDH he was admitted and prepped for surgery. The Medicine Service and Dr. ***** of Cardiology were consulted for assistance with medical management. Prior to admission he had been on Warfarin, ASA and Plavix (for AF and CAD w/***** in 2013). He was started on Keppra for seizure prophylaxis. On *****/*****/***** he was taken to the OR for a ***** hole drainage of the SDH with placement of a ***** ***** drain.  Please see separately dictated operative note by Dr. ***** ***** for details of this procedure. The procedure complicated by aberrant, rapid AF and hypotension. Postoperatively, the patient was extubated and transferred to the Neuro ICU for continued neurological surveillance and SBP/HR control.  An arterial line was placed. He was given 8 mg IV Metop and Esmolol, after which the tachycardia resolved. His Troponin was cycled as part of his post-op course. He was found to have mild elevation to 0.0 4 (which may have been somewhat unreliable in setting of AKI). It was ***** until a downward trend was appreciated.     He was notably unresponsive to sternal rub on *****/*****/*****. A Stat CT head was performed, and negative. He spontaneously improved following this although was delirious and unable to follow commands and he was unable to pass a swallow evaluation leading to a concern for aspiration.  ***** ***** tube was placed, and SLP and nutrition consulted. Tube feedings were titrated to goal without difficulty. On *****/***** the JP drain was discontinued. He was cleared for transfer to a neurosurgical floor on *****/***** and he was started on Levaquin for Klebsiella noted in the sputum he was on antibiotic's from *****/*****-*****/*****. On *****/*****, he was noted to have a bump in his Cr to 1.47 from baseline of 1.1. Medicine was consulted, who felt the AKI 
etiology was pre-renal. Nephrotoxic medications were ***** and he was given additional fluids. In the coming days, his Cr began to downward trend to his baseline.  G tube was placed without complication on *****/*****/*****.     A follow up head CT was done on *****/*****/***** and stable. He was started on his home regular dose of Coumadin with goal INR *****-*****. Plan to get outpatient CT head once therapeutic. Also plan to stop heparin for DVT prophylaxis once INR is therapeutic.     Throughout this hospitalization, he had several runs of self-limited (<10 beats), asymptomatic runs of rapid afib that appear similar in morphology to *****. Medicine felt this to be not concerning given normal electrolytes and stable troponin. They did not recommend any changes to his metoprolol regimen.     On the morning of discharge he was found to be afebrile with stable vital signs. Neurologically he was ***** (self, baseline since admission). PERRL, FS. Followed simple one ***** commands, at least antigravity x 4 . His incision sites were open to air and healing well.                Medications   Allergies: Cephalosporins    Prior to Admission Medications   Prescriptions   allopurinol (ZYLOPRIM) 300 MG tablet   Sig: Reported on *****/*****/*****   Note (*****/*****/*****): Received from: Partners LMR   aspirin 81 mg chewable tablet   Sig: Take 81 mg by mouth daily.   atorvastatin (LIPITOR) 20 MG tablet   Sig: Take 10 mg by mouth daily.   b complex vitamins capsule   Sig: Take 1 capsule by mouth daily.   clopidogrel (PLAVIX) 75 mg tablet   Sig: Take 75 mg by mouth daily.   furosemide (LASIX) 40 MG tablet   Sig: Take 40 mg by mouth.   metoprolol succinate (TOPROL-XL) 50 MG 24 hr tablet   Sig: Take 50 mg by mouth daily.   potassium chloride (***** 20%) 40 mEq/15 mL *****   Sig: Take by mouth.   ramipril (ALTACE) 2.5 MG capsule   Sig: Take 2.5 mg by mouth daily.   tamsulosin (FLOMAX) 0.4 mg *****   Sig: Take 0.4 mg by mouth daily.   warfarin (COUMADIN) 2 MG tablet   
  Sig: Take 2 mg by mouth daily. 2 mg Tues-Sun  3 mg on Monday ONLY      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          aspirin 81 mg chewable tablet       clopidogrel 75 mg tablet   Also known as:  PLAVIX       metoprolol succinate 50 MG 24 hr tablet   Also known as:  TOPROL-XL       ramipril 2.5 MG capsule   Also known as:  ALTACE         START taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 4 (four) hours as needed for mild pain or fever.   Last time this was given:  *****/*****/*****  7:53 PM       albuterol 2.5 mg /3 mL (0.083 %) nebulizer solution    Take 3 mL (2.5 mg total) by nebulization every 6 (six) hours as needed for wheezing.   Last time this was given:  *****/*****/*****  1:54 PM       amino acids-protein hydrolysate 15-60 gram-kcal/30 mL *****   Also known as:  ***** ***** CARB    Take 30 mL by mouth every 12 (twelve) hours.   Last time this was given:  *****/*****/*****  7:53 PM       amLODIPine 5 MG tablet   Also known as:  NORVASC    Take 1 tablet (5 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  9:00 AM       bisacodyl 10 mg suppository   Also known as:  DULCOLAX    Place 1 suppository (10 mg total) rectally daily as needed.   Last time this was given:  *****/*****/***** 12:22 PM       docusate 50 mg/5 mL liquid   Also known as:  COLACE    Take 10 mL (100 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  7:53 PM       heparin (PF) 5,000 unit/0.5 mL ***** syringe    Inject 0.5 mL (5,000 Units total) under the skin 3 (three) times a day. PLEASE STOP USING ONCE COUMADIN IS THERAPEUTIC (INR *****-*****)   Last time this was given:  *****/*****/*****  7:53 PM       hydrALAZINE 50 MG tablet   Also known as:  APRESOLINE    Take 1 tablet (50 mg total) by mouth every 8 (eight) hours.   Last time this was given:  
*****/*****/*****  4:59 AM       ipratropium bromide 0.02 % nebulizer solution    Take 2.5 mL (500 mcg total) by nebulization 4 (four) times a day.   Last time this was given:  *****/*****/*****  4:59 AM       ipratropium-albuterol 0.5-2.5 mg/3 mL nebulizer solution   Also known as:  DUONEB    Take 3 mL by nebulization every 6 (six) hours.   Last time this was given:  *****/*****/*****  6:04 AM       magnesium hydroxide 400 mg/5 mL Susp   Also known as:  MOM    Take 30 mL (2,400 mg total) by mouth 4 (four) times a day as needed.       metoprolol 50 MG tablet   Also known as:  LOPRESSOR    Take 1 tablet (50 mg total) by mouth every 6 (six) hours.   Last time this was given:  *****/*****/*****  6:04 AM       OLANZapine 5 MG disintegrating tablet   Also known as:  ZyPREXA *****    Take 1 tablet (5 mg total) by mouth nightly as needed.   Last time this was given:  *****/*****/*****  4:46 AM       ondansetron 4 MG disintegrating tablet   Also known as:  ZOFRAN-ODT    Take 1 tablet (4 mg total) by mouth every 6 (six) hours as needed.       polyethylene glycol 17 gram packet   Also known as:  GLYCOLAX    Take 17 g by mouth daily as needed (severe constipation).       senna 8.6 mg tablet   Also known as:  SENOKOT    Take 2 tablets by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  7:53 PM       sodium chloride 0.9 % nebulizer solution    Take 3 mL by nebulization every 4 (four) hours.   Last time this was given:  *****/*****/*****  4:59 AM         CONTINUE taking these medications       Dose, Frequency, and Details    allopurinol 300 MG tablet   Also known as:  ZYLOPRIM    Reported on *****/*****/*****   Last time this was given:  *****/*****/*****  9:00 AM       atorvastatin 20 MG tablet   Also known as:  LIPITOR    Take 10 mg by mouth daily.   Last time this was given:  *****/*****/*****  8:18 PM       b complex vitamins capsule    Take 1 capsule by mouth daily.       furosemide 40 MG tablet   Also known as:  LASIX    Take 40 mg by mouth.   Last time this was 
given:  *****/*****/***** 12:45 AM       potassium chloride 40 mEq/15 mL *****   Also known as:  ***** 20%    Take by mouth.       tamsulosin 0.4 mg *****   Also known as:  FLOMAX    Take 0.4 mg by mouth daily.   Last time this was given:  *****/*****/*****  7:53 PM       warfarin 2 MG tablet   Also known as:  COUMADIN    Take 2 mg by mouth daily. 2 mg Tues-Sun 3 mg on Monday ONLY   Last time this was given:  *****/*****/*****  8:18 PM           Warfarin (Coumadin) Discharge Instructions     Warfarin (Coumadin) ***** Instructions       Indications:  Atrial Fibrillation   Duration After Discharge:  Indefinite   Target INR:  2.0-3.0   Who will manage Warfarin?:  Your PCP, see first page of AVS for number   Next INR Date:  *****/*****/*****   Ordering Provider:  ***** *****, MD, PhD                Recent Warfarin (Coumadin) Administrations (last 72 hours)     Date/Time Action Medication Dose    *****/*****/***** 2018 Given    warfarin (COUMADIN) tablet 2 mg 2 mg    *****/*****/***** 2006 Given    warfarin (COUMADIN) tablet 2 mg 2 mg        INR   Date Value Ref Range Status   *****/*****/***** 1.2 (H) 0.9 - 1.1 Final   *****/*****/***** 1.2 (H) 0.9 - 1.1 Final   *****/*****/***** 1.1 0.9 - 1.1 Final                  Immunizations Administered for This Admission     Name *****    Pneumococcal polysaccharide PPSV23  Deferred (Contraindication)             Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: ***** *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  1:30 PM *****   Resume with ***** ***** *****, MD, SCD   ***** Department of Neurology (--)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  1:00 PM *****   Resume with ***** ***** *****, MD, SCD   ***** Department of Neurology (--)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****    
             Follow-Up Services            NORTHEAST REHABILITATION HOSPITAL ***** *****   Specialty:  Rehabilitation    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 0843  Activity as tolerated         *****/*****/***** 0843  Discharge Tube Feeding     Comments:  Tube Feeding Formula             Adult/Pediatric tube feeding, No tray *****/*****-Osmolite 1.0; Route(s):   Nasogastric tube, Gastrostomy; Daily volume goal of TF formula: 1,800;   Continuous/Cyclic/***** Regimens: Continuous; Tube Feeding Continuous rate   (mL/hr): 75  Diet effective now           Tube Feeding Flush             Free water feeding tube bolus Q6H ***** amount: 250  Every 6 hours       *****/*****/***** 0843  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 0843  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.       *****/*****/***** 1743  CT Head     Comments:  OUTPATIENT ONLY   Question:  Intravenous Contrast Request:  Answer:  Should NOT be used (radiology may call to confirm)                     Exam   Temperature: 36.7 C (98 F) (*****/*****/***** 0735) | Heart Rate: 81 (*****/*****/***** 0735) | BP: 162/76 (*****/*****/***** 0735) | Respiratory Rate: 22 (*****/*****/***** 0735)  | SpO2: 97 % (*****/*****/***** 0735)  O2 Device: None (Room air) (*****/*****/***** 2340)  O2 Flow Rate (L/min): 6 
| FiO2 (%): 28 % (*****/*****/***** 2350)      Weight: 83.6 kg (184 lb 4.9 oz) (*****/*****/***** 0800)  Height: 185.4 cm (6' 0.99"") (*****/*****/***** 0800)         BMI (Calculated): 24.3 (*****/*****/***** 0800)    Discharge Exam    Significant Discharge Exam Findings:  Exam:  ***** (self, baseline since admission)  PERRL, FS  Follows commands, at least antigravity x 4   Incision c/d/i              Orientation Level: Oriented to person   Cognition: Follows commands         Speech: *****     Vision: Functional with Correction                Data/Results    Results are shown for the following tests if performed (CBC, Na, K, BUN, Cr).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 6.23 *****/*****/***** *****    HCT 42.8 *****/*****/***** *****    ***** 14.0 *****/*****/***** *****    HGB 14.1 *****/*****/***** *****    PLT 147 (L) *****/*****/***** *****      Lab Results   Component Value Date/Time    BUN 39 (H) *****/*****/***** *****    CRE 1.20 *****/*****/***** *****    ***** 4.5 *****/*****/***** *****    ***** 3.2 (L) *****/*****/***** *****    ***** ***** *****/*****/***** *****                            "
150008503,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: cardiology consult

Signed by ***** *****, MD on *****/*****/***** at 5:05 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 5:58 pm

 

==============================================================  

DIVISION OF CARDIOLOGY CONSULT NOTE 

Date of admission:  *****/*****/*****

Date of note:  *****/*****/*****

==============================================================  

OUTPATIENT CARDIOLOGIST: ***** *****



PCP:  *****, ***** *****. MD, PHD



CHIEF COMPLAINT: Headache



REASON FOR CONSULT: evaluation for timing of anticoagulation



HISTORY OF PRESENTING ILLNESS:  

Mr. ***** is a ***** on coumadin for a mechanical MV w h/o stroke

in 2009 in the setting of subtherapeutic INR (1.4)who presented

on *****/*****/***** with headaches for 5 days. Patient went to his PCP who

recommended MRI performed at ***** which showed a 1.9cm subdural

hematoma on the R side with 1.2 MLS. He was ***** to OSH

where INR was found to be 5.4. The patient received vitamin K 10

units IV as well as ***** ***** 2500 units. There were no focal

neurologic symptoms. The patient has had a GCS of 15. He was

***** to *****, where he subsequently underwent evacuation

of the hematoma on *****/*****, with subsequent recurrence and

evacuation on *****/*****, with stable NCHCT on *****/*****. Patient noted no

inciting trauma before this event and his most recent INR before

presentation was 2.5. He was on a dose of 6mg of coumadin for the

three weeks before presentation, and had been on 5mg before that.

Patient currently notes improved headache, at *****/***** now. No chest

pain, SOB, pain elsewhere. No GI symptoms.



REVIEW OF SYSTEMS:  as above. No fevers/chills, chest pain,

palpitations, SOB



PAST MEDICAL HISTORY:  

mitral valve 2012

CVA 2013

h/o R splenic infarct

HLD

Seizure disorder



HOME MEDICATIONS:  

Coumadin 6mg daily

***** 40mg

ASA 81

Keppra BID

valium 5mg BID

oxycodone 10mg q6hr

celebrex 200mg daily



CURRENT MEDICATIONS:

Acetaminophen 650 mg PO/NG Q6H fever or pain 

HYDROmorphone (Dilaudid) 2-4 mg PO/NG Q3H:PRN pain 

Aspirin 81 mg PO/NG DAILY 

Bisacodyl 10 mg PO/PR DAILY:PRN constipation 

Docusate Sodium 100 mg PO/NG BID 

LeVETiracetam 1000 mg PO BID 

Famotidine 20 mg PO/NG Q12H 

Ondansetron 4 mg IV Q8H:PRN nausea 

Heparin 5000 UNIT SC TID 

Phenytoin Sodium Extended 100 mg PO TID 

HydrALAzine 10-20 mg IV Q6H:PRN for SBP > 160 

***** 17.2 mg PO/NG QHS 

HYDROmorphone (Dilaudid) 0.25-0.5 mg IV Q3H:PRN pain 



ALLERGIES:  

NKDA



SOCIAL HISTORY:

worked as a fast food cook, currently on disability. Lives with

girlfriend, children. No tobacco, no current alcohol (quite a

month ago), no illicits or history of IVDU



FAMILY HISTORY: 

No history of clotting or bleeding disorders that patient is

aware of 



PHYSICAL EXAMINATION:  

VS: 98.6 120/82 (SBP *****-*****) 97 (92-100) 16 99% RA

Gen: Pleasant, calm  

HEENT: No conjunctival pallor. No icterus. MMM.   

NECK: Supple, JVP low. 

CV: RRR. loud s1 click, normal s2. No murmurs, rubs.

LUNGS: No wheezes, rales, or rhonchi.  

ABD: NABS. Soft, NT, ND. No abdominal bruits

EXT: WWP, NO CCE. 

SKIN: healing area of R-sided SDH evacuation

NEURO: A&Ox3. CN 2-12 grossly intact. Preserved sensation

throughout. Some weakness on distal *****.



LABS/STUDIES:

INR 1.0

See below  



EKG:  

'Sinus rhythm. RSR' pattern in leads V1-V2, likely a normal

variant. 

Non-specific T wave flattening. Compared to the previous tracing

of *****-*****-***** *****-T wave flattening is more prominent.' 



2D-ECHOCARDIOGRAM:  

(2007):

PRE-CPB: The left atrium is markedly dilated. No thrombus is seen

in the left atrial appendage. No spontaneous echo contrast is

seen in the body of the right atrium. No atrial septal defect is

seen by 2D or color Doppler. Left ventricular wall thicknesses

are normal. The left ventricular cavity is mildly dilated.

Overall left ventricular systolic function is normal (LVEF>55%).

Right ventricular chamber size and free wall motion are normal.

The right ventricular cavity is mildly dilated. Right ventricular

systolic function is normal. The ascending, transverse and

descending thoracic aorta are normal in diameter and free of

atherosclerotic plaque. There are simple atheroma in the

descending thoracic aorta. There are three aortic valve leaflets.

No masses or vegetations are seen on the aortic valve. There is

no aortic valve stenosis. Trace aortic regurgitation is seen. The

mitral valve leaflets are moderately thickened. The mitral valve

leaflets are myxomatous. There is moderate/severe mitral valve

prolapse of the anterior leaflet.. There is partial mitral

leaflet flail of the A2 leaflet. No mass or vegetation is seen on

the mitral valve. Severe (4+) mitral regurgitation is seen. The

mitral regurgitation jet is eccentric and directed posteriorly..

The mitral annulus is enlarged and measured 3.9. The tricuspid

valve leaflets are mildly thickened. Moderate [2+] tricuspid

regurgitation is seen. There is no pericardial effusion. 

POST-CPB: On phenylephrine drip. Well-seated mechanical valve in

the mitral position. Trivial MR along washing jets. 3-D

reconstruction shows good valve excursion. MS gradient of 5 mmhg

at ***** ***** of 5.5 L/min. There is preserved biventricular

systolic function. The aortic contour is normal post-

decannulation.  



CT:

1.7 cm R subdural chronic subdural hematoma with 1.5 left midline

shift





ASSESSMENT AND PLAN:  

***** yo M with history of mechanical MV replacement, stroke in 2009

in the setting of subtherapeutic INR (1.4), who presented with

subdural hematoma on *****/***** in the setting of supratherapeutic INR

to 5.4. While an INR of 5.4 would not be expected to cause a

spontaneous bleed, it is possible his INR had been higher prior

to this result, or that previous embolism given had predisposed

the area to bleeding as patient has history of right-sided MCA

distribution infarcts. Given the patient has a mechanical mitral

valve and a previous history of likely cardiac thromboembolic

stroke, there is a significant risk of thrombosis. There is a

~4-8% risk per year of thrombotic events in patients without

anticoagulation and mechanical valves, but this number may be

much higher in patients with mechanical mitral valves. Given the

patient's prior history of likely cardioembolic stroke, maybe

even higher. Therefore, we would strongly recommend

anticoagulation as soon as deemed safe from neurosurgical

standpoint.



- recommend heparin gtt without bolus, PTT goal 60-80

- may stop aspirin for now

- if stable on heparin, can consider restarting coumadin tomorrow

- will continue to follow



Thank you for this consult. Patient was seen and discussed with

Dr. *****









Addendum by ***** *****, MD on *****/*****/***** at 5:58 pm:

On the date above, I was present for the key portions of the

history and examination of this patient. I have reviewed and

confirmed the findings and agree with the plan described above. I

would add the following: this patient with mechanical MVR has an

unacceptably high risk for thromboembolic event off of systemic

anticoagulation; thus as soon as safe from neurosurgical

perspective, would heparinize with transition to warfarin. If his

prior CVA was attributable to subtherapeutic INR, then reasonable

to stop ASA in the setting of seeming unprovoked SDH. "
150007686,0,1,"

Note Date: *****/*****/*****  Time: 1428

Note Type: Initial note

Note Title: Neurology consult note

Signed by ***** *****, MD on *****/*****/***** at 6:38 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 11:14 am

 

Neurology Resident ***** *****



Reason for Consult: agitation, AMS



HPI:

The patient is a ***** with R SDH s/p R craniotomy for SDH

evacuation on *****/*****/*****, as well as a history of T2DM, AFib and

mechanical heart valve originally on Coumadin, discharged *****/***** to

rehab on a heparin gtt bridge to Coumadin with goal INR 2.5-3.5.

He now presents to ***** ***** as transfer from ***** where he was

sent to from his rehab facility for agitation and combativeness

that was refractory to Seroquel/Haldol. ***** Head CT shows R

SDH ~1.0cm in max thickness w/ ~5-6mm midline shift. Prior to d/c

from ***** on *****/*****, he had a ***** Head CT which showed the R

SDH, also ~1.0cm in max thickness w/ ~5-6mm midline shift.



Notably, his ***** is 20mg/dL on ED presentation, which was treated

prior to ***** arrival.



Neurology consulted for help with AMS.



Currently on keppra 1g BID for sz ppx, EEG diffuse slowing R>L

and rare epileptiform dc, no sz. 

Labs notable for slight leukocytosis, but negative UA, CXR no

clear e/o PNA.

Hypoglycemia improved.

On hep gtt because INR was low at 1.2. 





ROS: 10 point ROS reviewed as in *****



============================

PMH:

T2DM

AFib

Mechanical heart valve

                       





======================

Medications:



Medications - Standing

Influenza Vaccine Quadrivalent 0.5 mL ***** ***** X1

Sodium Chloride 0.9%  Flush 3-10 mL IV Q8H and PRN, line flush

LevETIRAcetam 1000 mg PO BID

QUEtiapine Fumarate 100 mg PO/NG BID

QUEtiapine Fumarate 150 mg PO/NG QHS

Doxazosin 2 mg PO/NG *****

***** 8.6 mg PO/NG BID

Docusate Sodium 100 mg PO/NG BID

Thiamine 100 mg PO/NG DAILY

FoLIC Acid 1 mg PO/NG DAILY

Nicotine Patch 14 mg TD DAILY

Digoxin 0.25 mg PO/NG DAILY

Diltiazem Extended-Release 300 mg PO DAILY

Furosemide 40 mg PO/NG DAILY

Metoprolol Succinate XL 100 mg PO DAILY

Simvastatin 20 mg PO/NG QPM

FLUoxetine 40 mg PO/NG DAILY

Insulin SC

Heparin IV

LORazepam 0.5 mg IV ONCE MR1



Medications - PRN

Acetaminophen-*****-Butalbital *****-***** TAB PO Q6H:PRN Headache

Acetaminophen *****-***** mg PO/NG Q6H:PRN Pain - Mild

OxyCODONE (Immediate Release) 2.5-5 mg PO/NG Q4H:PRN BREAKTHROUGH

PAIN

Polyethylene Glycol 17 g PO/NG DAILY:PRN constipation

Bisacodyl 10 mg PO DAILY:PRN Constipation - First Line

Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol

Glucagon 1 mg IM *****:PRN hypoglycemia protocol

Glucose Gel 15 g PO PRN hypoglycemia protocol

==================================







Allergies:

No known allergies





Social History:

Former smoker 

Denies ETOH







Family History : NC





=====================

Physical Exam:

- General: Awake, cooperative, NAD.

- HEENT: NC/AT

- Neck: Supple

- Pulmonary: no increased WOB

- Cardiac: well perfused 

- Abdomen: soft, nontender, nondistended

- Extremities: no edema, pulses palpated

- Skin: no rashes or lesions noted.



Neurologic:



-Mental Status: Alert, oriented x 3. Able to relate history

without difficulty. Inattentive, mistakes with ***** and 

backward. Language is fluent with intact repetition and

comprehension. Normal prosody. There were no paraphasic errors.

Pt was able to name ***** ***** ***** ***** frequency objects. Speech

was not dysarthric. Able to follow both midline and appendicular

commands. There was no evidence of apraxia or neglect.



-Cranial Nerves:

I: Olfaction not tested.

II: PERRL 3 to 2mm and brisk. VFF to confrontation. 

III, IV, VI: EOMI without nystagmus. 

V: Facial sensation intact to light touch.

VII: No facial droop, facial musculature symmetric.

VIII: Hearing intact to finger-rub bilaterally.

IX, X: Palate elevates symmetrically.

*****: 5/5 strength in trapezii and SCM bilaterally.

XII: Tongue protrudes in midline.





-Motor: Normal bulk, tone throughout. No drift.

No adventitious movements, such as tremor, noted. No asterixis

noted.

  Delt Bic Tri ***** FFl *****  ***** Quad ***** ***** ***** EHL EDB

L  5    5   5   5   5  5   5   5    5  5     5     5   5

R  5    5   5   5   5  5   5   5    5  5     5     5   5



-DTRs:  

       [Bic] [Tri] [*****] [Quad] 

     L  2+    2+     2+      2+       

     R  2+    2+     2+      2+         





-Sensory: No deficits to light touch throughout. No extinction to

DSS.



-Coordination: 



-Gait: Deferred



====================

Laboratory Data:

*****/*****/*****: WBC: a) 10.8*****; b) 10.9*****

*****/*****/*****: HGB: a) 11.8*****; b) 11.3*****

*****/*****/*****: HCT: a) 34.2*****; b) 33.4*****

*****/*****/*****: Plt Count: a) 242; b) 231

*****/*****/*****: MCV: a) 94; b) 95

*****/*****/*****: RDW: a) 13.5; b) 13.3



*****/*****/*****: Neuts%: a) 69.4; b) 72.3*****

*****/*****/*****: Lymphs: a) 20.5; b) 17.1*****

*****/*****/*****: *****: a) 5.8; b) 6.0

*****/*****/*****: Eos: a) 2.5; b) 2.4

*****/*****/*****: BASOS: a) 0.6; b) 0.7



*****/*****/*****: PTT: a) 52.0*****; b) 34.7

*****/*****/*****: PT: 12.8*****

*****/*****/*****: INR: 1.2*****



*****/*****/*****: Na: a) 139 (New reference range as of *****/*****/*****); b)

139 (New reference range as of *****/*****/*****)

*****/*****/*****: K: a) 4.5 (New reference range as of *****/*****/*****); b)

5.5***** (Hemolysis falsely elevates this test; New reference range

as of *****/*****/*****)

*****/*****/*****: Cl: a) 99; b) 99

*****/*****/*****: CO2: a) 25; b) 30

*****/*****/*****: BUN: a) 14; b) 16

*****/*****/*****: Creat: a) 0.9; b) 1.1

*****/*****/*****: Glucose: a) 171***** (If fasting, 70-100 normal, >125

provisional diabetes); b) 240***** (If fasting, 70-100 normal, >125

provisional diabetes)

*****/*****/*****: Ca: 9.3

*****/*****/*****: PO4: 3.9

*****/*****/*****: Mg: 2.3



*****/*****/*****: AST: 29

*****/*****/*****: ALT: 37

*****/*****/*****: Alk Phos: 113

*****/*****/*****: Total Bili: 0.4

*****/*****/*****: LDH: 293*****

*****/*****/*****: Alb: 4.7



*****/*****/*****: CK-MB: 2

*****/*****/*****: Troponin T: <0.01 (***** > 0.10 ng/mL suggests Acute

*****)





*****/*****/*****: Urine Blood (*****): NEG

*****/*****/*****: Urine Nitrite (*****): NEG

*****/*****/*****: Urine Protein (*****): *****

*****/*****/*****: Urine Glucose (*****): NEG

*****/*****/*****: Urine Ketone (*****): NEG

*****/*****/*****: Urine ***** (*****): NEG

*****/*****/*****: Sp Grav: 1.016

*****/*****/*****: WBC: 2

*****/*****/*****: Bacteria: NONE



*****/*****/*****: Benzodiazepine: NEG (Benzodiazepine immunoassay screen

does not ***** ***** *****,; including Lorazepam, Clonazepam, and

Flunitrazepam)

*****/*****/*****: Barbiturate: POS*****

*****/*****/*****: Opiate: NEG (Opiate assay does not reliably detect

synthetic opioids; such as Methadone, Oxycodone, Fentanyl,

Buprenorphine, Tramadol,; Naloxone, Meperidine. See online Lab

***** for details)

*****/*****/*****: Cocaine: NEG

*****/*****/*****: Amphetamine: NEG

*****/*****/*****: Methadone: NEG (Methadone assay detects Methadone (not

other Opiates/Opioids); Quetiapine (Seroquel) may cause a false

positive result)





Radiologic Data:



Non-Contrast CT of Head:

IMPRESSION:  

  

Unchanged mixed density subdural hematoma, with the largest

component 

overlying the frontal convexity.  Unchanged 8 mm leftward midline

shift.  No 

new or increasing hemorrhage. 



EEG:

Diffuse slowing R>L, rare epileptic discharges no seizures. 

  



===================

ASSESSMENT: In summary, ***** with R SDH s/p R craniotomy for SDH

evacuation on *****/*****/*****, as well as a history of T2DM, AFib and

mechanical heart valve originally on Coumadin, discharged *****/***** to

rehab on a heparin gtt bridge to Coumadin with goal INR 2.5-3.5.

Stable CT head with R SDH ~1.0cm in max thickness w/ ~5-6mm

midline shift.

EEG with diffuse slowing R>L, rare epileptic discharges no

seizures,



Exam currently only notable for mild inattention otherwise non

focal.





Etiology of his symptoms is most c/w delirium/sundowning given

waxing waning course and agitation most prominent at night. 

There is also a possibility that his keppra contributes to

agitation as this is a known side effect of keppra. It is less

likely that a new vascular insult is the cause of his

intermittent agitation, but given his multiple risk factor we

agree with MRI brain. Would also recommend delirium precautions.

Regarding keppra possibly contributing to his symptoms, since he

did not have any known seizures can consider weaning keppra if

okay from a neurosurgical perspective.



Plan:

- ***** follow up MRI brain

- Delirium precautions (normalize day/night, avoid sedating and 

  anticholinergic medications, encourage family involvement)

- keppra management as above







This case was discussed and seen with Attending Dr. *****

*****



***** ***** MD

Neurology Resident, PGY-3

*****









Addendum by ***** *****, MD on *****/*****/***** at 11:14 am:

I saw ***** ***** ***** ***** at bedside with the neurology team

at 17:35 on *****/*****/***** and have reviewed pertinent labs. In

general, I agree with the assessment and plan as outlined in *****.

*****'s note with the following additions: Mr. ***** is a

pleasant ***** y/o man with recent traumatic subdural s/p craniotomy

who presents from an OSH due to agitation and combative behavior.

Initial head CT negative for interval growth of SDH or new

infarct. Continuous EEG consistent with slowing but no

epileptiform discharges or seizures. Neurology consulted for

evaluation of waxing and waning mental status.



On exam, he is alert and pleasant. He is oriented x 3 but at

times is inattentive. Speech is fluent. Naming is intact. He can

follow both simple and appendicular commands. Pupils equal and

reactive, EOMI full, face symmetric, sensation intact, tongue

midline. Motor exam reveals intact strength, good tone. Sensation

intact to light touch. Mild tremor but no dysmetria with *****.  



In summary, Mr. ***** is a ***** y/o man with recent traumatic SDH

who present with waxing and waning mental status in the setting

for serum glucose fluctuations. Agitation may be multifactorial

from large SDH, metabolic disturbances with delirium. Recommend

delirium precautions. ***** review MRI once completed, although

less concerned about a new infarct or bleed. Keppra may lead to

some agitation and change in mood but defer to NSG regarding

management.





***** *****, MD  "
150805440,0,1,"

Note Date: *****/*****/*****  Time: 1034

Note Type: Initial note

Note Title: ED PT Evaluation (1)

Electronically signed by ***** *****, PT License# ***** on *****/*****/***** at 12:02 pm  Affiliation: *****

 

PHYSICAL THERAPY INITIAL EVALUATION 

Rehabilitation Services - Inpatient Physical Therapy  



[x] Referral date and Reason for Referral reviewed in *****

    Activity Orders: Activity as tolerated



HPI/Subjective Complaint: ***** ***** ***** is a 83 male on

Aspirin 81mg daily with Parkinson's Disease who presents as

transfer from ***** Medical Center s/p ***** with NCHCT

concerning for tiny SDH along the falx versus calcification.

Patient states that he was walking with his dog earlier today

*****/*****/*****, stating ""the dog was walking me"" when he tripped and

fell forward onto his left hip. The patient states that ""it felt

like I was down for 7 hours

outside""; however, per OSH records, likely down for approximately

one hour until his wife found him and called EMS. Patient states

that he tried to call out for help sooner but his wife is deaf

and could not hear him. He was taken to ***** where trauma workup

revealed NCHCT with ""minimal hyperdensity along the midline

cerebral falx which does not definitely represent calcification.

A thin acute subdural hematoma cannot be excluded."" Therefore,

patient was transferred to ***** for neurosurgical evaluation. Pt

with no focal neurologic deficits, no plan for neurosurgical

intervention. Pt presents today for PT initial evaluation to

assess functional mobility and assist with D/C planning.



[x] Past Medical/Surgical History, Medications, Radiology, and

Labs reviewed in ***** with pertinent exceptions noted below: 

PMH:

CORONARY ARTERY DISEASE                                         

TREMOR/*****

HLD

BPH



*****Pt is a poor historian, difficulty obtaining prior

functioning/home set up and per notes in ***** currently unable to

reach pt's wife*****

Social/Occupational History: Lives with his wife and dog.

Retired.

 

Living Environment: Lives in ***** *****, reports there are stairs to

enter but unable to elaborate. DME: rollator, cane



Prior Functional Status/Activity Level: Pt reports he ambulates

with a rollator or cane, sometimes requires assistance. A for

ADLs/IADLs. Does not drive. History of falls.



OBJECTIVE TESTS 



Arousal, Attention, Cognition, Communication: Alert, eyes open

majority of session. Oriented to self, DOB, location ""medical

facility"", and reason for hospitalization. Not able to state

month, date, or year. Able to say *****/***** ***** with maximal cues.

Slightly tangential in conversation with difficulty answering

questions.



Hemodynamic Response/Aerobic Capacity

          Position    HR      BP        RR     O2     RPE 

Rest      Supine      58      *****/*****           98%RA

Activity  Sit         62      140/60*****          100%RA 

Activity  Ambulation  72      *****/*****           97%RA

Total Distance Walked: 10' 

*****Pt with reports of dizziness upon sitting at *****, *****. RN made

aware.



[x] Full systems review completed and found to be within normal

limits with the following exceptions:

Pulmonary: shallow breathing pattern. Non-labored breathing with

activity, no reports of *****.



Integumentary: PIV x2, telemetry, condom catheter 



Vascular: extremities warm to touch, no edema noted



Sensory: intact to light touch *****



Posture: increased thoracic kyphosis, rounded shoulders, and

forward head positioning in sitting/standing 



Range of Motion: 

BUEs WFL

***** WFL, positioned in hip and knee flexion with increased

stiffness noted



Muscle Performance: 

BUEs and ***** grossly >=*****/*****



Motor Function: able to move all extremities in isolation. BLE

tremor noted at rest.

 

Pain: denies pain throughout evaluation 

 

Limiting Symptoms: fatigue, dizziness 



Functional Status

     *****: CG     Use of rail: ***** 

     *****/***** to Sit: min A   Head of Bed Elevated: Y 

     Sit to Stand: CG to RW

     Ambulation: CG/min A with RW

     Stairs: NT

     Other Activity: Sit to supine mod *****



*****Abbreviation Key***** I=Independent S=Supervision CG=Contact

***** *****=***** ***** *****=Standard ***** *****=Straight *****

*****=Axillary Crutches



Gait: Pt able to ambulate ~10' at bedside with RW and CG/min A,

demonstrating shuffling gait pattern with narrow BOS and minimal

foot clearance. Maximal cues needed for sequencing and assist

needed to advance RW. 



Balance: No overt ***** with above mobility. ***** with BUE

support using RW with CG, demonstrates slight posterior lean. 



Team Communication:

Communicated with [x]RN []MD []OT [x]CM RE: Patient status, D/C

planning

[] Patient discussed at interdisciplinary team rounds



Intervention: 

[x] Patient/Caregiver Education RE: Role of PT, PT plan of care

and 

     [x] Fall risk reduction

     [x] Exercise prescription

     [x] Energy conservation

[x] Functional mobility training including: bed mobility,

transfers, ambulation 

[] Therapeutic exercise including:

[x] Balance training 

[x] Endurance training

[] Other: 



DIAGNOSIS 

Impairments of Body Functions and Structures, Activity

Limitations and Participation Restrictions 

- Knowledge deficit RE: fall risk, role of PT

- Impaired cognition

- Impaired balance

- Impaired activity tolerance 

- Impaired strength



Clinical Impression/Prognosis: Pt is an ***** with a history of

Parkinson's Disease who presents to physical therapy during

hospitalization s/p ***** with mild TBI. Pt is functioning well

below baseline limited by impairments in body structure and

function including impaired balance, strength, activity

tolerance, and cognition. Pt also presents with activity

limitations in mobility and self-care contributing to difficulty

in fulfilling societal role of home dwelling elder. Patient will

benefit from rehab, recommend D/C to interdisciplinary rehab

setting once medically stable. If plan is for D/C home, pt would

require 24 hour care and assist for all OOB mobility with RW for

safety. Positive prognostic indicators for eventual return home

include pt's prior functioning and motivation to improve.

Limiting factors include pt's ***** and severity of

current deficits. Acute PT will continue to follow and progress

while pt remains in house.



Goals:               Time *****: 2 weeks 

- Pt will perform supine to sit transfer I

- Pt will perform sit to stand transfer with S

- Pt will ambulate 100' with RW and S

- Pt will ascend/descend *****-***** stairs with rail and CG

- Pt/caregiver will be I with HEP



Recommended Discharge: [x]rehab  



Treatment Plan: 

[] Discharge from inpatient physical therapy

[x] Continued Patient/Caregiver Education RE: 

     [x] Role of PT, PT plan of care and 

     [x] Fall risk reduction

     [x] Exercise prescription

[x] Energy conservation

[x] Functional mobility training including: ambulation, stairs

[x] Therapeutic exercises

[x] Balance training 

[x] Therapeutic activities 

[x] Cognitive Training  

[x] Endurance Training 

[] Other:



Frequency/Duration: 2-3x/week for 2 weeks 



Recommendations for Nursing:  

[x] Patient is at high risk for deconditioning. Please maximize

independence in ***** and encourage frequent mobility including:

     [x] Ambulate short distances with RW and min A 3x/day

     [x] Assist of 1 for out of bed to chair with RW 3x/day

[x] Patient is at risk for pressure injury. Please limit sitting

time to one hour on standard air cushion given patient's

inability to effectively reposition in chair. 

[x] Patient is at risk for falls. Please use chair alarm when out

of bed.

[x] Patient is at risk for delirium. Please consider implementing

strategies to reduce risk including: 

     *****OOB to chair 3 day for all meals

     *****Familiar pictures and items within view 

     ***** or nonverbal music on during daytime 

     ***** on during day with shades ***** 

     *****Frequent Reorientation to clock, calendar, and window 

     *****Encourage participation with ADLs 

     *****Encourage family presence at bedside



Patient agrees with the above goals and is willing to participate

in the rehabilitation program. Please indicate with an 'X':

Yes[x] or No[]. If no please explain: 



Date: *****/*****/*****

Time: *****-*****



Physical Therapist Name: ***** *****, *****, *****

***** Therapist Pager: *****

"
114993651,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents          There are no health care agents on file.          Code Status at *****: Prior       Discharge address same as *****: Yes                   Hospitalization Summary     Admission Diagnosis     Difficulty swallowing             Principal Problem:    Achalasia  Active Problems:    Necrotic toes    Subdural hematoma    DLBCL (diffuse large B cell lymphoma)    Acute deep vein thrombosis (DVT) of femoral vein of left lower extremity  Resolved Problems:    Epigastric pain    Epigastric pain    Pneumonia    Hypokalemia    Hypernatremia    Headache          Surgical (OR) Procedures:   Surgeries this Admission     None          Non (OR) Procedures:   *****/***** 1037 ENDOSCOPY PROCEDURE    Items for Post-Hospitalization Follow-Up:    Needs to be reassessed in terms of odynophagia in about 3 weeks. If continues to do well, as he has with the hospitalization, try stopping the Reglan at that time. If the odynophagia recurs, would consign him to life-long Reglan despite risk of dyskinesia        Pending Results     None           Hospital Course   ***** PMHx diffuse large B-cell lymphoma (initially dx 2011) s/p ***** (*****-*****),  ***** cellular therapy infusion on protocol 16-272 (antibody coupled T-cell receptors not *****-T, *****/*****),  prostate cancer s/p prostatectomy (1995), obesity s/p ***** (2012), T2DM, and chronic SDH, Type 2 NSTEMI, DVT/bilateral PEs (not on AC 
due to subdural hematoma with midline shift), esophagitis/mucositis/achalasia, with recent admissions here for pyelo, and then PNA/fever+neutropenia. He was discharged originally with plan for home hospice but pt cancelled it as he wish to have the options to see all outpatient providers, and now presents s/p EGD  for odynophagia, epigastric pain and inability to tolerate PO intake and b/l necrotic toe.    Admission history as follows:    ***** PMHx diffuse large B-cell lymphoma (initially dx 2011) s/p ***** (*****-*****),  ***** cellular therapy infusion on protocol 16-272 (antibody coupled T-cell receptors not *****-T, *****/*****),  prostate cancer s/p prostatectomy (1995), obesity s/p ***** (2012), T2DM, and chronic SDH, Type 2 NSTEMI, DVT/bilateral PEs (not on AC due to subdural hematoma), esophagitis/mucositis/achalasia, with recent admissions here for pyelo, and then PNA/fever+neutropenia. He was discharged originally with plan for home hospice but pt cancelled it as he wish to have the options to see all outpatient providers, ER therapies, etc., and now presents s/p EGD day PTA for odynophagia, epigastric pain and inability to tolerate PO intake and b/l necrotic toe tips.     Pt reported that he continued to have odynophagia and could only tolerate soup or thin liquid vs solid due to pain. He decided to present to explore further options as he is unable to keep up with his PO intake. He also reported chronic headache not responding to oxycodone, *****, and decadron which was tried previously. Per wife she noted that he has b/l necrotic toe with bloody drainage that was present during prior admission. He is insensate of his toe. He has had extensive prior vascular workup for claudication with the consultant concluding that his leg symptoms were not due to arterial insufficiency in view of normal arterial studies.     Recent admissions include:  *****/*****/*****-*****-*****-***** for neutropenic sepsis, likely due to 
pneumonia  *****/*****-*****/*****/***** for pyelonephritis, type 2 NSTEMI, persistent prior subdural hematoma  *****/*****-*****/*****/***** for orthostasis and *****, prior SDH  *****/*****-*****/*****//2017 for SDH, *****  *****/*****-*****/*****/***** for acute SDH, esophagitis  *****/*****-*****/*****/***** for dyspnea (multifactorial)  *****/*****-*****/*****/***** for refractory DLBCL (transformed from underlying follicular lymphoma)      Hospital Course by Problem:    #Odynophagia:  Patient is found to have achalasia with patulous proximal esophagus, hypertonic LES. Barium swallow was performed demonstrating findings c/w esophageal spasm. LES spasm and disordered upper esoph contractions had been noted on a prior study of *****/*****/*****. EGD demonstrated mild esophagitis, a mild intrinsic stenosis was found 37 to 38 from incisors, and had dilatation performed. - *****-en-Y gastrojejunostomy with  gastrojejunal anastomosis characterized by  healthy appearing mucosa.                    - One non-bleeding jejunal ulcer with no  stigmata of bleeding.  Normal examined jejunum. He was seen in ***** ***** *****. ***** ***** of GI and Dr. ***** ***** of GI motility. He has been followed by them in the past for the same problem and has lost 50 pounds since the *****. He has had esophageal manometry in past consistent with type 3 achalasia (spasm, characterized by rapidly propagated esophageal pressurization attributable to spastic contractions). He had underwent botox injection of the distal esophagus on *****/*****. He was continued on omeprazole and sucralfate during that admission and at that time was tolerating a regular diet without odynophagia or dysphagia. Due to the highly spastic nature pro-motility agents are not likely to be successful, though ***** might improve some ***** symptoms. However, metoclopramide had already been started and the patient was convinced that his swallowing was improving, which was reflected by improved food intake. Diltiazem was added without adverse impact on BP or 
HR, and by the time of discharge he stated that he had no odynophagia or dysphagia and was eating slices of pizza without difficulty. The GI team has recommended peroral endoscopic myotomy (*****) and Dr. ***** ***** of GI Surgery was consulted. He was seen the patient before. Patient s/p *****-en-Y gastric bypass in 2012. He expressed some questions as to whether the data represented classic achalasia or whether his symptoms might arise from a combination of esophagitis, stricture and non-specific dysmotility. In view of his symptomatic improvement he recommended deferring procedure. He was also seen by SLP who concluded that he did not have oropharyngeal swallow problems.     #Necrotic toes:  Plantar tips of both great toes with well marginated dry gangrene. The source of this was not at all clear. Was present for several weeks, painless. Had had extensive evaluation in the past for claudication but did not have evidence of macrovascular peripheral arterial insufficiency. Non-invasive studies were repeated and again found to be normal. Was seen in ***** ***** *****. ***** *****. Has known venous thromboembolic disease and consideration was given to paradoxical emboli (though the rather marked symmetry would suggest against embolic phenomena). There was no other digital involvement. Patient was offered and refused amputation. No other options available and treated locally with ***** here, Bacitracin ointment at home. Echo was done but was not done as a bubble study. Limited views of the IAS did not suggest a shunt. Anticoagulation is not a treatment option in any case due to extensive, previously expanding SDH. Patient has had acute MI and in spite of that no intervention performed then due to absolute contraindication for antiplatelet or anticoagulation therapy per neurosurgery consultant. Alternate explanation is paraneoplastic vasculitis    #abnormal EKG:  He has had somewhat variable, fairly profound 
T-wave inversion that seems to have started in ***** of this year and may well be due to the SDH. He has prolonged QT as well. Lateral T-wave inversions can also be seen in esophageal spasm, but the rather abrupt transition to such at the corresponding moment in his medical hx suggests that it is the SDH. He has no overt indication of CAD that I can see. Had a negative perfusion study several years ago (2011). He has no wall motion abnormality on echo.     #Diffuse large B cell lymphoma  S/p ***** *****-***** and ***** cellular therapy infusion on protocol 16-272 (antibody coupled T-cell receptors technically not *****-T per onc, *****/*****). last treated with ***** cellular therapy infusion on protocol 16-272 on ***** *****, *****. There is additional *****-T treatment options available, however the patient has concluded that he doesn't what to try anything additional.  As of *****, Dr. ***** felt that his overall lymphoma burden was low.  Currently reaching out to update that facet I have spoken with Dr. ***** who feels that a reasonable ***** at life expectancy would be 3-6 months    #Subdural hematoma  Pt has known subdural hematoma over R cerebral convexity and midline shift.   -Head CT *****/***** showed no significant interval change  -he was on *****, decadron, fioricet with limited effect for headache, though this aspect is improved.   -as of prior admission, neurosurgery continues to recommend against anti-platelet ***** ***** *****      #T2DM  Good glycemic control this hospitalization. BGs *****-*****. No medication.          Medications   Allergies: Penicillins    Prior to Admission Medications   Prescriptions   MAG *****/ALUMINUM *****/***** (MYLANTA *****-STRENGTH ORAL)   Sig: Take 30 mL by mouth 3 (three) times a day as needed (indigestion).   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain (fever).   allopurinol (ZYLOPRIM) 
300 MG tablet   Sig: Take 150 mg by mouth daily. Pt to cut 300mg pill in half.   aluminum-magnesium hydroxide-simethicone (MAALOX) *****-*****-***** mg/5 mL Susp   Sig: Take 15 mL by mouth nightly.   butalbital-acetaminop-caf-cod (FIORICET WITH CODEINE) 50-300-40-30 mg Cap   Sig: Take 1 capsule by mouth 3 (three) times a day as needed.   Patient not taking: Reported on *****/*****/*****   calcium citrate (CALCITRATE) 950 mg (200 mg elemental) tablet   Sig: Take 1 tablet by mouth daily.   Note (*****/*****/*****): Received from: Partners LMR Received Sig: Dose: 950 MG; Form: Not available; Route: PO; Frequency: QD; Directions: Not available; Details: Not available; Date: *****/*****/*****   citalopram (CELEXA) 10 MG tablet   Sig: Take 1 tablet (10 mg total) by mouth daily.   collagenase (*****) ointment   Sig: Apply topically daily as needed.   Patient not taking: Reported on *****/*****/*****   dronabinol (MARINOL) 5 MG capsule   Sig: Take 1 capsule (5 mg total) by mouth 2 (two) times a day before meals.   ferrous sulfate 325 mg (65 mg elemental) tablet   Sig: Take 1 tablet (325 mg total) by mouth daily with breakfast.   Patient not taking: Reported on *****/*****/*****   fludrocortisone (FLORINEF) 0.1 mg tablet   Sig: Take 2 tablets (0.2 mg total) by mouth daily. Indications: Symptomatic Orthostatic Hypotension   lidocaine 5 % ointment   Sig: Apply topically daily as needed.   Patient not taking: Reported on *****/*****/*****   magnesium oxide (MAG-OX) 400 mg (240 mg elemental) tablet   Sig: Take 1 tablet (400 mg total) by mouth 3 (three) times a day.   midodrine (PROAMATINE) 10 MG tablet   Sig: Take 2 tablets (20 mg total) by mouth 3 (three) times a day.   multivitamins capsule   Sig: Take 1 capsule by mouth daily.   Note (*****/*****/*****): Received from: Partners LMR Received Sig: Dose: 1 TAB; Form: Not available; Route: PO; Frequency: QD; Directions: Not available; Details: Not available; Date: *****/*****/*****   omeprazole (PRILOSEC) 20 MG capsule   Sig: Take 40 mg by mouth 2 
(two) times a day.   ondansetron (ZOFRAN) 4 MG tablet   Sig: Take 4 mg by mouth 3 (three) times a day as needed.   Note (*****/*****/*****): Received from: ***** *****   oxyCODONE (ROXICODONE) 5 mg/5 mL solution   Sig: Take 10-15 mL (10-15 mg total) by mouth every 4 (four) hours as needed. Pt. may request partial fill   potassium chloride SA (K-*****,KLOR-CON) 20 MEQ ER tablet   Sig: Take 2 tablets (40 mEq total) by mouth 2 (two) times a day.   sucralfate (CARAFATE) 1 gram tablet   Sig: Take 1 g by mouth 4 (four) times a day.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          ferrous sulfate 325 mg (65 mg elemental) tablet       MYLANTA *****-STRENGTH ORAL   Replaced by:  aluminum-magnesium hydroxide-simethicone *****-*****-***** mg/5 mL Susp   You also have another medication with the same name ***** ***** ***** ***** continue taking as instructed.       ondansetron 4 MG tablet   Also known as:  ZOFRAN       potassium chloride SA 20 MEQ ER tablet   Also known as:  K-*****,KLOR-CON   Replaced by:  potassium chloride 20 mEq packet         START taking these medications       Dose, Frequency, and Details    bacitracin 500 unit/gram *****    Apply 1 application topically daily. OTC; OK to get 30gm tube instead of individual packets       dilTIAZem 180 MG 24 hr capsule   Also known as:  CARDIZEM CD    Take 1 capsule (180 mg total) by mouth nightly.   Last time this was given:  *****/*****/*****  8:30 PM       metoclopramide HCl 10 MG tablet   Also known as:  REGLAN    Take 1 tablet (10 mg total) by mouth 4 (four) times a day before meals and nightly.   Last time this was given:  *****/*****/***** 12:18 PM       potassium chloride 20 mEq packet   Also known as:  KLOR-CON    Take 40 mEq by mouth 2 (two) times a day.   Replaces:  potassium chloride SA 20 MEQ ER tablet   Last time this was given:  *****/*****/*****  2:27 AM         CHANGE how these medications are taken       Dose, Frequency, and 
Details    ***** aluminum-magnesium hydroxide-simethicone *****-*****-***** mg/5 mL Susp   Also known as:  MAALOX    Take 15 mL by mouth nightly.   What changed:    - Another medication with the same name ***** *****. Make sure you understand how and when to take each.  - Another medication with the same name ***** *****. Continue taking this medication, and follow the directions you see here.       ***** aluminum-magnesium hydroxide-simethicone *****-*****-***** mg/5 mL Susp   Also known as:  MAALOX    Take 30 mL by mouth every 6 (six) hours as needed.   What changed:  You were already taking a medication with the same name, and this prescription was added. Make sure you understand how and when to take each.   Replaces:  MYLANTA *****-STRENGTH ORAL       fludrocortisone 0.1 mg tablet   Also known as:  FLORINEF    Take 1 tablet (0.1 mg total) by mouth daily. Indications: Symptomatic Orthostatic Hypotension   For:  Symptomatic Orthostatic Hypotension   What changed:  how much to take   Last time this was given:  *****/*****/*****  8:11 AM       midodrine 10 MG tablet   Also known as:  PROAMATINE    Take 1 tablet (10 mg total) by mouth 3 (three) times a day.   What changed:  how much to take       ***** Notice:  This list has 2 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.      CONTINUE taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain (fever).       butalbital-acetaminop-caf-cod 50-300-40-30 mg Cap   Also known as:  FIORICET WITH CODEINE    Take 1 capsule by mouth 3 (three) times a day as needed.       calcium citrate 950 mg (200 mg elemental) tablet   Also known as:  CALCITRATE    Take 1 tablet by mouth daily.       citalopram 10 MG tablet   Also known as:  CeleXA    Take 1 
tablet (10 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:23 AM       collagenase ointment   Also known as:  *****    Apply topically daily as needed.       dronabinol 5 MG capsule   Also known as:  MARINOL    Take 1 capsule (5 mg total) by mouth 2 (two) times a day before meals.       lidocaine 5 % ointment    Apply topically daily as needed.       magnesium oxide 400 mg (240 mg elemental) tablet   Also known as:  MAG-OX    Take 1 tablet (400 mg total) by mouth 3 (three) times a day.       multivitamins capsule    Take 1 capsule by mouth daily.       omeprazole 20 MG capsule   Also known as:  PriLOSEC    Take 40 mg by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:24 AM       oxyCODONE 5 mg/5 mL solution   Also known as:  ROXICODONE    Take 10-15 mL (10-15 mg total) by mouth every 4 (four) hours as needed. Pt. may request partial fill   Last time this was given:  *****/*****/*****  8:30 PM       sucralfate 1 gram tablet   Also known as:  CARAFATE    Take 1 g by mouth 4 (four) times a day.       ZYLOPRIM 300 MG tablet   Also known as:  allopurinol    Take 150 mg by mouth daily. Pt to cut 300mg pill in half.   Last time this was given:  *****/*****/***** 11:38 AM                        Hospital Care Team   Service: Medicine  Inpatient Attending: ***** *****. providers found     Attending ***** *****: N/A  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  3:***** ***** *****   ***** ***** ***** ***** *****   ***** ***** Center for Outpatient Care - CT (***** ***** - Main Campus)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****           *****If you are having a CT Abdomen/Pelvis in addition to this CT exam please arrive 1 hour before your scheduled time to drink oral contrast. Some exams may require additional oral contrast at the time of the exam.*****  Please refer to 
the CT Abdomen/Pelvis instruction sheet for additional information.  Please check in ***** ***** 20 minutes prior to your scheduled exam time. You should not eat solid foods for two hours prior to your test. Please drink plenty of fluids such as water, clear soups, juice, or black ***** coffee or tea.  Medications: If you need to take your medication in the morning prior to the scan, take it with water. If you take any oral diabetic medications you may not be able to take these medications for 48 hours after receiving intravenous contrast, (x-ray dye) from your CT scan examination. Please consult your prescribing physician to answer any questions about substitute medications that may be necessary. You will receive specific instructions at the time of the exam.  What to wear: Wear loose-fitting, comfortable clothes with no metal (zippers, under wire *****, etc) for the test. Leave your watch, jewelry, and other valuables at home.  Other Information: If youve ever had an allergic reaction to contrast tell your doctor and the technologist. The doctor may prescribe special medicine for you to take before the exam and also while you are here for the exam. You should bring the last dose of medicine with you prior to the scan.  Children who are not patients are not allowed to enter the scan room. Please make alternative arrangements for them or have another adult accompany you to watch your child in the ***** ***** ***** you are having your scan.            ***** *****, ***** 10:30 AM *****   Follow Up with ***** ***** *****, MD   Acute Care Neurosurgery on WAC 8 (--)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  9:30 AM *****   Consult with ***** *****, MD   ***** Gastroenterology Associates (MGP GI OFFICE)    ***** ***** *****  ***** ***** ***** ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  2:15 PM *****   (Arrive by 2:00 PM)   Follow Up with ***** ***** *****, MD   ***** 
General & Gastrointestinal Surgery (--)    ***** ***** *****  ***** *****; ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  2:00 PM *****   New Patient with ***** *****, MD   ***** Cardiology Division (***** Main Cardiology)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            ***** ***** ***** - HOME CARE   Specialty:  Home Health Services    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****             Follow-Up Providers            ***** *****, MD   Specialty:  Gastroenterology, Internal Medicine    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Call today       Instructions:  Spoke with Dr. *****'s associate. Plan is to have you come in approximately 3 weeks to review your progress with the swallowing. Please call to make appointment                 Signed Discharge Orders     Ordered        *****/*****/***** 0900  Referral to Home Health HOMEBOUND     Question Answer Comment   Location of Home Care referral? ***** at *****    Referral Priority Admit within 24 hours    Physician to Follow Patient's Care in the Community PCP    Disciplines Requested Nursing (to assess, treat and teach)    Disciplines Requested Physical Therapy (to assess and treat)    Disciplines Requested Home Health ***** (for personal care assistance)    Services to Provide - Nursing Cardiovascular    Services to Provide - Nursing Pulmonary    Service to Provide - Physical Therapy Functional Mobility    Date of Face to Face Encounter: *****/*****/*****    This encounter with this patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care: PNA/Fever/ *****, diffuse Large B Cell Lymphoma, s/p ***** and *****-T cell therapy. s/p EGD for Epigastric pain, dehydration, necrotic toes    In addition to clinical findings elsewhere in the medical record documentation the patient is homebound 
due to: Use of an assistive device    To navigate home structural barriers patient requires to use of: walker           *****/*****/***** 0948  Activity as tolerated         *****/*****/***** 0948  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 0948  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1330  Activity as tolerated         *****/*****/***** 1330  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1330  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1330  Referral to Home Health HOMEBOUND     Question Answer Comment   Location of Home Care referral? ***** at *****    Referral Priority Admit within 48 hours    Physician to Follow Patient's Care in the Community PCP    Disciplines Requested Nursing (to assess, treat and teach)    Disciplines Requested Physical Therapy (to assess and treat)    Services to Provide - Nursing Cardiovascular    Services to Provide - Nursing Neurological    Services to Provide - Nursing GI    Service to Provide - Physical Therapy Functional Mobility    Service to Provide - Physical Therapy Musculoskeletal ROM/Strength    Service to Provide - Physical Therapy Safety    Additional Orders: fall risk    Date of Face to Face Encounter: 
*****/*****/*****    This encounter with this patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care: achalasia, lymphoma, subdural hematoma    In addition to clinical findings elsewhere in the medical record documentation the patient is homebound due to: Assistance of another person    Patient needs assistance of another person due to: impaired balance    Patient needs assistance of another person due to: congitive impairment and poor safety awareness                         Exam   Temperature: 37 째C (98.6 째F) (*****/*****/***** 1215) | Heart Rate: 77 (*****/*****/***** 1215) | BP: 142/65 (*****/*****/***** 1215) | Respiratory Rate: 18 (*****/*****/***** 1215)  | SpO2: 96 % (*****/*****/***** 1215)  O2 Device: None (Room air) (*****/*****/***** 1215)    | FiO2 (%): 21 % (*****/*****/***** 2310)      Weight: 70.6 kg (155 lb 10.3 oz) (*****/*****/***** 0753)  Height: 175.3 cm (5' 9.02"") (*****/*****/***** 0420)         BMI (Calculated): 23.3 (*****/*****/***** 1519)    Discharge Exam    Significant Discharge Exam Findings:  This is a pleasant, interactive male in no distress.  Temperature:  [36.7 째C (98.1 째F)-37.2 째C (98.9 째F)] 36.7 째C (98.1 째F)  Heart Rate:  [68-87] 87  Respiratory Rate:  [14-20] 18  BP: (*****-*****)/(59-69) 130/60  FiO2 (%):  [21 %] 21 %  ENT: Neck is supple and there is no adenopathy, thyroid is normal to palpation, oral mucosa is moist and there are no ulcers or other lesions.   Eye: PERRLA, EOM with FROM  Chest: good respiratory excursion, there are no rales, wheezes or ronchi  Cor: nl apical impulse. RRR. S1 and S2 are audible and S2 is physiologically split, there are no murmurs, clicks, rubs or gallops.   Vasc: right atrial pressure is normal as assessed by jugular venous wave, with normal wave form. Carotic upstrokes are normal and there are no bruits. Dorsalis pedis pulses are 2+ as are the posterior tibialis. There are no femoral bruits. There is no edema  Abd: soft and not tender. Liver is normal sized and not pulsatile, 
spleen tip is not palpable, and there are no masses  Ext: no evidence of synovitis.  Skin: no rashes                Orientation Level: Oriented X3   Cognition: Follows commands, Impulsive         Speech: Appropriate for age, Clear     Vision: Functional with Correction  Hearing: Functional with correction   Assistive Devices: *****       *****/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 3.09 (L) *****/*****/***** *****    RBC 2.51 (L) *****/*****/***** *****    HGB 7.8 (L) *****/*****/***** *****    HCT 24.6 (L) *****/*****/***** *****    MCH 31.1 *****/*****/***** *****    MCV 98.0 *****/*****/***** *****    PLT 131 (L) *****/*****/***** *****    RDW 17.6 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 144 *****/*****/***** *****    ***** 3.6 *****/*****/***** *****    ***** 104 *****/*****/***** *****    CO2 30 *****/*****/***** *****    BUN 8 *****/*****/***** *****    CRE 0.59 (L) *****/*****/***** *****    ***** 8.4 (L) *****/*****/***** *****    GLU 107 *****/*****/***** *****    GLUPOC 171 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.3 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 14.9 (H) *****/*****/***** *****    PTT 34.1 *****/*****/***** *****    INR 1.2 (H) *****/*****/***** *****          Patient consultation, exam, review of labs, discussion with experts here, receiving clinicians, required well in excess of 50 minutes.                 "
116121874,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information  ***** *****, ***** y.o. female (DOB = *****/*****/*****)    Home Address: ***** *****  ***** ***** ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: Patient is unable to respond  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): ***** Form                Care Plan *****: mary *****, dtr       Code Status at *****: DNR/DNI (No CPR/No Intubation)       Discharge address same as *****: Yes        Hospitalization Summary      Principal Problem:    Subdural hematoma  Resolved Problems:    ***** No resolved hospital problems. *****    Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    -BP control with primary care physician  -Ensure that pt is off Keppra (was on 7d course, last day on *****/*****)  -Consider ASA therapy after resolution of SDH        Pending Results     None           Hospital Course  92 F dementia (who lives in ***** *****), HTN presents with 1 day Hx of lethargy, then subsequently found by staff at assisted living to be confused, incontinent of stool and urine. No Hx or evidence of trauma. CT head with chronic SDH, possible acute component, requiring repeat imaging and observation.          SDH- patient had repeat CT imaging which was stable. She was seen by neurosurgery and was felt not to be a candidate for neurosurgical intervention. Patient denied a history of falls, but has poor memory. She did have a routine EEG done which was unremarkable. UA and serum tox were negative. A Brain MRI revealed the SDH, as well as chronic microvascular disease, foci of susceptibility in basal ganglia and cerebellum most consistent with hypertensive disease, and an old infarct. Given presumed *****, she was started a 7day course of Keppra (end date: 
*****/*****).  - Neurosurgery follow up scheduled for *****/*****/*****    Hypertension- Patient was intermittently hypertensive but asymptomatic. In conversation with her primary care physician, spironolactone 25 mg qd was started. She will require PCP follow up for continued management of her hypertension.     Silent infarct- noted on MRI Brain as noted above. She is on statin therapy. We deferred initiating aspirin therapy given her SDH, but this can be addressed with primary care physician as an outpatient after resolution of SDH and conversation with family regarding fall risk.             Medications  Allergies: Macrodantin (nitrofurantoin macrocrystal) and Sulfa (sulfonamide antibiotics)    Prescriptions prior to admission   Medication Sig    atorvastatin (LIPITOR) 10 MG tablet Take 1 tablet (10 mg total) by mouth daily.    metoprolol succinate (TOPROL-XL) 100 MG 24 hr tablet Take 1 tablet (100 mg total) by mouth daily.    multivitamins-minerals-folic acid-*****-lutein (CENTRUM SILVER) 0.4-300-250 mg-mcg-mcg Tab Take 1 tablet by mouth daily.        Discharge Medications      START taking these medications       Dose, Frequency, and Details    levETIRAcetam 500 MG tablet   Also known as:  KEPPRA    Take 1 tablet (500 mg total) by mouth 2 (two) times a day for 5 days.   Last time this was given:  *****/*****/*****  9:54 PM       spironolactone 25 MG tablet   Also known as:  ALDACTONE    Take 1 tablet (25 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  5:30 PM         CONTINUE taking these medications       Dose, Frequency, and Details    atorvastatin 10 MG tablet   Also known as:  LIPITOR    Take 1 tablet (10 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  9:54 PM       metoprolol succinate 100 MG 24 hr tablet   Also known as:  TOPROL-XL    Take 1 tablet (100 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:36 AM       multivitamins-minerals-folic acid-*****-lutein 
0.4-300-250 mg-mcg-mcg Tab   Also known as:  CENTRUM SILVER    Take 1 tablet by mouth daily.                       Immunizations Administered for This Admission            Pneumococcal polysaccharide PPSV23  Deferred (Contraindication)             Hospital Care Team  Service: Neurology  Inpatient Attending: ***** ***** *****,*****     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan  Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  3:00 PM   SURGERY CONSULT with ***** ***** *****, MD   Northeast Surgery Center (--)    ***** ***** ***** *****, ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            St ***** *****   Specialty:  Skilled Nursing Facility    ***** ***** *****  ***** ***** *****     Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 0902  Activity as tolerated         *****/*****/***** 0902  Discharge diet     Question Answer Comment   Diet Type Regular    ***** Restriction: Low fat (cardiac)    Sodium Restriction: NO ADDED *****           *****/*****/***** 0902  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.       *****/*****/***** 0902  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact the Neurology ***** Resident on call at  *****-*****-***** and ask for Dr. ***** ***** to be paged.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact the Neurology ***** Resident on call at  *****-*****-***** 
and ask for Dr. ***** ***** to be paged.                     Exam  Temperature: 36.5 C (97.7 F) (*****/*****/***** 0741) | Heart Rate: 70 (*****/*****/***** 0741) | BP: 140/80 mmHg (*****/*****/***** 0741) | Respiratory Rate: 16 (*****/*****/***** 0741)  | SpO2: 97 % (*****/*****/***** 0741)  O2 Device: None (Room air) (*****/*****/***** 0741)    |        Weight: 58.3 kg (128 lb 8.5 oz) (*****/*****/***** 2100)  Height: 157.5 cm (5' 2"") (*****/*****/***** 2100)         BMI (Calculated): 23.5 (*****/*****/***** 2100)    Discharge Exam    Significant Discharge Exam Findings:  GEN: NAD. Interactive. Well developed.  Skin: No rashes or bruising.  HEENT: Normocephalic and atraumatic head; pink conjunctiva, no evidence of icterus, teeth in good condition, moist mucous membranes, clear oropharynx.  Lungs: CTA bilaterally with good flow.  CV: RRR S1/S2. +systolic murmur at *****.  Extr: Warm and well perfused, no evidence of edema    Neurologic Exam:    Non-focal neurological exam. She does have poor memory, oriented to person, place (hospital, but not *****), but not month or year. Her orientation waxes and wanes. Able to days of week forwards, but not backwards.                 Orientation Level: Oriented to person, ***** to place (name of this place), Oriented to city, Oriented to state, Oriented to season, ***** to time (year)   Cognition: Follows commands         Speech: Clear     Vision: Functional  Hearing: Functional   Assistive Devices: None         Data/Results   Results are shown for the following tests if performed (CBC, Na, K, BUN, Cr).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 7.97 *****/*****/***** *****    HCT 35.5***** *****/*****/***** *****    HGB 11.8 *****/*****/***** *****    PLT 162 *****/*****/***** *****      Lab Results   Component Value Date/Time    BUN 21 *****/*****/***** *****    CRE 0.87 *****/*****/***** *****    ***** 3.6 *****/*****/***** *****    ***** ***** *****/*****/***** *****                              "
150010228,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: Inpatient PT Initial Evaluation (1)

Signed by ***** *****, PT License# ***** on *****/*****/***** at 4:42 pm  Affiliation: *****

 

PHYSICAL THERAPY INITIAL EVALUATION 

Rehabilitation Services - Inpatient Physical Therapy  



Attending Physician: *****,*****

Referral Date: *****/*****

Reason for Referral: 

Activity Orders: As tolerated. SBP <160



HPI/Subjective Complaint: Pt is a ***** yo female who was seen in

2015 after ETOH use and ***** resulting in ***** and SDH, both of

which were non-surgical.  She now is admitted from ***** with

concern for new ***** SDH on OSH imaging. Her husband

reportedly returned from a business trip to find her with a black

eye and the house a ***** and her with altered mental status.  She

was brought to an OSH where she was found to have LLE cellulitis,

BS in the 600s, and question of a small ***** SDH.  She was

transferred to ***** for further evaluation. On ***** ***** *****

here there were no acute findings and neurosurgery signed off. PT

was consulted to assess for dispo.



Past Medical/Surgical History: IDDM, ETOH abuse, ETOH withdrawal

seizures, pancreatitis, cirrhosis, anxiety attacks



Medications: ***** *****, *****, Cephalexin, Lorazepam. Pt has

not required Lorazepam for withdrawal symptoms this admission



Radiology: CT Head *****/*****: 1.  No acute intracranial hemorrhage. 

2.  Re- demonstration of the previously described nondisplaced

occipital bone fracture, unchanged since ***** ***** ***** 





Labs: 

*****/*****/*****: WBC: 5.9

*****/*****/*****: HGB: 12.2

*****/*****/*****: HCT: 38.2

*****/*****/*****: Plt Count: 72*****



*****Information obtained from previous PT eval during admission

***** *****, confirmed and updated with pt today*****

Social/Occupational History: pt lives at home with husband and 16

year old *****, has two other *****

- working, - driving she has to coordinate rides



Living Environment: mostly lives on ***** *****, stairs to access

basement where laundry is; few stairs to enter home with stairs



Prior Functional Status/Activity Level: 

ambulates with no AD

history of falls with previous ***** in ***** down flight of

stairs resulting in ***** and previous hospital admission, this

***** occurred unwitnessed, however the pt reports remembering the

context of the *****. She reports she was in her kitchen and

slipped on some water on the floor, she lunged forward and hit

her head on the refrigerator. 

community ambulator 

DME: none, walk in shower

physical activity: no formal exercise

pt enjoys walking her dog 

husband assists with medication management

has VNA 

 



OBJECTIVE TESTS 

Arousal, Attention, Cognition, Communication:

Orientation: Pt is orientated to: self, approximate date,

location, and reason for hospitalization. She reported the date

as ***** *****, Monday. 



Test of Attention: Pt is able to count back from 10, say days of

week backward. Pt was initially unable to complete ***** backwards

and required cues to initiate. After cueing she was able to

perform with 1 error. 

Pt demonstrates an impaired attention to the examiner, she was

tangential at times and needed intermittent cues to maintain

attention to the exam. 



Safety Awareness/Insight: Patient requires cues for safety

awareness regarding need for assist with  mobility



***** Term Memory: Pt is able to remember correct answers to

orientation questions 3 min  following re-orientation. She was

also able to remember her room number 



Hemodynamic Response/Aerobic Capacity

          Position    HR      BP      RR     O2     RPE Rest     

Supine      

          Sit         

          Stand       

Activity  

Recovery  

Total Distance Walked: 200ft     Minutes: 



Pulmonary: normal rhythm, no *****



Integumentary: ***** *****, *****. 

  R eye ecchymosis, no difficulty seeing out of that eye

  LLE cellulitis with outline. Appears as though the erythema is

receding from the previous drawn line



Vascular: mild swelling at area of LLE cellulitis, otherwise no

edema noted. 



Sensory *****: LT intact throughout



Pain:  pt denied pain.



Limiting Symptoms: none



Posture: cachectic 



Range Of Motion: *****



Muscle Performance: *****/***** *****. OT assessed *****, equal strength

bilaterally



Motor Function: no abnormal movement patterns noted during

mobility. Coordination intact with alternating toe taps and rapid

alternating movement of supination/pronation bilaterally.



Functional Status

     *****: ***** 

     *****/***** to Sit: I

     Sit to Stand: I

     Ambulation: I

     Stairs: 

     Other Activity: 

     Specify: 



*****Abbreviation Key***** I=Independent S=Supervision CG=Contact

***** *****=***** ***** *****=Standard ***** *****=Straight *****

*****=Axillary Crutches



Gait: Normal gait speed, normal stride, intermittent path

deviation but no losses of balance. 



Dynamic Gait Index

1. Gait level surface: 2

2. Change in gait speed: 3

3. Gait with horizontal head turns: 2

4. Gait with vertical head turns: 3

5. Gait and pivot turn: 3

6. ***** over obstacle: 2

7. ***** around obstacles: 3

8. Steps: 2

Total Score:  20/24



Balance: See DGI above. She had mild deficits noted during higher

level tasks of gait with head turns, stepping over obstacles. No

overt losses of balance during mobility



Additional Tests/Measures: 



Team Communication: 

Patient discussed at interdisciplinary team rounds.

Comm with RN RE: discharge planning, pt status

Comm with MD RE: paged team regarding d/c recs. 

Patient/Caregiver Education RE: fall precautions, role of PT 



Intervention: PT Evaluation as above. Co-rx with OT for this eval



DIAGNOSIS 

Impairments of Body Functions and Structures, Activity

Limitations and Participation Restrictions 

- Knowledge deficit RE: role of PT

                         safety with mobility





Clinical Impression/Prognosis: Pt is a ***** with a history of

ETOH cirrhosis, previous ***** with SAH, who presents to physical

therapy during hospitalization for ***** with ?SDH and also LLE

cellulitis. Pt is functioning fairly close to her baseline. She

demonstrated a mild balance impairment with higher level balance

challenges, but she was completely independent with her mobility.

She does not require any further inpatient PT services at this

time, and can be discharged to home when medically stable. 



Current Status: 

***** Mobility 

Based on the results of the AM-PAC, the patient presents with 

CMS severity: 

  0%    impaired (CH) = AM-PAC 24



Goal Status: 

***** Mobility 

with CMS severity: 

  0%    impaired (CH) = AM-PAC 24



DC status: 

***** Mobility 

Based on the results of the AM-PAC, the patient presents with CMS

severity: 

  0%    impaired (CH) = AM-PAC 24







Goals:               Time *****: *****

- Pt will verbalize role of PT

- Pt will verbalize ***** safety precautions

- 

- 

- 

- 



Recommended Discharge: (x)home 





Treatment Plan: D/C acute care PT

Frequency/Duration: N/A



Recommendations for Nursing: 

Ambulate in room independently OK

ambulate in ***** with supervision from nursing



Patient agrees with the above goals and is willing to participate

in the rehabilitation program. Please indicate with an 'X': Yes (

x ) or No ( ). If no please explain: 



Date: *****/*****/*****

Time: *****-*****



Physical Therapist Name: ***** *****, *****

***** ***** Pager: *****"
115038825,0,1,"Physician ***** ***** *****     Admit date: *****/*****/*****        Patient Information   ***** ***** ***** ***** y.o. *****/*****/*****          Hospitalization Summary   Diagnoses:     Reason for Admission: Weakness  Principal Problem:    Unsteady gait  Active Problems:    Palliative care patient  Resolved Problems:    ***** No resolved hospital problems. *****         Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:         Brief Summary/Assessment: ***** y.o. male with B-ALL (Ph-; on inotuzumab) and lung cancer (deferring XRT until after leukemia treatment), CAD s/p CABG, recent admission for *****, who presents with unsteady gait, no new stroke on imaging, symptoms likely *****/***** chronic subdural hematoma (mildly expanded in size with midline shift).  After involved, informed discussions with the patient and his family, ***** was eventually made comfort measures only. ***** died peacefully on *****/*****/***** at 5:08 AM with family surrounding him.       Hospital Course    Hospital Course:  DATE OF ADMISSION: *****/*****/*****  DATE OF DISCHARGE:  PRIMARY DIAGNOSIS: L. Sided Weakness  DISPOSITION:    =================================  BRIEF SUMMARY OF HOSPITALIZATION  =================================    ***** y.o. male with B-ALL (Ph-; on inotuzumab) and lung cancer (deferring XRT until after leukemia treatment), CAD s/p CABG, recent admission for *****, who presents with unsteady gait, no new stroke on imaging, symptoms likely *****/***** chronic subdural hematoma. Imaging revealed slight expansion in the size of his chronic subdural hematoma and neurology and neurosurgery were consulted for further workup and management.  After involved, informed discussions with the patient and his family, ***** was eventually made comfort measures only. ***** died peacefully on *****/*****/***** at 5:08 AM with family surrounding him.  The immediate cause of death was due to his progressive neurologic 
decline from a subdural hematoma.    =================================  HOSPITAL COURSE BY PROBLEM  =================================  #Unsteady Gait  #L. Sided Weakness  # R. Subdural Hematoma  Patient developed acute left sided weakness, gait instability, and inability to support himself standing on *****/***** after platelet transfusion. His neuro exam at that time remarkable for extinction to double stimulation on left leg, imbalance while standing, and inability to walk. Had 5/5 strength in all four extremities during seated exam. However, he was unable to lift his feet while standing. The remainder of the neurological exam was unremarkable and his NIHSS was 1. Upon further questioning, patient and wife report having other episodes of left sided weakness and one episode of ***** speech in the past. Imaging revealed mild expansion in the size of his chronic subdural hematoma with more midline shift, which was thought to be the etiology of his symptoms. Brain MRI and CT/CTA Head and Neck did not reveal acute stroke. He was started on keppra and a spot EEG showed theta slowing but no epileptiform discharges. He was transfused to keep his platelets above 50,000 and neurosurgery and neuro-oncology were both consulted. Given the concern that intervention would result in more risk than benefit, the previously suggested middle meningeal artery embolization was deferred and patient was managed with medical management (platelet transfusions). Neuro recommended MRI spine, which revealed a large marrow replacing process in the cervical, thoracic, and lumbar spine, concerning for a neoplastic process. Given this in conjugation with limited therapeutic options for the ALL and instability/weakness from progression of the subdural, the family made the decision to pursue hospice care. Palliative care was consulted for assistance with management. Therapeutics were de-escalated and comfort was ***** with IV dilaudid and concentrated 
morphine solution. The patient continued to decline, developing a left facial droop, *****, and hemiplegia.  After involved, informed discussions with the patient and his family, ***** was eventually made comfort measures only. ***** died peacefully on *****/*****/***** at 5:08 AM with family surrounding him.    #CAD s/p CABG  #EKG Changes:   Patient had a history of CABG x3 (***** to mid LAD, SVG to D1 to *****) performed in *****/***** and was noted to have ***** left hemi-diaphragm post-procedurally. On admission, he was noted to have new T wave inversions in V1-V2 with ST segment depressions in septal leads on EKG. Repeat EKG without dynamic changes and posterior EKG without concern for acute ischemia. He had no chest pain and troponins were flat 17-->17. He was continued on home atorvastatin and fractionated metoprolol, which were discontinued when the decision was made to pursue comfort care.     #B-ALL: *****-*****, *****-22 positive. Was treated with ***** chemotherapy, inotuzumab. C/b progressive cytopenia. Most recent bone marrow biopsy *****/***** with 51% blasts. He was continued on prednisone 10mg PO daily and allopurinol, which were discontinued when the decision was made to pursue comfort care.    #Hypercalcemia: Noted to have hypercalcemia on *****/*****/*****. Workup for hypercalcemia of malignancy was sent off. PTH was low at 5. PTHrP was normal. Likely secondary to bone metastasis. He was initially managed with IVF that were discontinued when the decision was made to pursue comfort care.    #Squamous Cell Lung Cancer: diagnosed in ***** ***** with squamous cell lung carcinoma. Previously treated with surgery and *****; has not received systemic therapy. Followed by Dr. *****. He is on 4L O2 at home, which was continued along with his home COPD inhalers and nebulizers.    #Pneumonia: diagnosed with CAP on previous admission, where he had been treated with levofloxacin-->augmentin on discharge. Sputum culture at that 
time growing mixed gram positive and negative organisms; legionella and strep pneumo negative. His augmentin was continued for a total 5 day course.     #Hypothyroidism: He was continued on his home dose of synthroid 175 mcg PO daily (350mcg daily on Wednesdays), which was discontinued when the decision was made to pursue hospice.     #COPD: Lung function tests (*****/*****): FEV1 = 53%, DLCO = 47%. He was continued on his home inhalers.     #Diabetes: Per wife, his outside endocrinologist had taken him off insulin due to lack of appetite and concern for hypoglycemia. Endocrinologist is comfortable with blood sugars <300. On last admission, glucoses were <300. His blood sugars were monitored during his admission and remained <300.    =================================  NOTABLE STUDIES  =================================  CTA Head/Neck (*****/*****/*****):  1. Since *****/*****/*****, minimally increased right sided subdural collection  measuring up to 1.6 cm in thickness from previously 1.4 cm. There is a trace  amount of acute hemorrhage along the anterior frontal lobe, which is not  significantly changed.     2. No significant change in small left frontoparietal subdural hematoma with  small foci of acute hemorrhage.     3. No evidence of interval acute intracranial hemorrhage, acute territorial  infarction or hydrocephalus.    4. No high-grade stenosis of the major intracranial arteries.     5. Mild atheromatous narrowing of the right internal carotid artery origin.     =================================  HISTORY OF PRESENT ILLNESS (FROM H&P)  =================================  ***** ***** is a ***** y.o. male with B-ALL (Ph-; on inotuzumab) and lung cancer (deferring XRT until after leukemia treatment), CAD s/p CABG who presents with unsteady gait.    Patient was recently admitted (*****/*****-*****/*****) for a presumed mechanical ***** while cytopenic during inotuzumab treatment. Imaging at that time revealed small chronic subdural hematoma. He 
had left sided weakness that improved with platelet transfusions and was discharged after clinical improvement. He was noted to have ***** pneumonia and treated with ceftriaxone and azithromycin and transitioned to augmentin upon discharge. He and wife denied any other falls that may have explained the chronic nature of the SDH. Neurosurgery was consulted during that admission and had recommended a meningeal artery embolization, which he deferred given his GOC. After shared decision making, patient decided to proceed with platelet transfusions for his subdural hematoma rather than pursuing a more invasive intervention.     The morning of admission, patient and wife report that he was able to walk somewhat normally. They have noticed a gradual decline in his strength recently that they attributed to his steroids and in particular noticed that his left leg seemed weaker. At a routine visit for platelet transfusions the day of admission, he experienced acute gait changes. After finishing the transfusion, patient was noted to be unsteady on his feet with a shuffling gait. He had L>R weakness and was also seen to have left arm weakness as well. The decision was made to admit him for a Head CT and further workup.    During evaluation upon admission, patient was noted to have worsened weakness. He was unable to stand unsupported, falling back towards his left side, and could not lift up his legs while standing. A stroke code was called and patient was taken to ***** ***** ***** and CTA Head/Neck, which showed the stable chronic SDH and no new stroke. Brain MRI was performed, which also did not reveal stroke or worsened SDH. Exam performed by stroke neurology resident notable for extinction to simultaneous touch in the L leg, inability to stand, and L>R difficulty in moving the legs. Neurosurgery was consulted for management of symptomatic subdural hematoma.                 Hospital Care Team   Service: Oncology    Inpatient 
Attending: ***** ***** *****, MD   Attending ***** *****: (*****)*****-*****    Outpatient Care Team:   PCP: ***** ***** *****, MD  *****-*****-*****            Post-Mortem    Immediate Cause of *****:  Subdural hematoma  Date/Time of *****:  *****/*****/*****  5:08 AM        Physical Exam:  No ***** resp of breath sounds, Fixed and ***** pupils, No heart sounds, No palpable pulses, No response to stimuli  Location of *****:  Hospital (Other than OR)  Primary Cause of *****:  Neurologic  Gender:  Male  Pronounced by?:  ***** *****, MD   Attending Physician *****?:  Yes   Autopsy Offered?:  Yes   Autopsy Permission Granted?:  No  New ***** ***** ***** Notified?:  Yes  Medical Examiner Notified?:  No       ______________________  ***** ***** *****, MD, PGY-2  ***** Medicine  Pager *****      "
150011917,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: Psychiatry CL Initial Note

Signed by ***** *****, MD on *****/*****/***** at 3:14 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 5:40 pm

 

***** PSYCHIATRIC CONSULTATION



Reason for consult: ***** management for agitation



DURATION: 1 hour, 25 minutes face-to-face time



HISTORY OF PRESENT ILLNESS: ***** year old medically complicated

woman with two recent hospitalizations here at ***** for a R

Subdural Hematoma *****/***** to ***** + supratherapeutic INR and a

hospital course complicated by new onset seizures and a L Hip

Fracture s/p surgery on *****/*****/*****, also with significant hx of

cerebrovascular disease w resultant cortical blindness, A fib now

back on coumadin, hypothyroidism who psychiatry is

consulted for ***** management for agitation.



According to reports from the primary team, the patient was

readmitted last night in the context of ***** mental status

that is waxing/waning, with + visual hallucinations, confusion

especially and an increase in aggressive behaviors ie. kicking

and shouting out.  Her sleep wake cycle is apparently disrupted

and she asks why she is being visited by doctors ""in the middle

of the night"" when it is the afternoon.  She denies feeling

depressed but notes that she is stressed due to the frequent

medical staff who ask her repetitive questions. She also cites

her recent home environment as ""the place where

you go to die.""  She has one prior suicide attempt ""years ago"" in

the context of a stroke and potential blindness by intentionally

***** on xanax. However, the patient denies any SI at this

time. As per Dr. *****'s note from *****/*****/*****, ""her appetite has

been decreased over the last year, pt reports 40 lb wt loss in

last year, however, according to Rehab Center note, her weight

had increased by 2 lbs from ***** to *****.""  In general,

the patient has difficulty in describing why she is in the

hospital although she does have some recollection of a recent

***** and having ""blood on the brain."" She does not provide any

explanation for reported aggressive behavior, however, she does

***** wonder why this does not feel like a hospital to her.

She denies any ***** but does at one point report that she sees a

photo of her children ""floating on the wall"" which is not

present.  



PAST PSYCHIATRIC HISTORY:  As per Dr. *****'s *****/*****/***** note:

""(per daughter, *****, and outside

records)

Prior Diagnoses: Per daughter, she has a life long history of

untreated anxiety.

Hospitalizations: none

Current treaters and treatment: no psychiatrist, no therapist.

Had a psychiatric consultation done at ***** ***** on *****/*****/*****.

Medication and ECT trials: tried Paxil x 2 days for anxiety

approx 12 years ago. Recently started on  

Suicide Attempts: One. In ***** *****, pt tried to commit suicide

after being informed of possible blindness *****/***** to occipital

stroke. She reported that she did not want to live if blind, and

***** on xanax (***** *****, *****). Was in *****, then transferred to

hospice care but patient had turn around.  However, per Hebrew

Rehabilitation Center Psychiatric Consultation note from

*****/*****/*****, the patient's AMS at this time was ""narcan responsive,""

and if this is accurate, occurred in the setting of opiate use in

the setting of delirium after her 2 acute CVAs in the ***** of

2012.

 

RECENT Medical History (during admission *****/*****/*****-*****/*****/*****)

- Right Subdural Hematoma s/p *****: admitted to neurosurgery on

*****/*****/*****, INR 3.5, received 2 units of FFP, Profil 9 and Vitamin

K. F/U with ***** in 8 weeks w repeat ***** *****.

- Left Hip Fracture: s/p closed reduction and percutaneous

pinning left femoral neck fracture on *****/*****/***** with Dr. *****.

- New onset seizures: hospital course complicated by seizures

characterized by bilateral UE shaking (L>R) and confusion; EEG

showed subclinical seizures as well, was started on levetiracetam

and phenytoin with improvement in her EEG and in her clinical

status. F/U with neurology. 

- UTI: *****/*****/*****: treated w ceftriaxone x 3 days



PAST Medical History:

- Atrial fibrillation on coumadin, but coumadin was held in 

setting of SDH. Per neurosurgery, she was ok to restart her 

coumadin 10 days from the accident. 

- Cerebrovascular Disease: Hx of multiple strokes including left

occipital and parietal stroke with cortical blindness and a

contralateral temporal lobe CVA

- Hypothyroidism

- HL

- peripheral neuropathy

- IBS

- insomnia""



CURRENT MEDICATIONS: 

1. MED Pneumococcal Vac Polyvalent 0.5 ml ***** ***** X1 

Follow Pneumovax immunization protocol  *****/***** @ 0012    

2. MED Heparin 5000 UNIT SC TID  *****/***** @ 0014    

3. MED Acetaminophen 650 mg PO/NG Q6H:PRN pain/fever  *****/***** @

0016    

4. MED Lorazepam 0.25 mg IV ONCE MR1 Duration: 1 Doses  *****/***** @

0046    

5. MED Levothyroxine Sodium 25 mcg PO/NG QHS  *****/***** @ 0101    

6. MED Metoprolol Tartrate 12.5 mg PO/NG DAILY  *****/***** @ 0101    

7. MED Phenytoin ***** 100 mg PO/NG TID  *****/***** @ 0101    

8. MED Pravastatin 10 mg PO DAILY  *****/***** @ 0101    

9. MED Quetiapine Fumarate 25 mg PO/NG QAM  *****/***** @ 0101    

10. MED ***** 1 TAB PO/NG *****  *****/***** @ 0101    

11. MED Thiamine 100 mg PO/NG DAILY  *****/***** @ 0101    

12. MED Vitamin B Complex 1 CAP PO/NG DAILY  *****/***** @ 0101    

13. MED Vitamin D 50,000 UNIT PO/NG DAILY  *****/***** @ 0101    

14. MED Warfarin 2.5 mg PO/NG *****  *****/***** @ 0101    

15. MED Quetiapine Fumarate 50 mg PO/NG QHS 

Hold for RR <10.   *****/***** @ 0103    

16. MED Lorazepam 0.25 mg IV ONCE MR1 Duration: 1 Doses  *****/***** @

0121    

17. MED Lorazepam 0.25 mg IV ONCE Duration: 1 Doses  *****/***** @ 0828



18. MED Gabapentin 300 mg PO/NG Q12H  *****/***** @ 1401    

19. MED Lorazepam 1 mg PO/NG TID anxiety  *****/***** @ 1402    

20. MED Quetiapine Fumarate 12.5 mg PO/NG BID:PRN severe

agitation  *****/***** @ 1404    

21. MED LeVETiracetam 750 mg PO BID Duration: 3 Days  





ALLERGIES: (Per Hebrew Rehabilitation Center Psychiatric

Consultation note from *****/*****/*****)

cipro, sulfa, adverse reactions to clopidogrel, and temazepam



SUBSTANCE ABUSE HISTORY: As per Dr. *****'s *****/*****/***** note: Quit

smoking over 50yrs ago. ***** ***** *****.



Family History: As per Dr. *****'s *****/*****/***** note:

Brother died due to cardiac disease. Mother with multiple 

strokes. Father died of bowel obstruction.



Social History: As per Dr. *****'s *****/*****/***** note: 

- Born and raised in ***** area. 

- Was married once, divorced. She had three children, one of her

sons is deceased. *****, *****, who accompanies pt in room, is

health care proxy (unclear if activated?). Pt did not ***** again

but had a significant other with whom she lived for 18 years and

then he died in a MVA at his age of 53.

- High School Education, worked mostly as a book *****, event

planner, clerical worker, now retired. 

- Has ***** in ***** ***** and ***** for much of her adult life,

came back to ***** in early 2012 to receive medical care and

family support.

- Has been in long term care (Hebrew Rehab Center) since *****

2012

- DNR.



EXAM: 

VS:  BP: 145/86  HR: 62  temp: 97.8   resp: 20 O2 sat: 98% RA 



Neurological:  

deferred at this time. No gross deficits on motor skills (i.e.

grasp intact). Gait not tested.



Cognition: 

Wakefulness/alertness: awake, alert

Patient specifically requests to abstain from formal cognitive

testing at this time and notes ***** ""all that forwards and

backwards"" testing.

 

Mental Status:

Appearance:  cachectic elderly woman, with pink ***** around

head, sitting upright in bed

Behavior: calm, cooperative

Speech/Language: some apparent difficulties both ***** and

productively (for full details will refer to Neurological exam on

aphasia v. dysarthria). 

Mood: ""Fine""

Affect: euthymic, reactive

Thought process: intermittently tangential responses but

difficult to assess due to poor hearing and mild apparent

aphasia.

Thought Content: no overt delusions. No *****. Possible VH (as

described of photo above in *****.)

Judgment: impaired

Insight: limited



DATA:

Labs: CBC/BMP/LFTs unremarkable. Notable Alk Ph of 126. Tox

negative. UA negative. 



Imaging: CT Head *****/***** showed ""continued evolution of the right

posterior subdural hematoma with stable right occipital and left

temporal lobe encephalomalacia.  No new hemorrhage or other acute

change."" 



ASSESSMENT: ***** year old medically complicated woman with two

recent hospitalizations here at ***** for a R Subdural Hematoma

*****/***** to ***** + supratherapeutic INR and a hospital course

complicated by new onset seizures and a L Hip Fracture s/p

surgery on *****/*****/*****, also with significant hx of cerebrovascular

disease w resultant cortical blindness, A fib now back on

coumadin, hypothyroidism who psychiatry is consulted for

***** management for agitation. Her behaviors are likely

*****/***** to a combination of both delirium (*****/***** to multiple medical

conditions + medications ie. *****) as well as an underlying

vascular *****. Small changes in psychopharmacologic

management, many of which were already planned, may improve her

behavioral control. 



AXIS I: Delirium *****/***** to a GMC (Subdural Hematoma, Seizures,

Cerebrovascular Disease, Recent Hip Surgery) + Delirium *****/***** to

Polypharmacy (*****); R/O Underlying Vascular Dementia

AXIS II: deferred

AXIS III:  R Subdural Hematoma *****/*****/***** complicated by new onset

seizures, L Hip Fracture s/p surgery on *****/*****/*****, cerebrovascular

disease w resultant cortical blindness, A fib on coumadin,

hypothyroidism 

AXIS IV: chronic medical illness, rehab facility

AXIS V: 30



PLAN:

- Would recommend tapering ativan; informed that this is planned

(going from ***** to TID) already with a further plan to

discontinue over time.

- Informed that plan is to taper keppra which is already in

motion. Agree with this plan if able to use alternative AEDs as

keppra is generally highest risk in this class of medication for

causing behavioral dysregulation and psychiatric sequelae. 

- For improved sleep and agitation, would recommend seroquel 12.5

mg QID PRN agitation/anxiety, and a continuation of Seroquel 25

mg PO daily and 50 mg PO qHS. 

- Would discontinue trazodone given history of falls and advanced

age in a woman with other risk factors.

- Would obtain daily ECG while on antipsychotic medications

- The patient will not be seen by psychiatry over the weekend

unless an urgent issue arises. In that event, please page *****

for consultation.



DISCUSSED WITH medical team (Dr. *****) AT 3PM.



This patient was seen with attending ***** *****. *****

*****.



***** *****, MD

PGY-3, Psychiatry







Addendum by ***** *****, MD on *****/*****/***** at 3:15 pm:

Would also add: 

-would incorporate as many environmental factors which contribute

to appropriate day-night shifts such as keeping shades open

during the day time





Addendum by ***** *****, MD on *****/*****/***** at 5:40 pm:

I met with this pt and Dr. *****.  Present for entire interview

and exam.  Attest to the information above and agree wtih a/p

which was discussed in detail. "
119821653,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     Status Name ***** ***** ***** ***** Home Work Mobile    Not Active *****,***** ***** .Primary Health Care ***** (Proxy form on file) *****-*****-***** (Home) *****-*****-***** - -          Code Status at *****: DNR/DNI (No CPR/No Intubation)       Discharge address same as *****: Yes                   Hospitalization Summary       Principal Problem:    Acute ischemic stroke  Active Problems:    Weakness    Palliative care by specialist  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     None          Non (OR) Procedures:          Pending Results     None           Hospital Course   ***** retired gastroenterologist h/o A-fib, HTN, aortic stenosis, recently admitted to neurosurgery *****/*****-*****/***** for traumatic right frontal SDH s/p evacuation and discharged to rehab, now returning with fatigue, worsened dysarthria and mild right-sided weakness, found to have a left basal ganglia lacunar infarct.    # L basal ganglia stroke:Patient's exam is only notable for mild dysarthria and trace right sided weakness. Patient was recently admitted to the neurosurgery service *****/*****-*****/***** for a traumatic SDH s/p evacuation. Given this, anticoagulation is risk/benefit consideration. NCHCT stable. Routine EEG without seizure. Palliative care consult for goals of care discussion. It was 
determined that PEG and even NGT is not within GOC. Patient is more awake today and passed his swallow testing on *****/***** for modified diet. TTE showed hyperdynamic EF, WMA, and severe AS. Labs were significant for LDL 147, hemoglobin A1C 5.2, TSH 1.69. We continued ASA 300mg daily. Blood pressure goal was normotension. PT/OT were consulted. Melatonin 3g was given nightly for sleep.     # Dysphagia: Patient was initially NPO. After a family meeting it was determined that PEG and even NGT is not within GOC. When he is more awake, his swallowing improves. On *****/*****, he passed his swallow testing for modified diet. That said he is at very high risk of aspiration and family is comfortable with this risk.     # Severe AS: Patient has severe AS although he is not a surgical candidate at this point. We avoided pre-load reducers to control blood pressure. Metoprolol was continued.     # Atrial fibrillation: Patient was rate controlled. Continued metoprolol XL 25mg daily. Continued ASA above. It was felt that the risk of anticoagulation ***** the benefit.     # Elevated troponin: Likely elevated in the setting of demand given likely CAD and severe AS. EKG was with no acute ischemic changes. There is evidence of new WMA compared to prior TTE which may suggest chronic ischemic disease. Trop remained stable.    # Hypertension: Currently normotensive during this admission. We avoided pre-load reducers.            Medications   Allergies: Erythromycin; Macrolide antibiotics; Oxytetracycline; and Tetracyclines    Prior to Admission Medications   Prescriptions   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 4 (four) hours as needed for mild pain (fever).   docusate sodium (COLACE) 100 MG capsule   Sig: Take 100 mg by mouth 2 (two) times a day.   metoprolol succinate (TOPROL-XL) 25 MG 24 hr tablet   Sig: Take 25 mg by mouth daily.   polyethylene glycol (GLYCOLAX) 17 gram packet 
  Sig: Take 17 g by mouth daily. Titrate to get soft stools   senna (SENOKOT) 8.6 mg tablet   Sig: Take 2 tablets by mouth 2 (two) times a day as needed for constipation.      Facility-Administered Medications: None        Discharge Medications      START taking these medications       Dose, Frequency, and Details    aspirin 325 MG tablet    Take 1 tablet (325 mg total) by mouth daily.       atorvastatin 40 MG tablet   Also known as:  LIPITOR    Take 1 tablet (40 mg total) by mouth daily.       melatonin 3 mg Tab    Take 1 tablet (3 mg total) by mouth nightly.         CHANGE how these medications are taken       Dose, Frequency, and Details    metoprolol succinate 25 MG 24 hr tablet   Also known as:  TOPROL-XL    Take 1.5 tablets (37.5 mg total) by mouth daily.   What changed:  how much to take   Last time this was given:  *****/*****/***** 11:32 AM         CONTINUE taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 4 (four) hours as needed for mild pain (fever).       docusate sodium 100 MG capsule   Also known as:  COLACE    Take 100 mg by mouth 2 (two) times a day.       polyethylene glycol 17 gram packet   Also known as:  MIRALAX    Take 17 g by mouth daily. Titrate to get soft stools       senna 8.6 mg tablet   Also known as:  SENOKOT    Take 2 tablets by mouth 2 (two) times a day as needed for constipation.                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate *****  Deferred (Contraindication)             Hospital Care Team   Service: Neurology  Inpatient Attending: ***** *****, *****     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:     Follow-Up Services            ***** *****   Specialty:  
Rehabilitation    ***** ***** *****.  ***** ***** *****-*****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1239  Activity as tolerated         *****/*****/***** 1239  Discharge diet     Comments:  pureed diet with nectar thick liquids, family accepts aspiration risks, PEG not within goals of care   Question Answer Comment   Diet Type Dysphagia    Solids Dysphagia puree    Liquids Nectar thick           *****/*****/***** 1239  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact Dr. ***** *****-*****-*****, *****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact Dr. ***** *****-*****-*****, *****-*****-*****.                     Exam   Temperature: 36.4 째C (97.5 째F) (*****/*****/***** 1139) | Heart Rate: 87 (*****/*****/***** 1139) | BP: 140/70 (*****/*****/***** 1139) | Respiratory Rate: 20 (*****/*****/***** 1139)  | SpO2: 97 % (*****/*****/***** 1139)  O2 Device: None (Room air) (*****/*****/***** 1139)  O2 Flow Rate (L/min): 0 |        Weight: 73 kg (160 lb 15 oz) (*****/*****/***** 0200)  Height: 188 cm (6' 2.02"") (*****/*****/***** 2100)              Discharge Exam    Significant Discharge Exam Findings:  MENTAL STATUS: Alert, oriented to self and time, not place. Globally inattentive, unable to perform days of the week backward. Naming intact to high but not low frequency items.Repetition intact.   CN II-XII:Blinks to threat bilaterally. PERRL 3->2mm. EOMI, no nystagmus. Light touch sensation intact throughout face. Mild nasolabial fold flattening and decreased smile activation in the right lower face. Tongue/palate midline. Marked dysarthria. Shoulder shrugs normal.   MOTOR: The bulk and tone were normal. Mild pronation of the right arm and orbiting around the right hand. Right deltoid *****/*****, bicep 5-/5, right tricep 4+/5, right wrist flexion/extension 5-/5, right finger ***** 4+/5. Right hip *****/*****, knee 
flexion 4+/5, knee extension 5-/5, ankle dorsi- and plantarflexion 5/5.Full strength left hemibody.   SENSATION: Diffusely intact to light touch.  REFLEXES: The deep tendon reflexes were 2+and symmetric at the triceps, biceps, brachioradialis, quadriceps; unable to elicit at the gastrocnemius/soleus. The toes were upgoing bilaterally.  CEREBELLAR: The finger-to-nosetesting was normal bilaterally.               Orientation Level: Oriented to person   Cognition: Follows commands (attempts)         Speech: *****, Expressive Aphasia     Vision: Functional with Correction  Hearing: Functional   Assistive Devices: Chair lift       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 4.87 *****/*****/***** *****    RBC 4.23 (L) *****/*****/***** *****    HGB 12.6 (L) *****/*****/***** *****    HCT 38.2 (L) *****/*****/***** *****    MCH 29.8 *****/*****/***** *****    MCV 90.3 *****/*****/***** *****    PLT 154 *****/*****/***** *****    RDW 14.5 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 145 *****/*****/***** *****    ***** 3.8 *****/*****/***** *****    ***** 106 *****/*****/***** *****    CO2 21 (L) *****/*****/***** *****    BUN 20 *****/*****/***** *****    CRE 0.94 *****/*****/***** *****    ***** 8.6 (L) *****/*****/***** *****    GLU 95 *****/*****/***** *****    GLUPOC 92 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.3 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 14.4 *****/*****/***** *****    INR 1.1 *****/*****/***** *****                        "
119058826,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): Health Care Proxy, ***** Form   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: DNR/DNI (No CPR/No Intubation)    To be discharged to: Discharged / Transferred to skilled nursing facility (SNF) with Medicare certification in anticipation of covered skilled care  Patient/Family/Caregiver discharge preference/goals : Skilled nursing facility  Patient/Family/Caregiver participated and agreed with DC plan: Yes  Patient/Family/Caregiver have been provided a list of discharge facilities/services to review/select: Skilled Nursing Facilities  Discharge address same as *****: No  Discharge Address: ***** & ***** ***** Center for Living (***** ***** *****, *****, *****. *****)  Phone : *****-*****-*****             Hospitalization Summary     Reason for Admission: Subdural hematoma  Principal Problem:    Subdural hematoma  Active Problems:    Encounter for palliative care  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    See hospital course. If he leaves the rehab, please consult home based palliative care *****-*****-*****.        Pending Results     Procedure Component Value Ref Range Date/Time    Blood culture, routine [*****] Collected: *****/*****/***** 2027    Lab Status: Preliminary result Specimen: Blood Updated: *****/*****/***** 0748     
Special Requests No Special Requests     BLOOD CULTURE NO GROWTH 6 DAYS             Hospital Course   ***** *****(*****)*****no AC/AP w/ PMHx of CAD,*****(***** 47%2018), Crohn's disease, with recent mechanical ***** *****/*****/***** found to have ***** on CTH.On ***** ***** scan *****/***** and clinic phone call last week, ***** had enlarged. Pt was reportedly asymptomatic soinitial plan wasfor repeatCTH*****/***** buton *****/*****the son thought ***** wasmore lethargic, prompting a visit to the ED. At *****, Tm 100.8, hyponatremic to 124, and UTI with 3+ LKE, 1+ bacteria, >100 WBCs. CTH with continued enlargement of *****, with small acute component.Admitted to NSG with Medicine consult, with repeat HCT stable. On *****/***** noted to have new onset L facial droop and more marked ***** weakness; CT, CTA, EEG unremarkable.    Per GOC discussion with Palliative Medicine team, patient would not want any surgical or invasive procedure (no feeding tube, no pressors, no ICU), but desires non-invasive imaging and antibiotics for medical management of active issues.     ***** *****(*****)*****no AC/AP w/ PMHx of CAD,*****(***** 47%2018), Crohn's disease, with recent mechanical ***** *****/*****/***** found to have ***** on CTH.On ***** ***** scan *****/***** and clinic phone call last week, ***** had enlarged. Pt was reportedly asymptomatic soinitial plan wasfor repeatCTH*****/***** buton *****/*****the son thought ***** wasmore lethargic, prompting a visit to the ED.     At *****, Tm 100.8, hyponatremic to 124, and UTI with 3+ LKE, 1+ bacteria, >100 WBCs. CTH with continued enlargement of *****, with small acute component.Admitted to the neurosurgical service on *****/*****/***** with a interval imaging showing stability of the patient's subdural hematoma. On *****/***** noted to have new onset L facial droop and more marked ***** weakness; CT, CTA, EEG unremarkable. He was continued on keppra for seizure prophylaxis.     Medicine was consulted and assisted in management of 
the patients hyponatremia, Cdiff and *****, the problems are summarized as below.    #Hyponatremia: For his hyponatremia, they felt this was likely SIADH and recommended avoiding salt loads and rechecking sporadically if within GOC, his sodium on day of dispo was 133. He was maintained on 1L fluid restriction.     #CDiff: For his Cdiff, medicine recommended c/w po vanc 125 q6 until *****/***** (inclusive) and they recommended that if he needs antibiosis in the future, would restart PO vanc prophylactically.    #Fever:  In regards to his fever, the patient had a ***** in place since his first hospitalization (placed *****/*****) up until *****/***** ***** when it was removed at his PCP's office. ***** ***** was re-placed in our ED on *****/***** *****. He reported some shaking chills, nausea, and mild abdominal pain while at his SNF, but no frank suprapubic pain, flank pain, or dysuria. Here he had a fever to 100.***** in the ED and has had chills. U/A (obtained as clean catch prior to ***** re-placement) showed 3+ LE and > 100WBC with blood and protein. Urine culture now growing moderate E faecalis which he grew in the same amount on *****/***** when he had no pyuria (also clean catch). Unclear if this picture represents true UTI or more likely that he had inflammation on the U/A from the indwelling catheter/its removal and the E faecalis just represents colonization. His fever could be explained by a variety of other causes including C diff or SDH. He appeared clinically worse on *****/*****, we broadened his empiric antimicrobial coverage to ceftriaxone and IV vancomycin and added IV metronidazole for severe C diff (see below). Since that time his exam has improved and no obvious source of infection other than his CDI has been identified. Therefore we discontinued all empiric therapy and are treating for CDI alone. His foley was discontinued and he is being straight cath'ed. He had a temperature to 100.6 in the evening of *****/*****, this was discussed with medicine and 
given the temp defervesced and the patient had no localizing symptoms, they recommended no further work-up and to move ahead with transition to SNF as within the patients GOC.     #CDI  Diagnosed *****/***** iso recent IV antibiotics for aspiration PNA and predisposition from Crohn's disease/ immunosuppression. Has been on PO vancomycin 125mg QID since that time. During this admission he is still having diarrhea and worse abdominal pain to palpation, thus IV metronidazole was added and CT A/P was obtained to evaluate for complications of C diff. CT A/P showed mild distal colonic thickening and mucosal hyperenhancement, but otherwise unremarkable exam. Given this exam and that he is improving in terms of WBC, decreased frequency of bowel movements, and abdominal examine, we will treat with oral vancomycin alone for 7 days after discontinuing IV antibiotics (*****/*****-*****/*****).    #*****: hold beta blocker and ***** for now. Would reinitiate only if within GOC, and then likely only low-dose beta blocker to avoid hypokalemia.  #palliative care: defer to the consult team, but can consider better nutrition, OOB if possible, relax visitor restrictions, consider low-dose morphine for dyspnea    Palliative care was also consulted at the patient and his family request Per GOC discussion with Palliative Medicine team, patient would not want any surgical or invasive procedure (no feeding tube, no pressors, no ICU), but desires non-invasive imaging and antibiotics for medical management of active issues and in line with this, he was continued on PO Vancomycin for his CDiff infection. He will not follow up with neurosurgery given further interventions would not be in line. A referral will be placed to home based palliative care.     At the families request, the patient was discharged back to the skilled nursing facility he had presented from on *****/*****/*****. He will follow up with his PCP and his family was in agreement.          Medications   
Allergies: Penicillins, Ace inhibitors, ***** extracts, Ragweed, and Valsartan-hydrochlorothiazide    Prior to Admission Medications   Prescriptions   ***** ***** 100-25 mcg/dose inhaler   Sig: inhale 1 puff into the lungs daily   FLUoxetine (PROZAC) 20 MG capsule   Sig: Take 1 capsule (20 mg total) by mouth daily.   Lactobacillus rhamnosus GG (CULTURELLE PROBIOTIC) 15 billion cell CpSP   Sig: Take 1 capsule by mouth daily.   Patient not taking: Reported on *****/*****/*****   Saccharomyces boulardii (*****) 250 mg capsule   Sig: Take 250 mg by mouth 2 (two) times a day.   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 650 mg by mouth every 4 (four) hours as needed for mild pain or fever.   bisacodyl (DULCOLAX) 10 mg suppository   Sig: Place 10 mg rectally daily as needed.   calcium acetate-aluminum sulfate (DOMEBORO) 952-1,347 mg *****   Sig: Apply 1 application (1 each total) topically 3 (three) times a day. To excoriated scrotal area   cholecalciferol (VITAMIN D3) 2,000 unit tablet   Sig: Take 2,000 Units by mouth daily.    Note (*****/*****/*****): Needs MD Verification. ***** Med Transfer Process.    colchicine (COLCRYS) 0.6 mg tablet   Sig: TAKE ONE TABLET BY MOUTH ONE TIME DAILY . ***** INCREASE TO 2 TABLETS FOR GOUT ATTACK   ipratropium (ATROVENT) 0.03 % nasal spray   Sig: *****-***** sprays each nostril once to four times daily as needed for runny nose   levETIRAcetam (KEPPRA) 500 MG tablet   Sig: Take 1 tablet (500 mg total) by mouth 2 (two) times a day.   lidocaine 4 %   Sig: Place 2 patches onto the skin daily.   magnesium hydroxide (MOM) 400 mg/5 mL Susp   Sig: Take 30 mL by mouth daily as needed (for constipation).   melatonin 3 mg Tab   Sig: Take 3 mg by mouth nightly at bedtime.   monobasic and dibasic sodium phosphates (***** ENEMA) 19-7 gram/118 mL *****   Sig: Place 1 enema rectally daily as needed (for constipation).   tamsulosin (FLOMAX) 0.4 mg Cap   Sig: take 1 capsule by mouth once a day   torsemide (DEMADEX) 20 
MG tablet   Sig: Take 20 mg by mouth daily.   triamcinolone (NASACORT AQ) 55 mcg/actuation nasal inhaler   Sig: 2 sprays by Nasal route daily.   vancomycin (VANCOCIN) 125 MG capsule   Sig: Take 125 mg by mouth 4 (four) times a day.   vedolizumab (ENTYVIO) 300 mg SolR injection   Sig: Inject 300 mg into the vein every 28 days.       Facility-Administered Medications: None        Medication List      STOP taking these medications     vancomycin 125 MG capsule  Commonly known as: VANCOCIN  Replaced by: vancomycin 50 mg/mL Soln        TAKE these medications        *****    ***** ENEMA 19-7 gram/118 mL *****  Generic drug: monobasic and dibasic sodium phosphates   Place 1 enema rectally daily as needed (for constipation).      acetaminophen 325 mg tablet  Commonly known as: TYLENOL  Last time this was given: ***** *****, ***** 10:56 AM   Take 650 mg by mouth every 4 (four) hours as needed for mild pain or fever.      bisacodyl 10 mg suppository  Commonly known as: DULCOLAX   Place 10 mg rectally daily as needed.      ***** ***** 100-25 mcg/dose inhaler  Generic drug: fluticasone furoate-vilanteroL   inhale 1 puff into the lungs daily      calcium acetate-aluminum sulfate 952-1,347 mg *****  Commonly known as: DOMEBORO  Last time this was given: ***** *****, *****  9:01 AM   Apply 1 application (1 each total) topically 3 (three) times a day. To excoriated scrotal area      cholecalciferol 2,000 unit tablet  Commonly known as: VITAMIN D3   Take 2,000 Units by mouth daily.      colchicine 0.6 mg tablet  Commonly known as: COLCRYS  Last time this was given: ***** *****, *****  9:01 AM   TAKE ONE TABLET BY MOUTH ONE TIME DAILY . ***** INCREASE TO 2 TABLETS FOR GOUT ATTACK      enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  Commonly known as: LOVENOX  Last time this was given: ***** *****, *****  9:01 AM   Inject 0.4 mL (40 mg total) under the skin daily.  Start taking on: ***** *****, *****      Entyvio 300 mg Solr injection  Generic drug: 
vedolizumab   Inject 300 mg into the vein every 28 days.      FLUoxetine 20 MG capsule  Commonly known as: PROzac  Last time this was given: ***** *****, *****  9:01 AM   Take 1 capsule (20 mg total) by mouth daily.      ipratropium 21 mcg (0.03 %) nasal spray  Commonly known as: ATROVENT   *****-***** sprays each nostril once to four times daily as needed for runny nose      Lactobacillus rhamnosus GG 15 billion cell Cpsp  Commonly known as: CULTURELLE PROBIOTIC  Last time this was given: ***** *****, *****  9:01 AM   Take 1 capsule by mouth daily.      levETIRAcetam 500 MG tablet  Commonly known as: KEPPRA  Last time this was given: Ask your nurse or doctor   Take 1 tablet (500 mg total) by mouth 2 (two) times a day.      ***** lidocaine 4 %  Last time this was given: Ask your nurse or doctor   Place 1 patch onto the skin daily as needed.  What changed: You were already taking a medication with the same name, and this prescription was added. Make sure you understand how and when to take each.      ***** lidocaine 4 %  Last time this was given: Ask your nurse or doctor   Place 1 patch onto the skin daily.  What changed: how much to take  Start taking on: ***** *****, *****      magnesium hydroxide 400 mg/5 mL Susp  Commonly known as: MOM   Take 30 mL by mouth daily as needed (for constipation).      melatonin 3 mg Tab  Last time this was given: ***** *****, *****  9:11 PM   Take 3 mg by mouth nightly at bedtime.      Saccharomyces boulardii 250 mg capsule  Commonly known as: *****   Take 250 mg by mouth 2 (two) times a day.      tamsulosin 0.4 mg Cap  Commonly known as: FLOMAX  Last time this was given: ***** *****, *****  9:01 AM   take 1 capsule by mouth once a day      torsemide 10 MG tablet  Commonly known as: DEMADEX  Last time this was given: ***** *****, *****  9:01 AM   Take 1 tablet (10 mg total) by mouth daily.  What changed:   쨌 medication strength  쨌 how much to take  Start taking on: ***** *****, *****      triamcinolone 55 mcg/actuation nasal 
inhaler  Commonly known as: NASACORT AQ   2 sprays by Nasal route daily.      vancomycin 50 mg/mL Soln  Commonly known as: VANCOCIN  Last time this was given: ***** *****, ***** 12:01 PM   Take 2.5 mL (125 mg total) by mouth every 6 (six) hours for 17 doses.  Replaces: vancomycin 125 MG capsule         ***** This list has 2 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.               Where to Get Your Medications      Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  쨌 lidocaine 4 %  쨌 lidocaine 4 %  쨌 torsemide 10 MG tablet  쨌 vancomycin 50 mg/mL Soln                    Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 2:00 PM ***** ***** *****, MD Mass General ***** ***** Center for Outpatient Care *****-*****-*****  Follow Up    *****/*****/***** 10:30 AM (Arrive by 10:15 AM) ***** ***** *****, MD ***** *****-*****-*****      *****/*****/***** 2:30 PM ***** ***** *****, MD, PhD; ***** NEURO ***** ***** ***** Department of Neurology *****-*****-*****  NEW PATIENT    *****/*****/***** 10:40 AM ***** ***** *****-*****, MD NSP PULM ***** 55 ***** GROUP *****-*****-***** NSP *****     *****/*****/***** 10:15 AM ***** ***** *****, MD ***** Dermatology and Skin Health *****-*****-*****  Follow Up        Follow-Up Services            Services            ***** and ***** ***** Center for Living    ***** ***** *****  ***** ***** *****   Phone: *****-*****-*****                 Signed Discharge 
Orders (From admission, onward)     Ordered        *****/*****/***** 1348  Activity as tolerated         *****/*****/***** 1348  Discharge diet     Comments: Diet Dysphagia; Pureed (***** 4); Mildly thick (***** 2); Fluid Restriction total / 24h: 1500 ML FLUID       *****/*****/***** 1348  No dressing needed         *****/*****/***** 1348  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****. After hours, please call ***** main line *****-*****-***** an...     Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****. After hours, please call ***** main line *****-*****-***** and ask for the neurosurgery resident on call to be paged.                 Discharge instructions and important events and results    GENERAL INSTRUCTIONS  PAIN:  -Pain in the form of headache, may persist for days, to weeks ***** brain injury/bleeding. The headaches will gradually improve, and go away, as the body absorbs the blood on its own.   -You may be prescribed a narcotic pain medication to treat this headache. It is very important to only take it as you need it, and wean yourself off, in the days following your discharge.     MEDICATIONS:  -Take your pain medicine as prescribed.   -Continue all other medications you were taking before surgery, unless otherwise directed  -You make take Tylenol or prescribed pain medications for any post discharge pain or discomfort.  -Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation. We generally recommend taking an over the counter stool softener, such as Docusate (Colace) while taking narcotic pain medication.  -Follow up with your primary care doctor for refills or new prescriptions of you home medications.  -Unless 
directed by your doctor, do not take any anti-inflammatory medicines such as Motrin, Aspirin, Advil, or Ibuprofen etc, as these can increase the bleeding in your head.      DIET  -Usually no special diet is prescribed after a traumatic brain injury. A normal well balanced diet is recommended for recovery, and you should resume any specially prescribed diet you were eating before your surgery.  Be sure however, to remain well hydrated, and increase your consumption of fiber, as pain medications may cause constipation.   -You were put on a 1L fluid restriction for his sodium     WHAT ***** ***** ***** *****:  -Exercise should be limited to walking; no lifting, straining, or excessive bending.  -When you go home, you may walk and go up and down stairs. Take your time, and rest if you need to.  -After 1 week, gradually increase your activities and distance walked as you are able to tolerate.      IMPORTANT INSTRUCTIONS:  Regarding Emergencies and After-Hour Calls  -If you have what you feel is a true emergency at any time, please present immediately to your local emergency room, where a doctor there will evaluate you and contact us if needed. Due to the complexity of neurosurgical procedures and treatment of neurosurgical problems, effective advice regarding emergency situations cannot be given over the telephone.    You were seen by palliative care this admission, when you are discharged from rehab and if you are interested in palliative care, you can call home based palliative care *****-*****-*****.                 Exam   Temperature: 36.4 째C (97.5 째F) (*****/*****/***** 1121) | Heart Rate: 91 (*****/*****/***** 1121) | BP: 101/58 (*****/*****/***** 1121) | Respiratory Rate: 20 (*****/*****/***** 1121)  | SpO2: 95 % (*****/*****/***** 1121)  O2 Device: None (Room air) (*****/*****/***** 1121)  O2 Flow Rate (L/min): 0.5 |        Weight: 59.9 kg (132 lb) (*****/*****/***** 2015)  Height: 160 cm (5' 3"") (*****/*****/***** 2015)         BMI (Calculated): 23.39 (*****/*****/***** 2015)    Discharge Exam    
Significant Discharge Exam Findings: ***** not to year, hard of hearing, soft spoken  PERRL EOMI  ***** limited by pain, minimal movement. Otherwise ***** x4.              Orientation Level: Oriented to person, ***** to place (name of this place), Oriented to time (year), Confused   Cognition: Follows one step directions         Speech: Delayed, Incomprehensible     Special Needs    Special Needs: None              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 8.03 *****/*****/***** *****    RBC 4.04 (L) *****/*****/***** *****    HGB 11.1 (L) *****/*****/***** *****    HCT 33.5 (L) *****/*****/***** *****    MCH 27.5 *****/*****/***** *****    MCV 82.9 *****/*****/***** *****    PLT 194 *****/*****/***** *****    RDW 15.5 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 133 (L) *****/*****/***** *****    ***** 3.8 *****/*****/***** *****    ***** 97 (L) *****/*****/***** *****    CO2 25 *****/*****/***** *****    BUN 25 *****/*****/***** *****    CRE 0.98 *****/*****/***** *****    ***** 8.4 (L) *****/*****/***** *****    GLU 105 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.4 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 16.3 (H) *****/*****/***** *****    ***** 1.3 (H) *****/*****/***** *****                        "
114433472,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****, ***** *****  ***** ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: Patient is unable to respond  What language do you prefer for written communication?: Patient is unable to respond    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     *****, ***** .Primary Health Care ***** (Proxy form on file) - Sister Not Active   Primary Phone: *****-*****-***** (Mobile)      Healthcare Proxy - Scan on *****/*****/*****  4:09 PM by ***** *****                       Code Status at *****: DNR/DNI (No CPR/No Intubation)    To be discharged to: Discharged / Transferred to an Inpatient rehabilitation (IRF) including rehabilitation distinct part unit of a hospital  Patient/Family/Caregiver discharge preference/goals : Inpatient rehab facility  Patient/Family/Caregiver participated and agreed with DC plan: Yes  Patient/Family/Caregiver have been provided a list of discharge facilities/services to review/select: ***** Rehab Hospitals  Discharge address same as *****: No  Discharge Address: ***** *****, 300 First *****, *****, *****  ***** : *****-*****-*****             Hospitalization Summary     Reason for Admission: Altered Mental Status  Principal Problem:    Altered mental status  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission     Procedure/Test Authorizing Provider    FL Gastrostomy Catheter Rescue ***** ***** *****, MD        Non (OR) Procedures:   *****/***** 1227 SHUNT *****  *****/***** 1752 Note By: ***** ***** *****, MD  *****/***** 0450 Arterial 
Line  *****/***** 1310 Arterial Line  *****/***** 0305 Arterial Line    Items for Post-Hospitalization Follow-Up:    - Continue Keppra 1g BID, pyridoxine  - Continue Sinemet, modafinil  - Outpatient neurology and ***** f/u  - Neurosurgery will arrange follow-up in ***** clinic on *****/***** weeks with CT head prior  - continue oral vancomycin for two weeks after cessation of antibiotics (*****/*****)  - c diff prophylaxis with vancomycin if needs antibiotics in the future         Pending Results     Procedure Component Value Ref Range Date/Time    Fungal culture w/ wet prep [*****] Collected: *****/*****/***** 1055    Lab Status: Preliminary result Specimen: Cerebrospinal Fluid Updated: *****/*****/***** 1120     Special Requests --     Test Added by MD/Care Unit on:  *****.*****'*****,***** *****/*****/***** ***** *****       WET PREP NO FUNGI SEEN     Fungal Cult/Wet Prep NO FUNGUS OR ***** ISOLATED AFTER 10 DAYS    Respiratory culture/smear [*****]  (Abnormal)  (Susceptibility) Collected: *****/*****/***** 1438    Lab Status: Preliminary result Specimen: Other from ***** *****: *****/*****/***** 0939     Special Requests No Special Requests     GRAM STAIN Moderate ***** , Rare SQUAMOUS EPITHELIAL CELLS , NO ORGANISMS SEEN     Respiratory Cult/Smear Moderate PSEUDOMONAS AERUGINOSA      Moderate BURKHOLDERIA CEPACIA COMPLEX      RESULT CALLED TO CARE UNIT AND/OR MD      Moderate STAPHYLOCOCCUS EPIDERMIDIS      NORMAL ***** *****    Mycobacterial culture/smear [*****] Collected: *****/*****/***** 1055    Lab Status: Preliminary result Specimen: Cerebrospinal Fluid Updated: *****/*****/***** 0907     Special Requests --     Test Added by MD/Care Unit on:  *****'*****,***** *****/*****/***** ***** *****       SMEAR NO ACID FAST BACILLI OBSERVED     Mycobacterial Culture NEGATIVE FOR MYCOBACTERIA AFTER 7 DAYS             Hospital Course   ***** y.o. male with DVT/PE (on apixaban), prostate cancer s/p TURP, CAD, NPH s/p VP shunt (2017) c/b SDH requiring multiple ***** (last *****/*****, VPS removed) with 
recent admission for AMS s/p VPS placement and EVD for SHD (*****/*****) and multiple prior UTIs who presented *****/***** with fevers, tachycardia, leukocytosis and inflammatory UA consistent with urosepsis who was intubated for airway protection with course c/b seizure-like activity and PsA *****.        DATE OF ADMISSION: *****/*****/*****   DATE OF DISCHARGE: *****/*****/*****   PRIMARY DIAGNOSIS: Altered mental status  DISPOSITION: ***** ***** Facility    ============================  Brief summary  ============================  ***** y.o. male with DVT/PE (on apixaban), prostate cancer s/p TURP, CAD, NPH s/p VP shunt (2017) c/b SDH requiring multiple ***** (last *****/*****, VPS removed) with recent admission for AMS s/p VPS placement and EVD for SHD (*****/*****) and multiple prior UTIs who presented *****/***** with fevers, tachycardia, leukocytosis and inflammatory UA consistent with urosepsis who was intubated for airway protection with course c/b seizure-like activity and PsA *****.     ============================  Hospital course by problem  ============================  #Altered mental status  #Altered Mental Status:  Relevant history: Patient presented from ***** rehab, where he was noted to be more somnolent, and essentially nonverbal. He was also noted to have a cough and ***** at *****. Upon arrival to ***** he had some movements (eyelid fluttering, arm movements) concerning for seizure. He was intubated for airway protection.    Baseline Mental Status: At baseline he is A&***** and conversant even if somewhat slowed in response time.     Notable workup: Imaging studies included CT Head: stable changes from prior without new SDH or worsening *****, EEG showed an array of abnormalities but no evidence of any seizures during LTM, Laboratory studies included workup for toxic/metabolic *****, TSH: 0.06 (fT4=0.9), Na: 139, BUN: 45, Ammonia: 23, Folate: 4.6 (from previous admission, not rechecked), B12: >700 and UA: >100 WBC 
with 3+ ***** from chronic foley. ***** of the VP shunt showed normal glucose and protein, no cells and no growth.   Consultants: Neurology and neurosurgery    Ultimately, the most likely cause of the patient's mental status was felt to be an acute infectious process likely a combination of c diff and UTI (see below). He was able to be extubated, and at the time of discharge was at his baseline mental status per his sister. Notably, there was concern of ongoing seizure activity while in the *****, but ultimately this did not correlate with EEG activity. Mental status improved as patients clinical picture improved. Likely some component of ICU delirium involved as hospital stay increased.    - Continue Keppra 1g BID, pyridoxine  - Continue Sinemet, modafinil  - Outpatient neurology and ***** f/u  - Neurosurgery will arrange follow-up in ***** clinic on *****/***** weeks with CT head prior    #Multiple Infectious etiologies  #Presumed UTI  #C Diff  #Ventilator Associated Pneumonia  Clinical picture most notable for possible infection (WBC >25k; AMS; tachycardia). UA dirty but notably off of a chronic foley. Urine culture grew 50-100k of mixed flora and <10k enterococcus. Blood cx negative. CSF studies without evidence of infection. Chest imaging consistent with possible aspiration on arrival. C diff toxin positive (hx of c diff infection) and increased stool output. No clear consensus about etiology. Patient treated broadly including meningitis coverage on admission. He was also treated with oral vancomycin for C diff. Patient developed increased secretions and respiratory culture grew PsA and burkholderia. Patient's antibiotics course was extended for cefepime for ***** through *****/***** (with c diff prophylaxis). Notably burkholderia was not cefepime resistant, but as patient improved clinically this was not felt to be the likely culprit in the ***** with the PsA also growing which was cefepime sensitive.     - continue oral 
vancomycin for two weeks after cessation of antibiotics (*****/*****)  - c diff prophylaxis with vancomycin if needs antibiotics in the future    #Goals of care  Of note, the patient is now DNR/DNI after ongoing conversations with the family about his goals.     - ***** in the chart    ============================  ============================           Medications   Allergies: Patient has no known allergies.    Prior to Admission Medications   Prescriptions   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.   amino acids-protein hydrolysate (***** ***** CARB) 15-60 gram-kcal/30 mL *****   Sig: 60 mL by Gastrostomy Tube route every 12 (twelve) hours.   apixaban (ELIQUIS) 5 mg tablet   Sig: 1 tablet (5 mg total) by Gastrostomy Tube route 2 (two) times a day.   carbidopa-levodopa (SINEMET) 25-100 mg per tablet   Sig: 1 tablet by Gastrostomy Tube route every 8 (eight) hours.   doxazosin (CARDURA) 2 MG tablet   Sig: Take 2 mg by mouth nightly at bedtime.   finasteride (PROSCAR) 5 mg tablet   Sig: 1 tablet (5 mg total) by Gastrostomy Tube route daily.   hydrOXYchloroQUINE (PLAQUENIL) 200 mg tablet   Sig: 1 tablet (200 mg total) by Gastrostomy Tube route 2 (two) times a day.   ipratropium-albuteroL (DUONEB) 0.5-3 mg (2.5 mg base)/3 mL nebulizer solution   Sig: Take 3 mL by nebulization every 6 (six) hours as needed for wheezing or shortness of breath/dyspnea.   levETIRAcetam (KEPPRA) 500 mg/5 mL (5 mL) Soln   Sig: 5 mL (500 mg total) by Gastrostomy Tube route 2 (two) times a day.   melatonin 5 mg Tab   Sig: 1 tablet (5 mg total) by Gastrostomy Tube route nightly at bedtime.   modafiniL (*****) 100 MG tablet   Sig: Take 100 mg by mouth daily.   nystatin (MYCOSTATIN) 500,000 unit tablet   Sig: Take 1 tablet by mouth 4 (four) times a day.   pyridoxine, vitamin B6, (B-6) 50 MG tablet   Sig: Take 50 mg by mouth daily.   sertraline (ZOLOFT) 
100 MG tablet   Sig: Take 100 mg by mouth daily.   simvastatin (ZOCOR) 40 MG tablet   Sig: 1 tablet (40 mg total) by Gastrostomy Tube route nightly at bedtime.      Facility-Administered Medications: None        Medication List      TAKE these medications        Instructions    acetaminophen 325 mg tablet  Commonly known as: TYLENOL  Last time this was given: Ask your nurse or doctor   Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.      apixaban 5 mg tablet  Commonly known as: ELIQUIS  Last time this was given: ***** *****, *****  8:02 AM   1 tablet (5 mg total) by Gastrostomy Tube route 2 (two) times a day.      carbidopa-levodopa 25-100 mg per tablet  Commonly known as: SINEMET  Last time this was given: ***** *****, ***** 12:03 PM   1 tablet by Gastrostomy Tube route every 8 (eight) hours.  What changed:   쨌 how to take this  쨌 when to take this  쨌 Another medication with the same name ***** *****. Continue taking this medication, and follow the directions you see here.      doxazosin 2 MG tablet  Commonly known as: CARDURA  Last time this was given: ***** *****, *****  8:01 AM   Take 2 mg by mouth nightly at bedtime.      finasteride 5 mg tablet  Commonly known as: PROSCAR  Last time this was given: ***** *****, *****  8:01 AM   1 tablet (5 mg total) by Gastrostomy Tube route daily.      hydrOXYchloroQUINE 200 mg tablet  Commonly known as: PLAQUENIL  Last time this was given: ***** *****, *****  8:01 AM   1 tablet (200 mg total) by Gastrostomy Tube route 2 (two) times a day.      ipratropium-albuteroL 0.5-3 mg (2.5 mg base)/3 mL nebulizer solution  Commonly known as: DUONEB   Take 3 mL by nebulization every 6 (six) hours as needed for wheezing or shortness of breath/dyspnea.      levETIRAcetam 500 mg/5 mL (5 mL) Soln  Commonly known as: KEPPRA  Last time this was given: ***** *****, *****  8:01 AM   Take 10 mL (1,000 mg total) by mouth 2 (two) times a day.  What changed:   쨌 how 
much to take  쨌 how to take this      melatonin 5 mg Tab  Last time this was given: ***** *****, *****  9:31 PM   1 tablet (5 mg total) by Gastrostomy Tube route nightly at bedtime.      modafiniL 100 MG tablet  Commonly known as: *****  Last time this was given: ***** *****, *****  8:02 AM   1 tablet (100 mg total) by Gastrostomy Tube route daily.  What changed: how to take this  Start taking on: ***** *****, *****      nystatin 500,000 unit tablet  Commonly known as: MYCOSTATIN  Last time this was given: Ask your nurse or doctor   Take 1 tablet by mouth 4 (four) times a day.      ***** No Carb 15-60 gram-kcal/30 mL *****  Generic drug: amino acids-protein hydrolysate  Last time this was given: ***** *****, *****  8:02 AM   60 mL by Gastrostomy Tube route every 12 (twelve) hours.      pyridoxine (vitamin B6) 50 MG tablet  Commonly known as: B-6  Last time this was given: ***** *****, *****  8:01 AM   1 tablet (50 mg total) by Gastrostomy Tube route daily for 45 doses.  What changed: how to take this  Start taking on: ***** *****, *****      sertraline 100 MG tablet  Commonly known as: ZOLOFT  Last time this was given: ***** *****, *****  8:01 AM   1 tablet (100 mg total) by Gastrostomy Tube route daily.  What changed:   쨌 how much to take  쨌 how to take this  쨌 Another medication with the same name ***** *****. Continue taking this medication, and follow the directions you see here.  Start taking on: ***** *****, *****      simvastatin 40 MG tablet  Commonly known as: ZOCOR  Last time this was given: ***** *****, *****  9:32 PM   1 tablet (40 mg total) by Gastrostomy Tube route nightly at bedtime.      vancomycin 50 mg/mL Soln  Commonly known as: VANCOCIN  Last time this was given: ***** *****, ***** 12:03 PM   Take 2.5 mL (125 mg total) by mouth every 6 (six) hours for 51 doses.           Where to Get Your Medications      Information about where to get these medications is not yet available    Ask your nurse or doctor about 
these medications  쨌 carbidopa-levodopa 25-100 mg per tablet  쨌 levETIRAcetam 500 mg/5 mL (5 mL) Soln  쨌 modafiniL 100 MG tablet  쨌 pyridoxine (vitamin B6) 50 MG tablet  쨌 sertraline 100 MG tablet  쨌 vancomycin 50 mg/mL Soln                    Hospital Care Team   Service: Medicine  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 1:45 PM (Arrive by 1:15 PM) ***** ***** ***** ***** Center for Outpatient Care - CT *****-*****-***** ***** Main    *****/*****/***** 10:45 AM ***** ***** *****, MD Acute Care Neurosurgery on WAC ***** *****-*****-*****     *****/*****/***** 12:00 PM ***** ***** ***** Imaging - RF/IR *****-*****-***** ***** Main        Follow-Up Services            Services            ***** *****    ***** ***** *****.  ***** ***** *****-*****   Phone: *****-*****-*****                 Signed Discharge Orders (From admission, onward)     Ordered        *****/*****/***** 1407  Activity as tolerated         *****/*****/***** 1407  Weight bearing status     Comments: Weight Bearing     None          *****/*****/***** 1407  Discharge diet         *****/*****/***** 1407  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1407  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.     Comments: For immediate questions regarding your 
hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.                 Discharge instructions and important events and results    Dear *****. *****,    You were recently admitted to ***** for altered mental status. The most likely cause of this all was an acute infection. We have treated your with antibiotics and your mental status seems to have improved. Because you also have c diff, you should continue taking oral vancomycin for two weeks. To keep building your strength, we are transferring you to ***** Rehab Facility for further care.     Please call your primary care physician or go to an emergency room if you have chest pain, shortness of breath, fevers, or you are again having changes in your mental status.     Please see the instructions below for the exact medications that you should take. Please keep all of your scheduled follow up appointments. In the interim, please do not hesitate to contact us with any questions or concerns.    It was a pleasure taking care of you while you were here. ***** regards,   Your Inpatient Team                 Exam   Temperature: 36.9 째C (98.5 째F) (*****/*****/***** 0759) | Heart Rate: (!) 119 (*****/*****/***** 1132) | BP: 131/62 (*****/*****/***** 1132) | Respiratory Rate: 20 (*****/*****/***** 0759)  | SpO2: 92 % (*****/*****/***** 1132)  O2 Device: None (Room air) (*****/*****/***** 1132)  O2 Flow Rate (L/min): 1  O2 Flow Rate (mL/min): 2 | FiO2 (%): 28 % (*****/*****/***** 0600)      Weight: 107.6 kg (237 lb 3.4 oz) (*****/*****/***** 0742)  Height: 182.9 cm (6') (*****/*****/***** 1800)         BMI (Calculated): 31.45 (*****/*****/***** 1800)    Discharge Exam    Significant Discharge Exam Findings: Gen: alert, appropriately responsive.   Neuro: gives *****-***** word answers to questions. No appreciable anisocoria.   Extremities: warm, well-perfused.   Chest: CTAB anteriorly  Abdomen: SNT, G-tube in situ              Orientation Level: Oriented to person   Cognition: 
Follows one step directions         Speech: Delayed, *****     Special Needs    Special Needs: None              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 13.22 (H) *****/*****/***** *****    RBC 4.38 (L) *****/*****/***** *****    ***** None *****/*****/***** *****    ***** None *****/*****/***** *****    ***** ***** GROWTH 7 DAYS *****/*****/***** *****    HGB 12.6 (L) *****/*****/***** *****    HCT 40.4 (L) *****/*****/***** *****    MCH 28.8 *****/*****/***** *****    MCV 92.2 *****/*****/***** *****    PLT 467 (H) *****/*****/***** *****    RDW 14.8 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 142 *****/*****/***** *****    ***** 4.1 *****/*****/***** *****    ***** 106 *****/*****/***** *****    CO2 26 *****/*****/***** *****    BUN 34 (H) *****/*****/***** *****    CRE 0.94 *****/*****/***** *****    ***** 9.7 *****/*****/***** *****    GLU 114 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.2 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 15.9 (H) *****/*****/***** *****    PTT 34.3 *****/*****/***** *****    INR 1.3 (H) *****/*****/***** *****          ***** *****. *****, MD  Internal Medicine and Pediatrics  PGY-3            "
115539691,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     Status Name ***** ***** ***** ***** Home Work Mobile    Not Active *****,***** ***** .Primary Health Care ***** (Proxy form on file) *****-*****-***** (Home) *****-*****-***** - -          Code Status at *****: Full Code (Presumed)                           Hospitalization Summary       Principal Problem:    Subdural hematoma  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** Left Frontal  Craniotomy  Subdural Hematoma Evacuation *****, ***** *****                ***** (OR) Procedures:          Pending Results     Procedure Component Value Ref Range Date/Time    Erythropoietin level [*****] Collected:  *****/*****/***** 1746    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 1755    Special Coagulation [*****] Collected:  *****/*****/***** 2333    Lab Status:  In process Updated:  *****/*****/***** 1043           Hospital Course   *****-year-old male with metastatic castration-resistant prostate cancer with involvement of thoracic spine managed at *****-*****. Historyof stroke *****/*****, ***** in *****/***** without ***** or loss of consciousnesswithout clear cause, last admitted to ***** for anemia *****/*****. At that time, head CT obtained as part of workup, found bilateral, left greater than right 
chronic subdural hematomas. Per daughter who is bedside, he was ambulating independentlyuntil the end of **********. Since then, he has participated in physical therapydaily; however, despite this, his ability to ambulate has steadily worsened. She presents a letter from ***** stating this is due to right-sided neglect and right-side imbalance. The patient was seenin clinic by Dr. ***** *****/*****/*****, who had planned to watch bilateral chronic *****. The patient was seen in clinic today for increasing confusion/lethargy lastingseveral days. He has chronic anemia from malignancy/chemotherapy. His last hemoglobin/hematocrit on*****/*****/***** were7.*****/*****.2. He was scheduled for an outpatient blood transfusion on *****/*****/*****.   Patient was admitted to the Neurosurgical Service on *****/***** for mini-craniotomy for left subdural hematoma evacuation with Dr. ***** on *****/*****.  Patient was taken to the operating room on the day of admission and underwent an uncomplicated procedure. Please see Dr. *****'s separately dictated operative note for details. Post-operatively patient was extubated and transferred to the Neurosurgical ICU for close monitoring. He remained hemodynamically stable, neurologically at baseline, and with his pain well-controlled throughout his hospital stay. On POD#3 he was transferred to the floor in stable condition and was deemed ready for discharge on POD#5.    NEURO: Patient remained neurologically at baseline throughout his hospital stay. A+O x 3, EOMI, PERRL, FS, TM, sensation grossly intact, ***** *****/***** x4, no drift. Post op imaging on *****/*****, *****/***** and *****/***** showed stable expected post-operative changes. Subdural drain placed during surgery was discontinued on *****/*****. He will continue Keppra 1500 BID. EEG placed overnight *****/*****-*****/***** showed no seizures, no focal or diffuse slowing, or any abnormal discharges and was discontinued on *****/*****.     CV: Hemodynamically stable at all times. Patient spontaneously went into atrial 
fibrillation in AM of *****/*****. He received 3 doses of 5 mg metoprolol IV and spontaneously converted back to normal sinus rhythm *****/***** but then returned to atrial fibrillation. The patient has a known history of second degree heart block type 1. Cardiology recommends outpatient follow-up with cardiologist after discharge from hospital as patient asymptomatic and as rate is controlled (below HR 100). ECGs obtained *****/***** and *****/***** showed no new changes apart from new-onset atrial fibrillation and the type 1 second degree heart block.     GU: Voiding on his own after foley removed with no signs of retention or UTI.     GI: Tolerating a regular diet with no nausea or vomiting. Evaluated by Nutrition *****/***** for low Phosphorus and being underweight. Nutrition recommends continuing Phosphorus repletion, checking Phosphorus daily or at least 3 times weekly until serum level is normalized, then checking weekly until demonstrating consistent serum levels WNL, and encouraging consumption of high-Phosphorus foods:e.g. milk (add ***** instant breakfast powder for more phosphorus and protein), cheese, yogurt, ice cream, cream soups, nuts, seeds. Also recommend encouraging intake of small, frequent meals to optimize PO intake.     HEME: SQH and SCDs for DVT prophylaxis. Hematology consult on *****/***** recommended PT and PTT mixing studies. PTT mixing study was positive, and lupus anticoagulant was obtained *****/***** and patient again seen by Hematology. Lupus anticoagulant panel came back negative *****/*****. Hematology documented his coagulopathy appears resolved *****/*****.    ID: ***** at all times. Perioperative ABX. Incision remained clean, dry, and intact with no evidence of erythema, warmth, or hematoma.    *****: Ambulating on his own and feels ready to dc to rehab. At the time of discharge his pain remained well controlled on oral medications. Patient will follow up with Dr. ***** in 1-2 weeks.         Medications   Allergies: Review of 
patient's allergies indicates no known allergies.    Prior to Admission Medications   Prescriptions   abiraterone (ZYTIGA) 250 mg Tab   Sig: Take 1,000 mg by mouth daily.    acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain.   atorvastatin (LIPITOR) 80 MG tablet   Sig: Take 1 tablet (80 mg total) by mouth daily.   calcium citrate (CALCITRATE) 950 mg (200 mg elemental) tablet   Sig: Take 1 tablet (950 mg total) by mouth 2 (two) times a day with meals.   cyanocobalamin (VIT B-12) 1000 MCG tablet   Sig: Take 1 tablet (1,000 mcg total) by mouth 2 (two) times a day.   latanoprost (XALATAN) 0.005 % ophthalmic solution   Sig: Place 1 drop into each eye nightly.   lidocaine 4 %   Sig: Place 1 patch onto the skin daily.   lisinopril (PRINIVIL,ZESTRIL) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth daily.   melatonin 3 mg Tab   Sig: Take 1 tablet (3 mg total) by mouth nightly.   Patient not taking: Reported on *****/*****/*****   potassium, sodium phosphates (PHOS-*****) *****-*****-***** mg *****   Sig: Take 1 packet by mouth 2 (two) times a day.   predniSONE (DELTASONE) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth daily.   thiamine (VITAMIN B-1) 100 MG tablet   Sig: Take 1 tablet (100 mg total) by mouth daily.      Facility-Administered Medications: None        Discharge Medications      START taking these medications       Dose, Frequency, and Details    docusate sodium 100 MG capsule   Also known as:  COLACE    Take 1 capsule (100 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:11 AM       ***** levETIRAcetam 500 MG tablet   Also known as:  KEPPRA    Take 3 tablets (1,500 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:11 AM       ***** levETIRAcetam 750 MG tablet   Also known as:  KEPPRA    Take 2 tablets (1,500 mg total) by mouth 2 (two) times a day.   Last time this was given:  
*****/*****/*****  8:11 AM       ondansetron 4 MG tablet   Also known as:  ZOFRAN    Take 1 tablet (4 mg total) by mouth every 6 (six) hours as needed.       polyethylene glycol 17 gram packet   Also known as:  MIRALAX    Take 17 g by mouth daily as needed (severe constipation).       potassium chloride 20 mEq packet   Also known as:  KLOR-CON    Take 20-80 mEq by mouth as needed (KCL Replacement *****).   Last time this was given:  *****/*****/*****  8:51 AM       traMADol 50 mg tablet   Also known as:  ULTRAM    Take 1 tablet (50 mg total) by mouth every 6 (six) hours as needed.   Last time this was given:  *****/*****/*****  5:21 AM       ***** Notice:  This list has 2 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.      CONTINUE taking these medications       Dose, Frequency, and Details    abiraterone 250 mg Tab   Also known as:  ZYTIGA    Take 1,000 mg by mouth daily.   Last time this was given:  *****/*****/*****  8:11 AM       acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain.   Last time this was given:  *****/*****/*****  6:31 AM       atorvastatin 80 MG tablet   Also known as:  LIPITOR    Take 1 tablet (80 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:35 PM       calcium citrate 950 mg (200 mg elemental) tablet   Also known as:  CALCITRATE    Take 1 tablet (950 mg total) by mouth 2 (two) times a day with meals.   Last time this was given:  *****/*****/*****  8:11 AM       cyanocobalamin 1000 MCG tablet   Also known as:  VIT B-12    Take 1 tablet (1,000 mcg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:11 AM       latanoprost 0.005 % ophthalmic solution   Also known as:  XALATAN    Place 1 drop into each eye nightly.   Last time this was given:  *****/*****/*****  8:34 PM       lidocaine 4 %    Place 
1 patch onto the skin daily.       lisinopril 5 MG tablet   Also known as:  PRINIVIL,ZESTRIL    Take 1 tablet (5 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:11 AM       melatonin 3 mg Tab    Take 1 tablet (3 mg total) by mouth nightly.   Last time this was given:  *****/*****/***** 11:50 PM       potassium, sodium phosphates *****-*****-***** mg *****   Also known as:  PHOS-*****    Take 1 packet by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:11 AM       predniSONE 5 MG tablet   Also known as:  DELTASONE    Take 1 tablet (5 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:11 AM       thiamine 100 MG tablet   Also known as:  Vitamin B-1    Take 1 tablet (100 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:11 AM                 Immunizations Administered for This Admission     Name *****    Influenza High-Dose Trivalent Preservative Free IM  Deferred (Patient Refused)             Hospital Care Team   Service: Neurology  Inpatient Attending: ***** ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, *****  1:40 PM *****   (Arrive by 1:25 PM)   NEW PATIENT with ***** ***** *****, MD   ***** at ***** ***** (--)    ***** ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, ***** 10:50 AM *****   BLOOD DRAW with DF LAB SERVICES NURSE   Laboratory Services, ***** (--)    ***** ***** *****  *****, ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, ***** 12:00 PM *****   ESTABLISHED PATIENT ON TX with ***** *****, CNP   ***** Center for Genitourinary Oncology, ***** (--)    ***** ***** *****  ***** *****, ***** *****  ***** ***** *****   *****-*****-*****           Please click on the ""My Medical Record"" tab at the top of 
this page and make any needed updates to your Medications, Allergies, and Current Health Issues sections.            ***** *****, *****  1:00 PM *****   BLOOD PRODUCT with ***** ***** *****, RN   Infusion Therapy Services ***** 11, ***** (--)    ***** ***** *****  ***** ***** ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            BENCHMARK ***** LIVING ***** ***** *****   Specialty:  Skilled Nursing Facility    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****             Follow-Up Providers            ***** ***** *****, MD, PhD   Specialty:  Neurosurgery    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Follow up in 2 week(s)       Instructions:  For follow-up, For wound re-check            ***** Cardiovascular   Specialty:  Cardiology    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Schedule an appointment as soon as possible for a visit in 2 week(s)       Instructions:  For new onset atrial fibrillation, evaluated by Cardiology during hospitalization                 Signed Discharge Orders     Ordered        *****/*****/***** 1210  Activity as tolerated         *****/*****/***** 1210  Bathing: Shower     Question:  Bathing  Answer:  Shower       *****/*****/***** 1210  Lifting: No more than 5 lbs     Question:  Lifting  Answer:  No more than 5 lbs       *****/*****/***** 1210  Housekeeping chores: Light     Question:  Housekeeping chores  Answer:  Light       *****/*****/***** 1210  No Driving: No driving while taking narcotics     Question:  No Driving  Answer:  No driving while taking narcotics       *****/*****/***** 1210  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1210  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at *****-*****-***** and ask him/her to be paged.     Comments:  For immediate questions regarding your 
hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at *****-*****-***** and ask him/her to be paged.       *****/*****/***** 1210  Activity as tolerated         *****/*****/***** 1210  Lifting: No more than 5 lbs     Question:  Lifting  Answer:  No more than 5 lbs       *****/*****/***** 1210  Housekeeping chores: Light     Question:  Housekeeping chores  Answer:  Light       *****/*****/***** 1210  Bathing: Shower     Question:  Bathing  Answer:  Shower       *****/*****/***** 1210  No Driving: No driving while taking narcotics     Question:  No Driving  Answer:  No driving while taking narcotics       *****/*****/***** 1210  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1210  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at *****-*****-***** and ask him/her to be paged.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at *****-*****-***** and ask him/her to be paged.                     Exam   Temperature: 37.1 째C (98.7 째F) (*****/*****/***** 1146) | Heart Rate: 83 (*****/*****/***** 1146) | BP: 160/70 (*****/*****/***** 1146) | Respiratory Rate: 16 (*****/*****/***** 1146)  | SpO2: 96 % (*****/*****/***** 1146)  O2 Device: None (Room air) (*****/*****/***** 1146)  O2 Flow Rate (L/min): 2 |        Weight: 75 kg (165 lb 5.5 oz) (*****/*****/***** 1703)  Height: 172.7 cm (5' 7.99"") (*****/*****/***** 1703)         BMI (Calculated): 25.1 (*****/*****/***** 1703)    Discharge Exam    Significant Discharge Exam Findings:  BP 185/81 | Pulse 71 | Temp 36.7 째C (98 째F) (Oral)  | Resp 22 | Ht 1.727 m (5' 7.99"") | Wt 75 kg (165 lb 5.5 oz) | SpO2 91% | BMI 25.15 kg/m2  AAOx3 , dysarthric speech  RUE *****/***** limited by wrist pain   RLE 4-/5   Left full                  Orientation Level: Oriented X7   Cognition: 
Follows commands         Speech: Slurred     Vision: Functional  Hearing: Functional   Assistive Devices: Wheelchair       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 5.37 *****/*****/***** *****    RBC 2.55 (L) *****/*****/***** *****    ***** ***** *****/*****/***** *****    ***** Compatible *****/*****/***** *****    ***** Compatible *****/*****/***** *****    HGB 8.3 (L) *****/*****/***** *****    HCT 24.8 (L) *****/*****/***** *****    MCH 32.5 (H) *****/*****/***** *****    MCV 97.3 (H) *****/*****/***** *****    PLT 115 (L) *****/*****/***** *****    RDW 20.9 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 141 *****/*****/***** *****    ***** 3.5 *****/*****/***** *****    ***** 106 *****/*****/***** *****    CO2 21 (L) *****/*****/***** *****    BUN 15 *****/*****/***** *****    CRE 0.48 (L) *****/*****/***** *****    ***** 7.4 (L) *****/*****/***** *****    GLU 111 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.4 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 15.6 (H) *****/*****/***** *****    PTT 37.2 (H) *****/*****/***** *****    INR 1.3 (H) *****/*****/***** *****                        "
150008246,0,1,"

Note Date: *****/*****/*****  Time: 0944

Note Type: Initial note

Note Title: Inpatient OT Evaluation (1)

Signed by ***** *****, *****/L License# ***** on *****/*****/***** at 2:53 pm  Affiliation: *****

 

OCCUPATIONAL THERAPY INITIAL EVALUATION

Rehabilitation Services - Inpatient Occupational Therapy



Attending Physician: *****-*****,*****

Referral Date:  *****/*****

Reason for Referral: Evaluation and Treatment 

Activity Orders: Ambulate twice daily if patient able



HPI/Subjective Complaint: Pt is a ***** yo woman with recent

hospitalization from *****/*****-*****/*****/***** for L crani on *****/*****/***** for

traumatic L SDH evacuation, who presents to the ED with

continuous aphasia. Neurosurgery was consulted felt pt's

presentation suggestive possibly of seizures or cortical

spreading depression. No progression of the SDH in repeat scan,

recommended neuro consult, increase Keppra and repeat EEG. Neuro

consulted, admitted to neurology to rule out possible stroke,

Other potential etiologies include epileptic aphasia from

frequent or continuous seizure. Pt also found to have possible

UTI, which may cause recrudescence of aphasia from ***** regardless

of any change in size of the SDH. The presence of UTI may also

increase the likelihood of seizures.  EEG shows slowing over left

side, No epileptiform discharges or seizures. 

Pt presents to OT today for initial evaluation. 







Past Medical/Surgical History: 

Left craniotomy for acute on chronic subdural evacuation on

*****/*****/*****

hypercholesterolemia 

*****

primary biliary cholangitis 

*****'s syndrome 

GERD 

L humerus fracture *****/*****, 80% functional recovery 



Medications: 

LevETIRAcetam 

Omeprazole 

Ursodiol 

CefTRIAXone 

Heparin 

Simvastatin 

Acetaminophen 

OxyCODONE 





Radiology: 

*****/***** MRI Head: 1. Stable left extra-axial fluid collection

measuring up to 12 mm in diameter with local mass effect, and 5

mm of unchanged rightward midline shift. 2. Evidence of

subarachnoid hemorrhage within the left frontoparietal and

temporal lobe sulci is also unchanged. 3. No evidence for

hypoperfusion on MRI contrast perfusion imaging. 4. Nonspecific,

1 cm T2 hyperintensity within the right frontal lobe is 

unchanged from the previous examination and may relate to area of

prior infarction or chronic small vessel ischemic disease. 

5. 5 mm of inferior descent of the cerebellar tonsils

bilaterally, unchanged from prior examination. Findings are

borderline, and there is no evidence for associated crowding of

the foramen magnum. 



*****/***** CXR: No acute intrathoracic process. 



*****/***** CT Head: No significant change in the mixed density

subdural fluid collection overlying the left cerebral hemisphere.





Labs:

*****/*****/*****: WBC: 5.5

*****/*****/*****: HGB: 11.0*****

*****/*****/*****: HCT: 33.6*****

*****/*****/*****: Plt Count: 228



*****The following obtained from ***** evaluation completed on *****/*****/*****

and confirmed/updated as needed with pt this date 

Social/Occupational History:

Pt lives alone, however daughter has been staying with her since

previous d/c - daughter reports she plans to go back to work

however will arrange for someone to be with pt at all time

following d/c

Supports include family and many friends 

Retired 3rd grade teacher but continues to intermittently

substitute teach 

Enjoys: spending time with friends, playing cards, walking 



Living Environment:

Lives in ***** *****-level home, stairs with rails

walk-in shower



Baseline Self Care/Activity Level:

I for ADLs

I for IADLs 

At home/In community: Ambulates without an assistive device

(+) Drives - not driving since previous hospital admission 



Adaptive equipment: none





OBJECTIVE TESTING

Current Activities of Daily Living: 

     Self Feeding: Supervision 

     Grooming: Independent, standing at sink (simulated) 

     UB Bathing: Supervision (simulated) 

     ***** Bathing: Supervision (simulated)

     UB Dressing: Supervision 

     ***** Dressing: Independent 

     Toileting: Independent (simulated) 

Specify: While seated at *****, pt independently ***** and *****

***** sock, noted impaired FMC during task however pt able to

complete tasks independently with increased time. Pt *****

hospital gown as ***** independently following set up assist. Upon

OT departure, pt eating breakfast utilizing ***** in R hand. 



Daily Activity Inpatient ***** Form - Activity Measure for

Post-Acute Care:

How much help from another person does the patient currently

need...

1. Putting on and taking off regular lower body clothing: 4

2. Bathing (including washing, rinsing, drying): 3

3. Toileting, which includes using toilet, bedpan or urinal: 4

4. Putting on and taking off regular upper body clothing: 3

5. Taking care of personal grooming such as brushing teeth: 4

6. Eating meals: 3



1 = Total  2 = A lot (*****/maxA)   3 = A little (S/CGA/minA)   

4 = None (Independent or Modified I)



Total Raw Score: *****/*****

t-***** Score: 44.27



Processing Skills: 

     Level of arousal: Alert 

     Orientation: Self (name ***** *****), date, location 

     Behaviors: Pleasant and Cooperative 

     Command Following: Follows 100% simple 1 step ADL 

     commands without cues 

     Memory: NT

     Attention: States *****, WNL, no errors. States *****, WNL,

      no errors  

     Insight/ Safety Awareness: Demonstrates how to use call 

     ***** to page RN 

     Thought process: Organized  

     Naming/***** Fluency: 

          Aphasic 

          Reports ***** finding difficulty  

          ***** *****/***** high frequency words and *****/***** low frequency 

          words 

     Communication: Able to make needs known, communicates 

     verbally and appropriately with therapist throughout 

     session 



Current Instrumental Activities of Daily Living: 

     Home Management: assist*****

     ***** Management: NT 

     Community Integration: assist*****  

Specify: *****not formally assessed based on current level of

functioning 



Motor Skills - Functional Mobility:

     *****: NT 

     Supine/Side-lying to Sit: Independent 

        HOB flat:     N

        Use of rail:  Y

     Sit to Stand: Independent 

     Bed to Chair: NT 

     Toilet Transfer: NT 

     Commode Transfer: NT 

     Shower/Tub Transfer: NT 

     Functional Ambulation: Independent 50'x6 

Specify: Pt performs all functional mobility independently this

date. 



Functional Balance: 

     Sitting (static): Independent 

     Sitting (dynamic): Independent 

     Standing (static): Independent 

     Standing (dynamic): Independent 



*****Abbreviation Key*****

I=Independent S=Supervision CG=Contact ***** *****=***** *****

*****=Standard ***** *****=Straight ***** *****=Axillary Crutches

UB=Upper Body *****=Lower Body



Hemodynamic Response/Aerobic Capacity

          Position    HR      BP      RR     O2     RPE Rest     

Rest      Supine      60      *****/*****

Activity  Stand p stairs 91   *****/*****

Recovery  Sit p amb   94      170/82





Range of Motion: BUE, WFL, PROM. 



Muscle Performance: Grossly *****/***** throughout bil UE and bil strong

grasp 

                 



Motor Control/Coordination: No abnormal tone. Dysmetria noted

with FNF assessment on R. L FNF assessment WFL. 



Integumentary: PIV



Sensation: Light touch grossly intact throughout BUE 



Vision: Visually attends to therapist, no c/o changes in vision 

                

Functional vision assessment: ***** environment without

difficulty 



Pain:  1.*****/***** at rest.  1.*****/***** with activity.  1.*****/***** at

recovery.

     Location: Head 

     Quality: Achy 

     Intervention: Pre-medicated 



Limiting Symptoms: None 



Team Communication: Communicated with RN pre and post treatment

re) pt status and d/c planning/recommendations; Communicated with

PT pre, during and post treatment in setting of co-treatment 



Patient/Caregiver Education RE: Role of OT and plan of care, d/c

planning/recommendations, provided built up foam handles,

***** and foam block to promote hand strengthening per pt

and daughter request  



Intervention: ***** ***** ***** Evaluation 



DIAGNOSIS

Impairments, Functional Limitations, Disabilities

- Impaired R FMC/dexterity 





Clinical Impression/Prognosis: Pt is a ***** y/o female who presents

to OT during acute hospitalization for worsening aphasia in the

setting of possible seizures. At baseline, pt is independent with

ADLs and functional transfers/mobility. Currently, pt is

functioning at baseline with ADLs and functional

transfers/mobility. Currently, pt is functioning at baseline with

ADLs and functional transfers/mobility. At this time, anticipate

pt has good potential for home d/c when medically stable. Would

recommend continued supervision for shower transfers and bathing.

Would also recommend home OT for formal home set up and safety

evaluation in addition to FMC/dexterity ther ex. No further acute

OT needs identified at this time, OT will sign off. Please

re-consult if change in status or further needs arise.   









Current Status: 

***** Self Care  

Based on the results of the AM-PAC, the patient presents with 

CMS severity: 

20%-40% impaired (*****) = AM-PAC 20-22



Goal Status: 

***** Self Care 

with CMS severity: 

20%-40% impaired (*****) = AM-PAC 20-22





DC status: 

***** Self Care 

Based on the results of the AM-PAC, the patient presents with CMS

severity: 

20%-40% impaired (*****) = AM-PAC 20-22













Goals:               Time *****: ***** at initial evaluation 

- Pt will ID use of ***** and foam block to improve R

FMC/dexterity 

- Pt will complete UBD with supervision 

- Pt will ambulate independently 





Recommended Discharge: ( )rehab (X)home with home OT following 0

OT visits



Treatment Plan: D/C OT 



Frequency/Duration: D/C OT 



Recommendations for Nursing: 

- Encourage participation with all ADLs

- Encourage frequent ambulation 





Patient agrees with the above goals and is willing to participate

in the rehabilitation program.  Please indicate with an 'X': Yes

(X) or No (   ). If no please explain:



Date: *****/*****/*****

*****:*****:*****-*****:40





Occupational Therapist Name: ***** *****, *****/L

Occupational Therapist Pager: *****"
111207479,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient will complete a new one      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Prior                                    Hospitalization Summary     Reason for Admission: Seizure  Principal Problem:    Seizure  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    Medication changes:     Keppra: dose increase to 750mg BID  Lamotrigine: started at 25mg daily     ***** lamotrigine uptitration by the dosage and frequency as outlined below. Patient should call their doctor if they develop a rash at any time.        AM   PM  Week 1  25 mg (1 tab)  0  Week 2  25 mg (1 tab)  25 mg (1 tab)   Week 3  25 mg (1 tab)  50 mg (2 tab)  Week 4  50 mg (2 tab)  50 mg (2 tab)  Week 5  75 mg (3 tab)  75 mg (3 tab)  Week 6  100 mg (4 tab)  100 mg (4 tab)  Week 7 150 mg (6 tab)  100 mg (4 tab)  Week 8 150 mg (6 tab)  150 mg (6 tab)   Ongoing 150 mg (6 tab)  150 mg (6 tab)        Pending Results     None             Hospital Course   ***** with a history of traumatic L frontotemporal SDH/SAH *****/*****/***** c/b seizures s/p evacuation (on keppra 1g BID), HTN, gout, COPD who presents with likely 2x seizures and prolonged post-ictal state.   History of Present Illness:     ***** 
***** is a ***** y.o. male with a history of traumatic L frontotemporal SDH/SAH *****/*****/***** c/b seizures s/p evacuation (on keppra 1g qd), HTN, gout, COPD who presents with likely 2x seizures and prolonged post-ictal state.    Pt presented to ***** Hospital on *****/*****/***** by ***** after his wife found him snoring loudly with low respiratory rate, not responding verbally or physically to any stimuli and with urinary incontinence. BG 136. At ***** ***** he was not communicative and not following commands, making intermittent eye contact and was moving his LEs. His baseline is being fully oriented. He was given narcan by ***** with no benefit. Pt then had a witnessed generalized seizure in the ED with tonic-clonic activity per chart, which resolved in 2 mins after IV ativan 2mg. He was given IV keppra 3g x1. CT Head revealed left frontal encephalomalacia, no acute findings. Work-up ***** for BMP with Na 136, K 3.5, bicarb 9, Cr 1.4, CBC w Hgb 17.7, Plt 144, UA non-infectious, urine ketones ""small"", utox negative, repeat BMP with bicarb 9, gap 30, Cr 1.4. Repeat BMP with Cr 1.1, bicarb 25. He was transferred to ***** for further care.     Per wife he had no preceding illness or symptoms, has been adherent to his keppra, and had not had seizures since his surgical evacuation. His baseline is independent, oriented and interactive but with minor speech and comprehension difficulties.     Pt follows with Dr. ***** ***** ***** at *****. His keppra was decreased in *****/***** to 1500 qd xr from 2g. In *****/***** clinic visit he was noted to have been taking 1g daily instead of 1500. This was continued, with possible future plan to transition to lamotrigine due to mood complaints.     Hospital Course:     The patient presented after at least two breakthrough generalized tonic clonic seizures.  Following this, he was disoriented with some aphasia for a prolonged period of time.  CT head was negative for acute findings; a workup was negative for infection 
or other metabolic or toxic factors that would be considered to have lowered the seizure threshold. He had not missed any doses of Keppra, per wife. For this reason, his current dose was felt to be inadequate for seizure prevention, and was increased from 1000mg daily to 750mg BID.  Additionally, lamotrigine was started at a dose of 25mg daily, with the intention to increase per schedule, as had been discussed previously by his epileptologist, Dr. ***** ***** *****.           Medications   Allergies: Metronidazole and Ciprofloxacin    Prior to Admission Medications   Prescriptions   allopurinol (ZYLOPRIM) 300 MG tablet   Sig: Take 300 mg by mouth daily.   donepeziL (ARICEPT) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth nightly at bedtime.   levETIRAcetam (KEPPRA XR) 500 mg 24 hr tablet   Sig: Take 2 tablets (1,000 mg total) by mouth daily.   metoprolol tartrate (LOPRESSOR) 25 MG tablet   Sig: Take 37.5 mg by mouth 2 (two) times a day. Indications: 1.5 tab      Facility-Administered Medications: None        Medication List      STOP taking these medications     levETIRAcetam 500 mg 24 hr tablet  Commonly known as: KEPPRA XR  Replaced by: levETIRAcetam 750 MG tablet        TAKE these medications        Instructions    allopurinol 300 MG tablet  Commonly known as: ZYLOPRIM  Last time this was given: ***** *****, *****  8:46 AM   Take 300 mg by mouth daily.      donepeziL 5 MG tablet  Commonly known as: Aricept  Last time this was given: ***** *****, *****  8:00 PM   Take 1 tablet (5 mg total) by mouth nightly at bedtime.      lamoTRIgine 25 MG tablet  Commonly known as: LaMICtal  Last time this was given: ***** *****, *****  8:46 AM   Take 1 tablet (25 mg total) by mouth daily. Wk 1: 25mg qAM. Wk 2: 25mg BID. Wk 3: 50mg qAM, 25mg qPM. Wk 4: 50mg BID. Wk 5: 75mg BID. Wk 6: 100mg BID. Wk 7: 100mg qAM, 150mg qPM. Wk 8: 150mg BID  Start taking on: ***** *****, *****      levETIRAcetam 750 MG tablet  Commonly known as: 
KEPPRA  Last time this was given: ***** *****, *****  8:46 AM   Take 1 tablet (750 mg total) by mouth 2 (two) times a day.  Replaces: levETIRAcetam 500 mg 24 hr tablet      metoprolol tartrate 25 MG tablet  Commonly known as: LOPRESSOR  For: 1.5 tab  Last time this was given: ***** *****, ***** 11:14 AM   Take 37.5 mg by mouth 2 (two) times a day. Indications: 1.5 tab           Where to Get Your Medications      These medications were sent to ***** ***** ***** #***** - *****, ***** - ***** ***** ***** ***** ***** ***** ***** ***** & ***** *****  ***** ***** *****, ***** ***** *****    Phone: *****-*****-*****   쨌 lamoTRIgine 25 MG tablet  쨌 levETIRAcetam 750 MG tablet                    Hospital Care Team   Service: Neurology  Inpatient Attending: ***** ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 2:00 PM ***** ***** *****, MD, PhD *****, Department of Neurology *****-*****-***** ***** Main    *****/*****/***** 8:00 AM ***** ***** *****, CCC-SLP ***** ***** Speech Language Therapy *****-*****-*****     *****/*****/***** 10:30 AM ***** ***** *****, MD ***** and Women's Department of Neurology *****-*****-***** ***** Main          Signed Discharge Orders (From admission, onward)     Ordered        *****/*****/***** 1341  Activity as tolerated         *****/*****/***** 1341  Discharge diet     Question:  Diet type  Answer:  Regular       *****/*****/***** 1341  For immediate questions regarding your hospitalization, your medications, and any pending test results please call the main number at ***** and ask for Dr. ***** ***** to be paged (pager #*****).     Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please call 
the main number at ***** and ask for Dr. ***** ***** to be paged (pager #*****).       *****/*****/***** 0723  COVID-19 PCR External Order     Comments: This order was created through External Result Entry     Question:  Does the patient have any symptoms?  Answer:  No                 Discharge instructions and important events and results    Dear *****. *****,    You were admitted to the neurology service at ***** after presenting with breakthrough seizures.    You have epilepsy due to your traumatic brain injury.  We believe that the dose of your anti-seizure medication, Keppra (levetiracetam) needs to be higher to prevent you from having more seizures in the future.  We have increased the dose of your Keppra to 750mg twice daily.  Your epilepsy doctor, Dr. ***** ***** *****, is in agreement with this plan.    We understand that Keppra has unfortunately had some negative effects on your mood.  Together with Dr. *****, we plan to transition you to another medication, Lamictal (lamotrigine), that will have a more positive effect on your mood.      ***** lamotrigine uptitration by the dosage and frequency as outlined below. Patient should call their doctor if they develop a rash at any time.        AM   PM  Week 1  25 mg (1 tab)  0  Week 2  25 mg (1 tab)  25 mg (1 tab)   Week 3  25 mg (1 tab)  50 mg (2 tab)  Week 4  50 mg (2 tab)  50 mg (2 tab)  Week 5  75 mg (3 tab)  75 mg (3 tab)  Week 6  100 mg (4 tab)  100 mg (4 tab)  Week 7 150 mg (6 tab)  100 mg (4 tab)  Week 8 150 mg (6 tab)  150 mg (6 tab)   Ongoing 150 mg (6 tab)  150 mg (6 tab)     Lamictal is an excellent anti-seizure medication, but the dose needs to be increased very slowly.  There is a very rare but very serious side effect with Lamictal, a life-threatening rash called *****-***** *****.  At the first sign of any rash, please stop Lamictal and call Dr. ***** immediately.      Thank you for the privilege of taking care 
of you at *****.    Warmly,  Your ***** Neurology Team                Exam   Temperature: 36.5 째C (97.7 째F) (*****/*****/***** 1150) | Heart Rate: 61 (*****/*****/***** 1200) | BP: 142/70 (*****/*****/***** 1150) | Respiratory Rate: 20 (*****/*****/***** 1150)  | SpO2: 96 % (*****/*****/***** 1200)  O2 Device: None (Room air) (*****/*****/***** 1150)    |        Weight: 81.5 kg (179 lb 10.8 oz) (*****/*****/***** 2355)  Height: 165.1 cm (5' 5"") (*****/*****/***** 2355)         BMI (Calculated): 29.9 (*****/*****/***** 2355)    Discharge Exam    Significant Discharge Exam Findings: MENTAL STATUS:  Alert, awake. Oriented to *****, but to ***** ***** *****.  Able to say the month and explain why he is in the hospital.  Some difficulty with R/L sided commands but can follow a two step command.  Mild word finding difficulty.     CRANIAL NERVES II-XII:  Visual fields full to confrontation in each eye individually.  Pupils equal and reactive to light (4mm -> 3mm). No ptosis. Extraocular movements intact without nystagmus or saccadic intrusion.  Light-touch normal on face bilaterally.  Face symmetric, slight R nasolabial fold flattening, symmetric forehead wrinkle, cheek puff.  Hearing grossly normal to finger rub bilaterally.  Palate elevates symmetrically. Tongue midline with protrusion. No dysarthria.  Shoulder shrugs normal bilaterally.    MOTOR: Normal bulk and tone, without bradykinesia, fasciculations, myoclonus or tremor. No pronator drift. Strength 5/5 throughout bilateral upper and lower extremities.    SENSATION:   Diffusely intact to light touch.    REFLEXES:   Deep tendon reflexes normal and symmetric bilaterally at the triceps, biceps, brachioradialis, quadriceps and gastrocnemius/soleus.R toe up, L toe down    CEREBELLAR:   *****-to-nose, heel-to-shin, and rapid alternating movements normal. Mirroring normal without past pointing. No truncal ataxia.    GAIT/*****:   Normal stance and stride. ***** and heel-walking intact. Tandem gait intact. ***** test negative.     
          Orientation Level: Oriented to person, ***** to place (name of this place), Oriented to city, Oriented to state, Oriented to time (year), Oriented to season(w/ choices/cueing)   Cognition: Follows commands         Speech: Expressive Aphasia, Clear     Special Needs    Special Needs: None              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 8.10 *****/*****/***** *****    RBC 4.70 *****/*****/***** *****    HGB 15.0 *****/*****/***** *****    HCT 45.2 *****/*****/***** *****    MCH 31.9 *****/*****/***** *****    MCV 96.2 *****/*****/***** *****    PLT 116 (L) *****/*****/***** *****    RDW 12.0 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 141 *****/*****/***** *****    ***** 3.7 *****/*****/***** *****    ***** 107 *****/*****/***** *****    CO2 20 (L) *****/*****/***** *****    BUN 8 *****/*****/***** *****    CRE 0.91 *****/*****/***** *****    ***** 8.3 (L) *****/*****/***** *****    GLU 95 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.2 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.5 *****/*****/***** *****    PTT 31.9 *****/*****/***** *****    INR 1.1 *****/*****/***** *****                        "
112623695,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** ***** *****., ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Surrogate Decision ***** Name: ***** ***** (spouse)      Surrogate Decision *****'s Phone Number: (*****)*****-*****  (*****)*****-*****     Care Plan *****: *****       ***** Status at *****: Full Code (Presumed)       Discharge address same as *****: No                   Hospitalization Summary     Admission Diagnosis     Subdural hematoma             Principal Problem:    SDH (subdural hematoma)  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     Past Procedures (*****/*****/***** to Today)       Date Procedures Providers     *****/*****/***** ***** ***** Bilateral *****, ***** *****                ***** (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    N/A        Pending Results     None           Hospital Course   ***** PMH Alzheimer's dementia, who presents after ***** 2-3 weeks ago, now with waxing and waning mental status, head CT demonstrating largely chronic 1cm bilateral SDH with scattered hyperdense components. He was diagnosed with Alzheimer's at age ***** with positive genetics testing. His dementia has progressed gradually over time. About three weeks ago, after falling with head strike, his wife states that he has worsened in his ability to communicate and ambulate independently, now requiring full assist. He often has nonsensical speech. Today at his assisted care living facility, she visited him and he was found to be unresponsive for a couple minutes. This prompted evaluation at 
OSH where head CT was performed, demonstrating aforementioned findings.    Neurologic: Mr. ***** ***** was admitted to the Neurosurgical service on *****/*****/*****. He was started on keppra for seizure prophylaxis. He was then taken to the OR on *****/*****/***** for bilateral burr ***** for subdural hematoma evacuation by Dr. *****.  Postoperatively, the patient was extubated and transferred to the neurosciences floor for neurological surveillance. He underwent routine post-operative head CT that indicated expected post-op changes. Neurology was consulted and recommended he stay on Keppra 1gm BID, and will follow up with Neurology, which they will arrange and contact the patient/patients family.     Cardiovascular: Patient remained hemodynamically stable during the hospital course.     Pulmonary: He arrived to ***** with oxygen saturation > 95% on room air. He was intubated for the operating room and extubated post operatively without difficulty. Oxygen saturation remained >95% on RA throughout the hospital course.     FEN/Renal/GI: His diet was advanced as tolerated post-op without evidence of nausea or vomiting. He was able to void spontaneously throughout his hospital stay.    By the day of discharge on *****/*****/*****, he continued to progress, voiding good amounts of urine and tolerating a regular diet with no complaints of nausea or vomiting. His cranial wound was clean and dry without signs of infection. He was seen and evaluated by PT/OT therapies, who recommended discharge to inpatient rehab and the screening process was started.     At the time of discharge, his neurological exam was: Wide awake, alert, oriented to name. PERRL. Following commands x 4 today.             Medications   Allergies: Review of patient's allergies indicates no known allergies.    Prior to Admission Medications   Prescriptions   HYDROcodone-acetaminophen (VICODIN) 5-500 mg per tablet   Sig: Take 1-2 tablets by mouth as directed.  Q4-6H PRN pain. 
Do not drive or operate machinery while on this medication. max daily: 8 tabs   Note (*****/*****/*****): ***** Med Transfer Process    LORazepam (ATIVAN) 0.5 MG tablet   Sig: Take 1 tablet (0.5 mg total) by mouth every 6 (six) hours as needed for anxiety.   donepezil (ARICEPT) 10 MG tablet   Sig: Take 1 tablet by mouth daily.   Note (*****/*****/*****): ***** Med Transfer Process    memantine (NAMENDA) 10 MG tablet   Sig: Dose: 10 MG; Form:  Take  1 TABLET; Route: PO; Frequency: BID; Directions: Not available; Details: Dispense: 180 Tablet(s); Date: *****/*****/*****   Note (*****/*****/*****): Needs MD Verification. ***** Med Transfer Process.    memantine 21 mg *****   Sig: Dose: 21 MG; Form:  Take  1 CAP SPR 24; Route: PO; Frequency: QD; Directions: Not available; Details: Dispense: 90 Capsule(s); Date: *****/*****/*****   Note (*****/*****/*****): Needs MD Verification. ***** Med Transfer Process.    oxyCODONE-acetaminophen (PERCOCET) 5-325 mg per tablet   Sig: Take 1-2 tablets by mouth as directed.  Q4-6H PRN pain   Note (*****/*****/*****): ***** Med Transfer Process       Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          HYDROcodone-acetaminophen 5-500 mg per tablet   Also known as:  VICODIN       oxyCODONE-acetaminophen 5-325 mg per tablet   Also known as:  PERCOCET         START taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 2 tablets (650 mg total) by mouth every 6 (six) hours.   Last time this was given:  *****/*****/***** 12:12 PM       bisacodyl 10 mg suppository   Also known as:  DULCOLAX    Place 1 suppository (10 mg total) rectally daily as needed.   Last time this was given:  *****/*****/***** 10:29 PM       docusate sodium 100 MG capsule   Also known as:  COLACE    Take 1 capsule (100 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:48 AM       enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe   Also 
known as:  LOVENOX    Inject 0.4 mL (40 mg total) under the skin daily.   Last time this was given:  *****/*****/*****  6:12 PM       levETIRAcetam 1000 MG tablet   Also known as:  KEPPRA    Take 1 tablet (1,000 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:48 AM       lisinopril 20 MG tablet   Also known as:  PRINIVIL,ZESTRIL    Take 1 tablet (20 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:48 AM       omeprazole 20 MG capsule   Also known as:  PriLOSEC    Take 1 capsule (20 mg total) by mouth daily before breakfast.   Last time this was given:  *****/*****/*****  8:49 AM       polyethylene glycol 17 gram packet   Also known as:  GLYCOLAX    Take 17 g by mouth daily as needed (severe constipation).       senna 8.6 mg tablet   Also known as:  SENOKOT    Take 2 tablets by mouth nightly.   Last time this was given:  *****/*****/*****  9:01 PM       sertraline 25 MG tablet   Also known as:  ZOLOFT    Take 1 tablet (25 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:49 AM         CHANGE how these medications are taken       Dose, Frequency, and Details    memantine 10 MG tablet   Also known as:  NAMENDA    Dose: 10 MG; Form:  Take  1 TABLET; Route: PO; Frequency: BID; Directions: Not available; Details: Dispense: 180 Tablet(s); Date: *****/*****/*****   What changed:  Another medication with the same name ***** *****. Continue taking this medication, and follow the directions you see here.   Last time this was given:  *****/*****/*****  8:48 AM         CONTINUE taking these medications       Dose, Frequency, and Details    donepezil 10 MG tablet   Also known as:  ARICEPT    Take 1 tablet by mouth daily.   Last time this was given:  *****/*****/*****  9:01 PM       LORazepam 0.5 MG tablet   Also known as:  ATIVAN    Take 1 tablet (0.5 mg total) by mouth every 6 (six) hours as needed for anxiety.                 Immunizations Administered for This Admission     Name *****    Influenza 
Quadrivalent PF IM  Deferred (Patient Refused)    Pneumococcal polysaccharide PPSV23  Deferred (Patient Refused)             Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: ***** *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Appointments Scheduled for Next 90 Days     ***** *****, ***** 10:30 AM *****   (Arrive by 10:15 AM)   Suture with ***** ***** *****, *****   ***** Neurosurgery (--)    ***** ***** *****  ***** ***** *****  ***** ***** *****   *****-*****-*****            ***** *****, *****  2:***** ***** *****   ***** ***** ***** ***** *****   ***** *****, ***** ***** (***** ***** ***** (*****))    ***** ***** *****  ***** ***** *****   *****-*****-*****           *****If you are having a CT Abdomen/Pelvis in addition to this CT exam please arrive 1 hour before your scheduled time to drink oral contrast. Some exams may require additional oral contrast at the time of the exam.*****  Please refer to the CT Abdomen/Pelvis instruction sheet for additional information.  Please check in ***** ***** 20 minutes prior to your scheduled exam time. You should not eat solid foods for two hours prior to your test. Please drink plenty of fluids such as water, clear soups, juice, or black ***** coffee or tea.  Medications: If you need to take your medication in the morning prior to the scan, take it with water. If you take any oral diabetic medications you may not be able to take these medications for 48 hours after receiving intravenous contrast, (x-ray dye) from your CT scan examination. Please consult your prescribing physician to answer any questions about substitute medications that may be necessary. You will receive specific instructions at the time of the exam.  What to wear: Wear loose-fitting, comfortable clothes with no metal (zippers, under wire *****, etc) for the test. Leave your watch, jewelry, and other valuables 
at home.  Other Information: If ***** ever had an allergic reaction to contrast tell your doctor and the technologist. The doctor may prescribe special medicine for you to take before the exam and also while you are here for the exam. You should bring the last dose of medicine with you prior to the scan.  Children who are not patients are not allowed to enter the scan room. Please make alternative arrangements for them or have another adult accompany you to watch your child in the ***** ***** ***** you are having your scan.            ***** *****, ***** 10:45 AM *****   (Arrive by 10:30 AM)   Follow Up with ***** ***** *****, MD   ***** Neurosurgery ***** ***** (--)    ***** ***** *****  ***** *****  ***** ***** *****   *****-*****-*****                 Follow-Up Services            ***** VALLEY HEALTH CENTER   Specialty:  Skilled Nursing Facility    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1526  Activity as tolerated         *****/*****/***** 1526  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1526  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.           Additional Patient Instructions     WOUND CARE:  -You or a family member should inspect your wound every day and report any of the following problems to your physician (increased redness, drainage, foul odor, or other changes concerning to you).   -Keep your incision clean and dry.  -You may wash your hair with a mild shampoo 4 days after surgery.  -Do NOT apply any lotions, ointments or other products to your incision.     -Do not lift objects over 
10 pounds until approved by your physician.    DIET  -Usually no special diet is prescribed after a craniotomy. A normal well balanced diet is recommended for recovery, and you should resume any specially prescribed diet you were eating before your surgery.  Be sure however, to remain well hydrated, and increase your consumption of fiber, as pain medications may cause constipation.     MEDICATIONS:  -Take all of your medications as ordered.  You do not have to take pain medication unless it is needed.  It is important that you are able to cough, breathe deeply, and is comfortable enough to walk.     -Do not use alcohol while taking pain medication.    -Take an over the counter stool softener for constipation (Colace or Docusate). If you become constipated, try products such as Dulcolax, Milk of Magnesia, first, and then Magnesium Citrate or ***** enema if needed). Often times, pain medication and anesthesia can cause constipation.  -You have been prescribed an anti-seizure medication. Continue to take this until you are told to discontinue by your physician.   -If you were on a medication such as Coumadin (Warfarin), or Plavix (clopidogrel), or Aspirin, prior to your surgery, you may safely resume taking this on *****.  - Please do not start taking any NSAIDs (Ibuprofen, Aleve, Advil, etc.) prior to discussion with your surgeon.   -If you are being sent home on steroid medication, make sure you are taking a medication to protect your stomach (Prilosec, Protonix, or Pepcid), as these medications can cause stomach irritation.  Make sure to take your steroid medication with meals, or a glass of milk.     ACTIVITY:  The first few weeks after you are discharged you may feel tired or fatigued. This is normal. You should become a little stronger every day. Activity is the most important measure you can take to prevent complications and to begin to feel like yourself again. In general:  -Follow the activity 
instructions given to you by your doctor and therapist.  -Increase your activity slowly.  -You may resume sexual activity as your tolerance allows.  -If you feel light headed or fatigued after increasing activity, rest, decrease the amount of activity that you do, and begin building your tolerance to activity more slowly.  -Do not lift objects over 10 pounds until approved by your physician.  -Avoid any activity that causes you to hold your breath and push, for example weight lifting, lifting or moving heavy objects, or straining at stool.  -Do your breathing exercises every two hours.    -Use your incentive spirometer 10 times every hour that you are awake.      WHEN TO CALL YOUR SURGEON:  With any surgery there are risks of complications. Although your surgery is over, there is the possibility of some of these complications developing. These complications include: infection, blood clots, or neurological changes. Call your Physician Immediately if you Experience:  -Confusion, fainting, blacking out, extreme fatigue, memory loss, or difficulty speaking.  -*****, or blurred vision. Loss of vision, either partial or total.  -Hallucinations  -Numbness, tingling, or weakness in your extremities or face.  -***** neck, and/or a fever of 101.***** or more.  -Severe sensitivity to light. (Photophobia)  -Severe headache or change in headache.  -Seizure  -Problems controlling your bowels or bladder.  -Productive cough with yellow or green sputum.  -Swelling, redness, or tenderness in your calf or thigh.  Important Instructions Regarding Emergencies and After-Hour Calls If you have what you feel is a true emergency at any time, please present immediately to your local emergency room, where a doctor there will evaluate you and contact us if needed. Due to the complexity of neurosurgical procedures and treatment of neurosurgical problems, effective advice regarding emergency situations cannot be given over the telephone.         
            Exam   Temperature: 36.4 C (97.6 F) (*****/*****/***** 1512) | Heart Rate: 77 (*****/*****/***** 1512) | BP: 97/62 (*****/*****/***** 1512) | Respiratory Rate: 18 (*****/*****/***** 1512)  | SpO2: 97 % (*****/*****/***** 1512)  O2 Device: None (Room air) (*****/*****/***** 1512)  O2 Flow Rate (L/min): 6 |        Weight: 90.6 kg (199 lb 11.8 oz) (*****/*****/***** 2321)  Height: 178 cm (5' 10.08"") (*****/*****/***** 2321)         BMI (Calculated): 28.6 (*****/*****/***** 2321)    Discharge Exam    Significant Discharge Exam Findings:  Exam at the time of discharge: Wide awake, alert, oriented to name. PERRL. Following commands x 4 today.               Orientation Level: Confused   Cognition: Unable to follow commands         Speech: Expressive Aphasia     Vision: Functional with Correction  Hearing: Functional   Assistive Devices: None         Data/Results    Results are shown for the following tests if performed (CBC, Na, K, BUN, Cr).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 9.58 *****/*****/***** *****    HCT 37.6 (L) *****/*****/***** *****    HGB 12.6 (L) *****/*****/***** *****    PLT 271 *****/*****/***** *****      Lab Results   Component Value Date/Time    BUN 20 *****/*****/***** *****    CRE 0.90 *****/*****/***** *****    ***** 3.9 *****/*****/***** *****    ***** ***** *****/*****/***** *****                            "
116510723,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     *****, ***** ***** Healthcare ***** (Proxy form on file) - ***** Not Active   Primary Phone:  *****-*****-***** (Mobile)               Code Status at *****: DNR/DNI (No CPR/No Intubation)       Patient/Family/Caregiver discharge preference/goals : Home                            Hospitalization Summary        Principal Problem:    Subdural hematoma  Active Problems:    Prostate cancer    Hypothyroidism    Gout    Atrial fibrillation    Subarachnoid hemorrhage  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:          Pending Results     Procedure Component Value Ref Range Date/Time    COVID-19 RT-PCR [*****] Collected:  *****/*****/***** 2202    Lab Status:  In process Updated:  *****/*****/***** 2224    Babesia species PCR [*****] Collected:  *****/*****/***** 1844    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 1900    Ehrlichia/anaplasma PCR [*****] Collected:  *****/*****/***** 1844    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 1900    Tularemia antibody [*****] Collected:  *****/*****/***** 1844    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 1900             Hospital Course   Mr. ***** ***** is a pleasant *****-year-old gentleman with a history of atrial 
fibrillation on anticoagulation, right central retinal artery occlusion, gout, hypertension, glaucoma, prostate ***** s/p XRT, resection, who comes into the hospital after reports of falling this morning.  He recalls feeling woozy prior to the *****.  He had also fallen 3 days ago while bending over in ***** ***** and mentions it being a hot day where he had little oral intake.  He had not been using his walker when he fell but denied any loss of consciousness.  Patient has not experienced any fever, nausea, labored breathing or chest pain.  This past ***** he sustained a ***** and was hospitalized for 3 weeks at mount ***** Hospital.  He was diagnosed with Meningo-encephalitis and a right thigh hematoma and later got ***** at ***** and thereafter had a skilled nursing facility.     By time he arrived to the ED, a CT scan of his head revealed a small right paraclinoid intracerebral hemorrhage without mass-effect or midline shift and a CT angiogram of his head and neck did not reveal any aneurysm or signs of active vascular hemorrhage.  A Lyme screen came back negative and also he is on blood thinners, patient had not used his p.m. dose of Eliquis.  He has no new focal neurological deficits at the moment is now being admitted for further observation.     Subdural hematoma: Head CT shows a right paraclinoid intracranial hemorrhage without mass-effect or midline shift. Discussed case with Dr. ***** from general surgery who recommended admission to the medical service with close monitoring.  Repeat ***** ***** this morning showed no interval worsening but did show redistribution of previously described bleed.  Case discussed with on-call neurosurgery resident at ***** who recommended close continued observation versus consideration of transfer for detailed neurologic examinations and monitoring.  They recommended continuing to hold anticoagulation with repeat ***** ***** in 6 hours.  Discussed with patient's daughter and 
primary care provider and both agree that transfer to ***** for close monitoring and potential neurosurgical evaluation are in the patient's best interest.  -Transfer to ***** for neurosurgical evaluation.  -Accepting physician via ***** consult is Dr. *****.  -Continue to hold Eliquis for atrial fibrillation.  Reversal agent not given due to stability of bleed and his overall clinical stability, but may explore this further at *****.         Medications   Allergies: Prazosin    Prior to Admission Medications   Prescriptions   DEXTRAN 70/HYPROMELLOSE (ARTIFICIAL TEARS *****)   Sig: Dose: 2 DROP; Form: Not available; Route: OU; Frequency: QID PRN Dry eyes  ; Directions: Not available; Details: Dispense: 1 Month(s) Supply; Date: *****/*****/*****   ELIQUIS 5 mg tablet   Sig: TAKE 1 TABLET TWICE A DAY   VIT C/VIT E AC/LUT/*****/ZINC (***** LUTEIN ORAL)   Sig: Dose: 1 TAB; Form: Not available; Route: PO; Frequency: QD; Directions: Not available; Details: Dispense: 0; Date: *****/*****/*****  Patient reports he takes 2 times a day.   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 6 (six) hours.   Patient not taking: Reported on *****/*****/*****   albuterol 90 mcg/actuation inhaler   Sig: Inhale 2 puffs into the lungs every 6 (six) hours as needed for wheezing.   allopurinol (ZYLOPRIM) 100 MG tablet   Sig: Take 1 tablet (100 mg total) by mouth daily.   aspirin 81 mg chewable tablet   Sig: Take 81 mg by mouth daily.   colchicine (COLCRYS) 0.6 mg tablet   Sig: Take 1 tablet (0.6 mg total) by mouth daily as needed. 1 tablet twice a day for 2 days; then 1 tablet per day   dorzolamide (TRUSOPT) 2 % ophthalmic solution   Sig: Place 1 drop into the left eye 2 (two) times a day.   Patient not taking: Reported on *****/*****/*****   folic acid (FOLVITE) 1 MG tablet   Sig: Take 1 tablet by mouth daily.   hydroCHLOROthiazide (HYDRODIURIL) 25 MG tablet   Sig: Take 1 tablet (25 mg total) by mouth daily.   latanoprost 
(XALATAN) 0.005 % ophthalmic solution   Sig: Place 1 drop into the left eye nightly at bedtime.   levothyroxine (SYNTHROID) 100 MCG tablet   Sig: Take 1 tablet (100 mcg total) by mouth daily.   tamsulosin (FLOMAX) 0.4 mg Cap   Sig: TAKE 2 CAPSULES (0.8MG     TOTAL) DAILY, ADMINISTER   30 MINUTES AFTER THE SAME  ***** EACH DAY   Patient taking differently: Take 0.4 mg by mouth daily.    timolol (TIMOPTIC) 0.25 % ophthalmic solution   Sig: Place 1 drop into the left eye daily.      Facility-Administered Medications: None        Medication List      STOP taking these medications     aspirin 81 mg chewable tablet      Eliquis 5 mg tablet  Generic drug:  apixaban        TAKE these medications        Instructions    ***** acetaminophen 325 mg tablet  Commonly known as:  TYLENOL  For:  pain   Take 2 tablets (650 mg total) by mouth every 6 (six) hours.  What changed:  Another medication with the same name ***** *****. Make sure you understand how and when to take each.      ***** acetaminophen 325 mg tablet  Commonly known as:  TYLENOL   Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.  What changed:  You were already taking a medication with the same name, and this prescription was added. Make sure you understand how and when to take each.      ***** acetaminophen 650 mg/20.3 mL Soln  Commonly known as:  TYLENOL   Take 20.3 mL (650 mg total) by mouth every 6 (six) hours as needed.  What changed:  You were already taking a medication with the same name, and this prescription was added. Make sure you understand how and when to take each.      ***** acetaminophen 650 MG suppository  Commonly known as:  TYLENOL   Place 1 suppository (650 mg total) rectally every 6 (six) hours as needed.  What changed:  You were already taking a medication with the same name, and this prescription was added. Make sure you understand how and when to take each.      albuterol 90 mcg/actuation inhaler  For:  bronchospasm 
prevention   Inhale 2 puffs into the lungs every 6 (six) hours as needed for wheezing.      allopurinol 100 MG tablet  Commonly known as:  ZYLOPRIM  Last time this was given:  ***** *****, *****  9:01 AM   Take 1 tablet (100 mg total) by mouth daily.      ARTIFICIAL TEARS *****   Dose: 2 DROP; Form: Not available; Route: OU; Frequency: QID PRN Dry eyes  ; Directions: Not available; Details: Dispense: 1 Month(s) Supply; Date: *****/*****/*****      colchicine 0.6 mg tablet  Commonly known as:  COLCRYS   Take 1 tablet (0.6 mg total) by mouth daily as needed. 1 tablet twice a day for 2 days; then 1 tablet per day      dorzolamide 2 % ophthalmic solution  Commonly known as:  TRUSOPT   Place 1 drop into the left eye 2 (two) times a day.      folic acid 1 MG tablet  Commonly known as:  FOLVITE  Last time this was given:  ***** *****, *****  9:01 AM   Take 1 tablet by mouth daily.      hydroCHLOROthiazide 25 MG tablet  Commonly known as:  HYDRODIURIL  Last time this was given:  ***** *****, *****  9:01 AM   Take 1 tablet (25 mg total) by mouth daily.  *****'s comments:  Please refill early; patient traveling.  Please expedited shipment; patient willing to pay for fastest shipment      latanoprost 0.005 % ophthalmic solution  Commonly known as:  XALATAN  Last time this was given:  ***** *****, ***** 12:09 AM   Place 1 drop into the left eye nightly at bedtime.      levothyroxine 100 MCG tablet  Commonly known as:  Synthroid  Last time this was given:  ***** *****, *****  5:36 AM   Take 1 tablet (100 mcg total) by mouth daily.      ondansetron (PF) 4 mg/2 mL injection  Commonly known as:  ZOFRAN   Inject 1 mL (2 mg total) into the vein every 4 (four) hours as needed.      ondansetron 4 MG disintegrating tablet  Commonly known as:  ZOFRAN-ODT   Take 1 tablet (4 mg total) by mouth every 6 (six) hours as needed.      pneumococcal 23-valent 25 mcg/0.5 mL injection  Commonly known as:  PNEUMOVAX 23   Inject 0.5 mL into the muscle once for 1 dose.      
***** LUTEIN ORAL   Dose: 1 TAB; Form: Not available; Route: PO; Frequency: QD; Directions: Not available; Details: Dispense: 0; Date: *****/*****/*****  Patient reports he takes 2 times a day.      sodium chloride 0.9 % syringe flush  Commonly known as:  NS   Inject 3 mL into the vein as needed.      tamsulosin 0.4 mg Cap  Commonly known as:  FLOMAX   TAKE 2 CAPSULES (0.8MG     TOTAL) DAILY, ADMINISTER   30 MINUTES AFTER THE SAME  ***** EACH DAY  What changed:  See the new instructions.      timolol 0.25 % ophthalmic solution  Commonly known as:  TIMOPTIC  Last time this was given:  ***** *****, *****  9:01 AM   Place 1 drop into the left eye daily.         ***** This list has 4 medication(s) that are the same as other medications prescribed for you. Read the directions carefully, and ask your doctor or other care provider to review them with you.               Where to Get Your Medications      These medications were sent to ***** ***** ***** Pharmacy - *****, ***** - ***** ***** ***** ***** ***** ***** ***** Registered ***** Sites  ***** ***** ***** *****, ***** ***** *****    Phone:  *****-*****-*****   쨌 pneumococcal 23-valent 25 mcg/0.5 mL injection     Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 acetaminophen 325 mg tablet  쨌 acetaminophen 650 MG suppository  쨌 acetaminophen 650 mg/20.3 mL Soln  쨌 ondansetron (PF) 4 mg/2 mL injection  쨌 ondansetron 4 MG disintegrating tablet  쨌 sodium chloride 0.9 % syringe flush             Immunizations Administered for This Admission     Name *****    Pneumococcal polysaccharide PPSV23    Deferred  (Patient Refused)              Hospital Care Team   Service: Medicine  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments 
(maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 9:30 AM MGC ***** ***** ***** ROOM Ophthalmic Consultants of ***** *****-*****-***** ***** *****    *****/*****/***** 10:00 AM MGC ***** BOS ***** Ophthalmic Consultants of ***** *****-*****-***** ***** *****    *****/*****/***** 10:30 AM ***** ***** *****, MD Ophthalmic Consultants of ***** *****-*****-***** ***** *****    *****/*****/***** 10:45 AM ***** ***** *****, MD, PhD Ophthalmic Consultants of ***** *****-*****-***** ***** *****    *****/*****/***** 10:15 AM ***** ***** *****, MD Ophthalmic Consultants of ***** *****-*****-***** ***** *****        Your Follow-Up Appointments            ***** ***** *****, MD   Specialty:  Internal Medicine   Relationship:  PCP - General  Partners Attributed Provider  Insurance Assigned Provider    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****       Follow up        Signed Discharge Orders (From admission, onward)    None                  Exam   Temperature: 36.8 째C (98.2 째F) (*****/*****/***** 0844) | Heart Rate: 66 (*****/*****/***** 0900) | BP: 156/62 (*****/*****/***** 0844) | Respiratory Rate: 18 (*****/*****/***** 0844)  | SpO2: 97 % (*****/*****/***** 0844)  O2 Device: None (Room air) (*****/*****/***** 0844)    |        Weight: 82.1 kg (181 lb 1.6 oz) (*****/*****/***** 2343)  Height: 175.3 cm (5' 9"") (*****/*****/***** 2343)         BMI (Calculated): 26.73 (*****/*****/***** 2343)    Discharge Exam    Significant Discharge Exam Findings:  Well-appearing man in no acute distress  Extraocular movements are intact  Heart irregularly irregular rhythm with normal rate, soft 2 out of 6 systolic murmur heard loudest at the left sternal border, intact peripheral pulses  Normal work of breathing, lungs clear to auscultation bilaterally  No facial asymmetry, cranial nerves grossly intact, intact strength in the upper extremities without any sensory deficits.             Orientation Level: Oriented X3   Cognition: Age appropriate         Speech: Appropriate for age     Special Needs    Special Needs:  None              Data/Results  
  Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 5.65 *****/*****/***** *****    RBC 2.97 (L) *****/*****/***** *****    HGB 11.4 (L) *****/*****/***** *****    HCT 31.9 (L) *****/*****/***** *****    MCH 38.4 (H) *****/*****/***** *****    MCV 107.4 (H) *****/*****/***** *****    PLT 160 *****/*****/***** *****    RDW 14.5 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 135 *****/*****/***** *****    ***** 3.5 *****/*****/***** *****    ***** 98 (L) *****/*****/***** *****    CO2 28 *****/*****/***** *****    BUN 18 *****/*****/***** *****    CRE 1.04 *****/*****/***** *****    ***** 8.7 (L) *****/*****/***** *****    GLU 104 *****/*****/***** *****          Lab Results   Component Value Date/Time    PT 14.8 (H) *****/*****/***** *****    INR 1.2 (H) *****/*****/***** *****              CT Head   Final Result      1.  No new or enlarging intracranial hemorrhage. Compared to *****/*****/*****, there has been mild interval redistribution of a small volume of extra-axial hemorrhage layering within the right side of the suprasellar cistern extending into the right middle cranial fossa, likely representing a combination of subarachnoid and subdural blood. A trace volume of intraventricular hemorrhage layering within the occipital horns is slightly more conspicuous when compared to prior and likely reflects redistribution of subarachnoid blood products.      2.  No significant mass effect on the brain parenchyma without evidence of obstructive hydrocephalus, midline shift, or uncal herniation.                  CT Angio Head   Final Result      1.  Limited evaluation of right paraclinoid intracranial hemorrhage, however grossly stable in size without evidence for active hemorrhage.      2.  No cerebral aneurysm or other acute cervicocerebral vascular abnormality.      3.  Moderate right and mild left proximal ***** stenosis.      4.  Multiple thyroid nodules, the largest measuring 2.2 cm.    
  Recommendation: Dedicated thyroid ultrasound for further characterization of thyroid nodules (last available study from *****/*****/*****)                     CT Angio Neck   Final Result      1.  Limited evaluation of right paraclinoid intracranial hemorrhage, however grossly stable in size without evidence for active hemorrhage.      2.  No cerebral aneurysm or other acute cervicocerebral vascular abnormality.      3.  Moderate right and mild left proximal ***** stenosis.      4.  Multiple thyroid nodules, the largest measuring 2.2 cm.      Recommendation: Dedicated thyroid ultrasound for further characterization of thyroid nodules (last available study from *****/*****/*****)                     CT Head   Final Result      1.  Right paraclinoid intracranial hemorrhage; favor subdural location, although subarachnoid hemorrhage is a possibility. No significant mass effect, midline shift, or herniation.      2.  No displaced skull fracture.      Recommendation: If clinical suspicion for a nontraumatic etiology is high, consider vascular imaging (head CTA or MRA)      Emergent findings discussed between Dr. ***** of the ED and Dr. ***** of Neuroradiology via phone at 7:50 PM on *****/*****/*****.            CT Head    (Results Pending)               "
150055914,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: Sleep Lab Studies

Signed by ***** *****, MD on *****/*****/***** at 12:32 pm  Affiliation: ***** practice

 

--------------- --------------- --------------- ---------------

Active Medication list as of *****/*****/*****:

 

Medications - Prescription

ALENDRONATE - alendronate 70 mg tablet. 1 tablet(s) by mouth

every week in the morning Take with water 30mins before anything

by mouth.  Don't lie down for at least 30 min after

FOLIC ACID - folic acid 1 mg tablet. 1 tablet(s) by mouth once a

day

FUROSEMIDE - furosemide 20 mg tablet. 1 tablet(s) by mouth Daily

INFLIXIMAB [REMICADE] - Remicade 100 mg intravenous solution. 400

mg (4mg/kg) IV every 8 weeks Include all supplies to infuse this

product. See attached Order

LEVETIRACETAM - levetiracetam 100 mg/mL oral solution. 7.5 mL by

mouth twice daily

LISINOPRIL - lisinopril 2.5 mg tablet. 1 tablet(s) by mouth Daily

METHOTREXATE SODIUM - methotrexate sodium 2.5 mg tablet. 10

Tablet(s) by mouth once a week

METOPROLOL SUCCINATE - metoprolol succinate ER 50 mg

tablet,extended release 24 hr. 1 tablet(s) by mouth Daily This

medication can not be crushed

METRONIDAZOLE - metronidazole 500 mg tablet. 1 tablet(s) by mouth

three times per day -  (Prescribed by Other Provider: Rehab) (Not

Taking as Prescribed)

RIVAROXABAN [XARELTO] - Xarelto 20 mg tablet. 20mg tablet(s) by

mouth qd with food

ROSUVASTATIN - rosuvastatin 40 mg tablet. 1 tablet(s) by mouth

every night

 

Medications - OTC

ACETAMINOPHEN [TYLENOL] - Dosage uncertain -  (Prescribed by

Other Provider)

ASPIRIN - aspirin 81 mg tablet. 1 Tablet(s) by mouth once a day -

(Prescribed by Other Provider) (On Hold from *****/*****/***** to

unknown for SDH)

B.BREVE-L.ACID-L.*****-S.THERMO [PROBIOTIC] - Probiotic 3 billion

cell chewable tablet. 1 tablet(s) by mouth three times per day

with meals

CALCIUM-VITAMIN D3-VITAMIN K [*****] - Dosage uncertain - 

(Prescribed by Other Provider)

CYANOCOBALAMIN (VITAMIN B-12) - cyanocobalamin (vit B-12) 500 mcg

tablet. 1 tablet(s) by mouth daily -  (OTC)

--------------- --------------- --------------- ---------------

***** *****, *****







***** ***** ***** MD

*****

***** ***** *****, ***** ***** *****

*****, *****  *****-*****



RE:  ***** ***** (*****-*****-*****)  DOB:  *****/*****/*****



Dear Dr. *****,



I saw *****. ***** for her pacemaker check.



As you know, she has:

1.  Syncope due to sick sinus syndrome .

2.  Subdural hematoma secondary to syncope.

3.  Status post DDD pacemaker (***** *****).

4.  Coronary artery disease status post IMI, (*****/*****)

5.  Paroxysmal atrial fibrillation.



As you know, Mrs. ***** was admitted to ***** ***** in *****

2018 following syncope and ***** during which she hit her head and

sustained a subdural hematoma.  At that time, there was a

question of whether she had an acute inferior myocardial infarct

as well and underwent cardiac catheterization during which she

did have coronary artery disease and significant stenosis of the

right coronary artery.  However, the vessel was not stented

because of ***** her in the presence of her subdural

hematoma.  She had a pacemaker implanted before discharge and

again because of her subdural hematoma.  Her atrial fibrillation

onset dates back to 2009.



Since her discharge, she has had weakness from her right leg 

resulting in difficulty in walking.



I note that her most recent ***** scan shows that her subdural

hematoma has resolved and she is due to see Dr. ***** from

Neurosurgery in followup to be cleared.



She denied any chest pain, undue shortness of breath, recurrent

syncope, palpitations, swelling of her ankles or nocturnal

dyspnea.



Review of other systems negative.



Her present medications are alendronate 70 mg weekly, furosemide

20 mg daily, Remicade for rheumatoid arthritis, levetiracetam 100

mg/mL 7.5 mL daily, lisinopril 2.5 mg daily, methotrexate 25 mg

weekly, metoprolol ER 50 mg daily, rosuvastatin 40 mg daily,

aspirin 81 mg daily.



Examination today revealed her to be generally well, comfortable,

alert, oriented, not short of breath at rest.



Her venous pressure was not elevated.  Carotids were normal. 

Thyroid was not palpable.  Rest of the head and neck exam was

unremarkable.



Her cardiac exam revealed a slightly irregular rhythm.  Venous

pressure, normal heart sounds, no significant murmurs.  No S3 and

no edema.



Her lungs were clear.



Abdomen was soft and benign.



Neurological examination was grossly normal.



Pacemaker was checked today.  She has a ***** Scientific, model

Accolade, MRI-compatible pacemaker implanted on ***** *****, *****. 

She has had significant episodes of atrial fibrillation since as

per her pacemaker.  The pacemaker is programmed to DDD and has at

least 11.5 years of remaining battery longevity.  Today, she was

in atrial flutter with P waves of 4.5 ***** and normal

atrial lead impedance.  The right ventricular lead revealed R

waves of 11 *****, pacing threshold 1.4 volts at 0.4

millisecond pulse width, impedance 852 ohms and her atrial

fibrillation burden is 87%.



Given the high burden of atrial fibrillation and the fact that

her subdural hematoma has resolved and she has had no further

episodes of syncope, I will start her on Xarelto 20 mg daily.



At some point in the future, we may need to revaluate her cardiac

catheterization to see if she needs an intervention, which was

initially postponed because of the danger of using

anticoagulants.



I plan to see her in four months for a pacemaker check.



With kind regards,



Sincerely yours,





***** *****. ***** MD



eScription document:*****-*****



Cc: ***** ***** MD

Division of Neurosurgery

110 ***** *****, ***** ***** *****

*****, ***** *****-*****



"
150867180,0,1,"

Note Date: *****/*****/*****  Time: 2037

Note Type: Initial note

Note Title: Neurosurgery Consult Note 

Electronically signed by ***** ***** *****, NP on *****/*****/***** at 1:05 am  Affiliation: *****

Electronically ***** by ***** *****, MD on *****/*****/***** at 9:41 am

 

Neurosurgery Consult Note 

*****/*****/*****



*****:chronic subdural hygroma vs hygroma 



*****:***** ***** old male hx of PE on eliquis presents with syncopal

falls. Patient denies *****, headache, nausea vomiting,

parasthesias. Head CT revealed right hygroma vs chronic subdural

hygroma. Of note patient found to be hypotensive, with pneumonia

and being admitted to ***** for further management. Neurosurgery

consulted for further evaluation. 



PMHx:

COPD

HIV (dx *****/*****; CD4 nadir 4 in *****/*****)

Peripheral Neuropathy

Genital HSV

Chronic HBV, cleared

Anxiety

BPH

HTN

PE in *****/*****

S/P Laminectomy 



Allergies:

***** (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir

Alafenamide Fumarate) 

***** (Abacavir Sulfate/Lamivudine/Zidovudine) 

Ziagen 



Medications prior to admission:

Apixaban 5mg BID 

Dolutegravir 50 mg PO DAILY 

Albuterol Inhaler 2 ***** ***** Q4H:PRN dyspnea  

Chantix (varenicline) 1 mg oral QAM  

Chantix (varenicline) 0.5 mg oral QPM  

Diazepam 10 mg PO DAILY  

Doxazosin 2 mg PO HS  

Emtricitabine-Tenofovir ***** (200mg-25mg) ***** 1 TAB 

PO DAILY  

Fluticasone Propionate 110mcg 2 ***** ***** DAILY  

Ipratropium Bromide MDI 2 ***** ***** BID  

Lisinopril 10 mg PO DAILY  

ValACYclovir 500 mg PO Q48H  



Social Hx:

Lives with friend 

Report ETOH use, once/week

Quit smoking 5 years ago currently on Chantix 



Family Hx: Non-contributory 



ROS:SEE HPI 



PHYSICAL EXAM:

Gen: ill appearing male, WD/WN, comfortable, NAD.

HEENT: Pupils: 4-3mm          EOMs Full 

Extrem: Warm and well-perfused.



Neuro:

Mental status: Awake and alert, cooperative with exam, normal

affect.

Orientation: Oriented to person, place, and date..

Language: Speech fluent with good comprehension. No dysarthria or

paraphasic errors.



Cranial Nerves:

I: Not tested

II: Pupils equally round and reactive to light,4 to 3mm

mm bilaterally. Visual fields are full to confrontation.

Photophobia baseline per patient after cataract surgery 

III, IV, VI: Extraocular movements intact bilaterally without

nystagmus.

V, VII: Facial strength and sensation intact and symmetric.

VIII: Hearing intact to voice.

IX, X: Palatal elevation symmetrical.

*****: Sternocleidomastoid and trapezius normal bilaterally.

XII: Tongue midline without fasciculations.



Motor: Normal bulk and tone bilaterally. No abnormal movements,

tremors. Strength full power 5/5 throughout. No pronator drift



Sensation: Intact to light touch 



Imaging 

CT Head:

1. Asymmetric prominence of the extra-axial CSF space along the

right frontal convexity measuring up to 8 mm wide with 3 mm of

leftward midline shift and no herniation. This may represent a

chronic subdural hematoma versus a traumatic subdural hygroma. 

2. No acute intracranial hemorrhage, calvarial fracture, or CT

evidence of 

acute infarct. 



Labs:

*****/*****/***** 01:00PM BLOOD WBC: 11.9***** RBC: 4.18***** Hgb: 14.1 Hct: 42.8

MCV: 102***** MCH: 33.7***** MCHC: 32.9 RDW: 14.2 *****: 53.1***** Plt Ct:

173 

*****/*****/***** 01:00PM BLOOD PT: 13.6***** PTT: 23.6***** INR(PT): 1.3***** 

*****/*****/***** 01:00PM BLOOD Plt Ct: 173



Assessment/Plan:***** year old male hx of PE on eliquis presents s/p

unwitnessed syncopal falls, Head CT without intracranial

hemorrhage. There is no neurosurgical intervention indicated.

There is no contraindication to Eliquis from *****

*****, may continue eliquis. 



-No follow up indicated 





I have reviewed this case with Dr. ***** who formulated

the above plan.





Thank you for this consult,



***** ***** NP 

*****

Neurosurgery 





Attending Physician:

***** *****, MD"
150000687,0,1,"

Note Date: *****/*****/*****  Time: 0755

Note Type: Initial note

Note Title: ID Inpatient Consult

Signed by ***** ***** *****, MD on *****/*****/***** at 4:51 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 8:19 pm

 

INFECTIOUS DISEASES INPATIENT CONSULT



REQUESTED BY:  Dr. *****

Service:  Neuro ICU

Reason for consult: meningitis coverage with PCN allergy



CHIEF COMPLAINT / HPI OBTAINED FROM:  

{}Patient {}Family/Friend {}Interpreter {X}Other: Medical records



Patient unresponsive



CHIEF COMPLAINT:  meningitis



HISTORY OF PRESENT ILLNESS:  

***** yo F with hx of DM, HTN, recent SDH,  Afib not on AC, also

with recent admit for coccygeal osteomyelitis, who presents with

unresponsiveness and reported seizure activity.



Of note in ***** she was admitted with fever after being found

down, no focal source of infection found at that time. Rehab

notes afterwards noted multiple chronic wounds and diabetic

ulcers including buttock, ischium. followed at ***** ***** wound

care clinic, worsening, with purulent *****, which led to the

***** admission and abx course as below.



She was recently again admitted in ***** for for deep sacral

ulcer non-healing since ***** in *****, and more recently in

***** w/ clinical, imaging and laboratory evidence all

suggestive of mixed deep infection with associated coccygeal

osteomyelitis. Bedside debridement x2 (*****/*****, *****/*****) by ACS. Pt

refused coccygeal bx, so she was treated broadly with antibiotics

(*****/ertapenem) with start date *****/*****/***** with planned end date

*****/*****. At that time, MRI showed some enhancement c/f coccygeal

osteo with associated ***** from ulcer extending towards

coccyx. Swab from *****/***** grew mixed flora and MSSA (pan S) and

that is all the micro we have.



She was now admitted *****/***** after being found unresponsive.

Apparently she had some loose stool over the past week with

vomiting x1 a week ago. She became confused day of admission and

then unresponsive and brought to ED. Apparently she was afebrile

at rehab in this context; ***** witnessed what seemed to be a tonic

clonic seizure. In ED received Ativan, keppra, head CT without

bleed or infarct. ***** 120s, trialed on BIPAP (DNR) but HR and BP

dropped profoundly, improved w/ fluids however. CTA head and neck

did not show large clots. CXR without clear PNA.



Initially she was covered with vanc/CTX/acyclovir, but given h/o

sacral osteo, changed *****/***** to meropenem, vanc, acyclovir (listed

as allergy to ampicillin).



Here labs initially with WBC 10, 9 this morning. Noted to have

anemia. Plts normal. Creatinine 0.8, LFTs largely reassuring. She

does have mildly elevated troponins. Serum tox screen neg. UA

reassuring. LP was done with WBC (7 tube 1, 5 tube 5), RBC (219,

123), pmn (55%, 51%), Lymph (29%, 32%). Total protein 50, glucose

116. 1+ PMNs. 



At the time of this interview she was unresponsive to verbal and

physical stimuli. ROS unable to be obtained.

 

PAST MEDICAL / SURGICAL HISTORY:  

Type 2 diabetes

Hypertension

Anemia

Glaucoma

Hearing deficit

MGUS

Breast cancer history

Hyperlipidemia

Atrial fibrillation, paroxysmal

Paroxysmal atrial flutter

CKD stage III

Microcytic anemia

Anemia of chronic kidney disease

Cognitive deficits/dementia

Open buttock wound    



FOREIGN BODIES:  none



SOCIAL HISTORY:  

Lives at home alone w/ rtc assistance. Strong family support. 

She was born in *****, but spent time in ***** growing up.

She denies alcohol/*****/*****.



FAMILY HISTORY: The Family History was reviewed and is

non-contributory for a past history of infection or

immunocompromised state. 

 

ALLERGIES:

----------------------------------------------------------------

Allergies  (Last Verified *****/*****/***** by *****,*****.):

----------------------------------------------------------------

Codeine                                                          

egg                                                              

Hydrochlorothiazide                                              

Hytrin                                                           

Motrin                                                           

Penicillins                                                      

Procardia                                                        

*****                                                          

Sulfa (Sulfonamide Antibiotics)                                  

Zestril                                                          

  

MEDICATIONS:  

--------------- --------------- --------------- ---------------

Active Inpatient Medication list as of *****/*****/***** at 0755:



Medications - Standing

Sodium Chloride 0.9%  Flush 3-10 mL IV Q8H and PRN, line flush

Vancomycin 500 mg IV Q 24H

Acyclovir 500 mg IV Q12H

Meropenem 1000 mg IV Q8H

Heparin 5000 UNIT SC BID

LevETIRAcetam 750 mg IV Q12H

Phenytoin Sodium (IV) 100 mg IV Q8H

Calcium Gluconate sliding scale (Critical Care-Ionized calcium)

IV

Potassium Chloride Replacement (Critical Care and Oncology) IV

Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS

Timolol Maleate 0.5% 1 DROP BOTH EYES BID

Magnesium Sulfate Replacement (Critical Care and Oncology) IV



Medications - PRN

HydrALAZINE 10-20 mg IV Q6H:PRN SBP>180

Labetalol 10-20 mg IV Q6H:PRN SBP>180

Metoprolol Tartrate 5 mg IV Q6H:PRN HR>120

--------------- --------------- --------------- ---------------





REVIEW OF SYSTEMS: Pertinent positives and negatives are noted in

the HPI and all other systems are reviewed and are negative.



PHYSICAL EXAM:  

VS:   Tc 98.1  HR 78 - 125, BP 121/69 99% RA

GENL: unresponsive even to sternal rub  

HEENT: PERRL, EOMI, sclerae anicteric, moist mucous membranes, no

ulcers / lesions / thrush  

NECK:  exam limited as unresponsive

*****: irreg rate no audible murmur 

PULM: clear to auscultation bilaterally w/o wheezes / rhonchi /

rales  

BACK: no focal tenderness, no costovertebral angle tenderness  

ABDM: non-distended, normoactive bowel sounds, soft, non-tender,

no hepatosplenomegaly  

MSK: no joint swelling or erythema  

EXTR: warm and well perfused, no edema, 2+ DP pulses palpable

bilaterally  

SKIN: no rashes, no jaundice. very superficial crack over left

heel without purulence. Small 1cm but deep hole over r *****

coccyx without active ***** 

NEURO: unresponsive 

PSYCH: non-anxious, normal affect 

ACCESS:  right picc



LABORATORY:

*****/*****/***** 02:00AM BLOOD WBC: 9.5 RBC: 3.55***** Hgb: 9.4***** Hct: 29.8*****

MCV: 84 MCH: 26.5 MCHC: 31.5***** RDW: 17.3***** *****: 53.2***** Plt Ct: 299



*****/*****/***** 02:00AM BLOOD WBC: 9.5 RBC: 3.55***** Hgb: 9.4***** Hct: 29.8*****

MCV: 84 MCH: 26.5 MCHC: 31.5***** RDW: 17.3***** *****: 53.2***** Plt Ct: 299



*****/*****/***** 08:55PM BLOOD Neuts: 84.6***** Lymphs: 5.3***** *****: 9.3 Eos:

0.1***** Baso: 0.1 Im Gran: 0.6 *****: 8.78***** *****: 0.55*****

*****: 0.97***** *****: 0.01***** *****: 0.01 

*****/*****/***** 02:00AM BLOOD Glucose: 167***** *****: 9 Creat: 0.8 Na: 142

K: 4.6 Cl: 106 HCO3: 21***** *****: 15 

*****/*****/***** 02:00AM BLOOD ALT: 39 AST: 45***** *****(LDH): 387***** *****(CPK):

162 *****: 122***** *****: 0.2 



MICROBIOLOGY DATA:  NGTD blood and CSF cultures



IMAGING DATA:

CTA head/neck:

CT HEAD WITHOUT CONTRAST: 

No acute intracranial abnormality. 

  

CTA HEAD: 

The vessels of the circle of ***** and their principal

intracranial branches 

are patent without stenosis, occlusion, or aneurysm formation.

The dural 

venous sinuses are patent. 

  

CTA NECK: 

The carotid and vertebral arteries and their major branches are

patent. 

  

OTHER: 

Mucous/secretions in the oropharynx and trachea, causing greater

than 50% 

occlusion of the tracheal lumen area (4:66).



CXR

 

IMPRESSION:  

  

Patient rotated to the right.  Right PICC terminates in the

proximal right atrium without evidence of pneumothorax. 

Difficult to exclude small right pleural effusion. 

  

ASSESSMENT: 

***** yo F with hx of DM, HTN, recent SDH,  Afib not on AC, also

with recent admit for coccygeal osteomyelitis, who presents with

unresponsiveness and reported seizure activity.



Her LP results are not consistent with a bacterial meningitis

(essentially normal WBC count of only 5, with reassuring

protein/glucose and PMN count. She has almost completed the

course for her sacral osteo, so given concerns about antibiotics

lowering the seizure threshold, and nothing on LP to support

bacterial meningitis, would discontinue antibiotics at this

point. However, would send CSF HSV PCR and continue IV acyclovir

until this has resulted negative. It's not clear that another

infection is responsible for her current presentation either; UA

and CXR are reassuring, and she has been afebrile, though await

blood culture results which are pending. 



We will continue to follow.



RECOMMENDATIONS: 

- discontinue meropenem/vancomycin

- continue IV acyclovir, add on CSF HSV PCR, and can DC acyclovir

if this results negative



{x} Recommendations discussed with primary team  



Thank you for asking us to participate in this patient's care.

Please call with questions or concerns.  



This is a preliminary note. The case will be discussed with the

Infectious Disease Consult Attending ***** *****. Changes/additions

will be made after discussion with the attending, and a signed

final note will be placed in the inpatient medical record.  





Addendum by ***** *****, MD on *****/*****/***** at 8:19 pm:

I have seen and examined the patient on *****/*****/***** and I have

reviewed the note of Dr. ***** dated *****/*****/*****. 



I have nothing to add or modify on the report of the history as

noted, or the examination as recorded in the note above. We have

discussed both the history and the examination and the plan for

further workup and care and I agree with all points of care for

this patient."
111793289,0,1,"    Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient/family will provide an existing copy      Health Care Agents          There are no health care agents on file.          Code Status at *****: DNR/DNI (No CPR/No Intubation)       Discharge address same as *****: Yes                   Hospitalization Summary     Admission Diagnosis     Subdural hematoma               Principal Problem:    Traumatic subarachnoid hemorrhage without loss of consciousness  Resolved Problems:    *****          Surgical (OR) Procedures:   Surgeries this Admission     None          Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    - F/u SPEP results and consideration of further work up of multiple myeloma (skeletal survey, bone marrow biopsy).  - Referral to outpatient pulmonologist for f/u of newly found pulmonary fibrosis.           Pending Results     Procedure Component Value Ref Range Date/Time    SPEP panel [*****]  (Abnormal) Collected:  *****/*****/***** 1250    Lab Status:  Preliminary result Specimen:  Blood Updated:  *****/*****/***** 1021     Total Protein 7.0 6.0 - 8.3 g/dL      IMMUNOGLOBULIN G 1509 (H) 614 - 1295 mg/dL      IgA 894 (H) 69 - 309 mg/dL      IMMUNOGLOBULIN M 55 53 - 334 mg/dL      SPEP PENDING           Hospital Course   ***** ***** ***** is a ***** y.o. R-handed male with PMHx L vocal cord lesion, carotid stenosis s/p bilateral *****, CAD s/p ***** to LCx 2006, angina pectoris, HTN, HLD, new dx pulmonary fibrosis who presents 
after ***** with *****, found to have mixed density R SDH and R SAH (non-operative).   The patient was admitted to the ***** with a traumatic right SDH and right SAH secondary to a witnessed mechanical ***** with *****. On admission the patient had no neurologic deficits noted on his exam. Neurosurgery was consulted and recommended a non-operative treatment course. The SDH/SAH were stable on interval scan *****/***** 9 am. He was continued on Keppra 500 mg BID for anticipated 7d course (*****/*****-*****/*****). Home aspirin was held, with plan to resume in about 4 weeks after new f/u head CT and Neurosurgery evaluation in clinic. The patient remained stable upon transfer to Neurology floor on *****/*****, with a non-focal exam. PT recommended home with home PT.     Regarding cause of the *****, the history was most concerning for orthostatic syncope in the setting of hypotension with antihypertensive, cardiac (arrhythmia, given bradycardia), mechanical *****. Less likely vasovagal with no preceding symptoms,. Had a negative CT-PE. Low suspicion for seizure with no tongue biting or loss of bowel/bladder control. No evidence of peripheral neuropathy in feet on exam. He had a routine EEG (only 20 minute study) without epileptiform discharges; this was considered sufficient given very low suspicion for seizure. He had no carotid bruits on exam. TTE showed LVEF 50% with segmental wall motion abnormalities (anterior akinesis and apical hypokinesis), with left atrial dilation, right atrial dilation, and RV dilation. Per Care Everywhere, last TTE was *****/***** with LVEF 55% without mention of wall motion abnormalities. D Dimer was elevated to 1623. Workup for bradycardia showed Lyme serology negative, TSH wnl. He had initial orthostatics *****/***** that were negative by HR (rise of 16 bpm) and SBP (***** ***** ***** mmHg) without symptoms. However in the setting of further blood pressure control with resuming home isordil he was found to have SBP drop from 
101 sitting to 84 standing with HR 70 to 88. Home blood pressure medications were adjusted: isordil was discontinued (was on for angina), captopril 12.5 mg TID was continued, and low-dose metoprolol 6.25 mg Q6H was re-introduced. His blood pressures and orthostatic VS improved on this regimen.    Besides the ***** and traumatic SDH, Mr. ***** the patient had addressed the following medical issues:    Pulmonary fibrosis. The patient was found to have evidence of pulmonary fibrosis on CXR but did not have a known prior diagnosis of this. He was breathing well on RA during admission. He had a high-resolution CT chest that showed severe emphysematous changes in the lungs bilaterally and changes most consistent with pulmonary fibrosis.     CAD s/p PCI, TTE with new WMAs: TTE showed stable LVEF 50% but new segmental WMAs including anterior akinesis and apical hypokinesis, and *****-atrial dilation and RV dilation, which were not seen previously. These new findings were communicated to his outpatient cardiologist Dr. ***** *****, who planned to follow-up with the patient after discharge for consideration of possible repeat stress and catheterization when safe from a neurology perspective.    Weight loss. Patient presented with recent 20 pound weight loss, concerning for possible malignancy or malnutrition. Malnutrition is favored given also slightly prolonged INR on admission (1.3) which resolved after administration of vitamin K. TSH was WNL as above. Nutrition recommended high-protein diet and Ensure Plus daily. Vit D was low at 12 and he was started on supplementation.     Macrocytic anemia. He was noted to have a mild macrocytic anemia on admission, with Hgb 11.3 and MCV 100.3. He was also thrombocytopenic to 135 and later was also leukopenic. He was iron replete (***** 30%), with normal B12 and folate. SPEP and serum free light chains were notable for elevated IgG (1509, ULN 1295) and IgA (894, ULN 309) with normal 
IgM; pattern was pending at time of discharge. ***** notable for elevated free K:L ratio of 2.16 (ULN 1.70). Given his cytopenias there was clinical concern for multiple myeloma. Pending SPEP pattern, skeletal survey and bone marrow biopsy should be considered in follow up.    The patient was recommended to schedule a rapid visit with his PCP and cardiologist.         Medications   Allergies: Review of patient's allergies indicates no known allergies.    Prior to Admission Medications   Prescriptions   aspirin 81 MG EC tablet   Sig: Take 1 tablet by mouth daily.   Note (*****/*****/*****): ***** Med Transfer Process    atorvastatin (LIPITOR) 20 MG tablet   Sig: Take 1 tablet by mouth nightly.   Note (*****/*****/*****): ***** Med Transfer Process    isosorbide mononitrate (IMDUR) 30 MG 24 hr tablet   Sig: Take 30 mg by mouth daily.   lisinopril (PRINIVIL,ZESTRIL) 10 MG tablet   Sig: Take 1 tablet by mouth daily.   Note (*****/*****/*****): ***** Med Transfer Process    metoprolol succinate (TOPROL-XL) 25 MG 24 hr tablet   Sig: Take 25 mg by mouth daily.   nitroglycerin (NITROSTAT) 0.4 MG SL tablet   Sig: Place 0.4 mg under the tongue every 5 (five) minutes as needed for chest pain.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          aspirin 81 MG EC tablet         START taking these medications       Dose, Frequency, and Details    acetaminophen 325 mg tablet   Also known as:  TYLENOL    Take 1-2 tablets (325-650 mg total) by mouth every 6 (six) hours as needed for mild pain.   Last time this was given:  *****/*****/*****  4:25 PM       cholecalciferol 2,000 unit tablet   Also known as:  VITAMIN D3   Start taking on:  *****/*****/*****    Take 1 tablet (2,000 Units total) by mouth daily.   Last time this was given:  *****/*****/*****  9:46 AM       levETIRAcetam 500 MG tablet   Also known as:  KEPPRA    Take 1 tablet (500 mg total) by mouth 2 (two) times a day for 6 doses.   Last time this was given:  
*****/*****/*****  9:46 AM         CONTINUE taking these medications       Dose, Frequency, and Details    atorvastatin 20 MG tablet   Also known as:  LIPITOR    Take 1 tablet by mouth nightly.   Last time this was given:  *****/*****/*****  8:55 PM       isosorbide mononitrate 30 MG 24 hr tablet   Also known as:  IMDUR    Take 30 mg by mouth daily.       lisinopril 10 MG tablet   Also known as:  PRINIVIL,ZESTRIL    Take 1 tablet by mouth daily.       metoprolol succinate 25 MG 24 hr tablet   Also known as:  TOPROL-XL    Take 25 mg by mouth daily.       nitroglycerin 0.4 MG SL tablet   Also known as:  NITROSTAT    Place 0.4 mg under the tongue every 5 (five) minutes as needed for chest pain.                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate *****  Deferred (Patient Refused)    Tdap *****/*****/*****             Hospital Care Team   Service: Neurology  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 2:30 PM ***** ***** ***** *****, ***** ***** *****-*****-***** ***** *****    *****/*****/***** 10:45 AM ***** *****, MD Acute Care Neurosurgery on WAC ***** *****-*****-*****     *****/*****/***** 11:00 AM ***** ***** *****, MD ***** Center for Laryngeal Surgery & Voice Rehabilitation *****-*****-*****          Follow-Up Services            ***** ***** ***** - HOME CARE   Specialty:  Home Health Services    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1338  Activity as tolerated         *****/*****/***** 1338  Discharge diet     Question Answer Comment   Diet Type Regular    ***** Restriction: Low fat (cardiac)    Sodium Restriction: NO ADDED *****           *****/*****/***** 1338  For immediate 
questions regarding your hospitalization, your medications, and any pending test results please contact ***** *****-***** at *****-*****-*****     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact ***** *****-***** at *****-*****-*****       *****/*****/***** 1338  Patient will not be referred to/is not appropriate for cardiac rehabilitation at this time         *****/*****/***** 1452  Referral to Home Health HOMEBOUND     Question Answer Comment   Location of Home Care referral? ***** at *****    Referral Priority Admit within 24 hours    Physician to Follow Patient's Care in the Community PCP    Disciplines Requested Nursing (to assess, treat and teach)    Disciplines Requested Physical Therapy (to assess and treat)    Disciplines Requested Occupational Therapy (to assess and treat)    Services to Provide - Nursing Neurological    Services to Provide - Nursing Cardiovascular    Service to Provide - Physical Therapy Functional Mobility    Service to Provide - Physical Therapy Safety    Service to Provide - Occupational Therapy Safety    Service to Provide - Occupational Therapy Mobility    Date of Face to Face Encounter: *****/*****/*****    This encounter with this patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care: sdh    In addition to clinical findings elsewhere in the medical record documentation the patient is homebound due to: Use of an assistive device    To navigate home structural barriers patient requires to use of: walker           *****/*****/***** 1452  Referral to Home Health HOMEBOUND     Question Answer Comment   Location of Home Care referral? ***** at *****    Referral Priority Admit within 24 hours    Physician to Follow Patient's Care in the Community PCP    Disciplines Requested Nursing (to assess, treat and teach)    Disciplines Requested Physical Therapy 
(to assess and treat)    Disciplines Requested Occupational Therapy (to assess and treat)    Services to Provide - Nursing Cardiovascular    Services to Provide - Nursing Neurological    Service to Provide - Physical Therapy Functional Mobility    Service to Provide - Physical Therapy Safety    Service to Provide - Occupational Therapy ADLs & IADLs    Service to Provide - Occupational Therapy Safety    Service to Provide - Occupational Therapy Mobility    Date of Face to Face Encounter: *****/*****/*****    This encounter with this patient was in whole, or in part, for the following medical condition, which is the primary reason for home health care: SDH    In addition to clinical findings elsewhere in the medical record documentation the patient is homebound due to: Use of an assistive device    To navigate home structural barriers patient requires to use of: walker           *****/*****/***** 0813  CT Head     Question Answer Comment   Is a particular imaging focus suggested (radiology may call to confirm)? Per Radiologist discretion/standard based on indications    Intravenous Contrast Request: Should NOT be used (radiology may call to confirm)    Does the patient have a known prior contrast reaction? No                         Exam   Temperature: 36.7 째C (98.1 째F) (*****/*****/***** 1245) | Heart Rate: 70 (*****/*****/***** 1245) | BP: 103/61 (*****/*****/***** 1245) | Respiratory Rate: 18 (*****/*****/***** 1245)  | SpO2: 100 % (*****/*****/***** 0800)  O2 Device: None (Room air) (*****/*****/***** 0800)    |        Weight: 67.9 kg (149 lb 11.1 oz) (*****/*****/***** 0516)  Height: 188 cm (6' 2"") (*****/*****/***** 0516)         BMI (Calculated): 19.2 (*****/*****/***** 0516)    Discharge Exam    Significant Discharge Exam Findings:  Awake, alert, grossly oriented to person place and situation, good participation with exam  CN: PERRL, no ptosis, EOMI, no facial weakness, midline tongue protrusion.   Full strength in all extremities. Sensation intact to light touch all extremities.   No dysmetria in 
extremities.   Independent and steady ambulation.                 Orientation Level: Oriented X3   Cognition: Follows commands         Speech: Clear     Vision: Functional with Correction              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 3.95 (L) *****/*****/***** *****    RBC 3.25 (L) *****/*****/***** *****    HGB 10.7 (L) *****/*****/***** *****    HCT 31.9 (L) *****/*****/***** *****    MCH 32.9 *****/*****/***** *****    MCV 98.2 *****/*****/***** *****    PLT 103 (L) *****/*****/***** *****    RDW 13.0 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 140 *****/*****/***** *****    ***** 3.9 *****/*****/***** *****    ***** 105 *****/*****/***** *****    CO2 25 *****/*****/***** *****    BUN 15 *****/*****/***** *****    CRE 0.80 *****/*****/***** *****    ***** 8.6 *****/*****/***** *****    GLU 90 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.0 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 14.4 *****/*****/***** *****    PTT 34.4 *****/*****/***** *****    INR 1.1 *****/*****/***** *****                        "
114644220,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): Health Care Proxy, Durable power of attorney for healthcare   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     *****, ***** .Primary Health Care ***** (Proxy form on file) - Spouse Not Active   Primary Phone: *****-*****-***** (Mobile)  Home Phone: *****-*****-*****               Code Status at *****: Full Code       Patient/Family/Caregiver discharge preference/goals : Home                            Hospitalization Summary      Reason for Admission    Seizure        Principal Problem:    Seizure  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:          Pending Results     None             Hospital Course   *****-year-old male with past medical history significant for metastatic prostate cancer on experimental therapy, radiation, chronic subdural hemorrhage coming in after syncopal/seizure episode.  Neurology consulted.  On Keppra.  Admitted for observation   *****-year-old male with past medical history significant for metastatic prostate cancer with known brain metastasis, chronic subdural hemorrhage anxiety depression coming in with a seizure episode     1.  Seizure/syncopal episode:  Has known brain metastasis and subdural hematoma.  Neurology consulted  Started on Keppra.  Changed to Vimpat.  PR interval in normal range  Could be related to low blood pressures/orthostatic hypotension and syncope  Treated with IV fluids  Blood pressure improved  No 
further syncopal or seizure episodes  Keppra changed to Vimpat after discussion with neurology.  Patient had a repeat CT scan with no acute changes.  Discussed with neurology.  Plan to discharge home on Vimpat and follow-up with neurosurgery/oncology in *****    2.  Metastatic prostate cancer:  Currently on a clinical trial in ***** and radiation  Oncology team contacted.    Continue Decadron  Also on leuprolide  Continue Dilaudid     3.  Elevated LFTs:  Secondary to metastatic prostate cancer  No obvious abdominal pain or tenderness  Continue to monitor     4.  Anxiety depression:  Continue Cymbalta, Zyprexa, Ativan as needed            Medications   Allergies: Patient has no known allergies.    Prior to Admission Medications   Prescriptions   DULoxetine (CYMBALTA) 30 MG capsule   Sig: Take 1 capsule (30 mg total) by mouth daily.   HYDROmorphone (DILAUDID) 2 MG tablet   Sig: Take 1 tablet (2 mg total) by mouth every 4 (four) hours as needed for pain (specific location in comments). *****-***** request partial fill   LORazepam (ATIVAN) 0.5 MG tablet   Sig: Take 1-2 tablets (0.5-1 mg total) by mouth every 6 (six) hours as needed for anxiety (and nausea).   Patient not taking: Reported on *****/*****/*****   OLANZapine (ZYPREXA *****) 5 MG disintegrating tablet   Sig: Take 1 tablet (5 mg total) by mouth nightly at bedtime.   Patient not taking: Reported on *****/*****/*****   RESTASIS 0.05 % suspension   Sig: Apply to both eyes 2 times a day   calcium carbonate/vitamin D3 (CALTRATE-600 PLUS VITAMIN D3 ORAL)   Sig: Take 1 tablet by mouth nightly at bedtime.    cetirizine (ZYRTEC) 10 MG tablet   Sig: Take 10 mg by mouth nightly at bedtime.    dexAMETHasone (DECADRON) 1 MG tablet   Sig: Take 2 tablets (2 mg total) by mouth as directed. 2 mg twice daily for 14 days, then 1 mg twice daily for 7 days, then 1 mg once daily for 7 days. Take with food.   Note (*****/*****/*****): Currently taking 2 mg daily    fluticasone propionate (FLONASE) 50 
mcg/actuation nasal spray   Sig: 1 spray by Nasal route daily as needed.    leuprolide, 1 month, (LUPRON ***** 1 MONTH) 7.5 mg IM injection syringe   Sig: Inject 7.5 mg into the muscle every 3 (three) months. Started on *****/*****/*****    lidocaine (LIDODERM) 5 %   Sig: Place 1 patch onto the skin daily. Remove & Discard patch within 12 hours or as directed by MD   ondansetron (ZOFRAN) 4 MG tablet   Sig: Take 1 tablet (4 mg total) by mouth every 8 (eight) hours as needed for nausea.   Patient not taking: Reported on *****/*****/*****   ondansetron (ZOFRAN-ODT) 8 MG disintegrating tablet   Sig: Take 1 tablet (8 mg total) by mouth every 8 (eight) hours as needed for nausea.   pantoprazole (PROTONIX) 40 MG tablet   Sig: Take 40 mg by mouth 2 (two) times a day.   polyethylene glycol (MIRALAX) 17 gram/dose powder   Sig: Take 17 g by mouth daily as needed.    prochlorperazine (COMPAZINE) 10 MG tablet   Sig: Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed.   simvastatin (ZOCOR) 20 MG tablet   Sig: TAKE 1 TABLET DAILY      Facility-Administered Medications: None        Medication List      TAKE these medications        Instructions    CALTRATE-600 PLUS VITAMIN D3 ORAL   Take 1 tablet by mouth nightly at bedtime.      cetirizine 10 MG tablet  Commonly known as: ZyrTEC   Take 10 mg by mouth nightly at bedtime.      dexAMETHasone 1 MG tablet  Commonly known as: DECADRON  Last time this was given: ***** *****, *****  8:12 AM   Take 2 tablets (2 mg total) by mouth as directed. 2 mg twice daily for 14 days, then 1 mg twice daily for 7 days, then 1 mg once daily for 7 days. Take with food.      DULoxetine 30 MG capsule  Commonly known as: CYMBALTA   Take 1 capsule (30 mg total) by mouth daily.      fluticasone propionate 50 mcg/actuation nasal spray  Commonly known as: FLONASE   1 spray by Nasal route daily as needed.      HYDROmorphone 2 MG tablet  Commonly known as: DILAUDID  Last time this was given: ***** *****, *****  8:11 AM   
Take 1 tablet (2 mg total) by mouth every 4 (four) hours as needed for pain (specific location in comments). *****-***** request partial fill  *****'s comments: Stopping Tramadol      lacosamide 100 mg Tab  Commonly known as: VIMPAT   Take 1 tablet (100 mg total) by mouth 2 (two) times a day.      leuprolide (1 month) 7.5 mg IM injection syringe  Commonly known as: LUPRON ***** 1 MONTH   Inject 7.5 mg into the muscle every 3 (three) months. Started on *****/*****/*****      lidocaine 5 %  Commonly known as: LIDODERM  Last time this was given: Ask your nurse or doctor   Place 1 patch onto the skin daily. Remove & Discard patch within 12 hours or as directed by MD      LORazepam 0.5 MG tablet  Commonly known as: ATIVAN   Take 1-2 tablets (0.5-1 mg total) by mouth every 6 (six) hours as needed for anxiety (and nausea).      OLANZapine 5 MG disintegrating tablet  Commonly known as: ZyPREXA *****   Take 1 tablet (5 mg total) by mouth nightly at bedtime.      ondansetron 4 MG tablet  Commonly known as: ZOFRAN   Take 1 tablet (4 mg total) by mouth every 8 (eight) hours as needed for nausea.      ondansetron 8 MG disintegrating tablet  Commonly known as: ZOFRAN-ODT   Take 1 tablet (8 mg total) by mouth every 8 (eight) hours as needed for nausea.      pantoprazole 40 MG tablet  Commonly known as: PROTONIX  Last time this was given: ***** *****, *****  8:12 AM   Take 40 mg by mouth 2 (two) times a day.      polyethylene glycol 17 gram/dose powder  Commonly known as: MIRALAX   Take 17 g by mouth daily as needed.      prochlorperazine 10 MG tablet  Commonly known as: COMPAZINE   Take 1 tablet (10 mg total) by mouth every 6 (six) hours as needed.      Restasis 0.05 % suspension  Generic drug: cycloSPORINE  Last time this was given: ***** *****, *****  8:12 AM   Apply to both eyes 2 times a day      simvastatin 20 MG tablet  Commonly known as: ZOCOR   TAKE 1 TABLET DAILY           Where to Get Your Medications      You can get these medications 
from ***** *****    Bring a paper prescription for each of these medications  쨌 lacosamide 100 mg Tab                    Hospital Care Team   Service: Medicine  Inpatient Attending: ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 11:50 AM ***** RAD ONC TRT MACHINE YELLOW *****-*****/***** and Women's Cancer Center Department of Radiation Oncology, At *****  Arrive at: CHECK-IN *****: Department of Radiation Oncology, Front Desk, L2 *****-*****-*****  TREATMENT    *****/*****/***** 3:30 PM (Arrive by 3:15 PM) ***** BTM CT1 ***** CT *****, ***** *****-*****-***** ***** Rad Main CT HEAD    *****/*****/***** 4:00 PM ***** BTM XRAY ORTHO ***** MSK Diagnostic X-ray *****, ***** *****-*****-***** ***** Rad Main XR FEMUR 2 VIEW (LEFT)    *****/*****/***** 4:15 PM ***** BTM XRAY ORTHO ***** MSK Diagnostic X-ray *****, ***** *****-*****-***** ***** Rad Main XR PELVIS VIEWS    *****/*****/***** 4:30 PM ***** ***** *****, MD ***** and Women's Department of Orthopaedics *****-*****-***** ***** Main NP XRAY    *****/*****/***** 5:00 ***** ***** *****, MD ***** Department of Neurosurgery *****-*****-***** ***** Main ESTABLISHED PATIENT    *****/*****/***** 2:00 PM ***** ***** *****-*****, MD *****-*****/***** and Women's Cancer Center Department of Radiation Oncology, At *****  Arrive at: VIDEO APPOINTMENT *****-*****-*****  VIRTUAL ESTABLISHED    *****/*****/***** 5:10 PM ***** RAD ONC TRT MACHINE YELLOW *****-*****/***** and Women's Cancer Center Department of Radiation Oncology, At *****  Arrive at: CHECK-IN *****: Department of Radiation Oncology, Front Desk, L2 *****-*****-*****  TREATMENT    *****/*****/***** 4:10 PM ***** RAD ONC TRT MACHINE YELLOW *****-*****/***** and Women's Cancer Center Department of Radiation Oncology, At *****  Arrive at: CHECK-IN *****: Department of Radiation Oncology, 
Front Desk, L2 *****-*****-*****  TREATMENT    *****/*****/***** 4:50 PM ***** RAD ONC TRT MACHINE YELLOW *****-*****/***** and Women's Cancer Center Department of Radiation Oncology, At *****  Arrive at: CHECK-IN *****: Department of Radiation Oncology, Front Desk, L2 *****-*****-*****  Final Treatment          Signed Discharge Orders (From admission, onward)             Ordered        *****/*****/***** 1153  Activity as tolerated            *****/*****/***** 1153  Discharge diet        Comments: Diet Regular       *****/*****/***** 1153  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** ***** *****, MD at *****-*****-*****.        Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** ***** *****, MD at *****-*****-*****.                              Exam   Temperature: 37.9 째C (100.2 째F) (*****/*****/***** 0722) | Heart Rate: 90 (*****/*****/***** 0821) | BP: 120/56 (*****/*****/***** 0722) | Respiratory Rate: 18 (*****/*****/***** 0821)  | SpO2: 92 % (*****/*****/***** 0722)  O2 Device: None (Room air) (*****/*****/***** 0722)    |        Weight: 77.6 kg (171 lb 1.2 oz) (*****/*****/***** 1624)  Height: 180.3 cm (5' 10.98"") (*****/*****/***** 1624)         BMI (Calculated): 23.87 (*****/*****/***** 1624)    Discharge Exam    Significant Discharge Exam Findings: GENERAL: Awake, appears comfortable, not in acute distress  HEENT: Pupils are equal and reactive to light, extraocular movements are intact, oropharynx appears normal, no cervical adenopathy  CHEST: Symmetrical chest expansion with breathing, breath sounds are clear  HEART: S1, S2 heard.  No murmurs, rubs and gallops  ABDOMEN: Soft, nondistended, non-tender, bowel sounds normal  EXTREMITIES: No pedal edema, no cyanosis or clubbing  NEURO: Alert and oriented to time place and person.  No focal neurological deficit  SKIN: No rashes, no skin changes  BP 120/56  | Pulse 90  | Temp 37.9 째C (100.2 째F) (Oral)  | Resp 18  | 
Ht 180.3 cm (5' 10.98"")  | Wt 77.6 kg (171 lb 1.2 oz)  | SpO2 92%  | BMI 23.87 kg/m짼                Orientation Level: Oriented X4   Cognition: Age appropriate         Speech: Appropriate for age              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 4.72 *****/*****/***** *****    RBC 2.51 (L) *****/*****/***** *****    HGB 7.2 (L) *****/*****/***** *****    HCT 23.4 (L) *****/*****/***** *****    MCH 28.7 *****/*****/***** *****    MCV 93.2 *****/*****/***** *****    PLT 128 (L) *****/*****/***** *****    RDW 19.9 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 131 (L) *****/*****/***** *****    ***** 3.8 *****/*****/***** *****    ***** 102 *****/*****/***** *****    CO2 22 *****/*****/***** *****    BUN 16 *****/*****/***** *****    CRE 0.67 *****/*****/***** *****    ***** 6.6 (L) *****/*****/***** *****    GLU 71 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.5 *****/*****/***** *****                            "
120934736,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     *****, ***** .Primary Health Care ***** (Proxy form on file) - Spouse Not Active   Primary Phone: *****-*****-***** (Mobile)  Home Phone: *****-*****-*****               Code Status at *****: Full Code                                    Hospitalization Summary      Reason for Admission    Laceration of head        Principal Problem:    Laceration of head  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None        Procedures this admission    None       Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    Given the patient's tenuous fluid balance with heart failure with ejection fraction of 35% documented last in her system, recent acute kidney injury, will decrease dose of torsemide on discharge to 40 mg daily instead of 60 mg daily.  Patient to monitor for lower limb swelling and difficulty breathing.  He does not have any other symptoms at this time.\    Also please remove scalp staples in 1 week at your primary care physician's office.       Pending Results     None             Hospital Course   ***** ***** ***** is a ***** y.o. male with PMH of CAD, hypertension, recent subdural hematoma status post traumatic ***** at home while on ***** therapy and recent discharge from rehab approximately 1 week ago who is presenting to the ER after sustaining a ***** at home resulting in a laceration on his head without intracranial abnormality 
who is unsteady to return to ***** *****.     #Mechanical ***** with head strikeCT head negative for acute bleeding, ***** resumed, scalp laceration stapled, trauma surgery evaluated patient monitored overnight, patient improved, will discharge home with home PT eval  #Acute kidney injury on chronic kidney disease Stage II secondary to dehydrationresolving, IV fluid rehydration completed, creatinine improving, baseline seems to be 1.1, currently at 1.4 but downtrending, will decrease dose of home torsemide from 60 mg daily to 40 mg daily, PCP to monitor for fluid overload, avoid nephrotoxic agents  #Hypertension-continue metoprolol  #Heart failure with reduced ejection fraction-chronic, will decrease torsemide dose to 40 mg daily, continue metoprolol extended release 25 mg, would suggest initiating patient on ACE or ***** in the outpatient setting after kidney function *****  #Atrial fibrillation-*****-VASc greater than 2, given recent subdural/subarachnoid hemorrhage, patient not on anticoagulation, to follow with cardiology, continue digoxin, digoxin level today within normal limits, no symptoms or signs of digoxin toxicity given AKI  #Subdural hematoma secondary to *****-chronic bleed stabilized  #Hypothyroidism-continue levothyroxine  #Coronary disease status post CABG-continue aspirin/statin/Plavix/Ranexa/metoprolol  #Mood disorder-continue sertraline  #Scalp laceration- removal of staples in 1 week at ***** office        20 minutes spent on discharge due to counseling and coordinating care including review of records, pertinent lab data and studies, as well as discussing diagnostic evaluation and work up, planned therapeutic interventions and future disposition of care. Where indicated, the assessment and plan reflect discussion of patient with consultants, other healthcare providers, family members, and additional research needed to obtain further information in ***** the plan of care of this 
patient.    Portions of the record may have been created with voice recognition software. Occasional wrong-word or ""sound-A-like"" substitutions may have occurred due to the inherited limitations of voice recognition software. Read the chart carefully and recognize, using context, where substitutions have occurred.         Medications   Allergies: Allopurinol, Ace inhibitors, Lisinopril, and Penicillins    Prior to Admission Medications   Prescriptions   FREESTYLE TEST Strp strips   Sig: 1 each by Miscellaneous route every morning. Test BS once daily  Dx:DM2 *****.42   acetaminophen (TYLENOL) 325 mg tablet   Sig: Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.   aspirin 81 MG EC tablet   Sig: Take 81 mg by mouth daily.   atorvastatin (LIPITOR) 40 MG tablet   Sig: Take 1 tablet (40 mg total) by mouth every evening.   blood-glucose meter (GLUCOSE MONITORING *****) *****   *****: 1 each by Other route every morning. Use as instructed - Test BS once daily  Dx:DM2 *****.42   cholecalciferol (VITAMIN D3) 2,000 unit capsule   Sig: Take 2,000 Units by mouth daily.    clopidogrel (PLAVIX) 75 mg tablet   Sig: Take 1 tablet (75 mg total) by mouth daily.   cyanocobalamin 500 MCG tablet   Sig: Take 500 mcg by mouth daily.  Indications: Vit B12   digoxin (LANOXIN) 125 mcg tablet   Sig: Take 1 tablet (0.125 mg total) by mouth every other day.   gemfibroziL (LOPID) 600 MG tablet   Sig: Take 1 tablet (600 mg total) by mouth 2 (two) times a day.   lancets 28 gauge Misc   Sig: 1 each by Miscellaneous route as needed. Test BS once daily  Dx:DM2 *****.42   lanolin alcohol-mineral oil-w.petrolatum-***** (EUCERIN) *****   Sig: Apply topically as needed (itching).   levothyroxine (SYNTHROID, LEVOTHROID) 112 MCG tablet   Sig: Take 112 mcg by mouth every morning.   magnesium oxide (MAG-OX) 400 mg (241.3 mg elemental) tablet   Sig: Take 1 tablet (400 mg total) by mouth every evening.   metoprolol succinate 
(TOPROL-XL) 25 MG 24 hr tablet   Sig: Take 1 tablet (25 mg total) by mouth daily.   nitroglycerin (NITROSTAT) 0.4 MG SL tablet   Sig: PLACE 1 TABLET (0.4 MG TOTAL) UNDER THE TONGUE EVERY 5 (FIVE) MINUTES AS NEEDED FOR CHEST PAIN.   pantoprazole (PROTONIX) 40 MG tablet   Sig: Take 1 tablet (40 mg total) by mouth 2 (two) times a day.   potassium chloride SA (K-*****,KLOR-CON) 20 MEQ ER tablet   Sig: Take 1 tablet (20 mEq total) by mouth daily.   ranolazine (RANEXA) 1,000 mg SR tablet   Sig: Take 1 tablet (1,000 mg total) by mouth 2 (two) times a day.   sertraline (ZOLOFT) 100 MG tablet   Sig: Take 2 tablets (200 mg total) by mouth daily.   torsemide (DEMADEX) 20 MG tablet   Sig: Take 2 tablets (40 mg total) by mouth daily.   Patient taking differently: Take 60 mg by mouth daily.    traZODone (DESYREL) 50 MG tablet   Sig: Take 1 tablet (50 mg total) by mouth nightly at bedtime as needed.      Facility-Administered Medications: None        Medication List      TAKE these medications        Instructions    acetaminophen 325 mg tablet  Commonly known as: TYLENOL  Last time this was given: ***** *****, *****  8:31 AM   Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed for mild pain or fever.      aspirin 81 MG EC tablet  Last time this was given: ***** *****, *****  8:29 AM   Take 81 mg by mouth daily.      atorvastatin 40 MG tablet  Commonly known as: LIPITOR  Last time this was given: ***** *****, *****  5:42 PM   Take 1 tablet (40 mg total) by mouth every evening.      blood-glucose meter kit  Commonly known as: glucose monitoring kit   1 each by Other route every morning. Use as instructed - Test BS once daily  Dx:DM2 *****.42  *****'s comments: Please dispense Free ***** Glucometer      cholecalciferol 2,000 unit capsule  Commonly known as: VITAMIN D3  Last time this was given: Ask your nurse or doctor   Take 2,000 Units by mouth daily.      clopidogrel 75 mg tablet  Commonly known as: PLAVIX  Last 
time this was given: ***** *****, *****  8:31 AM   Take 1 tablet (75 mg total) by mouth daily.      cyanocobalamin (vitamin B-12) 500 MCG tablet  For: Vit B12  Last time this was given: ***** *****, *****  8:23 AM   Take 500 mcg by mouth daily.  Indications: Vit B12      digoxin 125 mcg tablet  Commonly known as: LANOXIN  Last time this was given: ***** *****, *****  9:37 AM   Take 1 tablet (0.125 mg total) by mouth every other day.      FreeStyle Test Strp strips  Generic drug: blood sugar diagnostic   1 each by Miscellaneous route every morning. Test BS once daily  Dx:DM2 *****.42      gemfibroziL 600 MG tablet  Commonly known as: LOPID   Take 1 tablet (600 mg total) by mouth 2 (two) times a day.      lancets 28 gauge Misc   1 each by Miscellaneous route as needed. Test BS once daily  Dx:DM2 *****.42      lanolin alcohol-mineral oil-w.petrolatum-***** *****  Commonly known as: EUCERIN   Apply topically as needed (itching).      levothyroxine 112 MCG tablet  Commonly known as: SYNTHROID, LEVOTHROID  Last time this was given: ***** *****, *****  5:51 AM   Take 112 mcg by mouth every morning.      magnesium oxide 400 mg (241.3 mg elemental) tablet  Commonly known as: MAG-OX  Last time this was given: ***** *****, *****  5:42 PM   Take 1 tablet (400 mg total) by mouth every evening.      metoprolol succinate 25 MG 24 hr tablet  Commonly known as: TOPROL-XL  Last time this was given: ***** *****, *****  8:21 AM   Take 1 tablet (25 mg total) by mouth daily.      nitroglycerin 0.4 MG SL tablet  Commonly known as: NITROSTAT   PLACE 1 TABLET (0.4 MG TOTAL) UNDER THE TONGUE EVERY 5 (FIVE) MINUTES AS NEEDED FOR CHEST PAIN.      pantoprazole 40 MG tablet  Commonly known as: PROTONIX  Last time this was given: ***** *****, *****  8:21 AM   Take 1 tablet (40 mg total) by mouth 2 (two) times a day.      potassium chloride SA 20 MEQ ER tablet  Commonly known as: K-*****,KLOR-CON  Last time this was given: ***** *****, *****  8:21 AM   
Take 1 tablet (20 mEq total) by mouth daily.      ranolazine 1,000 mg SR tablet  Commonly known as: RANEXA  Last time this was given: ***** *****, *****  8:21 AM   Take 1 tablet (1,000 mg total) by mouth 2 (two) times a day.      sertraline 100 MG tablet  Commonly known as: ZOLOFT  Last time this was given: ***** *****, *****  8:22 AM   Take 2 tablets (200 mg total) by mouth daily.      torsemide 20 MG tablet  Commonly known as: DEMADEX  For: accumulation of fluid resulting from chronic heart failure, reduce dose due to kidney injury,recovering  Last time this was given: ***** *****, *****  8:21 AM   Take 2 tablets (40 mg total) by mouth daily.  What changed: how much to take      traZODone 50 MG tablet  Commonly known as: DESYREL  Last time this was given: ***** *****, *****  1:43 AM   Take 1 tablet (50 mg total) by mouth nightly at bedtime as needed.                       Hospital Care Team   Service: Medicine  Inpatient Attending: ***** *****, MD, MBBS     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 10:30 AM ***** ***** *****, MD Acute Care Neurosurgery on WAC ***** *****-*****-*****  Follow Up    *****/*****/***** 2:40 PM ***** ***** *****, MD ***** *****-*****-***** NSP *****     *****/*****/***** 12:00 PM (Arrive by 11:55 AM) ***** ***** *****, MD Interventional Cardiac Associates - ***** ***** *****-*****-*****  VIRTUAL ESTABLISHED    *****/*****/***** 8:00 PM ***** SLEEP ***** ***** ***** SLEEP CENTER *****-*****-*****      *****/*****/***** 9:00 AM ***** *****, MD NSP PULM ***** 55 ***** GROUP *****-*****-***** NSP *****     *****/*****/***** 8:00 AM ***** ***** *****, DPM ***** Podiatry *****-*****-*****  Routine Diabetic          Signed Discharge Orders (From admission, onward)             Ordered        
*****/*****/***** 1241  Activity as tolerated            *****/*****/***** 1241  Discharge diet        Comments: Diet Regular       *****/*****/***** 1241  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.        Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.         *****/*****/***** 1241  Remove Staples / Sutures        Comments: Please remove scalp staples in 1 week at primary care physicians office   Question Answer Comment   Location Scalp    Apply Steri strips? No                                Exam   Temperature: 36.4 째C (97.6 째F) (*****/*****/***** 1136) | Heart Rate: (!) 59 (*****/*****/***** 1136) | BP: 116/56 (*****/*****/***** 1136) | Respiratory Rate: 18 (*****/*****/***** 1136)  | SpO2: 99 % (*****/*****/***** 1136)  O2 Device: None (Room air) (*****/*****/***** 1136)    |        Weight: 72.1 kg (159 lb) (*****/*****/***** 0800)  Height: 167.6 cm (5' 6"") (*****/*****/***** 0800)         BMI (Calculated): 25.68 (*****/*****/***** 0800)    Discharge Exam    Significant Discharge Exam Findings: Constitutional: Alert and oriented x3, Not in acute distress  HEENT: Pupils equal, round, reactive to light, Moist mucous membranes    CVS: Pulse- Regular,Rate and Rhythm,Normal S1 & S2 , No murmurs, rubs or gallops, No lower limb swelling  Resp: Air entry Bilaterally, No wheezes, No Rales, No dullness on percussion  Abd: Soft, Non distended, Not tender, Not hot, Bowel sounds present,  Neuro: Power 5/5 Bilaterally, No focal deficits noted  Skin: No skin rash, No Skin Ulcers  Psych: Normal Mood and affect               Orientation Level: Oriented X3   Cognition: Age appropriate, Follows commands         Speech: Appropriate for age, Clear     Special Needs    Special Needs: None              Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the 
patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 6.85 *****/*****/***** *****    RBC 3.46 (L) *****/*****/***** *****    HGB 10.6 (L) *****/*****/***** *****    HCT 33.5 (L) *****/*****/***** *****    MCH 30.6 *****/*****/***** *****    MCV 96.8 *****/*****/***** *****    PLT 185 *****/*****/***** *****    RDW 15.8 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 142 *****/*****/***** *****    ***** 3.7 *****/*****/***** *****    ***** 103 *****/*****/***** *****    CO2 26 *****/*****/***** *****    BUN 27 (H) *****/*****/***** *****    CRE 1.44 (H) *****/*****/***** *****    ***** 8.8 (L) *****/*****/***** *****    GLU 125 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.0 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.8 *****/*****/***** *****    ***** 1.0 *****/*****/***** *****                        "
150015490,0,1,"

Note Date: *****/*****/*****  Time: 1700

Note Type: Initial note

Note Title: Neurology Consult Note

Signed by ***** *****, MD on *****/*****/***** at 10:18 pm  Affiliation: *****

***** by ***** *****, MD on *****/*****/***** at 8:45 am

 

Neurology Resident ***** ***** *****/*****



Reason for Consultation:



HPI: ***** ***** is a ***** year old male with a history of alcohol

use disorder and withdrawal seizures as well as necrotizing

alcohol induced pancreatitis, and IDDM who was ***** *****/*****/*****

and subsequently developed headache found to have SDH now s/p 3

SDH *****, currently with subdural drain in place on

Keppra, who was consulted for medication recommendations after a

possible complex partial seizure last night.



History elicited from chart review. The patient initially

presented after an assault on *****/*****/***** where he was found to have

a facial and nasal fracture and was *****. No surgery was

indicated at this time. Patient was discharged home and was told

not to do heavy lifting. A few weeks later he started having a

headache, and reported he had returned to work as a roofer, and

had been doing heavy lifting during this time. 



On *****/***** he presented to OSH with 1 week h/o worsening headache

where CTH showed large left SDH. He was taken to *****, had the SDH

evacuated and subdural drain was placed, removed two days later.

Patient was discharged on *****/***** on Keppra 1g PO BID. The patient

went home, then represented to OSH on *****/***** with worsening

headache, where NCHCT showed left SDH with more midline shift. He

was ***** to ***** for further management.



Patient was taken to ***** on *****/*****, had SDH evacuated again on *****/*****

with subdural drain placed, which was then removed on *****/*****. On

*****/*****, the patient reportedly had a ***** for 30 seconds for which

his Keppra was increased to 1500mg BID. On *****/***** the patient had

to be code purple due to agitation and and attempt to leave the

hospital. A repeat CTH for agitation was ordered, which showed a

recurrence of the left SDH with worsening midline shift. On *****/*****

the patient was taken back to the OR and had another SDH

evacuation, and the subdural drain is currently in place. 



The patient supposedly had a complex partial seizure last night,

for which neurology was consulted in order to determine which

second agent should be added in the face of a new possible

seizure disorder.



On neurologic review of systems, the patient endorses headache.

Denies lightheadedness, difficulty with producing or

comprehending speech. Denies blurred vision, diplopia, tinnitus,

dysarthria, or dysphagia. Denies focal muscle weakness, numbness,

parasthesia. 



On general review of systems, the pt denies recent fever or

chills.  No night sweats or recent weight loss or gain. Denies

cough, shortness of breath.  Denies chest pain or tightness,

palpitations.  Denies nausea, vomiting, diarrhea, constipation or

abdominal pain.  No recent change in bowel or bladder habits.  



PMH/PSH:

-Insulin-Dependent Diabetes

-H/o alcoholic pancreatitis

-Hypertension

-Hyperlipidemia

-Asthma

-h/o assault on *****/*****/*****                                          





Current Medications

1000 mL NS Continuous at 75 mL/hr

Acetaminophen-*****-Butalbital *****-***** TAB PO Q6H:PRN Pain - Moderate

Resumed from ***** ***** ***** for PRN duplicate override:

Alternating agents for similar severity Do not exceed 6

tablets/day. Do not exceed 4g Acetaminophen in 24 hours from any

source.

Acetaminophen 650 mg PO/NG Q8H:PRN Headache Resumed from *****

Order

Bisacodyl 10 mg PO/PR DAILY:PRN constipation

Calcium Carbonate 500 mg PO/NG QID:PRN indigestion Resumed from

Preop Order

CeFAZolin 2 g IV Q8H

Docusate Sodium 100 mg PO/NG BID

Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol Resumed from

Pre-Transfer Order

DiphenhydrAMINE 25 mg PO/NG Q6H:PRN itchiness

FoLIC Acid 1 mg PO/NG DAILY

Glucagon 1 mg IM *****:PRN hypoglycemia protocol Resumed from

Pre-Transfer Order

Glucose Gel 15 g PO PRN hypoglycemia protocol Resumed from

Pre-Transfer Order Treatment guidelines for patients who are

responsive and able to swallow oral carbohydrates. Glucose gel

may be given to patients who are NPO for procedure.

Gabapentin 300 mg PO/NG TID

Heparin 5000 UNIT SC BID

HydrALAZINE 10-20 mg IV Q6H:PRN SBP > 160

Insulin SC (per Insulin Flowsheet) Sliding ***** & Fixed Dose

Influenza Vaccine Quadrivalent 0.5 mL ***** ***** X1

LevETIRAcetam 1500 mg PO Q12H Resumed from *****-Transfer Order

Next Dose, 1500mg at 2000 *****/*****

LORazepam 0.5 mg PO/NG Q8H:PRN anxiety Resumed from ***** *****

Multivitamins 1 TAB PO DAILY

Ondansetron 4 mg IV Q8H:PRN nausea

Omeprazole 20 mg PO DAILY Resumed from ***** *****

OxyCODONE (Immediate Release) 5-10 mg PO/NG Q4H:PRN Pain -

Moderate

***** 8.6 mg PO/NG BID:PRN PRN Constipation Resumed from

Pre-Transfer Order

***** Lotion 1 ***** ***** QID:PRN rash

Thiamine 100 mg PO/NG DAILY



ALLERGIES:

 Latex - Rash        



SOCIAL HISTORY:

Unable to corroborate with patient                     



FAMILY HISTORY:

Unable to corroborate with patient                         



PHYSICAL EXAMINATION

 Vitals: T:afebrile  P:68  R: 16  BP:127/65  SaO2:99% RA

 General: Lying in bed with eyes closed, eyes open slightly to

voice

 HEENT: JVD in place

 Neck: Supple, no carotid bruits appreciated. 

 Pulmonary: Lungs CTA bilaterally without R/R/W

 Cardiac: RRR, nl. S1S2, no M/R/G noted

 Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or

organomegaly noted.

 Extremities: No LE edema.

 Skin: no rashes or lesions noted.



Neurologic:



-Mental Status: Opens eyes to voice. On earlier exam, patient

very agitated and kept repeating ""I need to go home"" but would

not answer questions or follow commands. *****, patient *****.

Tells me his name, knows he's at *****, can't give me a history

about why he is here, and says it is ***** *****, *****. He can't

remember what year he was born, and he can't correctly tell me

the date after I tell him we are in *****. He can repeat, name

high and low frequency objects. Cannot name ***** ***** ***** *****

or backwards. Able to read without difficulty. Speech was not

dysarthric. Able to show me a thumbs up. Pt was able to *****

3 objects and recall *****/***** at 5 minutes and the 3rd with choices.

There was no evidence of apraxia or neglect.



-Cranial Nerves:

 II, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without

nystagmus. Normal saccades. VFF to confrontation. Visual acuity

intact to reading. 

 V: Facial sensation intact to light touch.

 VII: No facial droop, facial musculature symmetric.

 VIII: Hearing intact to finger-rub bilaterally.

 IX, X: Palate elevates symmetrically.

 *****: 5/5 strength in trapezii.

 XII: Tongue protrudes in midline.



-Motor: Normal bulk, tone throughout. Patient initially refusing

to participate in exam because he was reporting headache.

*****, biceps, triceps, wrist extension full. IPs full

bilaterally, as were TA and gastroc. 



-Sensory: No deficits to light touch, pinprick, vibratory sense,

proprioception throughout. No extinction to DSS.



-DTRs:

   ***** Tri ***** ***** *****

 *****  2  2+   2+   2+   1

 R  2  2+   2+   2+   1

 Plantar response was withdrawal bilaterally. 1-2 beats clonus on

the left, non on the right. 



-Coordination: Refused to perform *****. ***** tapping with much

encouragement intact bilaterally. 



-Gait: Did not test because patient complaining of headache. 



Laboratory Data:



 136  96  7     *****=14 

------------<207 

4.1  26  0.7  



Ca: 8.9 Mg: 1.9 P: 3.8

  



8.3 > 11.*****/*****.2 < 176 

  



IMAGING:

 Non-Contrast CT of Head:

 

IMPRESSION:  

  

1.  No significant change in fluid collections, including

components of acute 

subdural hemorrhage.  Minimal left uncal herniation is stable. 

2.  Stable 6 mm rightward midline shift. 

3.  No new hemorrhage is identified. 





ASSESSMENT:

***** ***** is a ***** year old male with a history of alcohol use

disorder and withdrawal seizures as well as necrotizing alcohol

induced pancreatitis, and IDDM who was ***** *****/*****/***** and

subsequently developed headache found to have SDH now s/p 3 SDH

*****, currently with subdural drain in place on Keppra,

who was consulted for medication recommendations after a possible

complex partial seizure last night.

Neurological exam is significant for mental status oriented to

self and hospital only with fluctuation (agitation with code

***** today followed by period where he became ""aphasic"" and

not answering questions to primary team), some inattention and

potentially refusal to participate in exam, as well as

symmetrically increased reflexes in the lower extremities with

prominent withdrawal so unable to assess plantar response. CTH

this afternoon for continued fluctuation in mental status showed

no change from prior. 

An event overnight was called a complex partial seizure, but no

further description of the event is available. Differential for

mental status that fluctuates between agitation and A/*****-3

includes delirium vs non-convulsive status vs toxic-metabolic

effect. Clinically, he appears to appear delirious, as he will

follow commands and answer some questions in between periods of

agitation but remains confused and not fully oriented or able to

provide history. However, he does have structural brain damage

with fluctuating ICP given repeated drains and *****, so he is

at high risk for an epileptic focus. 



Recommendations:

- Trial of Ativan when agitated/not following commands to see if

he has symptomatic improvement. Would give 2mg of Ativan and

assess response. 

- cvEEG monitoring to rule out non-convulsive status

- Would recommend holding off on loading second AED at this point

given lack of clear description of seizure episode overnight.

However, if he cannot get EEG and continues to have AMS, Dilantin

would likely be first choice. 

- Recommend full toxic metabolic workup be repeated, including

LFTs and lipase. 

- West consult team to follow. 



Patient discussed with chief neurology resident Dr. *****. 



***** *****, MD

Neurology Resident PGY-2

*****

  





Addendum by ***** *****, MD on *****/*****/***** at 8:45 am:

I have seen and examined the patient on *****/*****/***** and have

reviewed the note of Dr. *****. I agree with her assessment and

plan.



Improved MS in the afternoon. Reports recurrent paresthesias

starting in right hand and rising to elbow suggestive of  partial

seizures.



Recommend:

-increase Keppra

- EEG"
116269678,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: Electronic copy of HCP available      Health Care Agents     *****, ***** ***** Healthcare ***** (Proxy form on file) - Father Not Active   Primary Phone:  *****-*****-***** (Mobile)  Home Phone:  *****-*****-*****           *****, ***** .Primary Health Care ***** (Proxy form on file) - Mother Not Active   Primary Phone:  *****-*****-***** (Mobile)  Home Phone:  *****-*****-*****  Work Phone:  *****-*****-*****                 Code Status at *****: Full Code (Presumed)                           Hospitalization Summary     Reason for Admission: Nausea and Vomiting  Principal Problem:    Hx of drug overdose  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     None          Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    [ ] AED levels pending at time of discharge  [ ] Tacro level pending at *****  [ ] Vimpat plan __________       Pending Results     Procedure Component Value Ref Range Date/Time    Blood culture, routine [*****] Collected:  *****/*****/***** 2029    Lab Status:  Preliminary result Specimen:  Blood Updated:  *****/*****/***** 0730     Specimen Source/ Description BLOOD BLOOD     SPECIAL REQUESTS None     CULTURE / TEST NO GROWTH 1 DAY     REPORT STATUS PENDING    Urine culture [*****] Collected:  *****/*****/***** 0008    Lab Status:  In process Specimen:  Urine Updated:  *****/*****/***** 0427    Tacrolimus level [*****] Collected:  *****/*****/***** 2029    
Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 2036    Lamotrigine level [*****] Collected:  *****/*****/***** 2029    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 2035    Lacosamide Level [*****] Collected:  *****/*****/***** 2029    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 2035             Hospital Course   ***** y.o. gentleman with a h/o non-ischemic cardiomypathy s/p LVAD placement then heart transplant on *****/*****/*****, on warfarin anticoagulation, traumatic SDH (evacuated *****/*****/*****, secondary to trauma associated a music concert) and afterwards had secondary hydrocephalus co-presenting in status (s/p Low fixed-pressure, left occipital VP shunt on *****/*****/*****; explanted on *****/*****/*****), seizure disorder on VPA 1500mg BID, Vimpat 200 mg BID, and Lamictal 200+300mg, who presents with nausea and vomiting of 2 days duration.     ----------------------------------------------------  HISTORY OF PRESENTING ILLNESS  ----------------------------------------------------  ***** ***** ***** is a ***** y.o. gentleman with a h/o non-ischemic cardiomypathy s/p LVAD placement then heart transplant on *****/*****/*****, on warfarin anticoagulation, traumatic SDH (evacuated *****/*****/*****, secondary to trauma associated a music concert) and afterwards had secondary hydrocephalus co-presenting in status (s/p Low fixed-pressure, left occipital VP shunt on *****/*****/*****; explanted on *****/*****/*****), seizure disorder on VPA 1500mg BID, Vimpat 200 mg BID, and Lamictal 200+300mg, who presents with nausea and vomiting of 2 days duration.    To briefly summarize his recent history, he was recently admitted between *****/*****/***** with fixed low pressure and underwent L occipital VPS explanation on *****/*****/*****. He tolerated the procedure well and was discharged home on *****/*****/*****.     He saw Dr. ***** in clinic today who noted that the patient has been having N/V x2 days with progressive motion induced vertigo. He underwent a head CT which 
was stable from prior. He was admitted to the neurology floor to exclude any central source and evaluate for sources of his symptoms. On medication review with his family, it was noted that they had been administering lacosamide 400mg BID (instead of 200mg BID), and -as a result- poison control was contacted who recommended holding the medication and checking a level. Continuous cardiac monitoring was started to ensure there was no evidence of arrythmias or bradycardia.    - Notable Admission Imaging -  Head CT (*****/*****/*****): Evolving postsurgical changes overlying the left frontoparietal regions with no evidence of superimposed acute pathology.    MRI/MRA Brain (*****/*****/*****): Unchanged compared to prior    -------------------------------------------------  HOSPITAL COURSE BY PROBLEM  -------------------------------------------------  # Nausea/Vomiting: The etiology of his nausea vomiting and vertigo is thought to be secondary to lacosamide toxicity. Work up included amylase, lipase, TSH with reflex, ammonia, lactate which were all relatively stable. EKG stable and maintained on telemetry without any acute findings. Symptomatic management with fluids, ondansetron and prochlorperazine PRN as well as holding nightly dose of vimpat completely resolved symptoms. Patient discharged with the following instructions regarding vimpat ________.    [ ] AED levels pending at time of discharge  [ ] Tacro level pending at *****  [ ] Vimpat plan is to continue on 200 mg BID         Medications   Allergies: Patient has no known allergies.    Prior to Admission Medications   Prescriptions   LORazepam (ATIVAN) 1 MG tablet   Sig: Take 1 tablet (1 mg total) by mouth every 6 (six) hours as needed (Seizure).   Patient not taking: Reported on *****/*****/*****   amoxicillin (AMOXIL) 500 MG capsule   Sig: 4 tabs 1-2 hrs prior to dentist*****Dr *****)   ascorbic acid, vitamin C, (VITAMIN C) 500 MG tablet   Sig: Take 1 tablet (500 mg total) by mouth 2 
(two) times a day.   aspirin 81 MG EC tablet   Sig: Take 1 tablet (81 mg total) by mouth daily.   Patient taking differently: Take 81 mg by mouth daily. ***** resume taking on ***** *****/*****/*****   calcium carbonate-vitamin D3 600 mg(1,500mg) -400 unit Cap   Sig: Take 1 tablet by mouth daily.   divalproex (DEPAKOTE) 500 MG DR *****   Sig: Take 1,500 mg by mouth 2 (two) times a day.   lacosamide (VIMPAT) 200 mg Tab   Sig: Take 1 tablet (200 mg total) by mouth 2 (two) times a day.   lamoTRIgine (LAMICTAL) 200 MG tablet   Sig: Please take by mouth as follows: 300mg (1.5 tabs) every morning and 200mg (1 tab) every night   magnesium oxide-Mg AA chelate 133 mg Tab   Sig: Take 4 tablets by mouth 2 (two) times a day.   mycophenolate mofetil (CELLCEPT) 500 mg tablet   Sig: Take 2 tablets (1,000 mg total) by mouth 2 (two) times a day. Decreased *****/*****   omeprazole (PRILOSEC) 20 MG capsule   Sig: Take 1 capsule (20 mg total) by mouth daily.   oxyCODONE 5 MG immediate release tablet   Sig: Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed for moderate pain. Partial fill ok   Patient not taking: Reported on *****/*****/*****   pravastatin (PRAVACHOL) 40 MG tablet   Sig: Take 1 tablet (40 mg total) by mouth nightly.   predniSONE (DELTASONE) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth daily.   tacrolimus (***** *****) 4 mg extended release 24 hour tablet   Sig: Take 8 mg by mouth daily.   therapeutic multivitamin tablet   Sig: Take 1 tablet by mouth daily.   vitamin E 400 UNIT capsule   Sig: Take 1 capsule (400 Units total) by mouth 2 (two) times a day.      Facility-Administered Medications: None        Medication List      STOP taking these medications     amoxicillin 500 MG capsule  Commonly known as:  AMOXIL      oxyCODONE 5 MG immediate release tablet        TAKE these medications        Instructions    mycophenolate mofetil 500 mg tablet  Commonly known as:  CELLCEPT  Last time this was given:  *****/*****/*****  8:31 
AM  This medication is very important:  It prevents organ rejection.   Take 2 tablets (1,000 mg total) by mouth 2 (two) times a day. Decreased *****/*****  *****'s comments:  Transplant date *****/*****/*****      predniSONE 5 MG tablet  Commonly known as:  DELTASONE  Last time this was given:  *****/*****/*****  8:31 AM  This medication is very important:  It prevents organ rejection.   Take 1 tablet (5 mg total) by mouth daily.  *****'s comments:  Heart transplant *****/*****/*****      tacrolimus 4 mg extended release 24 hour tablet  Commonly known as:  ***** *****  Last time this was given:  *****/*****/*****  8:31 AM  This medication is very important:  It prevents organ rejection.   Take 8 mg by mouth daily.      ascorbic acid (vitamin C) 500 MG tablet  Commonly known as:  VITAMIN C   Take 1 tablet (500 mg total) by mouth 2 (two) times a day.      aspirin 81 MG EC tablet  Last time this was given:  *****/*****/*****  8:30 AM   Take 1 tablet (81 mg total) by mouth daily.  What changed:  additional instructions      calcium carbonate-vitamin D3 600 mg(1,500mg) -400 unit Cap  Last time this was given:  Ask your nurse or doctor   Take 1 tablet by mouth daily.      divalproex 500 MG DR *****  Commonly known as:  DEPAKOTE  Last time this was given:  *****/*****/*****  8:31 AM   Take 1,500 mg by mouth 2 (two) times a day.      lacosamide 200 mg Tab  Commonly known as:  VIMPAT   Take 1 tablet (200 mg total) by mouth 2 (two) times a day.  *****'s comments:  For refills contact primary neurologist Dr. *****      lamoTRIgine 200 MG tablet  Commonly known as:  LaMICtal  Last time this was given:  *****/*****/*****  8:31 AM   Please take by mouth as follows: 300mg (1.5 tabs) every morning and 200mg (1 tab) every night      LORazepam 1 MG tablet  Commonly known as:  ATIVAN   Take 1 tablet (1 mg total) by mouth every 6 (six) hours as needed (Seizure).      magnesium oxide-Mg AA chelate 133 mg Tab   Take 4 tablets by mouth 2 (two) times a day.      omeprazole 20 MG capsule  Commonly 
known as:  PriLOSEC  Last time this was given:  *****/*****/*****  8:30 AM   Take 1 capsule (20 mg total) by mouth daily.      pravastatin 40 MG tablet  Commonly known as:  PRAVACHOL  Last time this was given:  *****/*****/*****  8:37 PM   Take 1 tablet (40 mg total) by mouth nightly.      therapeutic multivitamin tablet  Last time this was given:  *****/*****/*****  8:34 AM   Take 1 tablet by mouth daily.      vitamin E 400 UNIT capsule   Take 1 capsule (400 Units total) by mouth 2 (two) times a day.                       Hospital Care Team   Service: Neurology  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 9:30 AM ***** *****, *****-C ***** Department of Neurosurgery *****-*****-*****     *****/*****/***** 8:00 AM ***** BIOPSY MD ***** ***** Cardiac Transplant *****-*****-***** ***** Main    *****/*****/***** 9:00 AM ***** ***** *****, NP ***** Cardiac Transplant *****-*****-***** ***** Main    *****/*****/***** 11:40 AM ***** ***** *****, MD *****, Department of Neurology *****-*****-*****     *****/*****/***** 1:00 PM ***** ***** *****, MD ***** Neurology at ***** *****-*****-*****     *****/*****/***** 8:20 AM ***** 221 BONE DENS Skeletal Health/Osteoporosis Ctr. and Bone Density Unit *****-*****-***** ***** Rad *****    *****/*****/***** 8:40 AM ***** ***** *****, MD ***** Endocrine, Diabetes, and Hypertension *****-*****-*****           Signed Discharge Orders (From admission, onward)    Ordered        *****/*****/***** 1348  Activity as tolerated         *****/*****/***** 1348  Discharge diet     Comments:  Diet Regular       *****/*****/***** 1348  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD at *****-*****-***** and ask him/her to be paged.   
  Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** *****, MD at *****-*****-***** and ask him/her to be paged.       *****/*****/***** 1348  Activity as tolerated         *****/*****/***** 1348  Discharge diet     Comments:  Diet Regular       *****/*****/***** 1348  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact senior resident, ***** *****     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact senior resident, ***** *****           Discharge instructions and important events and results    Hello ***** ***** *****,    It was a pleasure taking care of you over the past 1 days in the hospital for your recent admission. As you are aware, you were admitted to the hospital for nausea and vomiting. While you were in the hospital, we were able to figure out that this is due to your vimpat dosing.     Before you go, it is important for me to remind you of the following:  1) Instructions to restart vimpat __________    It is important that you review all medication changes with your nurse before you leave.     If you have any chest pain, shortness of breath, lightheadedness, diarrhea, bloody stools, fevers, please seek medical care right away.     Again, it was truly a pleasure to take care of you in the hospital. I hope that you have a ***** recovery. If you have any questions before you leave, be sure to reach out.     Sincerely,    Your Neurology In-patient Team               Exam   Temperature: 36.5 째C (97.7 째F) (*****/*****/***** 0814) | Heart Rate: 88 (*****/*****/***** 1000) | BP: 118/62 (*****/*****/***** 0814) | Respiratory Rate: 18 (*****/*****/***** 0814)  | SpO2: 98 % (*****/*****/***** 0814)  O2 Device: None (Room air) (*****/*****/***** 0814)    |        Weight: 94.3 kg (208 lb) (*****/*****/***** 1900)  Height: 172.7 cm (5' 8"") (*****/*****/***** 
1900)         BMI (Calculated): 31.6 (*****/*****/***** 1900)    Discharge Exam    Significant Discharge Exam Findings:  BP 126/70  | Pulse 87  | Temp 36.7 째C (98 째F) (Oral)  | Resp 18  | Ht 172.7 cm (5' 8"")  | Wt 94.3 kg (208 lb)  | SpO2 99%  | BMI 31.63 kg/m짼     MENTAL STATUS: Alert, interactive, language fluent, follows commands  CRANIAL NERVES: PERRL, visual fields intact to finger counting, EOMI without double vision, facial movements full & symmetric, no dysarthria   MOTOR: Full strength in arms and legs  SENSORY: Intact to LT in arms and legs  REFLEXES: 2+ at elbows and knees  COORDINATION: ***** intact  GAIT: Deferred                Orientation Level: Oriented X7   Cognition: Follows commands         Speech: Clear     Vision: Functional with Correction  Hearing: Functional   Assistive Devices: Eyeglasses       Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 6.53 *****/*****/***** *****    RBC 3.77 (L) *****/*****/***** *****    HGB 11.9 (L) *****/*****/***** *****    HCT 36.2 (L) *****/*****/***** *****    MCH 31.6 *****/*****/***** *****    MCV 96.0 (H) *****/*****/***** *****    PLT 202 *****/*****/***** *****    RDW 12.5 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 142 *****/*****/***** *****    ***** 4.7 *****/*****/***** *****    ***** 102 *****/*****/***** *****    CO2 28 *****/*****/***** *****    BUN 25 (H) *****/*****/***** *****    CRE 1.03 *****/*****/***** *****    ***** 8.8 *****/*****/***** *****    GLU 97 *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 1.8 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.1 *****/*****/***** *****    INR 1.0 *****/*****/***** *****                        "
121229724,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** ***** *****  ***** ***** *****  ***** ***** ***** *****  Home Phone: *****-*****-***** (home)     What language do you prefer to use when discussing your healthcare?: English  What language do you prefer for written communication?: English    Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is available to place in chart      Health Care Agents          There are no health care agents on file.          Code Status at *****: DNR/DNI (No CPR/No Intubation)       Discharge address same as *****: Yes                   Hospitalization Summary       Principal Problem (Resolved):    Altered mental status  Active Problems:    ***** No active hospital problems. *****          Surgical (OR) Procedures:   Surgeries this Admission     None          Non (OR) Procedures:        Items for Post-Hospitalization Follow-Up:    #Goals of care: Patient and family reported he wishes to be DNR/DNI and do not re-hospitalize. ***** was filled out. In discussion with patient's family, the decision was made to discharge the patient home with hospice care at home as well as 24 hr personal care.   #Hypercalcemia: Pending labs: PTHrP, 1,25 ***** Vit D, - consider parathyroid scan as outpatient if work up unrevealing and within GOC  #L subdural hemorrhage: Outpatient ***** follow up   #Kidney Transplant: continued on Tacrolimus 1mg PO BID as well as prednisone QOD  #Mild Cognitive Impairment: Consider outpatient follow-up for consideration of cognitive rehabilitation therapy  # T2DM: Dose reduced to ***** ***** daily         Pending Results     Procedure Component Value Ref Range Date/Time    *****-*****-***** vitamin D [*****] Collected:  *****/*****/***** 0628    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 
0653    *****-*****-***** vitamin D [*****] Collected:  *****/*****/***** 0552    Lab Status:  In process Specimen:  Blood Updated:  *****/*****/***** 0556    PTH related protein [*****] Collected:  *****/*****/***** 0140    Lab Status:  In process Updated:  *****/*****/***** 0153           Hospital Course   ***** with h/o cognitive impairment, recent burr hole placement for SDH, depression, chronic pain, OSA not on CPAP, cystic kidney disease s/p ***** 2008 (b/l Cr ~1.4) c/b renal artery stenosis, on pred/tacro, T2DM c/b peripheral neuropathy, mod AS, and HFpEF (EF 63%) who presents with altered mental status c/f progressive brain injury and toxic-metabolic encephalopathy.    ***** with h/o cognitive impairment, recent burr hole placement for SDH, depression, chronic pain, OSA not on CPAP, cystic kidney disease s/p ***** 2008 (b/l Cr ~1.4) c/b renal artery stenosis, on pred/tacro, T2DM c/b peripheral neuropathy, mod AS, and HFpEF (EF 63%) who presents with altered mental status c/f progressive brain injury and toxic-metabolic encephalopathy, with improvement in mental status after tapering off medications.     =============================  HOSPITAL COURSE BY PROBLEM  =============================    #Altered mental status: Pt's recent decline began in *****/***** which led to the initial identification of sub-dural hematoma *****/***** at his last hospitalization. Work-up for his current presentation of acute decline revealed: head CT with subdural fluid collection that appeared slightly decreased in size in comparison to the prior CT, postsurgical changes with interval resorption of pneumocephalus, unchanged rightward midline shift, no evidence of uncal herniation, no evidence of new hemorrhage or infarct. Delirium work-up revealed hypercalcemia (see below), while polypharmacy was concerning for a contributing cause. Of note, he had no focal or asymmetric neurological deficits on exam, VBG was within normal limits, and TSH elevated 6.55, Free T4 WNL. Infectious 
work-up with urinalysis and chest X-ray were normal. In the setting of tapering off keppra (as below), patient underwent EEG which showed some diffuse theta/delta slowing of the background, no epileptiform abnormalities seen. Pt was also treated with an aggressive bowel regimen. In consultation with patient's outpatient endocrinologist, his lantus was dose reduced and switched to the morning with good effect.  Psychiatry was consulted, and in consultation with patient's outpatient psychiatrist Dr. *****, memantine, modafinil, and bupropion were stopped.  His PO risperidone was changed to 0.25mg Q8H PRN with melatonin ***** ***** After doing the above interventions, patient showed significant improvement in his mental status back to normal. In discussion with patient's family, the decision was made to discharge the patient home with hospice care at home as well as 24 hr personal care. Patient and family reported he wishes to be DNR/DNI and do not hospitalize. At discharge, patient was counseled to use the risperidone only sparingly for agitation not responding to verbal redirection.     #Mild hypercalcemia: On admission, Ca 11.3, iCa 1.40. His EKG was at his baseline notable for ECG w/ known RBBB and wide QRS, 1st degree AV block, unchanged from prior.  Thought not to be secondary to secondary hyperthyroidism as PTH in the 80s. On ddx include multiple myeloma, oncogenic hypercalcemia, or immobilization hypercalcemia. SPEP was normal pattern, ***** WNL, 25OH vitamin D 59. Patient received IV fluids and pamidronate x 2, and was continued on cinacalcet. At discharge, his Ca was 9.6 WNL.  - Pending labs: PTHrP, 1,25 ***** Vit D  - consider parathyroid scan as outpatient if work up unrevealing     #L Subdural hemorrhage: Reportedly chronic, identified when patient presented with mild speech and gait changes as well as confusion earlier this *****. ***** 3.5 cm with 1 cm midline shift. Now s/p burr hole on *****/*****/*****, with 
improvement in neurological symptoms. Subsequent CT scans have shown slow improvement, most recently with 19 mm thickness and residual midline shift on *****/*****. Keppra wean was continued as planned, and he completed his last dose on *****/*****.  - Outpatient ***** follow up      #Kidney transplant: ***** in 2008, c/b renal artery stenosis and HTN. On prednisone/tacrolimus for immunosuppression. Bactrim stopped during recent hospitalization due to AKI. Transplant Nephrology was following, and additionally provided recommendations for management of his hypercalcemia as noted above. Pt was continued on Tacrolimus 1mg PO BID.     #Mild cognitive impairment: MoCA *****/***** in *****/*****. At baseline: fully oriented, can do basic calculations, intact attention, memory w/ mild impairments (*****/***** recall at 5 minutes). Motor exam with a little bit of generalized weakness throughout, at least *****/***** without focal deficits. Eats w/ assistance. Ambulatory w/ a rolling walker, with two-person assist. As noted for management of altered mental status above, memantine was stopped while risperidone was dose adjusted to PRN.  - Consider outpatient follow-up for consideration of cognitive rehabilitation therapy    #T2DM: he was on 25 lantus QAM, lispro 5 TID at *****. This was dose reduced to 10 lantus QAM (5 if NPO), and the standing lispro was discontinued following recommendation from his Endocrinology. He required minimal lispro sliding scale of usually 1U with meals.   - Resume home ***** at 10U daily      #HTN: HFpEF and renal artery stenosis. Recently stopped HCTZ given the hypercalcemia, uptitrated to amlodipine 10 daily, lasix 40 daily, coreg 50 BID which were continued.      #Aortic stenosis with HFpEF: moderate AS, mean gradient 37 mmHg, valve area <1cm2.      #Depression: Follows with Dr. *****. Noted to have MoCA *****/***** in *****/*****. Bupropion was discontinued, while duloxetine was continued for management of altered mental status as noted 
above.    #Chronic pain: Has been on opioids for many years. Stopped prior to his presentation from ***** in reaction to altered mental status. His pain was managed with oxycodone 2.5 - 5mg PRN.     #Anemia: Pt with iron deficiency anemia, likely *****/***** CKD, started on daily ferrous sulfate supplementation.       ================================  ADMISSION HISTORY AND PHYSICAL  =================================    ***** ***** is a ***** y.o. male with h/o cognitive impairment, recent burr hole placement for SDH, depression, chronic pain, OSA not on CPAP, cystic kidney disease s/p ***** 2008 (b/l Cr ~1.4) c/b renal artery stenosis, on pred/tacro, T2DM c/b peripheral neuropathy, mod AS, and HFpEF (EF 63%) who presents with altered mental status.     The patient initially presented in early ***** with mild speech and gait changes, intermittent mild confusion with waxing and waning mental status, found to have large chronic L SDH, max thickness 3.5 cm with 1 cm midline shift. ***** hole evacuation of L-sided SDH on *****/*****, started on keppra 500 bid for seizure prophylaxis.      On returning home, had low-grade temps and was admitted on *****/***** due to concern for pulmonary edema and possible pneumonia. 7-day course vanc/levaquin. Course c/b flash pulmonary edema requiring ICU transfer, bumex gtt, and high-flow NC. Weaned to RA at discharge. Course notable for peak Cr 3.09 and cessation of home ACEi and bactrim, to be restarted outpatient. Also had decreased mental status on admission and slow response to questioning. EEG w/o seizure activity, head CT stable, continued on keppra ppx for SDH. Per neurosurgery, patient was to continue keppra until *****/*****.      Admitted to ***** on *****/*****, where he was receiving PT and OT. However, per his wife and daughter, he was not at his baseline even when he went to *****. He could engage only minimally with therapy and would frequently ***** asleep during rehab. Was still alert and 
oriented x3, but eating and drinking progressively less. They felt his last good day was Tuesday, 3 days prior to presentation. After that he began complaining of worsening double vision and difficulty seeing what others could see. He was more agitated and in the 24 hours prior to presentation, developed very bad headaches that left him crying and rocking back and forth.      Initially, AMS thought to be due to keppra. ***** conferred with Dr. ***** and Dr. ***** ***** and initiated an expedited keppra taper. He is now on 250 qday with last dose on *****/*****. Psychiatric meds were continued as is: wellbutrin 150 daily, duloxetine 60 daily, memantine 5 BID, and modafinil 200 daily. Risperidone was decreased on *****/***** from 0.25 BID to 0.25 QHS. For hypercalcemia with iCa 1.52, he was started on sensipar 30 mg daily and mIVF. HCTZ for HTN was stopped and amlodipine titrated to 10 instead.      CT on *****/*****: residual 19 mm left cerebral convexity heterogeneous, but predominantly hypodense, subdural fluid collection appears slightly decreased in size in comparison to the prior CT. Postsurgical changes with interval resorption of pneumocephalus. Unchanged rightward midline shift. No evidence of uncal herniation. No evidence of new hemorrhage or infarct.     Due to acute worsening on *****/*****, the patient was transferred to ***** for additional work up.      ED Course:   Initial Vitals: 36.7 째C (98 째F) | HR 61 | BP 163/70 | RR 24  | SpO2 94 % on room air. | Weight 73.6 kg (162 lb 4.1 oz)    In the ED, vitals as above.    On arrival to the floor, he was afebrile, BP 160/70, HR 60s. He was following some basic commands but very *****, poor attention.              Medications   Allergies: Cephalosporins    Prior to Admission Medications   Prescriptions   DULoxetine (CYMBALTA) 60 MG capsule   Sig: Take 1 capsule (60 mg total) by mouth daily.   acetaminophen (TYLENOL) 650 MG suppository   Sig: Place 1 suppository (650 mg 
total) rectally every 6 (six) hours as needed.   amLODIPine (NORVASC) 10 MG tablet   Sig: Take 1 tablet (10 mg total) by mouth daily.   atorvastatin (LIPITOR) 80 MG tablet   Sig: Take 1 tablet (80 mg total) by mouth nightly.   bisacodyl (DULCOLAX) 10 mg suppository   Sig: Place 1 suppository (10 mg total) rectally daily as needed.   buPROPion (WELLBUTRIN SR) 150 MG SR 12 hr tablet   Sig: Take 1 tablet (150 mg total) by mouth daily.   carvedilol (COREG) 25 MG tablet   Sig: Take 2 tablets (50 mg total) by mouth 2 (two) times a day with meals.   cinacalcet (SENSIPAR) 30 mg tablet   Sig: Take 1 tablet (30 mg total) by mouth daily with breakfast for 57 doses.   dextrose (*****) 50 % ***** syringe   Sig: Inject 0-50 mL (0-25 g total) into the vein as needed (see administration instructions).   docusate sodium (COLACE) 100 MG capsule   Sig: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.   furosemide (LASIX) 40 MG tablet   Sig: Take 1 tablet (40 mg total) by mouth daily.   heparin 5,000 unit/mL injection   Sig: Inject 1 mL (5,000 Units total) under the skin every 8 (eight) hours.   insulin glargine (LANTUS) 100 unit/mL injection vial   Sig: Inject 25 Units under the skin daily.   ipratropium bromide 0.02 % nebulizer solution   Sig: Take 2.5 mL (500 mcg total) by nebulization every 6 (six) hours as needed for wheezing.   levETIRAcetam (KEPPRA) 250 MG tablet   Sig: Take 1 tablet (250 mg total) by mouth daily for 2 doses.   memantine (NAMENDA) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth 2 (two) times a day.   modafinil (*****) 200 MG tablet   Sig: Take 1 tablet (200 mg total) by mouth daily.   nystatin (*****) powder   Sig: Apply topically 2 (two) times a day.   omeprazole (PRILOSEC) 40 MG capsule   Sig: Take 1 capsule (40 mg total) by mouth daily before breakfast for 180 doses.   oxyCODONE 5 MG immediate release tablet   Sig: Take 0.5-1 tablets (2.5-5 mg total) by mouth every 6 (six) hours as needed 
for moderate pain or severe pain. Pt. may request partial fill   pneumococcal 13-valent, PF, (PREVNAR-13) 0.5 mL IM syringe   Sig: Inject 0.5 mL into the muscle once for 1 dose.   polyethylene glycol (MIRALAX) 17 gram packet   Sig: Take 34 g by mouth 2 (two) times a day.   predniSONE (DELTASONE) 5 MG tablet   Sig: Take 1 tablet (5 mg total) by mouth every other day.   risperiDONE (RISPERDAL) 0.25 MG tablet   Sig: Take 1 tablet (0.25 mg total) by mouth nightly.   senna (SENOKOT) 8.6 mg tablet   Sig: Take 1 tablet by mouth 2 (two) times a day.   sodium chloride (NS) 0.9 % syringe flush   Sig: Inject 3 mL into the vein as needed.   sodium chloride solution   Sig: Inject 5-10 mL/hr into the vein continuous prn (*****).   sodium chloride solution   Sig: Inject 100 mL/hr into the vein continuous for 1 day.   tacrolimus (PROGRAF) 1 MG capsule   Sig: Take 1 capsule (1 mg total) by mouth nightly.      Facility-Administered Medications: None        Discharge Medications      STOP taking these medications          buPROPion 150 MG SR 12 hr tablet   Also known as:  WELLBUTRIN SR       heparin 5,000 unit/mL injection       insulin glargine 100 unit/mL injection vial   Also known as:  LANTUS       levETIRAcetam 250 MG tablet   Also known as:  KEPPRA       memantine 5 MG tablet   Also known as:  NAMENDA       modafinil 200 MG tablet   Also known as:  *****       pneumococcal 13-valent (PF) 0.5 mL IM syringe   Also known as:  PREVNAR-13       sodium chloride 0.9 % syringe flush   Also known as:  NS       sodium chloride solution         START taking these medications       Dose, Frequency, and Details    allopurinol 100 MG tablet   Also known as:  ZYLOPRIM    Take 1 tablet (100 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:12 AM       ferrous sulfate 324 mg (65 mg elem iron) *****    Take 1 tablet (324 mg total) by mouth daily with breakfast.   Last time this was given:  *****/*****/*****  8:12 AM       insulin 
degludec U-***** ***** unit/mL (3 mL) ***** injection pen   Also known as:  ***** *****    Inject 10 Units under the skin daily.       melatonin 5 mg Tab    Take 1 tablet (5 mg total) by mouth nightly.   Last time this was given:  *****/*****/*****  6:20 PM         CHANGE how these medications are taken       Dose, Frequency, and Details    DULoxetine 60 MG capsule   Also known as:  CYMBALTA    Take 1 capsule (60 mg total) by mouth nightly.   What changed:  when to take this   Last time this was given:  *****/*****/*****  8:45 PM       risperiDONE 0.25 MG tablet   Also known as:  RisperDAL    Take 1 tablet (0.25 mg total) by mouth 2 (two) times a day as needed (agitation).   What changed:    - when to take this  - reasons to take this   Last time this was given:  *****/*****/*****  3:00 PM       tacrolimus 1 MG capsule   Also known as:  PROGRAF    Take 1 capsule (1 mg total) by mouth 2 (two) times a day.   What changed:  when to take this   Last time this was given:  *****/*****/*****  8:12 AM         CONTINUE taking these medications       Dose, Frequency, and Details    acetaminophen 650 MG suppository   Also known as:  TYLENOL    Place 1 suppository (650 mg total) rectally every 6 (six) hours as needed.       amLODIPine 10 MG tablet   Also known as:  NORVASC    Take 1 tablet (10 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:12 AM       atorvastatin 80 MG tablet   Also known as:  LIPITOR    Take 1 tablet (80 mg total) by mouth nightly.   Last time this was given:  *****/*****/*****  8:45 PM       bisacodyl 10 mg suppository   Also known as:  DULCOLAX    Place 1 suppository (10 mg total) rectally daily as needed.       carvedilol 25 MG tablet   Also known as:  COREG    Take 2 tablets (50 mg total) by mouth 2 (two) times a day with meals.   Last time this was given:  *****/*****/*****  8:12 AM       cinacalcet 30 mg tablet   Also known as:  SENSIPAR    Take 1 tablet (30 mg total) by mouth daily with breakfast for 57 doses.   Last time this 
was given:  *****/*****/*****  8:12 AM       dextrose 50 % ***** syringe   Also known as:  *****    Inject 0-50 mL (0-25 g total) into the vein as needed (see administration instructions).       docusate sodium 100 MG capsule   Also known as:  COLACE    Take 1 capsule (100 mg total) by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  9:27 AM       furosemide 40 MG tablet   Also known as:  LASIX    Take 1 tablet (40 mg total) by mouth daily.   Last time this was given:  *****/*****/*****  8:12 AM       ipratropium bromide 0.02 % nebulizer solution    Take 2.5 mL (500 mcg total) by nebulization every 6 (six) hours as needed for wheezing.       nystatin powder   Also known as:  *****    Apply topically 2 (two) times a day.   Last time this was given:  *****/*****/*****  8:54 PM       omeprazole 40 MG capsule   Also known as:  PriLOSEC    Take 1 capsule (40 mg total) by mouth daily before breakfast for 180 doses.   Last time this was given:  *****/*****/*****  8:12 AM       oxyCODONE 5 MG immediate release tablet    Take 0.5-1 tablets (2.5-5 mg total) by mouth every 6 (six) hours as needed for moderate pain or severe pain. Pt. may request partial fill   Last time this was given:  *****/*****/*****  3:01 PM       polyethylene glycol 17 gram packet   Also known as:  MIRALAX    Take 34 g by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  2:18 PM       predniSONE 5 MG tablet   Also known as:  DELTASONE    Take 1 tablet (5 mg total) by mouth every other day.   Last time this was given:  *****/*****/*****  8:47 AM       senna 8.6 mg tablet   Also known as:  SENOKOT    Take 1 tablet by mouth 2 (two) times a day.   Last time this was given:  *****/*****/*****  9:26 AM                 Immunizations Administered for This Admission     Name *****    Pneumococcal conjugate *****  Deferred (Patient Refused)             Hospital Care Team   Service: Medicine  Inpatient Attending: ***** ***** *****, MD     Attending ***** *****: (*****)*****-*****  Discharge 
Unit: *****  Primary Care Physician: ***** ***** *****, MD  *****-*****-*****        Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center    *****/*****/***** 10:45 AM ***** *****, MD Acute Care Neurosurgery on WAC ***** *****-*****-*****     *****/*****/***** 10:30 AM ***** ***** *****, MD ***** *****-*****-*****     *****/*****/***** 10:40 AM (Arrive by 10:25 AM) ***** ***** *****, MD ***** Renal Associates *****-*****-*****     *****/*****/***** 10:30 AM ***** ***** *****, MD, MPH Ophthalmic Consultants of ***** in ***** *****-*****-***** ***** WALTHAM    *****/*****/***** 11:00 AM MGC ***** WAL ***** Ophthalmic Consultants of ***** in ***** *****-*****-***** ***** WALTHAM    *****/*****/***** 9:00 AM ***** ***** ***** Vascular Ultrasound Diagnostic Laboratory *****-*****-***** ***** Main VAS    *****/*****/***** 11:00 AM ***** ***** *****, MD Interventional Cardiac Associates - ***** ***** *****-*****-*****     *****/*****/***** 10:10 AM ***** ***** *****, MD ***** Dermatology, *****.*****. *****-*****-*****          Follow-Up Services            HEBREW ***** HOSPICE CARE, INC   Specialty:  Hospice    ***** ***** *****  ***** ***** *****   Phone:  *****-*****-*****                 Signed Discharge Orders     Ordered        *****/*****/***** 1429  Activity as tolerated         *****/*****/***** 1429  Discharge diet     Question:  Diet Type  Answer:  Regular       *****/*****/***** 1429  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD at (*****)*****-*****.       *****/*****/***** 1429  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at 
*****-*****-*****.     Comments:  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your PCP: ***** ***** *****, MD at *****-*****-*****.       *****/*****/***** 1429  Patient will not be referred to/is not appropriate for cardiac rehabilitation at this time                       Exam   Temperature: 36.8 째C (98.3 째F) (*****/*****/***** 1331) | Heart Rate: 63 (*****/*****/***** 1331) | BP: 115/59 (*****/*****/***** 1331) | Respiratory Rate: 18 (*****/*****/***** 1331)  | SpO2: 93 % (*****/*****/***** 1331)  O2 Device: None (Room air) (*****/*****/***** 1331)  O2 Flow Rate (L/min): 2 |        Weight: 70.8 kg (156 lb 1.4 oz) (*****/*****/***** 0802)  Height: 175.3 cm (5' 9"") (*****/*****/***** 1700)         BMI (Calculated): 24 (*****/*****/***** 1700)    Discharge Exam    Significant Discharge Exam Findings:  General: lying in bed, alert and oriented, answers most questions appropriately though hard of hearing  CV: regular rate and rhythm, nl S1/S2  Pulm: breathing comfortably on RA, CTAB  Extremities: warm and well perfused, no edema                Orientation Level: Oriented X3   Cognition: Follows commands         Speech: Clear     Vision: Functional with Correction  Hearing: Functional with correction           Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 3.85 (L) *****/*****/***** *****    RBC 3.90 (L) *****/*****/***** *****    HGB 8.4 (L) *****/*****/***** *****    HCT 30.0 (L) *****/*****/***** *****    MCH 21.5 (L) *****/*****/***** *****    MCV 76.9 (L) *****/*****/***** *****    PLT 127 (L) *****/*****/***** *****    RDW 19.3 (H) *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 143 *****/*****/***** *****    ***** 4.1 *****/*****/***** *****    ***** 105 *****/*****/***** *****    CO2 27 *****/*****/***** *****    BUN 20 *****/*****/***** *****    CRE 1.65 (H) *****/*****/***** *****    ***** 9.6 *****/*****/***** *****    GLU 141 (H) *****/*****/***** *****    
GLUPOC 160 (H) *****/*****/***** *****      Lab Results   Component Value Date/Time    MG 1.5 (L) *****/*****/***** *****                            "
122476267,0,1,"  Physician ***** *****       Admit date: *****/*****/*****      Discharge date: *****/*****/*****    Patient Information   ***** *****, ***** y.o. male (DOB = *****/*****/*****)    Home Address: ***** ***** *****  ***** ***** *****  Home Phone: *****-*****-***** (home)     Preferred Language: English  Written Language: English  Needs Interpreter: No     Type of Advance Care Directive(s): Health Care Proxy   Does patient have a Health Care Proxy form completed?: HCP is NOT available, patient will complete a new one      Health Care Agents    There are no Health Care Agents on file.       Code Status at *****: Full Code     Discharge Order              Discharge Patient        Discharge Disposition: Rehab Facility    Signed by: ***** *****, CNP                                                Historical information     Reason for Admission: SUbdural Hematoma  Principal Problem:    Subdural hematoma  Resolved Problems:    ***** No resolved hospital problems. *****          Surgical (OR) Procedures:   Surgeries this admission     Past Procedures (*****/*****/***** to Today)     Date Procedures Providers       *****/*****/***** SUBDURAL HEMATOMA EVACUATION *****, ***** ***** ***** case    *****: ***** *****, ***** *****, MD, PhD - *****, ***** *****, MD, PhD - Anesthesia *****, ***** *****, MD, PhD - Primary              Procedures this admission    None       Non (OR) Procedures:   *****/***** 1100 Note By: ***** ***** *****, CNP    Items for Post-Hospitalization Follow-Up:    Subdural Hematoma   Wound Healing        Pending Results     Procedure Component Value Ref Range Date/Time    Blood culture, routine [*****] Collected: *****/*****/***** 2342    Lab Status: Preliminary result Specimen: Blood Updated: *****/*****/***** 0638     Special Requests No Special Requests     BLOOD CULTURE NO GROWTH 5 DAYS    Blood culture, routine [*****]  (Abnormal)  (Susceptibility) Collected: *****/*****/***** 2342    Lab Status: Preliminary result Specimen: Blood Updated: *****/*****/***** 
1056     Special Requests No Special Requests     BLOOD CULTURE Anaerobic bottle: STAPHYLOCOCCUS CAPITIS      RESULT CALLED TO CARE UNIT AND/OR MD ***** *****/*****/*****             Hospital Course   ***** ***** is an ***** year old man referred to ***** for neurosurgical treatment of a Subdural Hematoma (SDH).     He has a PMH of CAD (s/p 3v CABG 2016) on ASA 81, recurrent falls, known clival chordoma. He presented with 1 week of dizziness, L sided weakness, confusion, ***** a chronic R SDH with 2 cm MLS. He was brought emergently from the ED to the OR for a R mini craniotomy and /SDH evacuation.     Follow Up on Discharge    Cardiology  [ ] fu ***** for bradyarrhythmia (after discharge from rehab)  [ ] cardiac workup for recurrent falls ?syncope    *****  [ ] ***** fu for clival chordoma- Follow-up with Dr. ***** scheduled on *****/***** with MRI brain prior  [ ] Neurosurgery trauma follow-up appointment scheduled for *****/***** with Dr. *****.  ===============================  History of Present Illness (*****/*****/*****)  ===============================    ***** (*****): ***** on ***** (last *****/*****, remote hx CABG) hx chordoma, pw progressive confusion, dizziness, mild ***** weakness/numbness x1 week. Wife just died, brought in by family. HCT with 1.8cm chronic appearing R SDH w/ 1.3cm MLS    ========================================  Summary of Hospital Course (*****/*****/*****-*****/*****/22)  ========================================    #SDH with MLS s/p Hematoma Evacuation (*****/*****/*****)  Presented with 1 week of progressive confusion and L sided weakness ***** mixed attenuating R SDH with 1.4 cm MLS and mass effect. He was administered 1u plt prior to *****. He underwent L frontal ***** with evacuation of 200 cc chronic appearing SDH blood with placement of hemovac. Post operatively was started on Keppra 500 BID, ancef, and ***** gtt for SBP <140. ASA was held. Post op CT showed interval decrease in L MLS with decreased R subdural collection and 
improvement in neurologic exam. Etiology of chronic SDH attributed to intermittent falls from dizziness.    #Intracranial Atherosclerosis, Asymptomatic  Noted to have multifocal intracranial atherosclerosis, most notably moderate L vertebral calcific plaque and ectatic R vert/basilar without compromised flow. There was no indication for additional antiplatelet agents.     #Chordoma  Noted to have chronic appearing clival chordoma on CTH, ***** to arrange OP fu.     #Intermittent Bradycardia  Noted to be in intermittent bradyarrhythmia without *****. Review of EKG suggestive of junctional escape rhythm at 40-50 BPM with multiple p morphologies, ectopic atrial conduction versus retrograde atrial activity from ***** junctional escape. He was advised to avoid beta-blockade. ***** require ***** on discharge to assess for symptomatic bradyarrhythmia as contributor to recurrent falls and need for pacemaker.    #HTN  Quickly weaned off nicardipine following SDH evacuation. Home losartan restarted on *****/*****/*****.    #T2DM  Held metformin, glimepiride, BG managed with SSI    #Gout  Allopurinol 300 daily held while NPO.    ---------------------------------------***** ***** Hospital Course------------    Mr. ***** was admitted to the Neurosurgical  service on *****/*****/***** and taken to the OR for a Urgent ***** ***** for SDH evacuation.  Please see separately dictated operative note by Dr. ***** for details of this procedure.  Postoperatively, the patient was extubated and transferred to the Neuro ICU for continuous neurological surveillance and SBP control.    On *****/*****/*****, Mr. *****  continued to progress well from his surgery.  The diet was advanced as tolerated. The foley catheter was discontinued, and the patient subsequently voided without difficulty.  The patient was then determined to be medically stable to transfer from the Neuro ICU to the neurosurgery floor. The patient was seen and evaluated by PT and OT 
therapies in anticipation of discharge. They recommended inpatient rehab.    By the day of discharge, Mr. ***** continued to progress, voiding good amounts of urine, and tolerating a regular diet with no complaints of nausea or vomiting. The cranial wound was clean and dry without signs of infection. The patient elicited only minimal discomfort, and expressed readiness for discharge to inpatient rehab accompanied by basic ambulance.     Teaching was provided regarding safety, wound care and medication management. Mr. ***** verbalized understanding and compliance with the discharge plan.          Medications   Allergies: Patient has no known allergies.    None        Medication List      TAKE these medications        Instructions    acetaminophen 325 mg tablet  Commonly known as: TYLENOL   Take 2 tablets (650 mg total) by mouth every 6 (six) hours as needed.      dextrose 50 % ***** syringe  Commonly known as: *****   Inject 0-50 mL (0-25 g total) into the vein as needed (see administration instructions).      docusate sodium 100 MG capsule  Commonly known as: COLACE   Take 1 capsule (100 mg total) by mouth 2 (two) times a day.      enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  Commonly known as: LOVENOX  Last time this was given: ***** *****, *****  9:31 PM   Inject 0.4 mL (40 mg total) under the skin daily.      famotidine 20 MG tablet  Commonly known as: PEPCID  Last time this was given: ***** *****, *****  9:22 AM   Take 1 tablet (20 mg total) by mouth 2 (two) times a day.      insulin lispro 100 unit/mL injection vial  Commonly known as: *****, HumaLOG  Last time this was given: ***** *****, ***** 12:44 PM   Inject 0-6 Units under the skin 3 (three) times a day with meals. OKAY TO GIVE IF NOT RECEIVING NUTRITIONAL INSULIN.  Sliding scale Insulin - Low dose    Blood glucose (mg/dL): Insulin dose   Glucose 70-150: 0 unit.    Glucose *****-*****: 1 unit.    Glucose *****-*****: 2 units.    Glucose *****-*****: 3 units.  
  Glucose *****-*****: 4 units.    Glucose *****-*****: 5 units.    Glucose >400: 6 units and call *****.      For blood glucose < 70 mg/dL call ***** AND if patient:  1. Able to take PO, give 15 g of carbohydrate (4 oz fruit juice, regular soda, 8 oz of skim milk, or 3 to 4 glucose tablets)  2. Unable to take PO and PIV PRESENT, administer ***** per prn medication order OR  3. Unable to take PO and NO PIV, call *****/RRT to obtain order for glucagon  Check blood glucose in 15 minutes and repeat if < 80 mg/dL and call *****      levETIRAcetam 500 MG tablet  Commonly known as: KEPPRA  Last time this was given: ***** *****, *****  9:22 AM   Take 1 tablet (500 mg total) by mouth 2 (two) times a day.      losartan 100 MG tablet  Commonly known as: COZAAR  Last time this was given: ***** *****, *****  9:23 AM   Take 1 tablet (100 mg total) by mouth daily.  Start taking on: ***** *****, *****      polyethylene glycol 17 gram packet  Commonly known as: MIRALAX  Last time this was given: ***** *****, *****  9:22 AM   Take 17 g by mouth daily.  Start taking on: ***** *****, *****      simethicone 80 mg chewable tablet  Commonly known as: MYLICON   Take 1 tablet (80 mg total) by mouth every 6 (six) hours as needed.           Where to Get Your Medications      Information about where to get these medications is not yet available    Ask your nurse or doctor about these medications  쨌 acetaminophen 325 mg tablet  쨌 dextrose 50 % ***** syringe  쨌 docusate sodium 100 MG capsule  쨌 enoxaparin 40 mg/0.4 mL ***** subcutaneous syringe  쨌 famotidine 20 MG tablet  쨌 insulin lispro 100 unit/mL injection vial  쨌 levETIRAcetam 500 MG tablet  쨌 losartan 100 MG tablet  쨌 polyethylene glycol 17 gram packet  쨌 simethicone 80 mg chewable tablet                    Hospital Care Team   Service: Neurosurgery  Inpatient Attending: ***** ***** *****, MD, PhD     Attending ***** *****: (*****)*****-*****  Discharge Unit: *****  Primary Care Physician: ***** *****, MD  None   
     Transitional Plan   Scheduled appointments:  Scheduled Appointments (maximum listed = 10)       Provider Department Dept Phone Center Visit Type    *****/*****/***** 11:15 AM (Arrive by 10:45 AM) ***** ***** ***** *****, ***** ***** *****-*****-***** ***** Main MRI BRAIN    *****/*****/***** 12:00 PM ***** ***** *****, MD ***** Neurosurgery Brain Tumor Center *****-*****-***** ***** Main Follow Up    *****/*****/***** 8:15 AM (Arrive by 8:00 AM) ***** IMG - CT ***** ***** MAIN ***** Imaging - CT, Main Campus *****-*****-***** ***** Main CT HEAD    *****/*****/***** 10:00 AM ***** ***** *****, MD, PhD Acute Care Neurosurgery on WAC ***** *****-*****-***** ***** Main Post Op Visit        Follow-Up Services            Services     ***** *****    ***** ***** *****.  ***** ***** *****-*****   Phone: *****-*****-*****                 Signed Discharge Orders (From admission, onward)             Ordered        *****/*****/***** 0937  Activity as tolerated            *****/*****/***** 0937  Discharge diet        Comments: Diet Dysphagia; Easy to chew (***** 7E); Thin (***** 0)       *****/*****/***** 0937  For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at (*****)*****-*****.        Comments: For immediate questions regarding your hospitalization, your medications, and any pending test results please contact your doctor in the hospital: ***** ***** *****, MD, PhD at (*****)*****-*****.       *****/*****/***** 1441  CT Head        References:    Enterprise Outpatient Imaging *****   Question Answer Comment   Is a particular imaging focus suggested (radiology may call to confirm)? Per Radiologist discretion/standard based on indications    Does the patient have a known prior CT contrast reaction? No    Intravenous Contrast Request: Should NOT be used (radiology may call to confirm)    Does this exam need to be performed at your institution***** for the purpose of imaging care coordination? No    Release to patient 
Automated                         Discharge instructions and important events and results       WOUND CARE:  Keep incision site clean and dry until staples are removed.  It is OK for the patient shower 4 days after surgery.   Do not let the water flow directly onto the incision.  Gently pat dry.  Do not expose incision to direct sunlight.   Do not apply any lotions, ointments or other products to the incision.    A staff member should inspect the wound every day and report any of the following problems to the physician:  Incisional redness, hardening, open areas or drainage from the wound site.    MEDICATIONS:  Do not give pain medication unless it is needed.    ***** off narcotic pain medication as tolerated.  Give stool softeners while giving narcotic pain medication.  The patient should have a bowel movement at least every three days.   The patient should not strain when going to the bathroom.   The patient should not use alcohol while taking pain medication.     Unless directed by the doctor, do not give any anti-inflammatory medicines such as Motrin, Aspirin, Advil, and Ibuprofen etc., as this can increase the patients chances of bleeding and affect bone healing.   Check with the surgeon if you are unsure.     Do not give more than 3 grams of Acetaminophen in 24 hours as this can affect the liver.     ACTIVITY:  No swimming, bathing, or submerging incision site in water until cleared by the physician.  The patient should avoid any activity that causes him to hold his breath and push.   He should avoid twisting, turning, stooping, bending over at the waist, or reaching over her head for six weeks.     He should use the incentive spirometer 10 times every hour that he is awake.      WHEN TO CALL THE SURGEON:  Incisional redness, hardening, open areas or drainage from the wound site.  Confusion, fainting, blacking out, extreme fatigue, memory loss, or difficulty speaking.  ***** or blurred vision.   Loss of 
vision, either partial or total.  Numbness, tingling, or weakness in the extremities or face.  ***** neck, and/or a fever of 101.***** or more.  Severe headache or change in headache.  Seizure activity.   Pain not controlled by usual measures.   Any questions or concerns.    For urgent issues during non-business hours, please call the main hospital line *****-*****-***** and ask for the Neurosurgery resident on call to be paged.                  Exam   Temperature: 37 째C (98.6 째F) (*****/*****/***** 0354) | Heart Rate: 60 (*****/*****/***** 0354) | BP: 138/63 (*****/*****/***** 0354) | Respiratory Rate: 20 (*****/*****/***** 0354)  | SpO2: 93 % (*****/*****/***** 0354)  O2 Device: None (Room air) (*****/*****/***** 0354)  O2 Flow Rate (L/min): 1 |        Weight: 101.7 kg (224 lb 3.3 oz) (*****/*****/***** 0830)  Height: 177.8 cm (5' 10"") (*****/*****/***** 0830)         BMI (Calculated): 32.17 (*****/*****/***** 0830)    Discharge Exam    Significant Discharge Exam Findings: Awake, oriented x3  PERRL, EOMI, FS, TML  BUE full strength no drift  Incision CDI             Orientation Level: Oriented X3   Cognition: Follows commands         Speech: Appropriate for age     Disability Identity and Disability Accommodations Comments    Disability Identity   Unavailable                   Data/Results    Results are shown for the following tests if performed (CBC, ***** 7, Mg, Coag).   If the patient did not have any of these tests, no results will be shown here.  Lab Results   Component Value Date/Time    WBC 8.03 *****/*****/***** *****    RBC 3.27 (L) *****/*****/***** *****    HGB 10.1 (L) *****/*****/***** *****    HCT 30.9 (L) *****/*****/***** *****    MCH 30.9 *****/*****/***** *****    MCV 94.5 *****/*****/***** *****    PLT 172 *****/*****/***** *****    RDW 13.7 *****/*****/***** *****     Lab Results   Component Value Date/Time    NA 143 *****/*****/***** *****    ***** 3.8 *****/*****/***** *****    ***** 110 (H) *****/*****/***** *****    CO2 24 *****/*****/***** *****    BUN 20 *****/*****/***** *****    CRE 0.85 *****/*****/***** *****    ***** 8.9 *****/*****/***** *****    GLU 130 (H) *****/*****/***** *****    GLUPOC 125 (H) 
*****/*****/***** *****      Lab Results   Component Value Date/Time    MG 2.1 *****/*****/***** *****      Lab Results   Component Value Date/Time    PT 13.5 *****/*****/***** *****    ***** 1.1 *****/*****/***** *****    PTT 28.5 *****/*****/***** *****                        "
150000337,0,1,"

Note Date: *****/*****/*****

Note Type: Initial note

Note Title: OT Initial Evaluation

Signed by ***** *****, OT License# ***** on *****/*****/***** at 4:42 pm  Affiliation: *****

 

OCCUPATIONAL THERAPY EVALUATION

Rehabilitation Services - Inpatient Occupational Therapy



Attending Physician: *****,***** 

Referral Date: *****/*****/*****

Medical Dx / *****: AMS/ 780.97      

Reason for Referral: eval and treat

Activity Orders: Activity as tolerated



HPI / Subjective Complaint: ***** y/o F with prior admission (*****/*****)

for left SDH and Left internal capsule hemorrhage with midline

shift who presents from home (d/c from ***** on *****/*****) an OSH with

concern for new SDH in setting of lethargy, AMS. Upon review of

imaging the SDH is improved from prior to discharge from *****.

+UTI, adm for IV antibiotics. 



Past Medical / Surgical History: R CVA in 1988 (residual L sided

weakness, ***** contracture, LLE tone), COPD on home O2, CHF,

EF<30%, HTN



Medications: Heparin, Acetaminophen, Albuterol, Atorvastatin 



Radiology:CT head *****/*****/*****: Stable appearance of left subdural

hematoma with no evidence of new hemorrhage. 



Labs:

Occupational Profile: ***** lives at home c husband and son, other

son local and nearby. ***** has a w/c accessible home c ramp to

enter, grab bars at toilet, shower chair. +hospital bed. Pt part

of 'bridge to hospice"" program



Baseline Occupational Performance (ADL, IADL): At baseline per

(OMR) pt transfers to and from w/c with assist from husband.

husband assists sit<>supine, pt able to maintain EOB sitting

balance c S, dependent w/c mobility, *****, history of 1

*****.



OBJECTIVE TESTING

Current Activities of Daily Living: 

     Self Feeding:dependent 

     Grooming: dependent 

     UE Bathing: dependent 

     LE Bathing: dependent 

     UE Dressing: dependent 

     LE Dressing: dependent 

     Toileting: incontinent 

Current Instrumental Activities of Daily Living:

     Home Management: Needs assist 

     ***** Management: NT 

     Community Integration: Needs assist

Specify: Pt requires total care with ADLs and DME. Pt husband ans

son assist. 



Performance Skills

Process Skills: Pt alert and orientated x2. Pt states name, birth

date. Pt states ""hospital"" as location from three choices

originally reports ""this is my home"". Pt states "" ***** and 2013

with cues. Pt able to recall after 5 mins ""*****"" as the month,

and ***** with choices. 



Communication/ Interactive Skills: Able to make needs know re:

pain, speech clear, non-fluent, answers all questions,

inconsistent with commands. follow 20% of commands with max cues.





Motor Skills - Functional Transfers:

     *****: NT 

     Supine / Side-lying to Sit: Mod assist 

     Sit to Stand: Mod assist

      Transfer: stand pivot the chair: mod assist x. 

     Ambulation: ***** *****/***** to baseline 

 Specify:



Aerobic Capacity

            Position    HR      BP      RR     O2     RPE

Rest         Supine      96     120/70         96% RA

Activity

Recovery     Seated             *****/*****



Range of Motion: R UE WFL, L UE limited to shoulder flexion 90

degrees *****/***** to contraction



Muscle Performance: unable to follow commands for formal testing,

*****/***** in R UE



Pain/ Limiting Symptoms: ____/10- unable to rate, reports pain in

belly. 

Sensation: reports intact to light touch 



Team Communication: RN pre/post session

Patient Education: OT role, re-orientation



Intervention: completed OT eval 



DIAGNOSIS

Impairments, Functional Limitations, Disabilities

1 - Impaired transfer

2 - Impaired cognition

3 - Impaired commands 

4 - Impaired activity tolerance 



Clinical Impression/ Prognosis: 77 y.o female c recent L SDH and

Left internal capsule hemorrhage with midline shift adm c AMS,

+UTI presents with the above abilities and limitations. Pt is

functioning close to baseline level, compared to recent adm and

therapy evaluation. Pt is able to progress to a safe level of

care to d/c home with total assistance from husband/son. Pt

requires 24 hr supervision and care, has all DME needed to return

to w/c of mobility. OT will continue to f/u to provide family

education if needed and progress cognitive re-***** to

prevent delirium. 



Patient Goals: ""go home""

Goals: (patient / family, objective, measurable)

Time ***** (expected attainment): one week 

1 - Min assist to the commode 

2 - Min assist from supine to EOB 

3 - A&O X3 

4 - follows 50% of one step commands with max cues



Anticipated Discharge: ( ) rehab    (X) home: 24hr

care/supervision, total assist with ADLs, IADLs, 



Treatment Plan: ADLs, mobility, transfers

Frequency / Duration: f/u as needed 



Recommendations for Nursing: Encourage self-care and ADLs,



Patient Agrees with the above goals and is willing to participate

in the rehabilitation program.  Please indicate with an 'X':

Yes (X) or No (   ).

If no please explain:





X____________________       ***** *****. ***** *****/L

Therapist Signature            Print Name



  _39754___  *****/*****/*****                 *****-*****  

  Pager #        Date                     Time "
